EL ühistegevuste grandileping - Sotsiaalministeerium

Failid

2-2.11554-1 22.10.2021 Muu leping.asice4477 KB

Sisu (failidest)

Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 EUROPEAN COMMISSION European Health and Digital Executive Agency The Director GRANT AGREEMENT NUMBER 101035969 — JA-02-2020 This Agreement (‘the Agreement’) is between the following parties: on the one part, the European Health and Digital Executive Agency (HaDEA) ('the Agency'), under the powers delegated by the European Commission ('the Commission'), represented for the purposes of signature of this Agreement by Florina TELEA, Head of unit, or his/her duly authorised representative, and on the other part, 1. ‘the coordinator’: ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS (NPHO), established in 3-5 AGRAFON ST., ATHENS 15123, Greece, VAT number: EL997032451, represented for the purposes of signing the Agreement by PANAGIOTIS ARKOUMANEAS and the following other beneficiaries, if they sign their ‘Accession Form’ (see Annex 3 and Article 40): 2. BUNDESMINISTERIUM FUER SOZIALES, GESUNDHEIT, PFLEGE UND KONSUMENTENSCHUTZ (BMSGPK), established in Radetzkystrasse 2, WIEN 1030, Austria, 3. NATSIONALEN CENTAR PO OBSHTESTVENO ZDRAVE I ANALIZI (NCPHA), established in ACAD IVAN GESHOV BLVD 15, SOFIA 1431, Bulgaria, VAT number: BG176094665, 4. HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO (CIPH), established in ROCKEFELLEROVA 7, ZAGREB 10000, Croatia, VAT number: HR75297532041, 5. ORGANISMOS KRATIKON YPIRESION YGEIAS (MHS CYPRUS), established in PRODROMOU 1 AND CHILONOS 17, NICOSIA 1448, Cyprus, VAT number: CY18007761X, 6. MINISTERSTVO ZDRAVOTNICTVI CESKE REPUBLIKY (MZCR), established in PALACKEHO NAMESTI 375/4, PRAHA 12801, Czech Republic, 7. SOTSIAALMINISTEERIUM (MSAE), established in Suur-Ameerika 1, TALLINN 10122, Estonia, 1 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 8. TERVEYDEN JA HYVINVOINNIN LAITOS (THL), established in MANNERHEIMINTIE 166, HELSINKI 00271, Finland, VAT number: FI22295006, 9. MINISTERE DES AFFAIRES SOCIALES ET DE LA SANTE (MOH FRANCE), established in AVENUE DUQUESNE 14, PARIS CEDEX 75350, France, VAT number: N/A, 10. BUNDESZENTRALE FUR GESUNDHEITLICHE AUFKLARUNG (BZgA), established in MAARWEG 149-161, KOLN 50825, Germany, VAT number: DE122948246, 11. ORSZAGOS KORHAZI FOIGAZGATOSAG (OKFO), established in DIOS AROK 3, BUDAPEST 1125, Hungary, VAT number: HU15845883, 12. EMBAETTI LANDLAEKNIS (DOHI), established in BARONSSTIG 47, REYKJAVIK 101, Iceland, 13. REGIONE LOMBARDIA (LOMBARDY REGION), established in PIAZZA CITTA DI LOMBARDIA 1, MILANO 20124, Italy, VAT number: IT12874720159, 14. LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJA (SAM), established in VILNIAUS G 33, VILNIUS LT 01506, Lithuania, 15. Ministry for Health - Government of Malta (MFH), established in Palazzo Castellania, Merchants Street 15, Valletta VLT 200, Malta, VAT number: MT12979127, 16. STICHTING TRIMBOS- INSTITUUT, NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION (TRIMBOS), established in DA COSTAKADE 45, UTRECHT 3521 VS, Netherlands, VAT number: NL805514806B01, 17. HELSEDIREKTORATET (HDIR), established in VITAMINVEIEN 4, OSLO 0213, Norway, VAT number: NO983544622, 18. INSTITUT ZA ZASTITU ZDRAVLJA SRBIJEDR MILAN JOVANOVIC BATUT (IPHS), established in DR SUBOTICA STREET 5, BEOGRAD 11000, Serbia, VAT number: RS102000930, 19. NACIONALNI INSTITUT ZA JAVNO ZDRAVJE (NIJZ), established in TRUBARJEVA CESTA 2, LJUBLJANA 1000, Slovenia, VAT number: SI44724535, 20. SERVICIO MURCIANO DE SALUD (SMS), established in C CENTRAL 7, MURCIA 30100, Spain, VAT number: ESQ8050008E, 21. FOLKHALSOMYNDIGHETEN (FOHM/PHAS), established in NOBELS VAG 18, SOLNA 171 82, Sweden, VAT number: SE202100654501, Unless otherwise specified, references to ‘beneficiary’ or ‘beneficiaries’ include the coordinator. The parties referred to above have agreed to enter into the Agreement under the terms and conditions below. By signing the Agreement or the Accession Form, the beneficiaries accept the grant and agree to implement it under their own responsibility and in accordance with the Agreement, with all the obligations and conditions it sets out. 2 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 The Agreement is composed of: Terms and Conditions Annex 1 Description of the action Annex 2 Estimated budget for the action Annex 2a Not applicable Annex 3 Accession Forms Annex 4 Model for the financial statements Annex 5 Model for the certificate on the financial statements (CFS) 3 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 TERMS AND CONDITIONS TABLE OF CONTENTS CHAPTER 1 GENERAL................................................................................................................................................9 ARTICLE 1 — SUBJECT OF THE AGREEMENT.........................................................................................9 CHAPTER 2 ACTION................................................................................................................................................... 9 ARTICLE 2 — ACTION TO BE IMPLEMENTED.........................................................................................9 ARTICLE 3 — DURATION AND STARTING DATE OF THE ACTION......................................................9 ARTICLE 4 — ESTIMATED BUDGET AND BUDGET TRANSFERS........................................................ 9 4.1 Estimated budget.................................................................................................................................. 9 4.2 Budget transfers....................................................................................................................................9 CHAPTER 3 GRANT.....................................................................................................................................................9 ARTICLE 5 — GRANT AMOUNT, FORM OF GRANT, REIMBURSEMENT RATE AND FORMS OF COSTS..............................................................................................................................................9 5.1 Maximum grant amount....................................................................................................................... 9 5.2 Form of grant, reimbursement rate and forms of costs....................................................................... 9 5.3 Final grant amount — Calculation.....................................................................................................10 5.4 Revised final grant amount — Calculation....................................................................................... 11 ARTICLE 6 — ELIGIBLE AND INELIGIBLE COSTS................................................................................12 6.1 General conditions for costs to be eligible........................................................................................ 12 6.2 Specific conditions for costs to be eligible........................................................................................12 6.3 Conditions for costs of affiliated entities to be eligible.....................................................................15 6.4 Ineligible costs....................................................................................................................................15 6.5 Consequences of declaration of ineligible costs................................................................................ 16 CHAPTER 4 RIGHTS AND OBLIGATIONS OF THE PARTIES........................................................................ 16 SECTION 1 RIGHTS AND OBLIGATIONS RELATED TO IMPLEMENTING THE ACTION................ 16 ARTICLE 7 — GENERAL OBLIGATION TO PROPERLY IMPLEMENT THE ACTION.........................16 7.1 General obligation to properly implement the action........................................................................ 16 7.2 Consequences of non-compliance...................................................................................................... 16 ARTICLE 8 — RESOURCES TO IMPLEMENT THE ACTION — THIRD PARTIES INVOLVED IN THE ACTION.........................................................................................................................................17 ARTICLE 8a — IMPLEMENTATION OF ACTION TASKS BY BENEFICIARIES NOT RECEIVING EU FUNDING...................................................................................................................................... 17 ARTICLE 9 — PURCHASE OF GOODS, WORKS OR SERVICES............................................................17 9.1 Rules for purchasing goods, works or services................................................................................. 17 4 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 9.2 Consequences of non-compliance...................................................................................................... 17 ARTICLE 10 — IMPLEMENTATION OF ACTION TASKS BY SUBCONTRACTORS............................18 10.1 Rules for subcontracting action tasks.............................................................................................. 18 10.2 Consequences of non-compliance.................................................................................................... 18 ARTICLE 11 — IMPLEMENTATION OF ACTION TASKS BY AFFILIATED ENTITIES........................18 11.1 Rules for calling upon affiliated entities to implement part of the action........................................19 11.2 Consequences of non-compliance.................................................................................................... 20 ARTICLE 11a — FINANCIAL SUPPORT TO THIRD PARTIES.................................................................20 SECTION 2 RIGHTS AND OBLIGATIONS RELATED TO THE GRANT ADMINISTRATION.............. 20 ARTICLE 12 — GENERAL OBLIGATION TO INFORM............................................................................20 12.1 General obligation to provide information upon request.................................................................20 12.2 Obligation to keep information up to date and to inform about events and circumstances likely to affect the Agreement........................................................................................................................20 12.3 Consequences of non-compliance.................................................................................................... 21 ARTICLE 13 — KEEPING RECORDS — SUPPORTING DOCUMENTATION.........................................21 13.1 Obligation to keep records and other supporting documentation.................................................... 21 13.2 Consequences of non-compliance.................................................................................................... 22 ARTICLE 14 — SUBMISSION OF DELIVERABLES................................................................................. 22 14.1 Obligation to submit deliverables.................................................................................................... 22 14.2 Consequences of non-compliance.................................................................................................... 22 ARTICLE 15 — REPORTING — PAYMENT REQUESTS.......................................................................... 22 15.1 Obligation to submit reports............................................................................................................ 22 15.2 Reporting periods............................................................................................................................. 23 15.2a Request(s) for further pre-financing payment(s)............................................................................23 15.3 Periodic reports — Requests for interim payments.........................................................................23 15.4 Final report — Request for payment of the balance....................................................................... 24 15.5 Information on cumulative expenditure incurred.............................................................................25 15.6 Currency for financial statements and conversion into euro........................................................... 25 15.7 Language of reports..........................................................................................................................25 15.8 Consequences of non-compliance.................................................................................................... 25 ARTICLE 16 — PAYMENTS AND PAYMENT ARRANGEMENTS...........................................................25 16.1 Payments to be made....................................................................................................................... 25 16.2 Pre-financing payment — Amount .................................................................................................25 16.3 Interim payments — Amount — Calculation..................................................................................26 16.4 Payment of the balance — Amount — Calculation........................................................................ 26 5 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 16.5 Notification of amounts due.............................................................................................................27 16.6 Currency for payments..................................................................................................................... 27 16.7 Payments to the coordinator — Distribution to the beneficiaries....................................................27 16.8 Bank account for payments..............................................................................................................28 16.9 Costs of payment transfers...............................................................................................................28 16.10 Date of payment............................................................................................................................. 28 16.11 Consequences of non-compliance.................................................................................................. 28 ARTICLE 17 — CHECKS, REVIEWS, AUDITS AND INVESTIGATIONS — EXTENSION OF FINDINGS..................................................................................................................................... 29 17.1 Checks, reviews and audits by the Agency and the Commission....................................................29 17.2 Investigations by the European Anti-Fraud Office (OLAF)............................................................30 17.3 Checks and audits by the European Court of Auditors (ECA)........................................................31 17.4 Checks, reviews, audits and investigations for international organisations..................................... 31 17.5 Consequences of findings in checks, reviews, audits and investigations — Extension of findings............................................................................................................................................. 31 17.6 Consequences of non-compliance.................................................................................................... 33 ARTICLE 18 — EVALUATION OF THE IMPACT OF THE ACTION....................................................... 33 18.1 Right to evaluate the impact of the action.......................................................................................33 18.2 Consequences of non-compliance.................................................................................................... 33 SECTION 3 OTHER RIGHTS AND OBLIGATIONS.......................................................................................33 ARTICLE 19 — PRE-EXISTING RIGHTS AND OWNERSHIP OF THE RESULTS (INCLUDING INTELLECTUAL AND INDUSTRIAL PROPERTY RIGHTS)................................................. 33 19.1 Pre-existing rights and access rights to pre-existing rights............................................................. 33 19.2 Ownership of results and rights of use............................................................................................ 34 19.3 Consequences of non-compliance.................................................................................................... 34 ARTICLE 20 — CONFLICT OF INTERESTS.............................................................................................. 34 20.1 Obligation to avoid a conflict of interests....................................................................................... 34 20.2 Consequences of non-compliance.................................................................................................... 34 ARTICLE 21 — CONFIDENTIALITY...........................................................................................................34 21.1 General obligation to maintain confidentiality................................................................................ 34 21.2 Consequences of non-compliance.................................................................................................... 35 ARTICLE 22 — PROMOTING THE ACTION — VISIBILITY OF EU FUNDING....................................35 22.1 Communication activities by the beneficiaries................................................................................ 35 22.2 Communication activities by the Agency and the Commission...................................................... 35 22.3 Consequences of non-compliance.................................................................................................... 36 ARTICLE 23 — PROCESSING OF PERSONAL DATA...............................................................................37 6 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 23.1 Processing of personal data by the Agency and the Commission................................................... 37 23.2 Processing of personal data by the beneficiaries............................................................................. 37 23.3 Consequences of non-compliance.................................................................................................... 37 ARTICLE 24 — ASSIGNMENTS OF CLAIMS FOR PAYMENT AGAINST THE AGENCY....................37 CHAPTER 5 DIVISION OF BENEFICIARIES’ ROLES AND RESPONSIBILITIES....................................... 38 ARTICLE 25 — DIVISION OF BENEFICIARIES’ ROLES AND RESPONSIBILITIES............................38 25.1 Roles and responsibilities towards the Agency............................................................................... 38 25.2 Internal division of roles and responsibilities.................................................................................. 38 25.3 Internal arrangements between beneficiaries — Consortium agreement.........................................39 CHAPTER 6 REJECTION OF COSTS — REDUCTION OF THE GRANT — RECOVERY — SANCTIONS — DAMAGES — SUSPENSION — TERMINATION — FORCE MAJEURE................................ 39 SECTION 1 REJECTION OF COSTS — REDUCTION OF THE GRANT — RECOVERY — SANCTIONS.............................................................................................................................................. 39 ARTICLE 26 — REJECTION OF INELIGIBLE COSTS.............................................................................. 39 26.1 Conditions......................................................................................................................................... 39 26.2 Ineligible costs to be rejected — Calculation — Procedure............................................................40 26.3 Effects............................................................................................................................................... 40 ARTICLE 27 — REDUCTION OF THE GRANT......................................................................................... 40 27.1 Conditions......................................................................................................................................... 40 27.2 Amount to be reduced — Calculation — Procedure.......................................................................41 27.3 Effects............................................................................................................................................... 41 ARTICLE 28 — RECOVERY OF UNDUE AMOUNTS............................................................................... 41 28.1 Amount to be recovered — Calculation — Procedure....................................................................41 ARTICLE 29 — ADMINISTRATIVE SANCTIONS..................................................................................... 43 SECTION 2 LIABILITY FOR DAMAGES.........................................................................................................43 ARTICLE 30 — LIABILITY FOR DAMAGES.............................................................................................43 30.1 Liability of the Agency.................................................................................................................... 43 30.2 Liability of the beneficiaries............................................................................................................ 44 SECTION 3 SUSPENSION AND TERMINATION............................................................................................44 ARTICLE 31 — SUSPENSION OF PAYMENT DEADLINE....................................................................... 44 31.1 Conditions......................................................................................................................................... 44 31.2 Procedure.......................................................................................................................................... 44 ARTICLE 32 — SUSPENSION OF PAYMENTS.......................................................................................... 44 32.1 Conditions......................................................................................................................................... 44 32.2 Procedure.......................................................................................................................................... 45 ARTICLE 33 — SUSPENSION OF THE ACTION IMPLEMENTATION................................................... 45 7 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 33.1 Suspension of the action implementation, by the beneficiaries.......................................................45 33.2 Suspension of the action implementation, by the Agency...............................................................46 ARTICLE 34 — TERMINATION OF THE AGREEMENT OR OF THE PARTICIPATION OF ONE OR MORE BENEFICIARIES..............................................................................................................47 34.1 Termination of the Agreement, by the beneficiaries........................................................................47 34.2 Termination of the participation of one or more beneficiaries, by the beneficiaries........................48 34.3 Termination of the Agreement or of the participation of one or more beneficiaries, by the Agency..............................................................................................................................................49 SECTION 4 FORCE MAJEURE.......................................................................................................................... 51 ARTICLE 35 — FORCE MAJEURE.............................................................................................................. 52 CHAPTER 7 FINAL PROVISIONS...........................................................................................................................52 ARTICLE 36 — COMMUNICATION BETWEEN THE PARTIES...............................................................52 36.1 Form and means of communication.................................................................................................52 36.2 Date of communication.................................................................................................................... 53 36.3 Addresses for communication.......................................................................................................... 53 ARTICLE 37 — INTERPRETATION OF THE AGREEMENT.....................................................................53 37.1 Precedence of the Terms and Conditions over the Annexes............................................................53 37.2 Privileges and immunities................................................................................................................ 54 ARTICLE 38 — CALCULATION OF PERIODS, DATES AND DEADLINES........................................... 54 ARTICLE 39 — AMENDMENTS TO THE AGREEMENT......................................................................... 54 39.1 Conditions......................................................................................................................................... 54 39.2 Procedure.......................................................................................................................................... 54 ARTICLE 40 — ACCESSION TO THE AGREEMENT............................................................................... 55 40.1 Accession of the beneficiaries mentioned in the preamble..............................................................55 40.2 Addition of new beneficiaries.......................................................................................................... 55 ARTICLE 41 — APPLICABLE LAW AND SETTLEMENT OF DISPUTES.............................................. 55 41.1 Applicable law..................................................................................................................................55 41.2 Dispute settlement............................................................................................................................ 55 ARTICLE 42 — ENTRY INTO FORCE OF THE AGREEMENT................................................................ 56 8 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 CHAPTER 1 GENERAL ARTICLE 1 — SUBJECT OF THE AGREEMENT This Agreement sets out the rights and obligations and the terms and conditions applicable to the grant awarded to the beneficiaries for implementing the action set out in Chapter 2. CHAPTER 2 ACTION ARTICLE 2 — ACTION TO BE IMPLEMENTED The grant is awarded for the action entitled ‘JA on Implementation of Best Practices in the area of Mental Health — JA-02-2020’ (‘action’), as described in Annex 1. ARTICLE 3 — DURATION AND STARTING DATE OF THE ACTION The duration of the action will be 36 months as of 01/10/2021 (‘starting date of the action’). ARTICLE 4 — ESTIMATED BUDGET AND BUDGET TRANSFERS 4.1 Estimated budget The ‘estimated budget’ for the action is set out in Annex 2. It contains the estimated eligible costs and the forms of costs, broken down by beneficiary (and affiliated entity) and budget category (see Articles 5, 6 and 11). 4.2 Budget transfers The estimated budget breakdown indicated in Annex 2 may be adjusted — without an amendment (see Article 39) — by transfers of amounts between beneficiaries, budget categories and/or forms of costs set out in Annex 2, if the action is implemented as described in Annex 1. However, the beneficiaries may not add costs relating to subcontracts not provided for in Annex 1, unless such additional subcontracts are approved by an amendment or in accordance with Article 10. CHAPTER 3 GRANT ARTICLE 5 — GRANT AMOUNT, FORM OF GRANT, REIMBURSEMENT RATE AND FORMS OF COSTS 5.1 Maximum grant amount The ‘maximum grant amount’ is EUR 5 398 424.04 (five million three hundred and ninety eight thousand four hundred and twenty four EURO and four eurocents). 5.2 Form of grant, reimbursement rate and forms of costs 9 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 The grant reimburses 80% of the action's eligible costs (see Article 6) (‘reimbursement of eligible costs grant’) (see Annex 2). The estimated eligible costs of the action are EUR 6 748 030.04 (six million seven hundred and forty eight thousand thirty EURO and four eurocents). Eligible costs (see Article 6) must be declared under the following forms ('forms of costs' or 'costs forms'): (a) for direct personnel costs: as actually incurred costs (actual costs); (b) for direct costs of subcontracting: as actually incurred costs (actual costs); (c) for other direct costs: as actually incurred costs (actual costs); (d) for indirect costs: on the basis of a flat-rate applied as set out in Article 6.2.D (‘flat-rate costs’); 5.3 Final grant amount — Calculation The ‘final grant amount’ depends on the actual extent to which the action is implemented in accordance with the Agreement’s terms and conditions. This amount is calculated by the Agency — when the payment of the balance is made — in the following steps: Step 1 – Application of the reimbursement rate to the eligible costs Step 2 – Limit to the maximum grant amount Step 3 – Reduction due to the no-profit rule Step 4 – Reduction due to substantial errors, irregularities or fraud or serious breach of obligations 5.3.1 Step 1 — Application of the reimbursement rate to the eligible costs The reimbursement rate (see Article 5.2) is applied to the eligible costs (actual costs and flat-rate costs; see Article 6) declared by the beneficiaries and affiliated entities (see Article 15) and approved by the Agency (see Article 16). 5.3.2 Step 2 — Limit to the maximum grant amount If the amount obtained following Step 1 is higher than the maximum grant amount set out in Article 5.1, it will be limited to the latter. 5.3.3 Step 3 — Reduction due to the no-profit rule The grant must not produce a profit. ‘Profit’ means the surplus of the amount obtained following Steps 1 and 2 plus the action’s total receipts, over the action’s total eligible costs. The ‘action’s total eligible costs’ are the consolidated total eligible costs approved by the Agency. 10 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 The ‘action’s total receipts’ are the consolidated total receipts generated during its duration (see Article 3). The following are considered receipts: (a) income generated by the action; (b) financial contributions given by third parties to the beneficiary or to an affiliated entity specifically to be used for costs that are eligible under the action. The following are however not considered receipts: (a) financial contributions by third parties, if they may be used to cover costs other than the eligible costs (see Article 6); (b) financial contributions by third parties with no obligation to repay any amount unused at the end of the period set out in Article 3. If there is a profit, it will be deducted in proportion to the final rate of reimbursement of the eligible actual costs approved by the Agency (as compared to the amount calculated following Steps 1 and 2). 5.3.4 Step 4 — Reduction due to substantial errors, irregularities or fraud or serious breach of obligations If the grant is reduced (see Article 27), the Agency will calculate the reduced grant amount by deducting the amount of the reduction (calculated in proportion to the seriousness of the errors, irregularities or fraud or breach of obligations, in accordance with Article 27.2) from the maximum grant amount set out in Article 5.1. The final grant amount will be the lower of the following two: - the amount obtained following Steps 1 to 3 or - the reduced grant amount following Step 4. 5.4 Revised final grant amount — Calculation If — after the payment of the balance (in particular, after checks, reviews, audits or investigations; see Article 17) — the Agency rejects costs (see Article 26) or reduces the grant (see Article 27), it will calculate the ‘revised final grant amount’ for the action or for the beneficiary concerned. This amount is calculated by the Agency on the basis of the findings, as follows: - in case of rejection of costs: by applying the reimbursement rate to the revised eligible costs approved by the Agency for the beneficiary concerned; - in case of reduction of the grant: by deducting the amount of the reduction (calculated in proportion to the seriousness of the errors, irregularities or fraud or breach of obligations, in accordance with Article 27.2) from the maximum grant amount set out in Article 5.1 or from the maximum EU contribution indicated for the beneficiary in the estimated budget (see Annex 2). In case of rejection of costs and reduction of the grant, the revised final grant amount will be the lower of the two amounts above. 11 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 ARTICLE 6 — ELIGIBLE AND INELIGIBLE COSTS 6.1 General conditions for costs to be eligible ‘Eligible costs’ are costs that meet the following criteria: (a) for actual costs: (i) they must be actually incurred by the beneficiary; (ii) they must be incurred in the period set out in Article 3, with the exception of costs relating to the submission of the periodic report for the last reporting period and the final report (see Article 15); (iii) they must be indicated in the estimated budget set out in Annex 2; (iv) they must be incurred in connection with the action as described in Annex 1 and necessary for its implementation; (v) they must be identifiable and verifiable, in particular recorded in the beneficiary’s accounts in accordance with the accounting standards applicable in the country where the beneficiary is established and with the beneficiary’s usual cost accounting practices; (vi) they must comply with the applicable national law on taxes, labour and social security, and (vii) they must be reasonable, justified and must comply with the principle of sound financial management, in particular regarding economy and efficiency; (b) for unit costs: not applicable; (c) for flat-rate costs: (i) they must be calculated by applying the flat-rate set out in Annex 2, and (ii) the costs (actual costs) to which the flat-rate is applied must comply with the conditions for eligibility set out in this Article. (d) for lump sum costs: not applicable; 6.2 Specific conditions for costs to be eligible Costs are eligible if they comply with the general conditions (see above) and the specific conditions set out below, for each of the following budget categories: A. direct personnel costs; B. direct costs of subcontracting; C. other direct costs; D. indirect costs; ‘Direct costs’ are costs that are directly linked to the action implementation and can therefore be attributed to it directly. They must not include any indirect costs (see Point D below). 12 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 ‘Indirect costs’ are costs that are not directly linked to the action implementation and therefore cannot be attributed directly to it. A. Direct personnel costs Types of eligible personnel costs A.1 Personnel costs are eligible if they are related to personnel working for the beneficiary under an employment contract (or equivalent appointing act) and assigned to the action (‘costs for employees (or equivalent)’). They must be limited to salaries, social security contributions, taxes and other costs included in the remuneration, if they arise from national law or the employment contract (or equivalent appointing act). They may also include additional remuneration for personnel assigned to the action (including payments on the basis of supplementary contracts regardless of their nature), if: (a) it is part of the beneficiary’s usual remuneration practices and is paid in a consistent manner whenever the same kind of work or expertise is required; (b) the criteria used to calculate the supplementary payments are objective and generally applied by the beneficiary, regardless of the source of funding used. A.2 The costs for natural persons working under a direct contract with the beneficiary other than an employment contract or seconded by a third party against payment are eligible personnel costs, if: (a) the person works under the beneficiary’s instructions and, unless otherwise agreed with the beneficiary, on the beneficiary’s premises; (b) the result of the work carried out belongs to the beneficiary, and (c) the costs are not significantly different from those for personnel performing similar tasks under an employment contract with the beneficiary. Calculation Personnel costs must be calculated by the beneficiaries as follows: - for persons working exclusively on the action: {monthly rate for the person multiplied by number of actual months worked on the action}. The months declared for these persons may not be declared for any other EU or Euratom grant. The ‘monthly rate’ is calculated as follows: {annual personnel costs for the person divided by 12} 13 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 using the personnel costs for each full financial year covered by the reporting period concerned. If a financial year is not closed at the end of the reporting period, the beneficiaries must use the monthly rate of the last closed financial year available. - for all other persons: {daily rate for the person multiplied by number of actual days worked on the action (rounded up or down to the nearest half-day)}. The number of actual days declared for a person must be identifiable and verifiable (see Article 13). The total number of days declared in EU or Euratom grants, for a person for a year, cannot be higher than the annual productive days used for the calculations of the daily rate. Therefore, the maximum number of days that can be declared for the grant are: {number of annual productive days for the year (see below) minus total number of days declared by the beneficiary, for that person for that year, for other EU or Euratom grants}. The ‘daily rate’ is calculated as follows: {annual personnel costs for the person divided by number of individual annual productive days} using the personnel costs and the number of annual productive days for each full financial year covered by the reporting period concerned. If a financial year is not closed at the end of the reporting period, the beneficiaries must use the daily rate of the last closed financial year available. The ‘number of individual annual productive days’ is the total actual days worked by the person in the year. It may not include holidays and other absences (such as sick leave, maternity leave, special leave, etc). However, it may include overtime and time spent in meetings, trainings and other similar activities. B. Direct costs of subcontracting (including related duties, taxes and charges, such as non- deductible value added tax (VAT) paid by beneficiaries that are not public bodies acting as public authority) are eligible if the conditions in Article 10.1.1 are met. C. Other direct costs C.1 Travel costs and related subsistence allowances (including related duties, taxes and charges, such as non-deductible value added tax (VAT) paid by beneficiaries that are not public bodies acting as public authority) are eligible if they are in line with the beneficiary’s usual practices on travel. C.2 The depreciation costs of equipment, infrastructure or other assets (new or second-hand) as recorded in the beneficiary’s accounts are eligible, if they were purchased in accordance 14 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 with Article 9.1.1 and written off in accordance with international accounting standards and the beneficiary’s usual accounting practices. The costs of renting or leasing equipment, infrastructure or other assets (including related duties, taxes and charges, such as non-deductible value added tax (VAT) paid by beneficiaries that are not public bodies acting as public authority) are also eligible, if they do not exceed the depreciation costs of similar equipment, infrastructure or assets and do not include any financing fees. The only portion of the costs that will be taken into account is that which corresponds to the duration of the action and rate of actual use for the purposes of the action. C.3 Costs of other goods and services (including related duties, taxes and charges, such as non- deductible value added tax (VAT) paid by beneficiaries that are not public bodies acting as public authority) are eligible, if they are purchased specifically for the action and in accordance with Article 9.1.1. Such goods and services include, for instance, consumables and supplies, dissemination, protection of results, certificates on the financial statements (if they are required by the Agreement), translations and publications. D. Indirect costs Indirect costs are eligible if they are declared on the basis of the flat-rate of 7% of the eligible direct costs (see Article 5.2 and Points A to C above). Beneficiaries receiving an operating grant1 financed by the EU or Euratom budget cannot declare indirect costs for the period covered by the operating grant. 6.3 Conditions for costs of affiliated entities to be eligible Costs incurred by affiliated entities are eligible if they fulfil — mutatis mutandis — the general and specific conditions for eligibility set out in this Article (Article 6.1 and 6.2) and Article 11.1.1. 6.4 Ineligible costs ‘Ineligible costs’ are: (a) costs that do not comply with the conditions set out above (Article 6.1 to 6.3), in particular: (i) costs related to return on capital; (ii) debt and debt service charges; (iii) provisions for future losses or debts; (iv) interest owed; 1 For the definition, see Article 121(1)(b) of Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council of 25 October 2012 on the financial rules applicable to the general budget of the Union and repealing Council Regulation (EC, Euratom) No 1605/2002 (OJ L 218, 26.10.2012, p.1) (‘Financial Regulation No 966/2012’): ‘operating grant’ means direct financial contribution, by way of donation, from the budget in order to finance the functioning of a body which pursues an aim of general EU interest or has an objective forming part of and supporting an EU policy. 15 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 (v) doubtful debts; (vi) currency exchange losses; (vii) bank costs charged by the beneficiary’s bank for transfers from the Agency; (viii) excessive or reckless expenditure; (ix) deductible VAT; (x) costs incurred during suspension of the implementation of the action (see Article 33); (xi) in-kind contributions provided by third parties; (b) costs declared under another EU or Euratom grant (including grants awarded by a Member State and financed by the EU or Euratom budget and grants awarded by bodies other than the Agency for the purpose of implementing the EU or Euratom budget); in particular, indirect costs if the beneficiary is already receiving an operating grant financed by the EU or Euratom budget in the same period; (c) costs for staff of a national (or local) administration, for activities that are part of the administration’s normal activities (i.e. not undertaken only because of the grant); (d) costs (especially travel and subsistence costs) for staff or representatives of EU institutions, bodies or agencies. 6.5 Consequences of declaration of ineligible costs Declared costs that are ineligible will be rejected (see Article 26). This may also lead to any of the other measures described in Chapter 6. CHAPTER 4 RIGHTS AND OBLIGATIONS OF THE PARTIES SECTION 1 RIGHTS AND OBLIGATIONS RELATED TO IMPLEMENTING THE ACTION ARTICLE 7 — GENERAL OBLIGATION TO PROPERLY IMPLEMENT THE ACTION 7.1 General obligation to properly implement the action The beneficiaries must implement the action as described in Annex 1 and in compliance with the provisions of the Agreement and all legal obligations under applicable EU, international and national law. 7.2 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see Article 27). 16 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 Such breaches may also lead to any of the other measures described in Chapter 6. ARTICLE 8 — RESOURCES TO IMPLEMENT THE ACTION — THIRD PARTIES INVOLVED IN THE ACTION The beneficiaries must have the appropriate resources to implement the action. If it is necessary to implement the action, the beneficiaries may: - purchase goods, works and services (see Article 9); - call upon subcontractors to implement action tasks described in Annex 1 (see Article 10); - call upon affiliated entities to implement action tasks described in Annex 1 (see Article 11). In these cases, the beneficiaries retain sole responsibility towards the Agency and the other beneficiaries for implementing the action. ARTICLE 8a — IMPLEMENTATION OF ACTION TASKS BY BENEFICIARIES NOT RECEIVING EU FUNDING Not applicable ARTICLE 9 — PURCHASE OF GOODS, WORKS OR SERVICES 9.1 Rules for purchasing goods, works or services 9.1.1 If necessary to implement the action, the beneficiaries may purchase goods, works or services. The beneficiaries must make such purchases ensuring the best value for money or, if appropriate, the lowest price. In doing so, they must avoid any conflict of interests (see Article 20). The beneficiaries must ensure that the Agency, the Commission, the European Court of Auditors (ECA) and the European Anti-fraud Office (OLAF) can exercise their rights under Articles 17 and 18 also towards their contractors. 9.1.2 Beneficiaries that are ‘contracting authorities’ within the meaning of Directive 2004/18/EC2 (or 2014/24/EU3) or ‘contracting entities’ within the meaning of Directive 2004/17/EC4 (or 2014/25/EU5) must comply with the applicable national law on public procurement. 9.2 Consequences of non-compliance 2 Directive 2004/18/EC of the European Parliament and of the Council of 31 March 2004 on the coordination of procedures for the award of public work contracts, public supply contracts and public service contracts (OJ L 134, 30.04.2004, p. 114). 3 Directive 2014/24/EU of the European Parliament and of the Council of 26 February 2014 on public procurement and repealing Directive 2004/18/EC (OJ L 94, 28.3.2014, p. 65). 4 Directive 2004/17/EC of the European Parliament and of the Council of 31 March 2004 coordinating the procurement procedures of entities operating in the water, energy, transport and postal services sectors (OJ L 134, 30.04.2004, p. 1). 5 Directive 2014/25/EU of the European Parliament and of the Council of 26 February 2014 on procurement by entities operating in the water, energy, transport and postal services sectors and repealing Directive 2004/17/EC (OJ L 94, 28.3.2014, p. 243). 17 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 If a beneficiary breaches any of its obligations under Article 9.1.1, the costs related to the contract concerned will be ineligible (see Article 6) and will be rejected (see Article 26). If a beneficiary breaches any of its obligations under Article 9.1.2, the grant may be reduced (see Article 27). Such breaches may also lead to any of the other measures described in Chapter 6. ARTICLE 10 — IMPLEMENTATION OF ACTION TASKS BY SUBCONTRACTORS 10.1 Rules for subcontracting action tasks 10.1.1 If necessary to implement the action, the beneficiaries may award subcontracts covering the implementation of certain action tasks described in Annex 1. Subcontracting may cover only a limited part of the action. The beneficiaries must award the subcontracts ensuring the best value for money or, if appropriate, the lowest price. In doing so, they must avoid any conflict of interests (see Article 20). The tasks to be implemented and the estimated cost for each subcontract must be set out in Annex 1 and the total estimated costs of subcontracting per beneficiary must be set out in Annex 2. The Agency may however approve subcontracts not set out in Annex 1 and 2 without amendment (see Article 39), if: - they are specifically justified in the periodic technical report and - they do not entail changes to the Agreement which would call into question the decision awarding the grant or breach the principle of equal treatment of applicants. The beneficiaries must ensure that the Agency, the Commission, the European Court of Auditors (ECA) and the European Anti-Fraud Office (OLAF) can exercise their rights under Articles 17 and 18 also towards their subcontractors. 10.1.2 The beneficiaries must ensure that their obligations under Articles 20, 21, 22 and 30 also apply to the subcontractors. Beneficiaries that are ‘contracting authorities’ within the meaning of Directive 2004/18/EC (or 2014/24/EU) or ‘contracting entities’ within the meaning of Directive 2004/17/EC (or 2014/25/EU) must comply with the applicable national law on public procurement. 10.2 Consequences of non-compliance If a beneficiary breaches any of its obligations under Article 10.1.1, the costs related to the subcontract concerned will be ineligible (see Article 6) and will be rejected (see Article 26). If a beneficiary breaches any of its obligations under Article 10.1.2, the grant may be reduced (see Article 27). Such breaches may also lead to any of the other measures described in Chapter 6. ARTICLE 11 — IMPLEMENTATION OF ACTION TASKS BY AFFILIATED ENTITIES 18 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 11.1 Rules for calling upon affiliated entities to implement part of the action 11.1.1 The following 'affiliated entities'6 may implement the action tasks attributed to them in Annex 1: - GESUNDHEIT OSTERREICH GMBH (GÖG), affiliated or linked to BMSGPK - NARODNI USTAV DUSEVNIHO ZDRAVI (NIMH), affiliated or linked to MZCR - TERVISE ARENGU INSTITUUT (NIHD), affiliated or linked to MSAE - INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), affiliated or linked to MOH FRANCE - SEMMELWEIS EGYETEM (SU), affiliated or linked to OKFO - DEBRECENI EGYETEM (UD), affiliated or linked to OKFO - ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI (MNIPR), affiliated or linked to LOMBARDY REGION - POLITECNICO DI MILANO (POLIMI), affiliated or linked to LOMBARDY REGION - UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA (UNIMIB), affiliated or linked to LOMBARDY REGION - AZIENDA SOCIO SANITARIA TERRITORIALE DI LECCO (ASST LECCO), affiliated or linked to LOMBARDY REGION - PROVINCIA LOMBARDO VENETA - ORDINEOSPEDALIERO DI SAN GIOVANNI DI DIO- FATEBENEFRATELLI (FBF), affiliated or linked to LOMBARDY REGION - SERVICIO MADRILENO DE SALUD (SERMAS), affiliated or linked to SMS - FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD (FPS), affiliated or linked to SMS - Servicio Vasco de Salud Osakidetza (Osakidetza), affiliated or linked to SMS - SERVICIO NAVARRO DE SALUD-OSASUNBIDEA (SNS-O), affiliated or linked to SMS - FUNDACION PARA LA FORMACION E INVESTIGACION SANITARIAS DE LA REGION DE MURCIA (FFIS), affiliated or linked to SMS - SERVEI CATALA DE LA SALUT (CatSalut), affiliated or linked to SMS 6 For the definition, see Article 122 of the Financial Regulation (EU, Euratom) No 966/2012: entities affiliated to the beneficiary are: (a) entities that form a ‘sole beneficiary’ (i.e. where an entity is formed of several entities that satisfy the criteria for being awarded a grant, including where the entity is specifically established for the purpose of implementing an action to be financed by a grant); (b) entities that satisfy the eligibility criteria and that do not fall within one of the situations referred to in Article 131(4) and that have a link with the beneficiary, in particular a legal or capital link, which is neither limited to the action nor established for the sole purpose of its implementation. 19 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 - SERVICIO ANDALUZ DE SALUD (SAS), affiliated or linked to SMS - REGION DE MURCIA (Consej- Mujer), affiliated or linked to SMS The affiliated entities may declare as eligible the costs they incur for implementing the action tasks in accordance with Article 6.3. The beneficiaries must ensure that the Agency, the Commission, the European Court of Auditors (ECA) and the European Anti-Fraud Office (OLAF) can exercise their rights under Articles 17 and 18 also towards their affiliated entities. 11.1.2 The beneficiaries must ensure that their obligations under Articles 13, 15, 20, 21 and 22 also apply to their affiliated entities. 11.2 Consequences of non-compliance If any obligation under Article 11.1.1 is breached, the costs of the affiliated entity will be ineligible (see Article 6) and will be rejected (see Article 26). If any obligation under Article 11.1.2 is breached, the grant may be reduced (see Article 27). Such breaches may also lead to any of the other measures described in Chapter 6. ARTICLE 11a — FINANCIAL SUPPORT TO THIRD PARTIES Not applicable SECTION 2 RIGHTS AND OBLIGATIONS RELATED TO THE GRANT ADMINISTRATION ARTICLE 12 — GENERAL OBLIGATION TO INFORM 12.1 General obligation to provide information upon request The beneficiaries must provide — during implementation of the action or afterwards and in accordance with Article 25.2 — any information requested in order to verify eligibility of the costs, proper implementation of the action and compliance with any other obligation under the Agreement. 12.2 Obligation to keep information up to date and to inform about events and circumstances likely to affect the Agreement Each beneficiary must keep information stored in the Participant Portal Beneficiary Register (via the electronic exchange system; see Article 36) up to date, in particular, its name, address, legal representatives, legal form and organisation type. Each beneficiary must immediately inform the coordinator — which must immediately inform the Agency and the other beneficiaries — of any of the following: (a) events which are likely to affect significantly or delay the implementation of the action or the EU’s financial interests, in particular: 20 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 (i) changes in its legal, financial, technical, organisational or ownership situation or those of its affiliated entities and (ii) changes in the name, address, legal form, organisation type of its affiliated entities; (b) circumstances affecting: (i) the decision to award the grant or (ii) compliance with requirements under the Agreement. 12.3 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see Article 27). Such breaches may also lead to any of the other measures described in Chapter 6. ARTICLE 13 — KEEPING RECORDS — SUPPORTING DOCUMENTATION 13.1 Obligation to keep records and other supporting documentation The beneficiaries must — for a period of five years after the payment of the balance — keep records and other supporting documentation, in order to prove the proper implementation of the action and the costs they declare as eligible. They must make them available upon request (see Article 12) or in the context of checks, reviews, audits or investigations (see Article 17). If there are on-going checks, reviews, audits, investigations, litigation or other pursuits of claims under the Agreement (including the extension of findings; see Article 17), the beneficiaries must keep the records and other supporting documentation until the end of these procedures. The beneficiaries must keep the original documents. Digital and digitalised documents are considered originals if they are authorised by the applicable national law. The Agency may accept non-original documents if it considers that they offer a comparable level of assurance. 13.1.1 Records and other supporting documentation on the technical implementation The beneficiaries must keep records and other supporting documentation on the technical implementation of the action, in line with the accepted standards in the respective field. 13.1.2 Records and other documentation to support the costs declared The beneficiaries must keep the records and documentation supporting the costs declared, in particular the following: (a) for actual costs: adequate records and other supporting documentation to prove the costs declared, such as contracts, subcontracts, invoices and accounting records. In addition, the beneficiaries’ usual cost accounting practices and internal control procedures must enable direct 21 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 reconciliation between the amounts declared, the amounts recorded in their accounts and the amounts stated in the supporting documentation; (b) for unit costs: not applicable; (c) for flat-rate costs: adequate records and other supporting documentation to prove the eligibility of the costs to which the flat-rate is applied. The beneficiaries do not need to identify the costs covered or provide supporting documentation (such as accounting statements) to prove the amount declared at a flat-rate; (d) for lump sum costs: not applicable; In addition, for personnel costs (declared as actual costs), the beneficiaries must keep time records for the number of days declared. The time records must be in writing and approved by the persons working on the action and their supervisors, at least monthly. In the absence of reliable time records of the days worked on the action, the Agency may accept alternative evidence supporting the number of days declared, if it considers that it offers an adequate level of assurance. As an exception, for persons working exclusively on the action, there is no need to keep time records, if the beneficiary signs a declaration confirming that the persons concerned have worked exclusively on the action. For costs declared by affiliated entities (see Article 11), it is the beneficiary that must keep the originals of the financial statements and the certificates on the financial statements of its affiliated entities. 13.2 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, costs insufficiently substantiated will be ineligible (see Article 6) and will be rejected (see Article 26), and the grant may be reduced (see Article 27). Such breaches may also lead to any of the other measures described in Chapter 6. ARTICLE 14 — SUBMISSION OF DELIVERABLES 14.1 Obligation to submit deliverables The coordinator must submit the ‘deliverables’ identified in Annex 1, in accordance with the timing and conditions set out in it. 14.2 Consequences of non-compliance If the coordinator breaches any of its obligations under this Article, the Agency may apply any of the measures described in Chapter 6. ARTICLE 15 — REPORTING — PAYMENT REQUESTS 15.1 Obligation to submit reports The coordinator must submit to the Agency (see Article 36) the technical and financial report(s) set 22 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 out in this Article. These reports include request(s) for payment and must be drawn up using the forms and templates provided in the electronic exchange system (see Article 36). 15.2 Reporting periods The action is divided into the following ‘reporting periods’: - RP1: from month 1 to month 18 - RP2: from month 19 to month 36 15.2a Request(s) for further pre-financing payment(s) Not applicable 15.3 Periodic reports — Requests for interim payments The coordinator must submit a periodic report within 60 days following the end of each reporting period. The periodic report must include the following: (a) a ‘periodic technical report’ containing: (i) an explanation of the work carried out by the beneficiaries; (ii) an overview of the progress towards the objectives of the action, including milestones and deliverables identified in Annex 1. This report must include explanations justifying the differences between work expected to be carried out in accordance with Annex 1 and that actually carried out; (iii) a summary for publication by the Agency; (iv) the answers to the ‘questionnaire’: covering issues related to the action implementation and its impact; (b) a ‘periodic financial report’ containing: (i) an ‘individual financial statement’ (see Annex 4) from each beneficiary and from each affiliated entity, for the reporting period concerned. The individual financial statement must detail the eligible costs (actual costs and flat-rate costs; see Article 6) for each budget category (see Annex 2). The beneficiaries and affiliated entities must declare all eligible costs, even if — for actual costs and flat-rate costs — they exceed the amounts indicated in the estimated budget (see Annex 2). Amounts which are not declared in the individual financial statement will not be taken into account by the Agency. If an individual financial statement is not submitted for a reporting period, it may be included in the periodic financial report for the next reporting period. 23 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 The individual financial statements of the last reporting period must also detail the receipts of the action (see Article 5.3.3). Each beneficiary and each affiliated entity must certify that: - the information provided is full, reliable and true; - the costs declared are eligible (see Article 6); - the costs can be substantiated by adequate records and supporting documentation (see Article 13) that will be produced upon request (see Article 12) or in the context of checks, reviews, audits and investigations (see Article 17), and - for the last reporting period: that all the receipts have been declared (see Article 5.3.3); (ii) an explanation of the use of resources and the information on subcontracting (see Article 10) from each beneficiary and from each affiliated entity, for the reporting period concerned; (iii) not applicable; (iv) a ‘periodic summary financial statement’, created automatically by the electronic exchange system, consolidating the individual financial statements for the reporting period concerned and including — except for the last reporting period — the request for interim payment; (v) a ‘certificate on the financial statements’ (drawn up in accordance with Annex 5) for each beneficiary and for each affiliated entity, if: - the (cumulative) amount of EU contribution it requests as reimbursement of actual costs (and for which no certificate has yet been submitted) is EUR 150 000 or more and - the maximum EU contribution indicated, for that beneficiary or affiliated entity, in the estimated budget (see Annex 2) as reimbursement of actual costs is EUR 200 000 or more. 15.4 Final report — Request for payment of the balance In addition to the periodic report for the last reporting period, the coordinator must submit the final report within 60 days following the end of the last reporting period. The final report must include the following: (a) a ‘final technical report’ with a summary for publication containing: (i) an overview of the results and their dissemination; (ii) the conclusions on the action and (iii) the impact of the action; 24 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 (b) a ‘final financial report’ containing a ‘final summary financial statement’, created automatically by the electronic exchange system, consolidating the individual financial statements for all reporting periods and including the request for payment of the balance. 15.5 Information on cumulative expenditure incurred Not applicable 15.6 Currency for financial statements and conversion into euro Financial statements must be drafted in euro. Beneficiaries and affiliated entities with accounting established in a currency other than the euro must convert the costs recorded in their accounts into euro at the average of the daily exchange rates published in the C series of the Official Journal of the European Union, calculated over the corresponding reporting period. If no daily euro exchange rate is published in the Official Journal of the European Union for the currency in question, they must be converted at the average of the monthly accounting rates published on the Commission’s website, calculated over the corresponding reporting period. Beneficiaries and affiliated entities with accounting established in euro must convert costs incurred in another currency into euro according to their usual accounting practices. 15.7 Language of reports All report(s) (including financial statements) must be submitted in the language of the Agreement. 15.8 Consequences of non-compliance If the report(s) submitted do not comply with this Article, the Agency may suspend the payment deadline (see Article 31) and apply any of the other measures described in Chapter 6. If the coordinator breaches its obligation to submit the report(s) and if it fails to comply with this obligation within 30 days following a written reminder, the Agency may terminate the Agreement (see Article 34) or apply any of the other measures described in Chapter 6. ARTICLE 16 — PAYMENTS AND PAYMENT ARRANGEMENTS 16.1 Payments to be made The following payments will be made to the coordinator: - a pre-financing payment; - one or more interim payments, on the basis of the request(s) for interim payment (see Article 15), and - one payment of the balance, on the basis of the request for payment of the balance (see Article 15). 16.2 Pre-financing payment — Amount 25 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 The aim of the pre-financing is to provide the beneficiaries with a float. It remains the property of the EU until the payment of the balance. The amount of the pre-financing payment will be EUR 2 699 212.02 (two million six hundred and ninety nine thousand two hundred and twelve EURO and two eurocents). The Agency will — except if Article 32 applies — make the pre-financing payment to the coordinator within 30 days, either from the entry into force of the Agreement (see Article 42) or from 10 days before the starting date of the action (see Article 3) , whichever is the latest. 16.3 Interim payments — Amount — Calculation Interim payments reimburse the eligible costs incurred for the implementation of the action during the corresponding reporting periods. The Agency will pay to the coordinator the amount due as interim payment within 90 days from receiving the periodic report (see Article 15.3), except if Articles 31 or 32 apply. Payment is subject to the approval of the periodic report. Its approval does not imply recognition of compliance, authenticity, completeness or correctness of its content. The amount due as interim payment is calculated by the Agency in the following steps: Step 1 – Application of the reimbursement rate Step 2 – Limit to 90% of the maximum grant amount 16.3.1 Step 1 — Application of the reimbursement rate The reimbursement rate (see Article 5.2) is applied to the eligible costs (actual costs and flat-rate costs; see Article 6) declared by the beneficiaries and the affiliated entities (see Article 15) and approved by the Agency (see above) for the concerned reporting period. 16.3.2 Step 2 — Limit to 90% of the maximum grant amount The total amount of pre-financing and interim payments must not exceed 90% of the maximum grant amount set out in Article 5.1. The maximum amount for the interim payment will be calculated as follows: {90% of the maximum grant amount (see Article 5.1) minus {pre-financing and previous interim payments}}. 16.4 Payment of the balance — Amount — Calculation The payment of the balance reimburses the remaining part of the eligible costs incurred by the beneficiaries for the implementation of the action. If the total amount of earlier payments is greater than the final grant amount (see Article 5.3), the payment of the balance takes the form of a recovery (see Article 28). 26 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 If the total amount of earlier payments is lower than the final grant amount, the Agency will pay the balance within 90 days from receiving the final report (see Article 15.4), except if Articles 31 or 32 apply. Payment is subject to the approval of the final report. Its approval does not imply recognition of compliance, authenticity, completeness or correctness of its content. The amount due as the balance is calculated by the Agency by deducting the total amount of pre- financing and interim payments (if any) already made, from the final grant amount determined in accordance with Article 5.3: {final grant amount (see Article 5.3) minus {pre-financing and interim payments (if any) made}}. If the balance is positive, it will be paid to the coordinator. The amount to be paid may however be offset — without the beneficiaries’ consent — against any other amount owed by a beneficiary to the Agency, the Commission or another executive agency (under the EU or Euratom budget), up to the maximum EU contribution indicated, for that beneficiary, in the estimated budget (see Annex 2). If the balance is negative, it will be recovered from the coordinator (see Article 28). 16.5 Notification of amounts due When making payments, the Agency will formally notify to the coordinator the amount due, specifying that it concerns an interim payment or the payment of the balance. For the payment of the balance, the notification will also specify the final grant amount. In the case of reduction of the grant or recovery of undue amounts, the notification will be preceded by the contradictory procedure set out in Articles 27 and 28. 16.6 Currency for payments The Agency will make all payments in euro. 16.7 Payments to the coordinator — Distribution to the beneficiaries Payments will be made to the coordinator. Payments to the coordinator will discharge the Agency from its payment obligation. The coordinator must distribute the payments between the beneficiaries without unjustified delay. Pre-financing may however be distributed only: (a) if 90% of the beneficiaries have acceded to the Agreement (see Article 40) and (b) to beneficiaries that have acceded to the Agreement (see Article 40). 27 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 16.8 Bank account for payments All payments will be made to the following bank account: Name of bank: PIRAEUS BANK S.A. Full name of the account holder: NATIONAL PUBLIC HEALTH ORGANISATION Full account number (including bank codes): IBAN code: GR4801720510005051082759656 16.9 Costs of payment transfers The cost of the payment transfers is borne as follows: - the Agency bears the cost of transfers charged by its bank; - the beneficiary bears the cost of transfers charged by its bank; - the party causing a repetition of a transfer bears all costs of the repeated transfer. 16.10 Date of payment Payments by the Agency are considered to have been carried out on the date when they are debited to its account. 16.11 Consequences of non-compliance 16.11.1 If the Agency does not pay within the payment deadlines (see above), the beneficiaries are entitled to late-payment interest at the rate applied by the European Central Bank (ECB) for its main refinancing operations in euros (‘reference rate’), plus three and a half points. The reference rate is the rate in force on the first day of the month in which the payment deadline expires, as published in the C series of the Official Journal of the European Union. If the late-payment interest is lower than or equal to EUR 200, it will be paid to the coordinator only upon request submitted within two months of receiving the late payment. Late-payment interest is not due if all beneficiaries are EU Member States (including regional and local government authorities or other public bodies acting on behalf of a Member State for the purpose of this Agreement). Suspension of the payment deadline or payments (see Articles 31 and 32) will not be considered as late payment. Late-payment interest covers the period running from the day following the due date for payment (see above), up to and including the date of payment. Late-payment interest is not considered for the purposes of calculating the final grant amount. 16.11.2 If the coordinator breaches any of its obligations under this Article, the grant may be reduced (see Article 27) and the Agreement or the participation of the coordinator may be terminated (see Article 34). Such breaches may also lead to any of the other measures described in Chapter 6. 28 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 ARTICLE 17 — CHECKS, REVIEWS, AUDITS AND INVESTIGATIONS — EXTENSION OF FINDINGS 17.1 Checks, reviews and audits by the Agency and the Commission 17.1.1 Right to carry out checks The Agency or the Commission will — during the implementation of the action or afterwards — check the proper implementation of the action and compliance with the obligations under the Agreement, including assessing deliverables and reports. For this purpose, the Agency or the Commission may be assisted by external persons or bodies. The Agency or the Commission may also request additional information in accordance with Article 12. The Agency or the Commission may request beneficiaries to provide such information to it directly. Information provided must be accurate, precise and complete and in the format requested, including electronic format. 17.1.2 Right to carry out reviews The Agency or the Commission may — during the implementation of the action or afterwards — carry out reviews on the proper implementation of the action (including assessment of deliverables and reports) and compliance with the obligations under the Agreement. Reviews may be started up to five years after the payment of the balance. They will be formally notified to the coordinator or beneficiary concerned and will be considered to have started on the date of the formal notification. If the review is carried out on a third party (see Articles 9 to 11a), the beneficiary concerned must inform the third party. The Agency or the Commission may carry out reviews directly (using its own staff) or indirectly (using external persons or bodies appointed to do so). It will inform the coordinator or beneficiary concerned of the identity of the external persons or bodies. They have the right to object to the appointment on grounds of commercial confidentiality. The coordinator or beneficiary concerned must provide — within the deadline requested — any information and data in addition to deliverables and reports already submitted (including information on the use of resources). The Agency or the Commission may request beneficiaries to provide such information to it directly. The coordinator or beneficiary concerned may be requested to participate in meetings, including with external experts. For on-the-spot reviews, the beneficiaries must allow access to their sites and premises, including to external persons or bodies, and must ensure that information requested is readily available. Information provided must be accurate, precise and complete and in the format requested, including electronic format. On the basis of the review findings, a ‘review report’ will be drawn up. 29 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 The Agency or the Commission will formally notify the review report to the coordinator or beneficiary concerned, which has 30 days to formally notify observations (‘contradictory review procedure’). Reviews (including review reports) are in the language of the Agreement. 17.1.3 Right to carry out audits The Agency or the Commission may — during the implementation of the action or afterwards — carry out audits on the proper implementation of the action and compliance with the obligations under the Agreement. Audits may be started up to five years after the payment of the balance. They will be formally notified to the coordinator or beneficiary concerned and will be considered to have started on the date of the formal notification. If the audit is carried out on a third party (see Articles 9 to 11a), the beneficiary concerned must inform the third party. The Agency or the Commission may carry out audits directly (using its own staff) or indirectly (using external persons or bodies appointed to do so). It will inform the coordinator or beneficiary concerned of the identity of the external persons or bodies. They have the right to object to the appointment on grounds of commercial confidentiality. The coordinator or beneficiary concerned must provide — within the deadline requested — any information (including complete accounts, individual salary statements or other personal data) to verify compliance with the Agreement. The Agency or the Commission may request beneficiaries to provide such information to it directly. For on-the-spot audits, the beneficiaries must allow access to their sites and premises, including to external persons or bodies, and must ensure that information requested is readily available. Information provided must be accurate, precise and complete and in the format requested, including electronic format. On the basis of the audit findings, a ‘draft audit report’ will be drawn up. The Agency or the Commission will formally notify the draft audit report to the coordinator or beneficiary concerned, which has 30 days to formally notify observations (‘contradictory audit procedure’). This period may be extended by the Agency or the Commission in justified cases. The ‘final audit report’ will take into account observations by the coordinator or beneficiary concerned. The report will be formally notified to it. Audits (including audit reports) are in the language of the Agreement. The Agency or the Commission may also access the beneficiaries’ statutory records for the periodical assessment of flat-rate amounts. 17.2 Investigations by the European Anti-Fraud Office (OLAF) 30 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 Under Regulations No 883/20137 and No 2185/968 (and in accordance with their provisions and procedures), the European Anti-Fraud Office (OLAF) may — at any moment during implementation of the action or afterwards — carry out investigations, including on-the-spot checks and inspections, to establish whether there has been fraud, corruption or any other illegal activity affecting the financial interests of the EU. 17.3 Checks and audits by the European Court of Auditors (ECA) Under Article 287 of the Treaty on the Functioning of the European Union (TFEU) and Article 161 of the Financial Regulation No 966/20129, the European Court of Auditors (ECA) may — at any moment during implementation of the action or afterwards — carry out audits. The ECA has the right of access for the purpose of checks and audits. 17.4 Checks, reviews, audits and investigations for international organisations Not applicable 17.5 Consequences of findings in checks, reviews, audits and investigations — Extension of findings 17.5.1 Findings in this grant Findings in checks, reviews, audits or investigations carried out in the context of this grant may lead to the rejection of ineligible costs (see Article 26), reduction of the grant (see Article 27), recovery of undue amounts (see Article 28) or to any of the other measures described in Chapter 6. Rejection of costs or reduction of the grant after the payment of the balance will lead to a revised final grant amount (see Article 5.4). Findings in checks, reviews, audits or investigations may lead to a request for amendment for the modification of Annex 1 (see Article 39). Checks, reviews, audits or investigations that find systemic or recurrent errors, irregularities, fraud or breach of obligations may also lead to consequences in other EU or Euratom grants awarded under similar conditions (‘extension of findings from this grant to other grants’). Moreover, findings arising from an OLAF investigation may lead to criminal prosecution under national law. 17.5.2 Findings in other grants 7 Regulation (EU, Euratom) No 883/2013 of the European Parliament and of the Council of 11 September 2013 concerning investigations conducted by the European Anti-Fraud Office (OLAF) and repealing Regulation (EC) No 1073/1999 of the European Parliament and of the Council and Council Regulation (Euratom) No 1074/1999 (OJ L 232, 18.09.2013, p. 1). 8 Council Regulation (Euratom, EC) No 2185/1996 of 11 November 1996 concerning on-the-spot checks and inspections carried out by the Commission in order to protect the European Communities' financial interests against fraud and other irregularities (OJ L 292, 15.11.1996, p. 2). 9 Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council of 25 October 2012 on the financial rules applicable to the general budget of the Union and repealing Council Regulation (EC, Euratom) No 1605/2002 (OJ L 298, 26.10.2012, p. 1). 31 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 The Agency or the Commission may extend findings from other grants to this grant (‘extension of findings from other grants to this grant’), if: (a) the beneficiary concerned is found, in other EU or Euratom grants awarded under similar conditions, to have committed systemic or recurrent errors, irregularities, fraud or breach of obligations that have a material impact on this grant and (b) those findings are formally notified to the beneficiary concerned — together with the list of grants affected by the findings — no later than five years after the payment of the balance of this grant. The extension of findings may lead to the rejection of costs (see Article 26), reduction of the grant (see Article 27), recovery of undue amounts (see Article 28), suspension of payments (see Article 32), suspension of the action implementation (see Article 33) or termination (see Article 34). 17.5.3 Procedure The Agency or the Commission will formally notify the beneficiary concerned the systemic or recurrent errors and its intention to extend these audit findings, together with the list of grants affected. 17.5.3.1 If the findings concern eligibility of costs: the formal notification will include: (a) an invitation to submit observations on the list of grants affected by the findings; (b) the request to submit revised financial statements for all grants affected; (c) the correction rate for extrapolation established by the Agency or the Commission on the basis of the systemic or recurrent errors, to calculate the amounts to be rejected, if the beneficiary concerned: (i) considers that the submission of revised financial statements is not possible or practicable or (ii) does not submit revised financial statements. The beneficiary concerned has 90 days from receiving notification to submit observations, revised financial statements or to propose a duly substantiated alternative correction method. This period may be extended by the Agency or the Commission in justified cases. The Agency or the Commission may then start a rejection procedure in accordance with Article 26, either on the basis of the revised financial statements, the alternative method or the correction rate announced. 17.5.3.2 If the findings concern substantial errors, irregularities or fraud or serious breach of obligations: the formal notification will include: (a) an invitation to submit observations on the list of grants affected by the findings and (b) the flat-rate the Agency or the Commission intends to apply according to the principle of proportionality. The beneficiary concerned has 90 days from receiving notification to submit observations or to propose a duly substantiated alternative flat-rate. 32 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 The Agency or the Commission may then start a reduction procedure in accordance with Article 27, either on the basis of the alternative flat-rate or the flat-rate announced. 17.6 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, any insufficiently substantiated costs will be ineligible (see Article 6) and will be rejected (see Article 26). Such breaches may also lead to any of the other measures described in Chapter 6. ARTICLE 18 — EVALUATION OF THE IMPACT OF THE ACTION 18.1 Right to evaluate the impact of the action The Agency or the Commission may carry out interim and final evaluations of the impact of the action measured against the objective of the EU programme. Evaluations may be started during implementation of the action and up to five years after the payment of the balance. The evaluation is considered to start on the date of the formal notification to the coordinator or beneficiaries. The Agency or the Commission may make these evaluations directly (using its own staff) or indirectly (using external bodies or persons it has authorised to do so). The coordinator or beneficiaries must provide any information relevant to evaluate the impact of the action, including information in electronic format. 18.2 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, the Agency may apply the measures described in Chapter 6. SECTION 3 OTHER RIGHTS AND OBLIGATIONS ARTICLE 19 — PRE-EXISTING RIGHTS AND OWNERSHIP OF THE RESULTS (INCLUDING INTELLECTUAL AND INDUSTRIAL PROPERTY RIGHTS) 19.1 Pre-existing rights and access rights to pre-existing rights Where industrial and intellectual property rights (including rights of third parties) exist prior to the Agreement, the beneficiaries must establish a list of these pre-existing industrial and intellectual property rights, specifying the owner and any persons that have a right of use. The coordinator must — before starting the action — submit this list to the Agency. Each beneficiary must give the other beneficiaries and their affiliated entities access to any pre-existing industrial and intellectual property rights needed for the implementation of the action and compliance with the obligations under the Agreement. 33 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 19.2 Ownership of results and rights of use The results of the action (including the reports and other documents relating to it) are owned by the beneficiaries. The beneficiaries must give the Agency and the Commission the right to use the results for their communication activities under Article 22. 19.3 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see Article 27). Such a breach may also lead to any of the other measures described in Chapter 6. ARTICLE 20 — CONFLICT OF INTERESTS 20.1 Obligation to avoid a conflict of interests The beneficiaries must take all measures to prevent any situation where the impartial and objective implementation of the action is compromised for reasons involving economic interest, political or national affinity, family or emotional ties or any other shared interest (‘conflict of interests’). They must formally notify to the Agency without delay any situation constituting or likely to lead to a conflict of interests and immediately take all the necessary steps to rectify this situation. The Agency may verify that the measures taken are appropriate and may require additional measures to be taken by a specified deadline. 20.2 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see Article 27) and the Agreement or participation of the beneficiary may be terminated (see Article 34). Such breaches may also lead to any of the other measures described in Chapter 6. ARTICLE 21 — CONFIDENTIALITY 21.1 General obligation to maintain confidentiality During implementation of the action and for five years after the payment of the balance, the parties must keep confidential any data, documents or other material (in any form) that is identified as confidential at the time it is disclosed (‘confidential information’). They may use confidential information to implement the Agreement. The confidentiality obligations no longer apply if: (a) the disclosing party agrees to release the other party; (b) the information becomes generally and publicly available, without breaching any confidentiality obligation; 34 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 (c) the disclosure of the confidential information is required by EU or national law. 21.2 Consequences of non-compliance If a beneficiary breaches any of its obligations under this Article, the grant may be reduced (see Article 27). Such breaches may also lead to any of the other measures described in Chapter 6. ARTICLE 22 — PROMOTING THE ACTION — VISIBILITY OF EU FUNDING 22.1 Communication activities by the beneficiaries 22.1.1 General obligation to promote the action and its results The beneficiaries must promote the action and its results. 22.1.2 Information on EU funding — Obligation and right to use the EU emblem Unless the Agency requests or agrees otherwise, any communication activity related to the action (including at conferences, seminars, in information material, such as brochures, leaflets, posters, presentations, etc., in electronic form, via social media, etc.) and any infrastructure, equipment or major results funded by the grant must: - display the EU emblem and - include the following text: “This [insert appropriate description, e.g. report, publication, conference, infrastructure, equipment, insert type of result, etc.] was funded by the European Union’s Health Programme (2014-2020).” When displayed in association with another logo, the EU emblem must have appropriate prominence. For the purposes of their obligations under this Article, the beneficiaries may use the EU emblem without first obtaining approval from the Agency. This does not, however, give them the right to exclusive use. Moreover, they may not appropriate the EU emblem or any similar trademark or logo, either by registration or by any other means. 22.1.3 Disclaimer excluding Agency and Commission responsibility Any communication activity related to the action must indicate the following disclaimer: "The content of this [insert appropriate description, e.g. report, publication, conference, etc.] represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.” 22.2 Communication activities by the Agency and the Commission 22.2.1 Right to use the beneficiaries’ materials, documents or information 35 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 The Agency and the Commission may use information relating to the action, documents notably summaries for publication and public deliverables as well as any other material, such as pictures or audio-visual material received from any beneficiary (including in electronic form). This does not change the confidentiality obligations in Article 21, which still apply. The right to use the beneficiary’s materials, documents and information includes: (a) use for its own purposes (in particular, making them available to persons working for the Agency, the Commission or any other EU institution, body, office or agency or body or institutions in EU Member States; and copying or reproducing them in whole or in part, in unlimited numbers); (b) distribution to the public (in particular, publication as hard copies and in electronic or digital format, publication on the internet, as a downloadable or non-downloadable file, broadcasting by any channel, public display or presentation, communicating through press information services, or inclusion in widely accessible databases or indexes); (c) editing or redrafting for communication and publicising activities (including shortening, summarising, inserting other elements (such as meta-data, legends, other graphic, visual, audio or text elements), extracting parts (e.g. audio or video files), dividing into parts, use in a compilation); (d) translation; (e) giving access in response to individual requests under Regulation No 1049/200110, without the right to reproduce or exploit; (f) storage in paper, electronic or other form; (g) archiving, in line with applicable document-management rules, and (h) the right to authorise third parties to act on its behalf or sub-license the modes of use set out in Points (b), (c), (d) and (f) to third parties if needed for the communication and publicising activities of the Agency or the Commission. If the right of use is subject to rights of a third party (including personnel of the beneficiary), the beneficiary must ensure that it complies with its obligations under this Agreement (in particular, by obtaining the necessary approval from the third parties concerned). Where applicable (and if provided by the beneficiaries), the Agency or the Commission will insert the following information: “© – [year] – [name of the copyright owner]. All rights reserved. Licensed to the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) and the European Union (EU) under conditions.” 22.3 Consequences of non-compliance If the beneficiary breaches any of its obligations under this Article, the grant may be reduced (see Article 27). 10 Regulation (EC) No 1049/2001 of the European Parliament and of the Council of 30 May 2001 regarding public access to European Parliament, Council and Commission documents, OJ L 145, 31.5.2001, p. 43. 36 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 Such breaches may also lead to any of the other measures described in Chapter 6. ARTICLE 23 — PROCESSING OF PERSONAL DATA 23.1 Processing of personal data by the Agency and the Commission Any personal data under the Agreement will be processed by the Agency or the Commission under Regulation No 23/200111 and according to the ‘notifications of the processing operations’ to the Data Protection Officer (DPO) of the Agency or the Commission (publicly accessible in the DPO register). Such data will be processed by the ‘data controller’ of the Agency or the Commission, for the purposes of implementing, managing and monitoring the Agreement or protecting the financial interests of the EU or Euratom (including checks, reviews, audits and investigations; see Article 17). The persons whose personal data are processed have the right to access and correct their own personal data. For this purpose, they must send any queries about the processing of their personal data to the data controller, via the contact point indicated in the privacy statement(s) on the Agency and Commission websites. They also have the right to have recourse at any time to the European Data Protection Supervisor (EDPS). 23.2 Processing of personal data by the beneficiaries The beneficiaries must process personal data under the Agreement in compliance with applicable EU and national law on data protection (including authorisations or notification requirements). The beneficiaries may grant their personnel access only to data that is strictly necessary for implementing, managing and monitoring the Agreement. The beneficiaries must inform the personnel whose personal data are collected and processed by the Agency or the Commission. For this purpose, they must provide them with the privacy statement(s) (see above), before transmitting their data to the Agency or the Commission. 23.3 Consequences of non-compliance If a beneficiary breaches any of its obligations under Article 23.2, the Agency may apply any of the measures described in Chapter 6. ARTICLE 24 — ASSIGNMENTS OF CLAIMS FOR PAYMENT AGAINST THE AGENCY The beneficiaries may not assign any of their claims for payment against the Agency to any third party, except if approved by the Agency on the basis of a reasoned, written request by the coordinator (on behalf of the beneficiary concerned). If the Agency has not accepted the assignment or the terms of it are not observed, the assignment will have no effect on it. 11 Regulation (EC) No 45/2001 of the European Parliament and of the Council of 18 December 2000 on the protection of individuals with regard to the processing of personal data by the Community institutions and bodies and on the free movement of such data (OJ L 8, 12.01.2001, p. 1). 37 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 In no circumstances will an assignment release the beneficiaries from their obligations towards the Agency. CHAPTER 5 DIVISION OF BENEFICIARIES’ ROLES AND RESPONSIBILITIES ARTICLE 25 — DIVISION OF BENEFICIARIES’ ROLES AND RESPONSIBILITIES 25.1 Roles and responsibilities towards the Agency The beneficiaries have full responsibility for implementing the action and complying with the Agreement. The beneficiaries are jointly and severally liable for the technical implementation of the action as described in Annex 1. If a beneficiary fails to implement its part of the action, the other beneficiaries become responsible for implementing this part (without being entitled to any additional EU funding for doing so), unless the Agency expressly relieves them of this obligation. The financial responsibility of each beneficiary is governed by Articles 28, 29 and 30. 25.2 Internal division of roles and responsibilities The internal roles and responsibilities of the beneficiaries are divided as follows: (a) Each beneficiary must: (i) keep information stored in the Participant Portal Beneficiary Register (via the electronic exchange system) up to date (see Article 12); (ii) inform the coordinator immediately of any events or circumstances likely to affect significantly or delay the implementation of the action (see Article 12); (iii) submit to the coordinator in good time: - individual financial statements for itself and its affiliated entities and, if required, certificates on the financial statements (see Article 15); - the data needed to draw up the technical reports (see Article 15); - any other documents or information required by the Agency or the Commission under the Agreement, unless the Agreement requires the beneficiary to submit this information directly. (b) The coordinator must: (i) monitor that the action is implemented properly (see Article 7); (ii) act as the intermediary for all communications between the beneficiaries and the Agency (in particular, providing the Agency with the information described in Article 12), unless the Agreement specifies otherwise; (iii) provide a pre-financing guarantee if requested by the Agency (see Article 16.2); 38 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 (iv) request and review any documents or information required by the Agency and verify their completeness and correctness before passing them on to the Agency; (v) submit the deliverables and reports to the Agency (see Articles 14 and 15); (vi) ensure that all payments are made to the other beneficiaries without unjustified delay (see Article 16). The coordinator may not subcontract the above-mentioned tasks. 25.3 Internal arrangements between beneficiaries — Consortium agreement The beneficiaries must have internal arrangements regarding their operation and co-ordination to ensure that the action is implemented properly. These internal arrangements must be set out in a written ‘consortium agreement’ between the beneficiaries, which may cover: - internal organisation of the consortium; - management of access to the electronic exchange system; - distribution of EU funding; - additional rules on rights and obligations related to pre-existing rights and results (see Article 19); - settlement of internal disputes; - liability, indemnification and confidentiality arrangements between the beneficiaries. The consortium agreement must not contain any provision contrary to the Agreement. CHAPTER 6 REJECTION OF COSTS — REDUCTION OF THE GRANT — RECOVERY — SANCTIONS — DAMAGES — SUSPENSION — TERMINATION — FORCE MAJEURE SECTION 1 REJECTION OF COSTS — REDUCTION OF THE GRANT — RECOVERY — SANCTIONS ARTICLE 26 — REJECTION OF INELIGIBLE COSTS 26.1 Conditions The Agency will — at the time of an interim payment, at the payment of the balance or afterwards — reject any costs which are ineligible (see Article 6), in particular following checks, reviews, audits or investigations (see Article 17). The rejection may also be based on the extension of findings from other grants to this grant (see Article 17.5.2). 39 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 26.2 Ineligible costs to be rejected — Calculation — Procedure Ineligible costs will be rejected in full. If the rejection of costs does not lead to a recovery (see Article 28), the Agency will formally notify the coordinator or beneficiary concerned of the rejection of costs, the amounts and the reasons why (if applicable, together with the notification of amounts due; see Article 16.5). The coordinator or beneficiary concerned may — within 30 days of receiving notification — formally notify the Agency of its disagreement and the reasons why. If the rejection of costs leads to a recovery, the Agency will follow the contradictory procedure with pre-information letter set out in Article 28. 26.3 Effects If the Agency rejects costs at the time of an interim payment or the payment of the balance, it will deduct them from the total eligible costs declared, for the action, in the periodic or final summary financial statement (see Article 15.3 and 15.4). It will then calculate the interim payment or payment of the balance as set out in Article 16.3 or 16.4. If the Agency — after an interim payment but before the payment of the balance — rejects costs declared in a periodic summary financial statement, it will deduct them from the costs declared in the next periodic summary financial statement or final summary financial statement. It will then calculate the interim payment or payment of the balance as set out in Article 16.3 or 16.4. If the Agency rejects costs after the payment of the balance, it will deduct the amount rejected from the total eligible costs declared, by the beneficiary, in the final summary financial statement. It will then calculate the revised final grant amount as set out in Article 5.4. If the revised final grant amount is lower than the final grant amount, the Agency will recover the difference (see Article 28). ARTICLE 27 — REDUCTION OF THE GRANT 27.1 Conditions The Agency may — at the payment of the balance or afterwards — reduce the grant, if: (a) a beneficiary (or a natural person who has the power to represent or take decisions on its behalf) has committed: (i) substantial errors, irregularities or fraud or (ii) serious breach of obligations under the Agreement or during the award procedure (including improper implementation of the action, submission of false information, failure to provide required information, breach of ethical principles) or (b) a beneficiary (or a natural person who has the power to represent or take decisions on its behalf) has committed — in other EU or Euratom grants awarded to it under similar conditions — systemic or recurrent errors, irregularities, fraud or serious breach of obligations that have a material impact on this grant (extension of findings from other grants to this grant; see Article 17.5.2). 40 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 27.2 Amount to be reduced — Calculation — Procedure The amount of the reduction will be proportionate to the seriousness of the errors, irregularities or fraud or breach of obligations. Before reduction of the grant, the Agency will formally notify a ‘pre-information letter’ to the coordinator or beneficiary concerned: - informing it of its intention to reduce the grant, the amount it intends to reduce and the reasons why and - inviting it to submit observations within 30 days of receiving notification. If the Agency does not receive any observations or decides to pursue reduction despite the observations it has received, it will formally notify confirmation of the reduction (if applicable, together with the notification of amounts due; see Article 16). 27.3 Effects If the Agency reduces the grant at the time of the payment of the balance, it will calculate the reduced grant amount for the action and then determine the amount due as payment of the balance (see Article 5.3.4 and 16.4). If the Agency reduces the grant after the payment of the balance, it will calculate the revised final grant amount for the action or for the beneficiary concerned (see Article 5.4). If the revised final grant amount is lower than the final grant amount, the Agency will recover the difference (see Article 28). ARTICLE 28 — RECOVERY OF UNDUE AMOUNTS 28.1 Amount to be recovered — Calculation — Procedure The Agency will — at the payment of the balance or afterwards — claim back any amount that was paid but is not due under the Agreement. The coordinator is fully liable for repaying debts of the consortium (under the Agreement) even if it has not been the final recipient of those amounts. In addition, the beneficiaries (including the coordinator) are jointly and severally liable for repaying any unpaid debts under the Agreement (due by the consortium or any beneficiary, including late- payment interest) — up to the maximum EU contribution indicated, for each beneficiary, in the estimated budget (as last amended; see Annex 2). Undue amounts paid by the Agency for costs declared by an affiliated entity will be considered as amounts unduly paid to the beneficiary. 28.1.1 Recovery at payment of the balance If the payment of the balance takes the form of a recovery (see Article 16.4), the Agency will formally notify a ‘pre-information letter’ to the coordinator: - informing it of its intention to recover, the amount due as the balance and the reasons why and 41 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 - inviting the coordinator to submit observations within 30 days of receiving notification. If no observations are submitted or the Agency decides to pursue recovery despite the observations it has received, it will confirm the amount to be recovered and formally notify to the coordinator a debit note with the terms and the date for payment (together with the notification of amounts due; see Article 16.5). If payment is not made by the date specified in the debit note, the Agency or the Commission will recover the amount: (a) by ‘offsetting’ it — without the coordinator’s consent — against any amounts owed to the coordinator by the Agency, Commission or another executive agency (from the EU or Euratom budget). In exceptional circumstances, to safeguard the EU’s financial interests, the Agency may offset before the payment date specified in the debit note; (b) not applicable; (c) by holding the other beneficiaries jointly and severally liable — up to the maximum EU contribution indicated, for each beneficiary, in the estimated budget (as last amended; see Annex 2) (d) by taking legal action (see Article 41) or by adopting an enforceable decision under Article 299 of the Treaty on the Functioning of the EU (TFEU) and Article 79(2) of the Financial Regulation No 966/2012. If payment is not made by the date in the debit note, the amount to be recovered (see above) will be increased by late-payment interest at the rate set out in Article 16.11, from the day following the payment date in the debit note, up to and including the date the Agency or the Commission receives full payment of the amount. Partial payments will be first credited against expenses, charges and late-payment interest and then against the principal. Bank charges incurred in the recovery process will be borne by the beneficiary, unless Directive 2007/64/EC applies. 28.1.2 Recovery of amounts after payment of the balance If — after the payment of the balance — the Agency revised the final grant amount for the action or for the beneficiary concerned (see Article 5.4), due to a rejection of costs or reduction of the grant, and the revised final grant amount is lower than the final grant amount (see Article 5.3), the Agency will: - if the rejection or reduction does not concern a specific beneficiary or its affiliated entities: claim back the difference from the coordinator (even if it has not been the final recipient of the amount in question) or - otherwise: claim back the difference from the beneficiary concerned. The Agency will formally notify a pre-information letter to the coordinator or beneficiary concerned: 42 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 - informing it of its intention to recover, the amount to be repaid and the reasons why and - inviting it to submit observations within 30 days of receiving notification. If no observations are submitted or the Agency decides to pursue recovery despite the observations it has received, it will confirm the amount to be recovered and formally notify to the coordinator or beneficiary concerned a debit note. This note will also specify the terms and the date for payment. If payment is not made by the date specified in the debit note, the Agency or the Commission will recover the amount: (a) by ‘offsetting’ it — without the coordinator’s or beneficiary’s consent — against any amounts owed to the coordinator or beneficiary by the Agency, Commission or another executive agency (from the EU or Euratom budget). In exceptional circumstances, to safeguard the EU’s financial interests, the Agency may offset before the payment date specified in the debit note; (b) by holding the other beneficiaries jointly and severally liable, up to the maximum EU contribution indicated, for each beneficiary, in the estimated budget (as last amended; see Annex 2) (c) by taking legal action (see Article 41) or by adopting an enforceable decision under Article 299 of the Treaty on the Functioning of the EU (TFEU) and Article 79(2) of the Financial Regulation No 966/2012. If payment is not made by the date in the debit note, the amount to be recovered (see above) will be increased by late-payment interest at the rate set out in Article 16.11, from the day following the date for payment in the debit note, up to and including the date the Agency or the Commission receives full payment of the amount. Partial payments will be first credited against expenses, charges and late-payment interest and then against the principal. Bank charges incurred in the recovery process will be borne by the beneficiary, unless Directive 2007/64/EC applies. ARTICLE 29 — ADMINISTRATIVE SANCTIONS In addition to contractual measures, the Agency or the Commission may also adopt administrative sanctions under Articles 106 and 131(4) of the Financial Regulation No 966/2012 (i.e. exclusion from future procurement contracts, grants and expert contracts and/or financial penalties). SECTION 2 LIABILITY FOR DAMAGES ARTICLE 30 — LIABILITY FOR DAMAGES 30.1 Liability of the Agency The Agency cannot be held liable for any damage caused to the beneficiaries or to third parties as a consequence of implementing the Agreement, including for gross negligence. 43 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 The Agency cannot be held liable for any damage caused by any of the beneficiaries or third parties involved in the action, as a consequence of implementing the Agreement. 30.2 Liability of the beneficiaries Except in case of force majeure (see Article 35), the beneficiaries must compensate the Agency for any damage it sustains as a result of the implementation of the action or because the action was not implemented in full compliance with the Agreement. SECTION 3 SUSPENSION AND TERMINATION ARTICLE 31 — SUSPENSION OF PAYMENT DEADLINE 31.1 Conditions The Agency may — at any moment — suspend the payment deadline (see Article 16.2 to 16.4) if a request for payment (see Article 15) cannot be approved because: (a) it does not comply with the provisions of the Agreement (see Article 15); (b) the technical or financial report(s) have not been submitted or are not complete or additional information is needed, or (c) there is doubt about the eligibility of the costs declared in the financial statements and additional checks, reviews, audits or investigations are necessary. 31.2 Procedure The Agency will formally notify the coordinator of the suspension and the reasons why. The suspension will take effect the day notification is sent by the Agency (see Article 36). If the conditions for suspending the payment deadline are no longer met, the suspension will be lifted — and the remaining period will resume. If the suspension exceeds two months, the coordinator may request the Agency if the suspension will continue. If the payment deadline has been suspended due to the non-compliance of the technical or financial report(s) (see Article 15) and the revised report or statement is not submitted or was submitted but is also rejected, the Agency may also terminate the Agreement or the participation of the beneficiary (see Article 34.3.1(i)). ARTICLE 32 — SUSPENSION OF PAYMENTS 32.1 Conditions The Agency may — at any moment — suspend payments, in whole or in part for one or more beneficiaries, if: 44 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 (a) a beneficiary (or a natural person who has the power to represent or take decision on its behalf) has committed or is suspected of having committed: (i) substantial errors, irregularities or fraud or (ii) serious breach of obligations under this Agreement or during the award procedure (including improper implementation of the action, submission of false information, failure to provide required information, breach of ethical principles) or (b) a beneficiary (or a natural person who has the power to represent or take decision on its behalf) has committed — in other EU or Euratom grants awarded to it under similar conditions — systemic or recurrent errors, irregularities, fraud or serious breach of obligations that have a material impact on this grant (extension of findings from other grants to this grant; see Article 17.5.2). If payments are suspended for one or more beneficiaries, the Agency will make partial payment(s) for the part(s) not suspended. If suspension concerns the payment of the balance, the payment (or recovery) of the amount(s) concerned after suspension is lifted will be considered to be the payment that closes the action. 32.2 Procedure Before suspending payments, the Agency will formally notify the coordinator or beneficiary concerned: - informing it of its intention to suspend payments and the reasons why and - inviting it to submit observations within 30 days of receiving notification. If the Agency does not receive observations or decides to pursue the procedure despite the observations it has received, it will formally notify confirmation of the suspension. Otherwise, it will formally notify that the suspension procedure is not continued. The suspension will take effect the day the confirmation notification is sent by the Agency. If the conditions for resuming payments are met, the suspension will be lifted. The Agency will formally notify the coordinator or beneficiary concerned. During the suspension, the periodic report(s) for all reporting periods except the last one (see Article 15.3) must not contain any individual financial statement(s) from the beneficiary concerned and its affiliated entities. The coordinator must include them in the next periodic report after the suspension is lifted or — if suspension is not lifted before the end of the action — in the last periodic report. The beneficiaries may suspend implementation of the action (see Article 33.1) or terminate the Agreement or the participation of the beneficiary concerned (see Article 34.1 and 34.2). ARTICLE 33 — SUSPENSION OF THE ACTION IMPLEMENTATION 33.1 Suspension of the action implementation, by the beneficiaries 33.1.1 Conditions 45 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 The beneficiaries may suspend implementation of the action or any part of it, if exceptional circumstances — in particular force majeure (see Article 35) — make implementation impossible or excessively difficult. 33.1.2 Procedure The coordinator must immediately formally notify to the Agency the suspension (see Article 36), stating: - the reasons why and - the expected date of resumption. The suspension will take effect the day this notification is received by the Agency. Once circumstances allow for implementation to resume, the coordinator must immediately formally notify the Agency and request an amendment of the Agreement, to set the date on which the action will be resumed, extend the duration of the action and make other changes necessary to adapt the action to the new situation (see Article 39) — unless the Agreement or the participation of a beneficiary has been terminated (see Article 34). The suspension will be lifted with effect from the resumption date set out in the amendment. This date may be before the date on which the amendment enters into force. Costs incurred during suspension of the action implementation are not eligible (see Article 6). 33.2 Suspension of the action implementation, by the Agency 33.2.1 Conditions The Agency may suspend implementation of the action or any part of it, if: (a) a beneficiary (or a natural person who has the power to represent or take decisions on its behalf) has committed or is suspected of having committed: (i) substantial errors, irregularities or fraud or (ii) serious breach of obligations under this Agreement or during the award procedure (including improper implementation of the action, submission of false declaration, failure to provide required information, breach of ethical principles) or (b) a beneficiary (or a natural person who has the power to represent or take decisions on its behalf) has committed — in other EU or Euratom grants awarded to it under similar conditions — systemic or recurrent errors, irregularities, fraud or serious breach of obligations that have a material impact on this grant (extension of findings from other grants to this grant; see Article 17.5.2). 33.2.2 Procedure Before suspending implementation of the action, the Agency will formally notify the coordinator or beneficiary concerned: - informing it of its intention to suspend the implementation and the reasons why and 46 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 - inviting it to submit observations within 30 days of receiving notification. If the Agency does not receive observations or decides to pursue the procedure despite the observations it has received, it will formally notify confirmation of the suspension. Otherwise, it will formally notify that the procedure is not continued. The suspension will take effect five days after confirmation notification is received (or on a later date specified in the notification). It will be lifted if the conditions for resuming implementation of the action are met. The coordinator or beneficiary concerned will be formally notified of the lifting and the Agreement will be amended, to set the date on which the action will be resumed, extend the duration of the action and make other changes necessary to adapt the action to the new situation (see Article 39) — unless the Agreement has already been terminated (see Article 34). The suspension will be lifted with effect from the resumption date set out in the amendment. This date may be before the date on which the amendment enters into force. Costs incurred during suspension are not eligible (see Article 6). The beneficiaries may not claim damages due to suspension by the Agency (see Article 30). Suspension of the action implementation does not affect the Agency’s right to terminate the Agreement or participation of a beneficiary (see Article 34), reduce the grant or recover amounts unduly paid (see Articles 27 and 28). ARTICLE 34 — TERMINATION OF THE AGREEMENT OR OF THE PARTICIPATION OF ONE OR MORE BENEFICIARIES 34.1 Termination of the Agreement, by the beneficiaries 34.1.1 Conditions and procedure The beneficiaries may terminate the Agreement. The coordinator must formally notify termination to the Agency (see Article 36), stating: - the reasons why and - the date the termination will take effect. This date must be after the notification. If no reasons are given or if the Agency considers the reasons do not justify termination, the Agreement will be considered to have been ‘terminated improperly’. The termination will take effect on the day specified in the notification. 34.1.2 Effects The coordinator must — within 60 days from when termination takes effect — submit a periodic report (for the open reporting period until termination; see Article 15.3) and the final report (see Article 15.4). 47 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 If the Agency does not receive the report(s) within the deadline (see above), only costs which are included in an approved periodic report will be taken into account. The Agency will calculate the final grant amount (see Article 5.3) and the balance (see Article 16.4) on the basis of the report(s) submitted. Only costs incurred until termination are eligible (see Article 6). Costs relating to contracts due for execution only after termination are not eligible. Improper termination may lead to a reduction of the grant (see Article 27). After termination, the beneficiaries’ obligations (in particular, Articles 15, 17, 18, 19, 20, 21, 22, 24, 26, 27 and 28) continue to apply. 34.2 Termination of the participation of one or more beneficiaries, by the beneficiaries 34.2.1 Conditions and procedure The participation of one or more beneficiaries may be terminated by the coordinator, on request of the beneficiary concerned or on behalf of the other beneficiaries. The coordinator must formally notify termination to the Agency (see Article 36) and inform the beneficiary concerned. If the coordinator’s participation is terminated without its agreement, the formal notification must be done by another beneficiary (acting on behalf of the other beneficiaries). The notification must include: - the reasons why; - the opinion of the beneficiary concerned (or proof that this opinion has been requested in writing); - the date the termination takes effect. This date must be after the notification, and - a request for amendment (see Article 39), with a proposal for reallocation of the tasks and the estimated budget of the beneficiary concerned (see Annexes 1 and 2) and, if necessary, the addition of one or more new beneficiaries (see Article 40). If termination takes effect after the period set out in Article 3, no request for amendment must be included, unless the beneficiary concerned is the coordinator. In this case, the request for amendment must propose a new coordinator. If this information is not given or if the Agency considers that the reasons do not justify termination, the participation will be considered to have been terminated improperly. The termination will take effect on the day specified in the notification. 34.2.2 Effects The beneficiary concerned must submit to the coordinator: (i) a technical report and 48 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 (ii) a financial statement covering the period from the end of the last reporting period to the date when termination takes effect. This information must be included by the coordinator in the periodic report for the next reporting period (see Article 15.3). If the request for amendment is rejected by the Agency (because it calls into question the decision awarding the grant or breaches the principle of equal treatment of applicants), the Agreement may be terminated according to Article 34.3.1(c). If the request for amendment is accepted by the Agency, the Agreement is amended to introduce the necessary changes (see Article 39). Improper termination may lead to a reduction of the grant (see Article 27) or termination of the Agreement (see Article 34). After termination, the concerned beneficiary’s obligations (in particular Articles 15, 17, 18, 19, 21, 22, 24, 26, 27 and 28) continue to apply. 34.3 Termination of the Agreement or of the participation of one or more beneficiaries, by the Agency 34.3.1 Conditions The Agency may terminate the Agreement or the participation of one or more beneficiaries, if: (a) one or more beneficiaries do not accede to the Agreement (see Article 40); (b) a change to their legal, financial, technical, organisational or ownership situation (or those of its affiliated entities) is likely to substantially affect or delay the implementation of the action or calls into question the decision to award the grant; (c) following termination of participation for one or more beneficiaries (see above), the necessary changes to the Agreement would call into question the decision awarding the grant or breach the principle of equal treatment of applicants (see Article 39); (d) implementation of the action is prevented by force majeure (see Article 35) or suspended by the coordinator (see Article 33.1) and either: (i) resumption is impossible, or (ii) the necessary changes to the Agreement would call into question the decision awarding the grant or breach the principle of equal treatment of applicants; (e) a beneficiary is declared bankrupt, being wound up, having its affairs administered by the courts, has entered into an arrangement with creditors, has suspended business activities, or is subject to any other similar proceedings or procedures under national law; (f) a beneficiary (or a natural person who has the power to represent or take decisions on its behalf) has been found guilty of professional misconduct, proven by any means; (g) a beneficiary does not comply with the applicable national law on taxes and social security; 49 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 (h) a beneficiary (or a natural person who has the power to represent or take decisions on its behalf) has committed fraud, corruption, or is involved in a criminal organisation, money laundering or any other illegal activity; (i) a beneficiary (or a natural person who has the power to represent or take decisions on its behalf) has committed: (i) substantial errors, irregularities or fraud or (ii) serious breach of obligations under the Agreement or during the award procedure (including improper implementation of the action, submission of false information, failure to provide required information, breach of ethical principles); (j) a beneficiary (or a natural person who has the power to represent or take decisions on its behalf) has committed — in other EU or Euratom grants awarded to it under similar conditions — systemic or recurrent errors, irregularities, fraud or serious breach of obligations that have a material impact on this grant (extension of findings from other grants to this grant; see Article 17.5.2); (k) despite a specific request by the Agency, a beneficiary does not request — through the coordinator — an amendment to the Agreement to end the participation of one of its affiliated entities that is in one of the situations under points (e), (f), (g), (h), (i) or (j) and to reallocate its tasks 34.3.2 Procedure Before terminating the Agreement or participation of one or more beneficiaries, the Agency will formally notify the coordinator or beneficiary concerned: - informing it of its intention to terminate and the reasons why and - inviting it, within 30 days of receiving notification, to submit observations and — in case of Point (i.ii) above — to inform the Agency of the measures to ensure compliance with the obligations under the Agreement. If the Agency does not receive observations or decides to pursue the procedure despite the observations it has received, it will formally notify to the coordinator or beneficiary concerned confirmation of the termination and the date it will take effect. Otherwise, it will formally notify that the procedure is not continued. The termination will take effect: - for terminations under Points (b), (c), (e), (g), (i.ii) and (k) above: on the day specified in the notification of the confirmation (see above); - for terminations under Points (a), (d), (f), (h), (i.i) and (j) above: on the day after the notification of the confirmation is received. 34.3.3 Effects (a) for termination of the Agreement: The coordinator must — within 60 days from when termination takes effect — submit a periodic 50 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 report (for the last open reporting period until termination; see Article 15.3) and a final report (see Article 15.4). If the Agreement is terminated for breach of the obligation to submit reports (see Articles 15.8 and 34.3.1(i)), the coordinator may not submit any reports after termination. If the Agency does not receive the report(s) within the deadline (see above), only costs which are included in an approved periodic report will be taken into account. The Agency will calculate the final grant amount (see Article 5.3) and the balance (see Article 16.4) on the basis of the report(s) submitted. Only costs incurred until termination takes effect are eligible (see Article 6). Costs relating to contracts due for execution only after termination are not eligible. This does not affect the Agency’s right to reduce the grant (see Article 27) or to impose administrative sanctions (Article 29). The beneficiaries may not claim damages due to termination by the Agency (see Article 30). After termination, the beneficiaries’ obligations (in particular Articles 15, 17, 18, 19, 21, 22, 24, 26, 27 and 28) continue to apply. (b) for termination of the participation of one or more beneficiaries: The coordinator must — within 60 days from when termination takes effect — submit a request for amendment (see Article 39), with a proposal for reallocation of the tasks and estimated budget of the beneficiary concerned (see Annexes 1 and 2) and, if necessary, the addition of one or more new beneficiaries (see Article 40). If termination is notified after the period set out in Article 3, no request for amendment must be submitted unless the beneficiary concerned is the coordinator. In this case the request for amendment must propose a new coordinator. The beneficiary concerned must submit to the coordinator: (i) a technical report and (ii) a financial statement covering the period from the end of the last reporting period to the date when termination takes effect. This information must be included by the coordinator in periodic report for the next reporting period (see Article 15.3). If the request for amendment is rejected by the Agency (because it calls into question the decision awarding the grant or breaches the principle of equal treatment of applicants), the Agreement may be terminated according to Article 34.3.1(c). If the request for amendment is accepted by the Agency, the Agreement is amended to introduce the necessary changes (see Article 39). After termination, the concerned beneficiary’s obligations (in particular Articles 15, 17, 18, 19, 20, 21, 22, 24, 26, 27 and 28) continue to apply. SECTION 4 FORCE MAJEURE 51 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 ARTICLE 35 — FORCE MAJEURE ‘Force majeure’ means any situation or event that: - prevents either party from fulfilling their obligations under the Agreement, - was unforeseeable, exceptional situation and beyond the parties’ control, - was not due to error or negligence on their part (or on the part of third parties involved in the action), and - proves to be inevitable in spite of exercising all due diligence. The following cannot be invoked as force majeure: - any default of a service, defect in equipment or material or delays in making them available, unless they stem directly from a relevant case of force majeure, - labour disputes or strikes, or - financial difficulties. Any situation constituting force majeure must be formally notified to the other party without delay, stating the nature, likely duration and foreseeable effects. The parties must immediately take all the necessary steps to limit any damage due to force majeure and do their best to resume implementation of the action as soon as possible. The party prevented by force majeure from fulfilling its obligations under the Agreement cannot be considered in breach of them. CHAPTER 7 FINAL PROVISIONS ARTICLE 36 — COMMUNICATION BETWEEN THE PARTIES 36.1 Form and means of communication Communication under the Agreement (information, requests, submissions, 'formal notifications', etc.) must: - be made in writing and - bear the number of the Agreement. Until the payment of the balance: all communication must be made through the electronic exchange system and using the forms and templates provided there. After the payment of the balance: formal notifications must be made by registered post with proof of delivery (‘formal notification on paper’). Communications in the electronic exchange system must be made by persons authorised according to the Participant Portal Terms & Conditions. For naming the authorised persons, each beneficiary must 52 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 have designated — before the signature of this Agreement — a ‘legal entity appointed representative (LEAR)’. The role and tasks of the LEAR are stipulated in his/her appointment letter (see Participant Portal Terms & Conditions). If the electronic exchange system is temporarily unavailable, instructions will be given on the Agency and Commission websites. 36.2 Date of communication Communications are considered to have been made when they are sent by the sending party (i.e. on the date and time they are sent through the electronic exchange system). Formal notifications through the electronic exchange system are considered to have been made when they are received by the receiving party (i.e. on the date and time of acceptance by the receiving party, as indicated by the time stamp). A formal notification that has not been accepted within 10 days after sending is considered to have been accepted. Formal notifications on paper sent by registered post with proof of delivery (only after the payment of the balance) are considered to have been made on either: - the delivery date registered by the postal service or - the deadline for collection at the post office. If the electronic exchange system is temporarily unavailable, the sending party cannot be considered in breach of its obligation to send a communication within a specified deadline. 36.3 Addresses for communication The electronic exchange system must be accessed via the following URL: https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/myarea/projects The Agency will formally notify the coordinator and beneficiaries in advance any changes to this URL. Formal notifications on paper (only after the payment of the balance) addressed to the Agency must be sent to the following address: European Health and Digital Executive Agency (HADEA) Health and Food EU4Health Covent Garden Building B-1049 Belgium Formal notifications on paper (only after the payment of the balance) addressed to the beneficiaries must be sent to their legal address as specified in the Participant Portal Beneficiary Register. ARTICLE 37 — INTERPRETATION OF THE AGREEMENT 37.1 Precedence of the Terms and Conditions over the Annexes The provisions in the Terms and Conditions of the Agreement take precedence over its Annexes. 53 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 Annex 2 takes precedence over Annex 1. 37.2 Privileges and immunities Not applicable ARTICLE 38 — CALCULATION OF PERIODS, DATES AND DEADLINES In accordance with Regulation No 1182/7112, periods expressed in days, months or years are calculated from the moment the triggering event occurs. The day during which that event occurs is not considered as falling within the period. ARTICLE 39 — AMENDMENTS TO THE AGREEMENT 39.1 Conditions The Agreement may be amended, unless the amendment entails changes to the Agreement which would call into question the decision awarding the grant or breach the principle of equal treatment of applicants. Amendments may be requested by any of the parties. 39.2 Procedure The party requesting an amendment must submit a request for amendment signed in the electronic exchange system (see Article 36). The coordinator submits and receives requests for amendment on behalf of the beneficiaries (see Annex 3). If a change of coordinator is requested without its agreement, the submission must be done by another beneficiary (acting on behalf of the other beneficiaries). The request for amendment must include: - the reasons why; - the appropriate supporting documents, and - for a change of coordinator without its agreement: the opinion of the coordinator (or proof that this opinion has been requested in writing). The Agency may request additional information. If the party receiving the request agrees, it must sign the amendment in the electronic exchange system within 45 days of receiving notification (or any additional information the Agency has requested). If it does not agree, it must formally notify its disagreement within the same deadline. The deadline may 12 Regulation (EEC, Euratom) No 1182/71 of the Council of 3 June 1971 determining the rules applicable to periods, dates and time-limits (OJ L 124, 8/6/1971, p. 1). 54 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 be extended, if necessary for the assessment of the request. If no notification is received within the deadline, the request is considered to have been rejected. An amendment enters into force on the day of the signature of the receiving party. An amendment takes effect on the date agreed by the parties or, in the absence of such an agreement, on the date on which the amendment enters into force. ARTICLE 40 — ACCESSION TO THE AGREEMENT 40.1 Accession of the beneficiaries mentioned in the preamble The other beneficiaries must accede to the Agreement by signing the Accession Form (see Annex 3) in the electronic exchange system (see Article 36) within 30 days after its entry into force (see Article 42). They will assume the rights and obligations under the Agreement with effect from the date of its entry into force (see Article 42). If a beneficiary does not accede to the Agreement within the above deadline, the coordinator must — within 30 days — request an amendment to make any changes necessary to ensure proper implementation of the action. This does not affect the Agency's right to terminate the Agreement (see Article 34). 40.2 Addition of new beneficiaries In justified cases, the beneficiaries may request the addition of a new beneficiary. For this purpose, the coordinator must submit a request for amendment in accordance with Article 39. It must include an Accession Form (see Annex 3) signed by the new beneficiary in the electronic exchange system (see Article 36). New beneficiaries must assume the rights and obligations under the Agreement with effect from the date of their accession specified in the Accession Form (see Annex 3). ARTICLE 41 — APPLICABLE LAW AND SETTLEMENT OF DISPUTES 41.1 Applicable law The Agreement is governed by the applicable EU law, supplemented if necessary by the law of Belgium. 41.2 Dispute settlement If a dispute concerning the interpretation, application or validity of the Agreement cannot be settled amicably, the General Court — or, on appeal, the Court of Justice of the European Union — has sole jurisdiction. Such actions must be brought under Article 272 of the Treaty on the Functioning of the EU (TFEU). As an exception, if such a dispute is between the Agency and ‘EMBAETTI LANDLAEKNIS’, ‘HELSEDIREKTORATET’, ‘INSTITUT ZA ZASTITU ZDRAVLJA SRBIJEDR MILAN JOVANOVIC BATUT’, the competent Belgian courts have sole jurisdiction. 55 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 Associated with documentCHAFEA MGA — Multi:-v2.1 Ref. Ares(2021)5882948 27/09/2021 If a dispute concerns administrative sanctions, offsetting or an enforceable decision under Article 79(2) of the Financial Regulation No 966/2012 and Article 299 TFEU (see Articles 28, 29 and 30), the beneficiaries must bring action before the General Court — or, on appeal, the Court of Justice of the European Union — under Article 263 TFEU. Actions against enforceable decisions must be brought against the Commission (not against the Agency). ARTICLE 42 — ENTRY INTO FORCE OF THE AGREEMENT The Agreement will enter into force on the day of signature by the Agency or the coordinator, depending on which is later. SIGNATURES For the coordinator For the Agency [--TGSMark#signature-896563726_75_210--] [--TGSMark#signature-service_75_210--] PANAGIOTIS ARKOUMANEAS with ECAS id n0031gkx signed in the Signed by Florina TELEA with ECAS id teleafa as an authorised Participant Portal on 28/09/2021 at 09:54:20 (transaction id SigId- representative on 28-09-2021 15:37:48 (transaction id SigId-57054- 52414-TIxAUsDpStzSwTvjaFx2zu7FtUNnw2OtEGNJwcTB2TvdbhmJGjm Digmj18aIlPRzakzy44lopOKTFo2PxP5nsXmlp9WBN8AZFqV9FloX2L VCNfMeKHNUvPOGaaNA1zuRjjGlniYq7zMG7W- mWZ2JOwBppTY81NmCgXStqjeuWoV9cA- rS0vSrmBGYCagVEG22GDby-tu1JxiKjgptH9yI3DDbujebhQFRytziqtvEG rS0vSrmBGYCagVEG22GDby-ZrrsQ5Anp7iVEqqCZyMYzLNnMJfrk8a YcDTpvC60x3no9uw3LnZAzahs9UsXK1kzicG0DgfesJmKaCgHPW). o0YsyGVMq4x5GYoif8S9eKk2jqlVRnQxC4tL1GZPzHl8VvrF4uandCV) Timestamp by third party at 2021.09.28 15:37:52 CEST 2021.09.28 10:54:25 CEST 56 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 EUROPEAN HEALTH AND DIGITAL EXECUTIVE AGENCY (HADEA) HADEA.A – Health and Food A.1 – EU4Health ANNEX 1 (part A) Project NUMBER — 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Table of Contents 1.1. The project summary................................................................................................................................. 3 1.2. The list of beneficiaries..............................................................................................................................4 1.3. Workplan Tables - Detailed implementation..............................................................................................5 1.3.1. WT1 List of work packages........................................................................................................... 5 1.3.2. WT2 List of deliverables................................................................................................................ 6 1.3.3. WT3 Work package descriptions................................................................................................... 8 Work package 1........................................................................................................................... 8 Work package 2......................................................................................................................... 15 Work package 3......................................................................................................................... 20 Work package 4......................................................................................................................... 25 Work package 5......................................................................................................................... 30 Work package 6......................................................................................................................... 36 1.3.4. WT4 List of milestones................................................................................................................ 42 1.3.5. WT5 Critical Implementation risks and mitigation actions........................................................... 46 1.3.6 WT6 Summary of project effort in person-months........................................................................48 1.3.7. WT7 Tentative schedule of project reviews.................................................................................50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 1.1. The project summary Project Number 1 101035969 Project Acronym 2 JA-02-2020 One form per project General information Project title 3 JA on Implementation of Best Practices in the area of Mental Health Starting date 4 01/10/2021 Duration in months 5 36 Call (part) identifier 6 HP-JA-2020-2 JA-02-2020 Topic • Joint Action to Support for Member States’ implementation of best practices in the area of mental health Fixed EC Keywords Free keywords Mental Health Reform , suicide prevention. best practices Abstract 7 Mental disorders are one of the greatest public health challenges in terms of prevalence, burden of disease and disability and they cause major burden to economies, demanding policy action. More than one in six people across EU countries had a mental health issue in 2016, equivalent to about 84 million people. Moreover, in 2016, 165,000 deaths were attributed to mental and behavioural disorders, including self-harm, in EU.The burden of mental illness in the European WHO region is estimated to account for 14.4% of years lived with disability (YLDs) and 5.8% of disability-adjusted life-years (DALYs), placing thus mental illness as the second biggest contributor to YLDs after musculoskeletal disorders and as fourth in terms of DALYs in the WHO European region. Total costs pertaining to ill mental health have been gauged at more than 4% of GDP- or over 600 billion- across EU in 2015. Many European countries have in place policies and programmes to address mental illness at different ages. Nevertheless, much more can be done to manage and promote mental health. Delivery of MH care services takes various forms across EU. Some countries still rely on big psychiatric hospitals, while others are delivering the care for MH mostly in community settings.This need for prioritizing mental health becomes more imperative, in light of the ongoing COVID-19 pandemic. Converging evidence substantiate emerging mental health needs and difficulties faced by the mental health care systems to tackle them. Building upon 15+ years of EU efforts including the Joint Action for Mental Health and Well-being the European Framework for Action and the EU Compass, the Members of the SGPP have selected two best practices (i) the Mental health reform in Belgium and (ii) Suicide prevention form Austria to be implemented during the new Joint Action on mental health, with an aim to extend the benefits of these best practices to participating countries. Page 3 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 1.2. List of Beneficiaries Project Number 1 101035969 Project Acronym 2 JA-02-2020 List of Beneficiaries Project Project No Name Short name Country entry exit month8 month ETHNIKOS ORGANISMOS DIMOSIAS 1 NPHO Greece 1 36 YGEIAS BUNDESMINISTERIUM FUER 2 SOZIALES, GESUNDHEIT, PFLEGE UND BMSGPK Austria 1 36 KONSUMENTENSCHUTZ NATSIONALEN CENTAR PO 3 NCPHA Bulgaria 1 36 OBSHTESTVENO ZDRAVE I ANALIZI HRVATSKI ZAVOD ZA JAVNO 4 CIPH Croatia 1 36 ZDRAVSTVO ORGANISMOS KRATIKON YPIRESION 5 MHS CYPRUS Cyprus 1 36 YGEIAS MINISTERSTVO ZDRAVOTNICTVI 6 MZCR Czech Republic 1 36 CESKE REPUBLIKY 7 SOTSIAALMINISTEERIUM MSAE Estonia 1 36 TERVEYDEN JA HYVINVOINNIN 8 THL Finland 1 36 LAITOS MINISTERE DES AFFAIRES SOCIALES 9 MOH FRANCE France 1 36 ET DE LA SANTE BUNDESZENTRALE FUR 10 BZgA Germany 1 36 GESUNDHEITLICHE AUFKLARUNG 11 ORSZAGOS KORHAZI FOIGAZGATOSAG OKFO Hungary 1 36 12 EMBAETTI LANDLAEKNIS DOHI Iceland 1 36 13 REGIONE LOMBARDIA LOMBARDY REGION Italy 1 36 LIETUVOS RESPUBLIKOS SVEIKATOS 14 SAM Lithuania 1 36 APSAUGOS MINISTERIJA 15 Ministry for Health - Government of Malta MFH Malta 1 36 STICHTING TRIMBOS- INSTITUUT, 16 NETHERLANDS INSTITUTE OF MENTAL TRIMBOS Netherlands 1 36 HEALTH AND ADDICTION 17 HELSEDIREKTORATET HDIR Norway 1 36 INSTITUT ZA ZASTITU ZDRAVLJA 18 IPHS Serbia 1 36 SRBIJEDR MILAN JOVANOVIC BATUT NACIONALNI INSTITUT ZA JAVNO 19 NIJZ Slovenia 1 36 ZDRAVJE 20 SERVICIO MURCIANO DE SALUD SMS Spain 1 36 21 FOLKHALSOMYNDIGHETEN FOHM/PHAS Sweden 1 36 Page 4 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 1.3. Workplan Tables - Detailed implementation 1.3.1. WT1 List of work packages WP Person- Start End WP Title Lead beneficiary10 Number9 months11 month12 month13 Coodination and Management of the WP1 1 - NPHO 121.50 1 36 JA WP2 Dissemination 4 - CIPH 105.65 1 36 WP3 Evaluation 16 - TRIMBOS 179.10 1 36 WP4 Sustainability 11 - OKFO 161.25 1 36 Transfer and pilot Implementation of WP5 the Belgian best practice on reform 10 - BZgA 321.96 1 36 of the mental health (MH) services Transfer and pilot implementation of (selected elements of) of the WP6 2 - BMSGPK 210.19 1 36 Austrian Best Practce on Suicide Prevention (SP) “SUPRA” Total 1 099.65 Page 5 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 1.3.2. WT2 list of deliverables Due Deliverable WP Dissemination Deliverable Title Lead beneficiary Type 15 Date (in Number14 number9 level16 months)17 Confidential, only for members of the consortium D1.1 Project Handbook WP1 1 - NPHO Report 2 (including the Commission Services) D2.1 Introductory leaflet WP2 4 - CIPH Report Public 3 Websites, D2.2 Project Website WP2 4 - CIPH patents Public 3 filing, etc. D2.3 Dissemination strategy WP2 11 - OKFO Report Public 6 Mid-term report on D2.4 WP2 4 - CIPH Report Public 18 Dissemination Layman Version of the D2.5 WP2 4 - CIPH Report Public 36 Final Report Final Report on D2.6 WP2 4 - CIPH Report Public 36 Dissemination D3.1 Evaluation Strategy WP3 16 - TRIMBOS Report Public 9 Mid-term report on D3.2 WP3 16 - TRIMBOS Report Public 18 Evaluation D3.3 Meta-synthesis report WP3 16 - TRIMBOS Report Public 36 D3.4 Final evaluation report WP3 16 - TRIMBOS Report Public 36 Conceptual model for translating knowledge D4.1 into policy and practice WP4 16 - TRIMBOS Report Public 18 changes selected and applied in the JA D4.2 Policy toolkit WP4 16 - TRIMBOS Report Public 24 Common sustainability D4.3 WP4 16 - TRIMBOS Report Public 36 plan A public summary D5.1 report/executive WP5 10 - BZgA Report Public 14 summary of the SANA Analysis Report on the D5.2 WP5 10 - BZgA Report Public 29 pilot implementation A Synthesis Report on the results of the use of indicators for 13 - LOMBARDY D5.3 mental health and the WP5 Report Public 28 REGION developed dashboard of MH indicators is elaborated Page 6 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Due Deliverable WP Dissemination Deliverable Title Lead beneficiary Type15 Date (in Number14 number9 level16 months)17 A “training kit” for use of and adaptation by 13 - LOMBARDY D5.4 WP5 Other Public 35 interested countries is REGION elaborated D6.1 SUPRA handbook WP6 2 - BMSGPK Report Public 6 Situation analysis and D6.2 needs analysis (SANA) WP6 2 - BMSGPK Report Public 20 profiles Drafted National / D6.3 Regional suicide WP6 2 - BMSGPK Report Public 29 prevention strategies Page 7 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 1.3.3. WT3 Work package descriptions Work package number 9 WP1 Lead beneficiary 10 1 - NPHO Work package title Coodination and Management of the JA Start month 1 End month 36 Objectives Overall, WP1 Coordination will be responsible for overall, coordination and management of the JA ImpleMENTAL, ensuring that the JA work plan is executed as planned or according to changes agreed during the executing phase and that progress is consistently monitored against project objectives and deliverables, making adjustments where necessary to the work plan, congruent with decisions made within the General Assembly. WP1 will contribute to the scientific aspects of the project, in close cooperation with all WP leaders, especially WP5 & WP6, during the whole implementation period of the JA ImpleMENTAL, link the activities of all work packages, address the scientific interlinkages among the WPs, including between the two technical ones, facilitate scientific dialogue and communication across the WPs and work for the delivery of highquality results within the identified objectives and constraints in order to achieve deliverable acceptance. Further, WP1 will be responsible for establishing, maintaining and managing the relevant governance, performing and advisory structures/bodies, coordinating and organizing their meetings, and taking minutes of Annual Consortium meetings, General Assembly, Executive Board meetings, Member States Policy Committee and Stakeholder Forum (see below for description of these structures). WP1 efforts will also focus on ensuring communication with all relevant stakeholders, enhancing political and scientific relevance and ensuring the project reaches its objectives and expected impact. The specific objectives of this WP are: • Objective 1.1. At the strategic level, to create and coordinate a governance and performing structure to ensure that the project reaches its objectives and expected impact. • Objective 1.2. At the managerial level, to put in place the procedures and tools needed to ensure that the project progress is in conformity with the work plan and consortium agreement; Monitor and guide the progress of individual WPs; oversee conformity of all activities to Grant Agreement rules; and to organize project meetings, and prepare project reports. • Objective 1.3: At the administrative and financial level, to develop and implement the consortium agreement, to coordinate and ensure the administrative and financial management and to communicate with and report to HaDEA and DG Sante. • Objective 1.4: At the scientific level, to contribute in the scientific aspects of the JA and to ensure its scientific integrity, robust methodology, policy implications and deliverable acceptance. Description of work and role of partners WP1 - Coodination and Management of the JA [Months: 1-36] NPHO, BMSGPK, NCPHA, CIPH, MHS CYPRUS, MZCR, MSAE, THL, MOH FRANCE, BZgA, OKFO, DOHI, LOMBARDY REGION, SAM, MFH, TRIMBOS, HDIR, IPHS, NIJZ, SMS, FOHM/PHAS WP1 - Coordination and management of the project [Months: 1-36] NPHO The wide coverage of the Action brings to the fore the challenging task of addressing the diversity across member states. The three-phase implementation strategy, described in the means and methods section, will be followed by the JA overall as well as each implementation site to promote the systematic uptake of the two best practices by the services and policies of the implementing countries, and hence improving the population health. A Project Handbook will be developed to summarize the project objectives, the monitoring framework and management tools, the selected approach to achieve the goals, including project governance roles and responsibilities, the implementation strategy, the key controlling process, communication management plan, conflict resolution, policies, rules and project mind-sets. The systematic monitoring of the activities will help to check whether they are implemented according to the plan, whether results, deliverables and milestones are delivered on due dates, if there are obstacles or difficulties which may prevent the project from delivering, and to assure the overall quality of the project implementation. Task 1.1: Establishing, maintaining and managing the organisational structure and the relevant directing, management, performing layers and advisory bodies of the Consortium to ensure the implementation of the action and compliance with the Grant Agreement. Page 8 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Structure Leader: NPHO-Coodinator/ Contributors: Directing, managing perfoming layers and advisory bodies of the Consortium; Start date: M1 End date: M36 Task description: Task 1.1a. Roles and responsibilities of the Coordinator for the Grant Agreement and Consortium Agreement. The Coordinator will fulfill the roles and responsibilities described for the Coordinator in the Grant Agreement The coordinator must: (i) monitor that the action is implemented properly (ii) act as the intermediary for all communications between the beneficiaries and the Agency (iii) request and review any documents or information required by the Agency and verify their completeness and correctness before passing them on to the Agency (iv) submit the deliverables and reports to the Agency (v) ensure that all payments are made to the other beneficiaries without unjustified delay The Coordinator will also be responsible for developing and implementing the Consortium Agreement. The Consortium Agreement describes the internal arrangements and agreements among beneficiaries (and their affiliated entities), the consortium management procedures, settlement of internal disputes, and any other critical aspects such as liability and confidentiality, and will be signed by all competent authorities at the start of the project. The Consortium Agreement must not contain any provision contrary to the Grant Agreement. Task 1.1b. Setting up and coordination of the Consortium This task involves setting up, coordinating and managing the relevant governing management, perfoming and advisory bodies which will ensure the relevance of the activities the Consortium in line with the work plan and national strategies. • The Consortium is composed of the beneficiaries of the Grant Agreement (Competent Authorities) and their affiliated entities. According to the Grant Agreement the beneficiaries are jointly responsible for implementing the Joint Action. By signing the Agreement or the Accession Form, the beneficiaries accept the grant and agree to implement it under their own responsibility and in accordance with the Agreement, with all the obligations and conditions it sets out. The beneficiaries are jointly and severally liable for the technical implementation of the action. • DG SANTE, HaDEA, WHO and user’s representatives will be invited to participate in meetings and advisory bodies of the Consortium. A Kick-off meeting (online in M1) will ensure that project stakeholders are aware of the scope of the project, the project governance structure, the roles & responsibilities of the team members as well as the project rules. The Annual Consortium meetings (physical meetings in M12, M24 and M36, will not only provide a review of the project progress but will also, in cooperation wih WP2, facilitate knowledge transfer and exchange of processes, experiences and evidence inthe course of the JA implementation. The Annual Consortium meeting in M36 is also referred as the Final Conference. The following directing, managing, peforming layers constitute the organisational structure and advisory bodies of the Consortium that are governed by the Coordinator: ● General Assembly: Chaired by the JA Coordinator, the General Assembly (GA) is the directing and major decision- making body of the consortium where JA partners meet to discuss the progress and results of the JA. It represents the interests of those who design, manage and implement the project’s deliverables. It takes decisions on the strategic orientation and execution of the JA and provides overall strategic guidance. It also takes major decisions about the implementation and revision of the work plan. Decisions are taken by means of majority votes. The European Commission, DG SANTE and the European Health and Digital Executive Agency (HaDEA) representatives, participate as observers. The General Assembly shall consist of one representative of each Competent Authority. AEs can participate but have no voting rights. The body meets at least bi-annually. Online GA meetings will be held during the online Kick off meeting (M1) and in M6,18 &30. Physical meetings of the General Assembly will take place at the same dates as the Annual Consortium meetings in M12, M24, 36. Onsite GA meetings are coinciding with Annual Consortium meetings but are considered separate events. ● Coordinator: is the legal entity that acts as the intermediary between the members of the Parties of the Consortium and HaDEA and DG Sante. The Coordinator shall perform the tasks assigned to it as described in the Grant Agreement and the Consortium Agreement. The Coordinator shall report to and be liable to the General Assembly. The role of the Coordinator is entrusted to the National Public Health Organisation of Greece (NPHO) which will be responsible for overall coordination and management of the JA ImpleMENTAL. Page 9 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 • Executive Board (ExB): Chaired by the JA Coordinator, it is composed of the JA Coordinator, the senior scientific technical management NPHO team, the senior Legal and Financial NPHO Team and all WP leaders/co-leaders. It is the project core team which comprises the specialist roles responsible for creating the project deliverables, thus collaborating with the JA Coordinator in executive decisions and implementation of the work plan on a daily basis. The European Commission, DG SANTE and European Health and Digital Executive Agency (HaDEA) representatives participate as “advisors”. Executive Board Members meet in person or via teleconference every six months and hold short teleconferences on a bi-weekly or monthly basis. These meetings allow the board to have oversight of the project’s current and future activities and results and to discuss progress and difficulties encountered as well as potential solutions. Bi-annually meetings will take place online in M6, 18 and onsite, in M12, M24,M30 & M36. In M12, M24 & M36 ExB meetings are coinciding with Annual Consortium meetings and in M30 with Member State Policy Committee meeting in M30, but are considered separate events. Decisions will be taken based on consensus whenever possible. In case no consensus can be reached, decisions will be taken by majority votes. Advisory bodies of the Consortium The Member State Policy Committee and the Stakeholder Forum have an advisory role of political and scientific relevance also ensuring that the project reaches its objectives and expected impact. Member States Policy Committee: Chaired by the Coordinator, the Member States Policy Committee is composed of representatives nominated by the political/governmental authorities at national/regional level in participating countries. The Members of the Steering Group on Health Promotion, Disease Prevention and Management of Non-Communicable Diseases (SGPP) have selected two best practices (i) the community-based Mental health system reform in Belgium and (ii) the multi level Suicide prevention from Austria to be implemented during this Joint Action with the aim to extend the benefits of these best practices to participating Member States. The Member States Policy Committee will ensure the engagement of National Ministries in the implementation of the two best practices. The aim is to reach out to and engage Ministries national/regional policy-makers, to reflect on and assess the policy relevance and value of JA achievements, and to explore integration of the JA results into national/regional policies. Ministries will be consulted and informed on the implementation process (in collaboration with WP5 and WP6) and on the sustainability work (in collaboration with WP4). This will ensure keeping mental health issues at the forefront of the political agenda for health during and after the completion of the Joint Action. The members will be nominated at the start of the project. Representatives from DG SANTE, HaDEA, WHO-Europe will participate in the meetings. Executive board members will participate in the meetings. The body meets at least bi-annually. The meetings of the Member States Policy Committee are scheduled online in M6 & M18 and onsite in M12, M24, 30 & M36. The meetings in M12, M24 & M36 are coinciding with Annual Consortium Meetings but are considered separate events. A one standalone special Member State Policy committee meeting will take place onsite in M30. Member States Policy Committee members will also be invited to attend the Kick off meeting in M1 and the Annual Consortium meetings. Stakeholder Forum: Chaired by the JA Coordinator, will be composed by representatives of DG SANTE, HaDEA, WHO-Europe, OECD and representatives of major stakeholders e.g.: Associations of users and family/relatives, Health and mental health professionals, media professionals. Executive board members will participate in the meetings. Recruitment criteria and process will be discussed and decided in the initial phase of the JA. The Stakeholder Forum will enable the relevant external stakeholders to follow and contribute to the JA progress and discuss with JA partners the topics linked to it. In particular, it allows the stakeholders to bring in their views, interests and expectations into the JA process and advise on issues of practical relevance/importance for achieving the expected results. The body meets at least annually, onsite meetings are scheduled in M12, M24, & M36, coinciding with Annual Consortium Meetings but are considered separate events. Representatives of the stakeholder forum will also be invited to attend the Annual Consortium meetings. Task 1.2 To ensure smooth management and implementation of the project. Lead: NPHO; Contributors: all partners; Start date: M1 End date: M36 Task description: The management approach of the JA is based on the PM2 methodology of the European Commission, adapted to the context of the JA ImpleMENTAL to ensure smooth management and implementation wp1 will: • Task 1.2a. Develop the project Handbook to establish the high-level approach for implementing the project objectives. Page 10 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 The Project Handbook is one of the main artefacts of the Joint Action. It summarises the project objectives and documents the selected approach for achieving the project goals. It documents the Critical Success Factors (CSFs), the resource allocation. It defines the key controlling processes, the conflict resolution and escalation procedure, policies and rules, and the project mindsets. The Project Handbook also describes the project organizational structure, the key stakeholders, and their roles and responsibilities. It also documents the plans necessary for managing the project Processes which include: 1. the requirements Management Plan, 2. the project Change Management Plan, 3. The Risk Management Plan, 4. the Quality Management Plan, 5.the deliverable acceptance plam, 6.the Issue Management Plan, and 6. The Communications Management Plan as well as any methodology-tailoring decisions. It also included the plans guidelines and other documents) are necessary for the project including the guidelines of the implementation strategy which will facilitate the uptake in the existing mental health systems of the two best practices. The project handbook also mentions the key project progress measurements to be use for monitoring and controlling activities.The Project Handbook is based on the Grant Agreement which includes the agreed project work plan, as well as the Consortium Agreement. The Project Handbook will be the reference document for all project members and stakeholders, and along with the Project Work Plan, is the basis on which the project is managed and executed. The Project Handbook will be kept up to date by the Coordinator. • Task 1.2b: Monitoring and guiding the progress of individual WPs. Progress will be monitored and reported on by the JA WP Lead and Co-Lead Partners. This task will ensure a smooth implementation of the activities, effective monitoring of the milestones and deliverables and the ability to meet the project expected results by defining high quality criteria and deliverables acceptance procedures The monitoring framework will gather data and monitor the progress of tasks, key outputs (—i.e. completed and verified deliverables and milestones) achieved as planned, resource utilization, Logs—i.e. the status and evolution of risks and issues, changes and decisionsand people productivity. The monitoring framework will be closely aligned with the evaluation framework to avoid duplication of work. Ongoing monitoring data will be strategically used to ensure that the JA ImpleMENTAL achieves desired results. Task 1.2c: Based on monitoring data control activities will plan, propose and implement corrective actions to address existing or potentialperformance risks or issues, while updating the relevant project plans and logs Task 1.3: Coordination of the project communication management plan Leader : NPHO / Contributors: All partners ; Start date: M1 End date: M36 Task description: WP1 will develop the Communications Management Plan to ensure that all project stakeholders have the information they need to perform their roles throughout the project. The Communications Management Plan defines and documents the communication items content, format, frequency, the audience and expected results. It also defines how to communicate project status and the assignment of activities to the various stakeholders, and the communication strategy for each stakeholder, based on their interests, expectations and influence in the project.Planning and executing project communication activities is essential for project success. The primary forms of internal communication and exchange of documents among JA ImpleMENTAL partners will be e-mail, web or teleconferences, File sharing management platform transfer and face-to-face meetings. For legal and administrative issues, the AEs will communicate with their CAs, and these will do the same with the Coordinator. The following activities will be carried out to effectively inform stakeholders: • Task 1.3a: Develop stakeholder matrix amd level of information to be communicated according to the communication management plan. • Task 1.3b: Act as liaison with coordinators or contact points of other ongoing or recently completed EU projects or initiatives and Joint Actions of relevant topics to ensure clear communication and exchange of information; Link specifically with (policy aspects of) the actions focused on implementation of other good practices in mental health • Task 1.3c: Regularly update the share-point platform for all internal documents; • Task 1.3d: Support WP collaboration and interactions through regular emails and web/audio conferences; • Task 1.3e: Meetings (ExBmeetings, General Assembly Meetings, Annual Consortium Meetings, Member State Policy Committee meetings, Stakeholder forum) • Task 1.3f: Communication documentation: Minutes of Meetings. Project Reports, Project Work Plan (updated estimates of effort and schedule), Project Logs. Task 1.4: Financial management Leader: NPHO / Contributors: All Partners ; Start date: M1 End date: M36 Task description: The Chief Financial NPHO officer will coordinate this task and assist the JA Coordinator in: • Task 1.4a: Communicating rules for financial administration and management and supporting their implementation; Page 11 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 • Task 1.4b: Managing and distributing EC payments; • Task 1.4c: Evaluating and monitoring project costs in order to oversee and check the overall costs incurred per Work package and per partner (competent authority and affiliated entities) while partners are fully liable for their linked third parties. • Task 1.4d: Preparing interim and final financial reports for HaDEA and acquiring all information and documents needed for this task including but not limited to the collection of internal reports from members of the consortium; • Task 1.4e: Assisting individual project partners on specific administrative and financial issues; • Task 1.4f: Adapting, if necessary, financial planning and aspects of the project activities based on the progress of the project, the completion of milestones and deliverables and partner engagement. Task 1.5 Scientific contribution in the scientific aspects of the JA in order to ensure its scientific integrity, robust methodology, policy implications and deliverable acceptance Leader : NPHO / Contributors: All wp leaders-co-leaders ; Start date: M1 End date: M36 Task description: WP1 will provide scientific contribution in scientific aspects of the project, in close cooperation with WP5 & WP6, of the project during the whole implementation period in order to ensure that the JA wokplan is implemented as planned or according to changes agreed during the executing phase. WP1 in close cooperation with all WP lealders will link the activities of all work packages, address the scientific interlinkages among the WPs, including between the two technical ones, as there are areas which may potentially overlap between them (.g. SANA, see below), facilitate scientific dialogue and communication across the WPs will establish mechanisms to ensure the scientific integrity, robust methodology, evidence-based policy implications and work for the delivery of highquality results within the identified objectives and constraints in order to achieve deliverable acceptance.This task will support compliance with the European General Data Protection Regulation (GDPR),providing that data is maintained and kept according to the regulated principles. WP1 deliverables acceptance planning activities, will include the review and acceptance of deliverables and dissemination documents. The quality assurance activities implemented by WP1 aim to increase the likelihood that deliverables will be accepted by HaDEA and that the resources involved in the acceptance will be used in an efficient way. They include a) the agreement on the process for the deliverable structure contents of the deliverable and the acceptance criteria, that the organization in charge of the deliverable agrees with the WP(co)Leader and the Coordinator, according to its description agreed in the Grant Agreement and b) the deliverable review and acceptance process which will be included in the project handbook. Participation per Partner Partner number and short name WP1 effort 1 - NPHO 93.00 2 - BMSGPK 0.00 GÖG 2.00 3 - NCPHA 1.00 4 - CIPH 2.00 5 - MHS CYPRUS 1.00 6 - MZCR 1.00 NIMH 1.00 7 - MSAE 1.00 8 - THL 1.00 9 - MOH FRANCE 1.00 10 - BZgA 2.00 11 - OKFO 1.00 SU 0.50 Page 12 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Partner number and short name WP1 effort UD 0.50 12 - DOHI 1.00 13 - LOMBARDY REGION 0.50 ASST LECCO 0.50 FBF 0.50 14 - SAM 1.00 15 - MFH 1.00 16 - TRIMBOS 2.00 17 - HDIR 1.00 18 - IPHS 1.00 19 - NIJZ 2.00 20 - SMS 1.00 FFIS 1.00 21 - FOHM/PHAS 1.00 Total 121.50 List of deliverables Due Deliverable Deliverable Title Lead beneficiary Type 15 Dissemination level 16 Date (in Number14 months)17 Confidential, only for members of the D1.1 Project Handbook 1 - NPHO Report consortium (including 2 the Commission Services) Description of deliverables D1.1 Project Handbook (M6): The Project Handbook is one of the main artefacts of the JA and summarises the project objectives and documents the selected approach for achieving the project goals. It also highlights the communication plan, it documents the Critical Success Factors (CSFs), defines the key controlling processes, the resource allocation, the conflict resolution and escalation procedure, policies and rules, and the project mindsets. The Project Handbook also documents the project governance roles and their roles and responsibilities, and defines the plans necessary for managing the project as well as any methodology-tailoring decisions. It documents the selected approach for achieving the project goals and establishes the implementation strategy, as well as the management and monitoring framework. D1.1 : Project Handbook [2] Report Page 13 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Schedule of relevant Milestones Due Milestone Milestone title Lead beneficiary Date (in Means of verification number18 months) Organisation of kick-off meeting online completed MS1 1 - NPHO 1 (meeting, agenda & preparatory documents) MS2 Project Management platform 1 - NPHO 6 All governance structures are MS3 established, with clear roles 1 - NPHO 4 and responsibilities Organization of onsite Consortium meetings MS4 including Final Conference 1 - NPHO 12 completed (meeting, agenda & preparatory documents) - 1 Organization of onsite Consortium meetings MS5 including Final Conference 1 - NPHO 24 completed (meeting, agenda & preparatory documents)- 2 Organization of onsite Consortium meetings MS6 including Final Conference 1 - NPHO 36 completed (meeting, agenda & preparatory documents) -3 Member State Policy Committee onsite meeting MS7 1 - NPHO 30 completed (meeting, agenda & preparatory documents) Organization of General Assembly, Executive board, Member States Policy MS8 1 - NPHO 36 Committee, Stakeholder forum meetings completed (onsite or online) Page 14 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Work package number 9 WP2 Lead beneficiary 10 4 - CIPH Work package title Dissemination Start month 1 End month 36 Objectives 1. To facilitate coherent and effective external and internal communication of the JA and to ensure that its objectives, activities, results and deliverables are known to stakeholders, interested bodies, beneficiaries and the wider audience of the action (including citizen outreach), as well as to offer specific discussions on the different social, cultural and/ or political contexts. 2. To develop a communication and dissemination plan to raise awareness about project findings as well as to discuss the translatability and applicability of findings for other contexts and Member States in Europe. 3. To disseminate country-specific evidence on the effectiveness and the implementation process of the intervention. 4. To facilitate knowledge transfer and exchange of processes, experiences and evidence in the course of WP implementation by different communication channels to various target audiences. The specific objectives of the Work Package are: ● To ensure the project’s visibility through traditional and new media and that the results and deliverables of the Joint Action are known both to the general public and the stakeholders. ● Develop sustainable tools for internal communication (coordinated by WP1) ● To actively engage stakeholders throughout the course of the project in order to ensure that: o the aim of the knowledge transfer through replication of the selected good practices would be transparently introduced to the citizens and other stakeholders, o the results of the project are applicable and appropriate to stakeholders. o WP2 will interact with all other WPs, to align activities and to ascertain dissemination of all project results ● To improve knowledge sharing, capacity and use of the JA methodologies, tools and practices by supporting the work of all WPs with relevant communication and engagement tools. An event management platform should be developed in case conferences and training need to be managed digitally ● Through communication and dissemination of project results, enable the implementation of results in national mental health policies and thus ensure sustainability. Description of work and role of partners WP2 - Dissemination [Months: 1-36] CIPH, NPHO, BMSGPK, NCPHA, MHS CYPRUS, MZCR, MSAE, THL, MOH FRANCE, BZgA, OKFO, DOHI, LOMBARDY REGION, SAM, MFH, TRIMBOS, HDIR, IPHS, NIJZ, SMS, FOHM/PHAS T2.1: Development Of The Visual Identity of the Project (LEADER: CIPH, MAJOR CONTRIBUTOR OKFO, PARTICIPANTS: ALL) (M1-M6) A project website will be created at the beginning of the project to showcase information about the project (including work packages), news and updates, and information about mental health. The website will be published in English. The project will also be featured on the websites of each of the partner organisations. The JA website can serve as an important repository of relevant information about mental health (e.g. links to previous JA: https:// www.mentalhealthandwellbeing.eu/ and relevant ongoing EU projects: http://www.magnet4europe.eu/ etc.), which will be continuously updated with the latest content during the whole duration of the JA. All the dissemination related material, such as project logo, templates for internal and public documents, leaflet format, etc., will be defined at the very beginning of the project in order to establish the project image as soon as possible. The corporate identity and communication tools will be developed for the project in line with what will be developed by JA to ensure consistency. A temporary “Landing” page of JA Website will be launched with limited content and simplified layout to support early communication with stakeholders and the general public before the delivery of the final website. T2.2: Stakeholder analysis (LEADER: OKFO, MAJOR CONTRIBUTOR: CIPH, PARTICIPANTS: ALL) (M1-M6) This task aims at mapping the stakeholders involved in mental health in all MS/partners involved in the JA including existing networks and EU-funded or international projects. This task will take place at the beginning of the project. The objective is to identify all categories of the population who could directly benefit from the project (professionals, population groups, patients, citizens), who could be the best advocates (policy makers, Member States governments, Page 15 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 health managers, private sector) or who could develop resistance to the implementation of the JAs at the very beginning. In addition the analysis will offer information about stakeholder groups who may have an impact on potential barriers/ enablers to the implementation. Each country has been asked to provide a detailed list of key stakeholders before the beginning of the project. Templates for the stakeholder mapping will be developed (M3) and distributed to all partners involved in the JA and stakeholder analysis should be completed by M6. Complementary to the groups provided by JA partners, collaborating stakeholders will be also chosen through an open call that will be conducted based on the experiences of JA TEHDAS. This method will also contribute to collecting information for the stakeholder analysis through the learnings of processing stakeholders’ interest and need. T2.3: Development of the Dissemination strategy (LEADER: OKFO, MAJOR CONTRIBUTOR: CIPH, PARTICIPANTS: ALL) (M1-M7) This strategy is to specify the dissemination aims and objectives, making an analysis/mapping of stakeholders and specific target groups and plan communication and dissemination activities, detailed activity planning, stakeholder mapping and identification of the tailored target groups, messages catered towards various target groups (final targets and multipliers, including decision makers and journalists), the timing of the dissemination actions and the visibility of European Union co-funding, as well as the description of the JA internal and overall communication. Specific needs of the 2 technical WPs will be taken into account. The strategy will be based on the analysis implemented in Task 2.2 and it will be updated on an annual basis. T2.4: Identifying Dissemination Channels and Networks (LEADER: OKFO, MAJOR CONTRIBUTOR: CIPH, PARTICIPANTS: ALL) (M6-36) This task consists of identifying communication channels (e.g. websites, news updates, media, social media, events) and networks (building on existing networks), in agreement with the EC (and their channels, such as the EU Health Policy Platform ) and with JA partners. The JA dissemination material will be included in the EU Health Policy Platform to guarantee sustainable dissemination of the JA results. An ad hoc website will be also used along with other relevant websites according to specific objectives. T2.5: Development of Communication Tools (LEADER: CIPH, MAJOR CONTRIBUTOR OKFO, PARTICIPANTS: ALL) (M8-36) This task consists of the creation of relevant communication tools, e.g. two main deliverables of a leaflet at the beginning of the JA and a layman version of the final report at the end of the JA. Other communication tools will be used, such as newsletters, posters, press releases, presentations, blogs, and personal and/or online events (meetings, conferences, workshops, exhibitions) and press communication kits. Furthermore, this task includes the standard communication work that a JA requires, like writing, editing, finding pictures, posting on social media and developing infographics. More than one social media platform will be used as there may be differences in what is predominantly used in specific age groups and countries, like for example Facebook, Instagram, Twitter and WhatsApp depending upon the information which will be disseminated. The main language will be English and, when appropriate, translations will be made into other languages in cooperation with MS. The templates and design of communication tools will follow defined publicity guidelines, including the use of a brand style logo and further mandatory elements. The aim is to provide effective visibility and accessibility of the results and outputs of the JA. Communication tools for communication and file sharing with project partners will be provided by the Croatian Institute of Public Health. The project results will also be shared on the database of health projects managed by the European Commission's European Health and Digital Executive Agency (HaDEA):https:// hadea.ec.europa.eu/index_el and in Project & Result area at European Commission's Funding & tender opportunities in order to increase visibility and sustainable of project results after the project ends. Using the EU Health Policy Platform (EU HPP) throughout the JA will support the virtual exchange management of stakeholders. The organization of webinars and online policy dialogues would additionally support the visibility and accessibility of the outputs and results of the JA. The JA will create the network dedicated to this project at the Agora Network of the EU HPP and publish news related to the project on the Agora Network of the EU HPP, which is accessible to all users, or dedicated networks of e.g. Exchange Networks, Stakeholder Networks or Member State-led Networks with selected members could contribute to share knowledge and information on this specific topic more effectively. T2.6: EU Level Dissemination Events and Final Conference (LEADER: CIPH, MAJOR CONTRIBUTOR OKFO, PARTICIPANTS: ALL) (M1-36) Presentations of implementation of best practices in the area of mental health at meetings, conferences and symposiums, workshops with key stakeholder groups at EU level to disseminate project findings and processes for broader applicability and final conference of the Joint Action. The visibility of EU co-financing will be ensured. Page 16 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Participation per Partner Partner number and short name WP2 effort 1 - NPHO 7.00 2 - BMSGPK 0.00 GÖG 3.50 3 - NCPHA 1.50 4 - CIPH 33.00 5 - MHS CYPRUS 2.00 6 - MZCR 2.00 NIMH 1.50 7 - MSAE 2.00 8 - THL 1.00 9 - MOH FRANCE 1.50 10 - BZgA 3.50 11 - OKFO 8.50 SU 16.00 UD 2.00 12 - DOHI 1.50 13 - LOMBARDY REGION 0.00 MNIPR 1.00 UNIMIB 0.50 ASST LECCO 1.00 FBF 0.65 14 - SAM 1.50 15 - MFH 2.00 16 - TRIMBOS 3.50 17 - HDIR 1.50 18 - IPHS 1.50 19 - NIJZ 2.00 20 - SMS 0.25 SERMAS 0.15 FPS 0.15 Osakidetza 0.15 SNS-O 0.15 FFIS 0.70 CatSalut 0.15 SAS 0.15 Page 17 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Partner number and short name WP2 effort Consej- Mujer 0.15 21 - FOHM/PHAS 2.00 Total 105.65 List of deliverables Due Deliverable Deliverable Title Lead beneficiary Type15 Dissemination level16 Date (in Number14 months)17 D2.1 Introductory leaflet 4 - CIPH Report Public 3 Websites, D2.2 Project Website 4 - CIPH patents filing, Public 3 etc. D2.3 Dissemination strategy 11 - OKFO Report Public 6 Mid-term report on D2.4 4 - CIPH Report Public 18 Dissemination Layman Version of the D2.5 4 - CIPH Report Public 36 Final Report Final Report on D2.6 4 - CIPH Report Public 36 Dissemination Description of deliverables D.2.1 Introductory Leaflet [3] - This is a publication with core project information to promote the JA with easy-to-understand details. D2.2. Project Website [3] - This website will provide project and WP level information on all activities of the project. It will also feature a dedicated page for events and well as the newsletters. D. 2.3 Dissemination Strategy [6] - Strategy specifies the dissemination aims and objectives, detailed activity planning, identification of the target groups, dissemination channels, the timing of the dissemination actions and the visibility of European Union co- funding, as well as the description of JA. D 2.4 Mid-term Report on Dissemination [18] - Data analytics driven analysis to answer the key communications questions: Who are the followers of the news/ information presented by the project? Which content resonates with the audience? D.2.5 Layman version of the Final Report [36] This is a short, 4 pages version of the final report with infographics, written for the wide public as a target group. D.2.6 Final report on Dissemination [36] - Data analytics driven analysis, making the final evaluation of the communication activities. D2.1 : Introductory leaflet [3] Report D2.2 : Project Website [3] Main tool to showcase information about the JA D2.3 : Dissemination strategy [6] Specifying dissemination aims and objectives, mapped stakeholders and specific target groups as well as planning communication and dissemination activities D2.4 : Mid-term report on Dissemination [18] Page 18 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Reports on the implementation of the dissemination activities and CDP D2.5 : Layman Version of the Final Report [36] The report targets at a non-specialist audience and serves to inform decision makers and non-technical parties of the JA objectives and results. D2.6 : Final Report on Dissemination [36] Key element of communication tools Schedule of relevant Milestones Due Milestone Milestone title Lead beneficiary Date (in Means of verification number18 months) Launching ImpleMENTAL- MS9 network on the EU Health 11 - OKFO 5 Policy Platform Launching Landing page of MS10 4 - CIPH 3 JA Website MS11 Final Conference 4 - CIPH 36 Launching Final Results on the EU Health Policy MS12 11 - OKFO 36 Platform and specific websites Page 19 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Work package number 9 WP3 Lead beneficiary 10 16 - TRIMBOS Work package title Evaluation Start month 1 End month 36 Objectives This Work Package covers both an internal evaluation of JA-ImpleMENTAL’s process and achievement of outcomes against the specified objectives as well as an evaluation of the impact of JA-ImpeMENTAL on the target group and on mental health systems and policy in Europe. The two main objectives of this WP are therefore: Objective 1: 1. To assess the achievement of project objectives set out in the JA and whether outcomes of the JA meet the needs of and/or within Member States; 2. To assess the JA’s impact by evaluating the implementation of all WPs of JA- ImpleMENTAL Specific objectives related to Objective 1: ● Develop a monitoring and evaluation strategy for the internal evaluation of the Joint Action, including evaluation tools and indicators ● Perform an interim- and final evaluation that result in an interim and final evaluation report Objective 2: 1. To assess the JA’s impact by evaluating the implementation processes across MS in implementing good practices for mental health, including key ingredients, challenges, and considerations for further implementation and scale-up. Specific objectives related to objective 2 ● Development of a monitoring and evaluation strategy for assessing the implementation process and implementation outcomes of the good practices in MS (covered in technical WP’s 5 and 6) including development of metrics and tools ● Provide ongoing evaluation support and guidance to MS on evaluation activities related to the implementation of the 2 good practices ● Evaluate and synthesise lessons learned from implementation (process and outcomes) of good practices (in close collaboration with the technical WP leaders and task leaders) The evaluation WP is designed to work closely with the implementation WP’s to streamline evaluation efforts and feed findings and lessons learned to the Sustainability WP. This WP should be seen as a learning network that measures and evaluates change and implementation processes across MS implementing the good practices, and evaluate. Description of work and role of partners WP3 - Evaluation [Months: 1-36] TRIMBOS, NPHO, BMSGPK, CIPH, MHS CYPRUS, MZCR, MSAE, THL, BZgA, OKFO, DOHI, LOMBARDY REGION, SAM, MFH, HDIR, NIJZ, SMS, FOHM/PHAS Task 3.1 Develop an evaluation strategy for evaluation of the JA, to assess the output from all WP’s Task lead: Trimbos Co-lead: Fundacion ́ para la Formacion ́ e InvestigacionSanitarias ́ de la Region ́ de Murcia (FFIS) PARTICIPANTS: ALL (M1-M12) This task involves the development of an evaluation strategy to monitor and evaluate the output from all work packages. This task involves close cooperation and input from WP1 as well as from the Executive Board to this JA, governed under WP1. This includes developing an evaluation approach, reviewing indicators across WPs based on the overall and specific objectives, and developing tools to conduct the evaluation. The evaluation plan will assess both the process and impact of the horizontal and vertical WPs of the JA through a systematic appraisal in terms of results (if the JA achieved its objectives) and in terms of quality (whether the outcomes meet the needs of the target groups and mental health policy priority areas). This includes developing an evaluation approach, reviewing indicators across WPs based on the overall and specific objectives, and developing tools to conduct the evaluation. Evaluation will pay specific attention to the sustainability of activities, e.g., inclusion of activities at the national levels and if they are embedded in organizational structures/services and/or policies. Task 3.2 Evaluate the Joint Action (all WPs) Task lead:Trimbos Co-lead:Fundacioń para la Formacion ́ e InvestigacionSanitarias ́ de la Region ́ de Murcia (FFIS) Page 20 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 PARTICIPANTS: ALL (M1-M36) This task involves conducting an evaluation of all actions undertaken to assess if the project is being implemented as planned and reaches its objectives. Coordination with the monitoring processes of WP1 is essential to avoid overlap and duplication of work. The evaluation will consist of a process evaluation, which will include different components including self-evaluation (per WP), review of progress on (content) indicators per WP. The evaluation will culminate in a report with recommendations to suggest how the implementation of the JA could be improved to optimise processes in the JA. Task 3.3 Evaluation of the implementation of pilot practices in WP5/6 Task lead: Trimbos PARTICIPANTS: ALL implementing countries (M1-M36) This task is concerned with creating an evaluation strategy for assessing the implementation of pilot practices in the technical work packages (WP5 and WP6). This strategy will provide options for technical WP’s and MS in assessing the implementation process and outcomes. The evaluation strategy will be developed at the beginning of the project, via a consultative process with endorsement and active involvement of WP1, 5, and 6 leaders. Activities include: 1) Development of a common evaluation strategy. It is anticipated that evaluation of the implementation process and some implementation outcomes may be feasible to assess within the timeframe and resources of the JA; however, a full impact evaluation will not be feasible. Choices will need to be made early in the JA as a Consortium about a strategy (developed in this WP, in close collaboration with WP1 and technical WP’s) on how to reflect the diversity of practices implemented across MS in a meaningful evaluation. The evaluation strategy will therefore: a) Reflect evaluation options to capture the diversity of approaches to implementing the 2 good practices across MS b) Determine methods and tools (in collaboration with WP5, particularly task 5.4) c) Determine research/evaluation priorities/questions and developing/agreeing on a set of (process, output and outcomes) indicators d) Develop common tools (e.g., questionnaires, general guidelines for evaluation, forms/logbooks, checklists) 2) Member States will develop a pilot-specific evaluation plan on the basis of the aforementioned evaluation strategy developed by the WP3 team. The plan will be tailored to pilot organization and context, and describe the evaluation processes, the evaluation questions/focus, methods, tools and indicators used for evaluation of the pilot practice, stakeholders and other resources involved. The plan will include, but is not limited to, relevant research and evaluation questions, evaluation methodology, tools and indicators for evaluation. a) Where necessary, organise (digital) workshops for implementing partners in each technical WP to prepare and provide guidance for the development of an evaluation plan by each MS; 3) Member States carry out evaluation activities in accordance with their tailored evaluation plan, by implementing partners in each MS (using monitoring methods and tools defined for each pilot) with collaboration and support from the WP3 team. Guidance and support are provided by WP3 leaders (and WP6 and WP5 leaders where needed) 4) The task leader will serve as an evaluation hub, providing ongoing guidance and support on evaluation and research to MS and to other WPs. This includes providing advice and feedback from the research and evaluation perspective to MS on adapting the common evaluation strategy to their own local circumstances. Each MS will do a local adaptation of the common evaluation strategy mentioned above, adapted for local relevance, data sources, and resources. 5) Preparation of an evaluation report by each implementing MS describing evaluation methods and steps, reporting evaluation results; 6) Contributing to discussions in technical WPs on metrics and tools employed in WP5/6 that can support MS in implementation of good practices. Task 3.4 Develop a meta-synthesis of local evaluations in MS in order to identify success factors and barriers in implementation Task lead: Trimbos PARTICIPANTS: ALL Implementing countries (M25-M36) This task concerns conducting a meta-synthesis of the pilot evaluations in MS, and recommendations for continued implementation of the good practices as well as evaluation needs and priorities to assess impact. The meta-synthesis will focus on both process outcomes and implementation outcomes (such as acceptability of the new model of care, uptake of the reform, or sustainability considerations), using mixed methods. Specific sub-tasks include: 1) Develop, adapt and finalize a methodology for the meta-synthesis 2) Write a summary report based on the meta-synthesis that will a) synthesise the insights gained through the EU MS pilot evaluations; 2) integrate and reflect on results and insights of cross-country collaboration and exchange of implementation experiences, and 3) outline policy and practice implications and recommendations. Page 21 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 3) Leading a consultative process of the draft synthesis with MS 4) Package and disseminate findings from the meta-synthesis to be fed back into implementation and sustainability work packages, particularly to support objectives of WP4 (Sustainability) to ensure in particular that policy and practice implications are considered against sustainability indicators outlined in WP4 and discussed in workshops and policy dialogues led by WP4. Participation per Partner Partner number and short name WP3 effort 1 - NPHO 14.00 2 - BMSGPK 0.00 GÖG 10.35 4 - CIPH 10.60 5 - MHS CYPRUS 9.20 6 - MZCR 3.00 NIMH 7.00 7 - MSAE 9.80 8 - THL 5.00 10 - BZgA 10.70 11 - OKFO 3.65 SU 0.50 UD 7.75 12 - DOHI 5.40 13 - LOMBARDY REGION 0.00 MNIPR 1.00 POLIMI 2.00 UNIMIB 3.50 ASST LECCO 2.00 FBF 1.50 14 - SAM 5.40 15 - MFH 7.00 16 - TRIMBOS 22.05 17 - HDIR 5.40 19 - NIJZ 9.80 20 - SMS 2.50 SERMAS 0.50 FPS 0.50 Osakidetza 0.50 SNS-O 0.50 FFIS 11.50 Page 22 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Partner number and short name WP3 effort CatSalut 0.50 SAS 0.50 Consej- Mujer 0.50 21 - FOHM/PHAS 5.00 Total 179.10 List of deliverables Due Deliverable Deliverable Title Lead beneficiary Type 15 Dissemination level 16 Date (in Number14 months)17 D3.1 Evaluation Strategy 16 - TRIMBOS Report Public 9 Mid-term report on D3.2 16 - TRIMBOS Report Public 18 Evaluation D3.3 Meta-synthesis report 16 - TRIMBOS Report Public 36 D3.4 Final evaluation report 16 - TRIMBOS Report Public 36 Description of deliverables D 3.1 Evaluation Strategy[9] -Preparation and publication of the evaluation strategy [9] D 3.2 Mid-term report on Evaluation [18] -Report on the progress, processes and outcomes, and recommendations for the remaining work period D 3.3 Meta-synthesis report [36] -Report on lessons learned across MS in the implementation of good practices D 3.4. Final Evaluation report [36] - The final evaluation report outlining the central outcomes and conclusions related to the objectives. D3.1 : Evaluation Strategy [9] Report on the final evaluation of the JA based on the Strategy D3.2 : Mid-term report on Evaluation [18] Report on the progress, processes and outcomes, and recommendations for the remaining work period. D3.3 : Meta-synthesis report [36] Meta synthesis on the results from the good practices based on the evaluation framework D3.4 : Final evaluation report [36] The final evaluation report outlining the central outcomes and conclusions related to the objectives. Schedule of relevant Milestones Due Milestone Milestone title Lead beneficiary Date (in Means of verification number18 months) Evaluation framework for MS13 16 - TRIMBOS 9 internal evaluation of the JA Page 23 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Schedule of relevant Milestones Due Milestone Milestone title Lead beneficiary Date (in Means of verification number18 months) Evaluation framework for MS14 evaluation of the two good 16 - TRIMBOS 9 practices MS piloting good practices have an adapted evaluation plan in place to reflect local MS15 contexts and resources for 16 - TRIMBOS 12 the effective evaluation of the pilot implementation of the good practices in each MS Page 24 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Work package number 9 WP4 Lead beneficiary 10 11 - OKFO Work package title Sustainability Start month 1 End month 36 Objectives Although a project is by definition limited in time, the purpose is to make the results and outcomes sustainable. The sustainability plan or strategy for the potential uptake and integration in national policies should therefore pay attention to the transfer of knowledge and to the processes needed for embedding knowledge into policy and practice. The key to sustainability is finding a win-win for all stakeholders, requiring a value-based approach that focuses on maximizing the benefits from the implementation of good practices while minimizing adverse effects and unnecessary costs. The WP will provide recommendations to MSs to identify and overcome local/specific obstacles and to turn pilot results into permanent policy. The objectives of this WP is to: ● Actively engage key stakeholders involved at national and European level in the knowledge transfer in the area of mental health, and communicate the value and impact of the knowledge generated in the JA; ● Determine a framework for stakeholder collaboration and knowledge translation to embed results and lessons learned in ongoing practice and policy and facilitate creation of networks on both national and international level that can be sustained after the JA ends; ● Consolidate information and knowledge generated in a format relevant and useful for policy makers via a policy toolkit containing guidance for MS how to proceed after the pilot promoting sustainable implementation; ● Estimate the benefits and value of the implementation of the two good practices and identify considerations for economic sustainability; ● Support all individuals implementing MS in creating optimal preconditions for a sustainable implementation of the intervention(s) after the JA has finished. Description of work and role of partners WP4 - Sustainability [Months: 1-36] OKFO, NPHO, BMSGPK, NCPHA, CIPH, MHS CYPRUS, MZCR, MSAE, THL, MOH FRANCE, BZgA, DOHI, LOMBARDY REGION, SAM, MFH, TRIMBOS, HDIR, IPHS, NIJZ, SMS, FOHM/PHAS Throughout this WP, collaboration with the dissemination, evaluation and the technical WPs is essential to ensure data and findings are translated into policy lessons, and that considerations and ingredients for sustaining the good practices and mental health policies are identified. This WP will also work closely with the JA Member State Policy Committee in WP1 (consisting of governmental experts) to maximise opportunities for sustaining the results of the JA and implementing good practices beyond the lifespan of the JA in national policies and programs. Specific activities include: Task 4.1: Develop a unified conceptual model to guide the process of translating knowledge into policy & practice. Task lead: Trimbos Co-lead: OKFO (HU) PARTICIPANTS: ALL (M13-M36) This activity is concerned with selecting a knowledge to policy translation model and adapting it to the context of the JA. This model will be validated with the JA consortium and used as a framework for consolidating information for policy dialogues, and the sustainability plan. This task is linked to D.4.1 (M18), and follow-up activity will be performed till M36. ________________________________________Task 4.2: Support the process of embedding knowledge gained from the implementation of the good practices through thematic workshops to facilitate networking, and support stakeholders in understanding how changes/results from pilots can be sustained Task lead: Trimbos PARTICIPANTS: ALL (M01-M36) These workshops will not only facilitate the development of a network focused on mental health system development, but also provide a platform to make the case for why mental health transformations are important now, and what envisaged outcomes of these transformations can be in the short and long-term. Delivery of workshops with MS/C will start once there are already lessons learned in WP5 and WP6 that can be identified from implementation. Preparatory work to design the workshops and detail a strategy for it will be done during M01-M13. Where possible, a stakeholder analysis (potentially developed in the other WPs) will be used to assist with identification of stakeholders. Based on input from these networks, a policy toolkit will be developed containing all relevant Page 25 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 information for individual MS to take the next steps in creating support among relevant stakeholders, specifically local and national policy makers. This task is linked to D.4.2 (M24), M.4.2 (M27), and follow-up activity will be performed till M36. Task 4.3: Policy dialogues in MS/C to jointly develop a roadmap to advance mental health policy priorities in Europe beyond the JA Task lead: OKFO (HU) Co-lead: Trimbos (NL) PARTICIPANTS: ALL) (M01-M36) This activity involves the design and execution of policy dialogue sessions, which generate possibilities/opportunities around a key policy question (e.g., how to finance community mental health teams for the next 5 years) with a corresponding action plan (with responsibilities, budget, communication channels). Policy dialogues will bring together decision-makers at local, regional and national level together in the MS/C implementing the good practices around the core issues needed for sustainable changes in mental health systems development. Priorities for key policy questions, needs and issues to be discussed in the policy dialogue sessions, will be mapped, and presented in an initial set of prioritised needs and challenges for sustaining good practices across member states. Information will be collected through online questionnaires to the advisory bodies of the Joint Action (the Member State Policy Committee and the Stakeholder forum ), in collaboration with WP1, as well as inputs from other work packages, especially lessons learned from the SANAs that will be delivered in WP5 and WP6. The policy dialogues - through events offering specific discussions on the different social, cultural and/or political contexts and gain information about the background of possible barriers/enablers to implementation - will also package evidence on the implementation process and (potential) impact evaluation of the implemented practices to support decision-makers in understanding the results of the JA and how this can guide subsequent decisions in mental health system changes. In case of MS implementing the mental health reform, this task will build on the country specific implementation roadmaps which will define objectives and main milestones for a continuation, extension or scale-up of the pilots beyond the JA's duration. This task is linked to M.4.1. (M20), M.4.3 (30), and follow-up activity will be performed till M36. Task 4.4: Elaboration of a common sustainability plan (CSP), built on the results achieved at the previous milestones of the WP and the cooperation with all WPs. Task lead: OKFO (HU) PARTICIPANTS: ALL) (M13-M36) The CSP will: • Contain information or ‘signposts’ that can assist the MS/C scale-up of the service delivery transformations • Define core elements for sustainability • Contain a guide for estimating investments, trade-offs and financial planning for sustaining results in mental health care transformations • Develop, identify and use SMART indicators, in close cooperation with WP 5 & 6 to monitor and evaluate the effectiveness and efficiency of the sustained practice. These indicators can serve as determinants of new mental health system developments beyond the lifespan of the JA. This task is linked to D.4.3 (M36). Task 4.5: Support next adopters (i.e. outside of this JA) identified through the stakeholder analysis practices(s) by informing them about key ingredients and processes for scale-up Task lead: OKFO (HU) PARTICIPANTS: ALL (M19-M36) This activity will focus first on identification of ‘next adopters’ (MS or perhaps regional authorities) interested in implementing partial or complete versions of the good practices. Second, this activity will provide advice and guidance to these next adopters. These consultations with organizations/MS will focus on going through the Common Sustainability Plan and highlighting policy and implementation considerations for implementing the good practices on the basis of lessons learned in this JA. This task is linked to M.4.4 (M34), and follow-up activity will be performed till M36. Participation per Partner Partner number and short name WP4 effort 1 - NPHO 11.50 2 - BMSGPK 0.00 GÖG 7.00 Page 26 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Partner number and short name WP4 effort 3 - NCPHA 2.50 4 - CIPH 11.50 5 - MHS CYPRUS 7.00 6 - MZCR 2.00 NIMH 5.00 7 - MSAE 7.00 8 - THL 4.00 9 - MOH FRANCE 0.75 INSERM 0.75 10 - BZgA 7.00 11 - OKFO 14.75 SU 14.75 UD 5.00 12 - DOHI 4.00 13 - LOMBARDY REGION 0.50 MNIPR 3.50 POLIMI 1.00 ASST LECCO 1.75 FBF 3.00 14 - SAM 4.50 15 - MFH 4.00 16 - TRIMBOS 16.00 17 - HDIR 3.00 18 - IPHS 2.50 19 - NIJZ 7.00 20 - SMS 1.80 SERMAS 0.55 FPS 0.55 Osakidetza 0.55 SNS-O 0.55 FFIS 1.35 CatSalut 0.55 SAS 0.55 Consej- Mujer 0.55 21 - FOHM/PHAS 3.00 Total 161.25 Page 27 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 List of deliverables Due Deliverable Deliverable Title Lead beneficiary Type 15 Dissemination level 16 Date (in Number14 months)17 Conceptual model for translating knowledge D4.1 into policy and practice 16 - TRIMBOS Report Public 18 changes selected and applied in the JA D4.2 Policy toolkit 16 - TRIMBOS Report Public 24 Common sustainability D4.3 16 - TRIMBOS Report Public 36 plan Description of deliverables D. 4.1 Conceptual model for translating knowledge into policy and practice changes selected and applied in the JA [18] - A unified conceptual model to guide the process of translating knowledge into policy & practice (by Task4.1, M13-M36, and follow-up activity will be performed till M36) D. 4.2 Policy toolkit [24] - Policy toolkit, including a roadmap for mental health system development for policymaker (by Task4.2, M1-M36, and follow-up activity will be performed till M36) D. 4.3 Common sustainability plan [36] - A common sustainability plan, built on the results achieved at the previous milestones of the WP and the cooperation with all WPs (by Task4.4, M13-M36) D4.1 : Conceptual model for translating knowledge into policy and practice changes selected and applied in the JA [18] A unified conceptual model to guide the process of translating knowledge into policy & practice (by Task4.1, M13- M36, and follow-up activity will be performed till M36) D4.2 : Policy toolkit [24] Policy toolkit, including a roadmap for mental health system development for policymaker D4.3 : Common sustainability plan [36] Plan on how sustainable change can be promoted Schedule of relevant Milestones Due Milestone Milestone title Lead beneficiary Date (in Means of verification number18 months) Initial set of prioritised needs and challenges for sustaining MS16 11 - OKFO 9 good practices are mapped across member states Workshops completed incl. MS17 synthesis and Initial set of 11 - OKFO 27 practical recommendations Short report of the synthesis MS18 of the dialogue sessions and 11 - OKFO 30 roadmap finalized Page 28 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Schedule of relevant Milestones Due Milestone Milestone title Lead beneficiary Date (in Means of verification number18 months) Knowledge to policy model is MS19 validated and adopted by MS/ 11 - OKFO 34 C Page 29 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Work package number 9 WP5 Lead beneficiary 10 10 - BZgA Transfer and pilot Implementation of the Belgian best practice on reform of the mental Work package title health (MH) services Start month 1 End month 36 Objectives The overall objective is to support adaptations in the management and organisation of mental health (MH) services from institutionalised MH care towards the (sustainable) establishment of intersectoral, community-based, client-centred and integrated local MH promotion, care and prevention networks and services in the participating countries. Specific objectives: Support the introduction, further development or scale-up of intersectoral community-based and client-centred MH promotion, care and prevention networks in the participating countries based on key features, practical experiences and lessons learned from the selected Belgian best practice example “Towards better mental health services through mental health care networks and pathways”. The WP focuses on: ● Capturing, understanding and mapping the situation and identifying needs with regard to the development of the systems towards intersectoral, community-based and client-centred MH services within the participating countries; ● Promoting learning and cross-country exchange on methods, tools, practices and experiences in the development, establishment, maintenance and promotion of sustainable intersectoral, community-based and client-centred MH promotion, care and prevention networks; ● Supporting the sustainable establishment, further development and/or scale-up of intersectoral, community-based and client-centred MH networks and services by adapting and pilot implementing (elements) of the Belgian best practice example for 1) children/adolescents and/or 2) adults (incl. elderly people) in the local contexts of the participating countries, based on the results of the situational analysis and needs assessment and the priorities within the countries; ● Supporting the use of information, data and indicators to monitor, evaluate and improve intersectoral, community- based and client-centred MH networks and services and to assess developments in MH systems; ● Supporting capacity and competence building of stakeholders for the establishment and operation of intersectoral, community-based and client-centred MH networks and services; ● Identifying success factors and barriers and drawing lessons for the establishment and implementation of intersectoral community-based MH networks and the development of client-centred care services; ● Preparing and informing the further development and/or scale-up of intersectoral, community-based and client-centred MH networks and services in the participating countries and in Europe beyond the JA. Description of work and role of partners WP5 - Transfer and pilot Implementation of the Belgian best practice on reform of the mental health (MH) services [Months: 1-36] BZgA, NPHO, NCPHA, CIPH, MHS CYPRUS, MSAE, MOH FRANCE, OKFO, LOMBARDY REGION, SAM, MFH, TRIMBOS, IPHS, NIJZ, SMS This WP aims in particular at identifying, transferring, pilot implementing and integrating selected elements of the Belgian best practice example at system and/or at service level in order to establish, improve or scale up intersectoral, community-based and client-centred MH promotion, care and prevention networks and services in a number of participating countries. The organisational model of the Belgian practice example of community-based and client- centred MH services integrates intersectoral and multidisciplinary networks at local/regional level, based on three key pillars/elements. These networks provide integrated services tailored to the individual needs of the users/patients (children/adolescents, adults and the elderly) within five core functions/areas of services. The WP will be structured around different tasks and cover both target groups of 1) children/adolescents and 2) adults (incl. the elderly). Task 5.1 Preparatory work: establishing WP structures and content (M1-8) Leader: DE, Co-leader: IT, Participants: all WP countries, other WP leaders 5.1.1. Kick-off-session (virtual/online) (WP lead, co-lead, participating countries) within the frame of the JA kick-off Presentation and discussion of the Belgian best practice example, planned WP activities, structures (Working Groups) and timetable, definition of working rules (meetings, communication formats, links with other WPs). 5.1.2. Set-up of two WP5 Advisory Groups of experts on MH promotion, care and prevention for 1) children/adolescents, 2) adults (incl. the elderly) 5.1.3. Conduct meetings and exchanges with regional and/or national ministries and other relevant national, regional and/or (other) institutions, affiliated entities or collaborating partners relevant to or taking part in the WP5 in each Page 30 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 participating country, with the aim of mobilising resources and sharing information as a preparatory step to the implementation of WP5. 5.1.4. A preparatory (virtual) country “visit” to Belgium to better understand the context, the core elements, the functioning and the operation of the Belgian best practice example. 5.1.5. Elaboration of an Analytical Framework for the assessment and transfer (of elements) of the Belgian best practice example in relation to the contexts of each country. The framework will guide the development and implementation of the WP tasks, frame common elements/topics identified and selected to be taken into consideration during the pilot implementation, for monitoring and evaluation (WP1 & WP3) and for cross-country thematic exchange (WP5 and 4). 5.1.6. Carrying out workshop(s) for cross-country exchange on selected common elements/topics and/or to prepare and agree with the Analytical Framework and/or questionnaire for the situation analysis & needs assessment. Task 5.2 Conduction of a situation analysis and needs assessment (M7-14) Leader: DE, Co-leader: IT, Participants: all WP countries, other WP leaders 5.2.1. Conducting a country-specific situation analysis & needs assessment (SANA) in each participating country. In a first step, a general overview of the main building blocks of each country’s MH system (i.e. policy and legislation, governance, financing, workforce, organisation and care delivery at MH service level, information system) will be provided, based on a simple template for country profiles developed jointly with the WP6 leaders (and with input from the WP1 and WP3 leaders). The second step involves carrying out a more specific analysis and assessment of the situation and needs at a level (national or regional or local) chosen by each country and relevant for pilot implementation. 5.2.2. Compilation of the results into country specific profiles/reports by each country. Task 5.3. Adaptation, development and pilot implementation of (selected elements) of the Belgian best practice (M14-27) Leader: DE, Co-leader: IT, Participants: WP countries, other WP leaders 5.3.1. Elaboration of a simple, logical transfer/change model for adaptation of elements of the Belgian best practice example to the local contexts of each country, leading to the development of a draft implementation/action plan for pilot implementation. 5.3.2. Pilot implementation of the adapted/defined practices in each implementing country. 5.3.3. Conduction of workshop(s) of participating countries for cross-country exchange on the process of pilot implementation. 5.3.4. Documentation of pilot implementation in the implementation reports (based on a common framework and guidelines developed by the WP/tasks leaders) by each implementing country. 5.3.5. Elaboration of an (cross-country) Analysis and Synthesis Report on the pilot implementation based on the country reports and on the analytical framework. 5.3.6. Reflection on and identification of needs and goals for continued implementation, scaling-up or extension of the pilot practice after the end of the JA and elaboration of a simple implementation roadmap as a strategic plan defining goals, desired outcomes, main steps and milestones for achieving the goals. This will be carried out for each country pilot practice with technical support and guidance from WP 4. Task 5.4 Adaptation, development and (pilot) application of a dashboard of MH indicators (M7-28) Leader: IT, Co-leader: DE, Participants: WP countries, other WP leaders 5.4.1. Analysis of the Health/Mental Health Information Systems (H&MH-IS) of the country, as part of the SANA under task 5.2; 5.4.2. Set up and consultations with a network of experts from institutions, affiliated entities or collaborating partners responsible for the collection and use of MH-related data in the participating countries in order to develop a preliminary list of indicators; 5.4.3. Conduction of a consensus workshop to discuss and agree on MH-related indicators to be collected, to exchange information across countries and to explore the possibilities and feasibility of developing a dashboard of indicators; 5.4.4. Development of a manual for building indicators (harmonisation of definitions and descriptions of indicators, development of a list of variables, details of data processing, etc.); 5.4.5. Data extraction from computerised databases on MH and health care; 5.4.6. Building up and applying a dashboard of indicators at country level or within the country (e.g. at regional level) and at the central level of JA; 5.4.7. Elaboration of a Synthesis Report containing a cross-country analysis of the MH indicators and with recommendations for improving actions in this area. The implementation of Task 5.4 will take into account ongoing projects at international and national level aimed at developing and/or compiling MH indicators in order to avoid possible duplication of work. The activities of task 5.4 will also be aligned with the general monitoring and evaluation framework and the activities in WP1 and WP3. Page 31 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Task 5.5 Training and capacity building (M10-35) Leader: IT, Co-leader: DE, Participants: WP countries 5.5.1. Elaboration of a training and capacity building plan for the WP The scope and content of the training and capacity building activities will be defined in the plan, taking into account identified needs, available capacities, resources and time. Due to the Covid-19 pandemic, the development of online and web-based training formats will be considered/preferred, training and capacity building will focus on the acquisition of knowledge and the development of competences/skills, possibly in the following three main areas (linked to the key features and functions of the Belgian best practice example): 1) Development and operation of (local) intersectoral MH networks, 2) Use of methods and tools supporting and shaping the development and coordination of needs/client- centred networks as well as health promotion, care and prevention services and interventions, 3) Thematic training on selected themes and practices of specific relevance both for the target groups of children/adolescents and adults and for the pilot implementation in the countries. The plan will provide for the development of a “training kit” of training modules, curriculum materials and/or tools, which will be made available for further adaptation and use for training and capacity building by interested countries. 5.5.2. Development of a training kit (incl. training modules/curricula/materials/tools) and delivery of the training according to the training and capacity building plan; 5.5.3. Continuous and final assessment of the training and capacity building results. Participation per Partner Partner number and short name WP5 effort 1 - NPHO 23.00 3 - NCPHA 10.50 4 - CIPH 21.13 5 - MHS CYPRUS 21.13 7 - MSAE 21.10 9 - MOH FRANCE 6.75 INSERM 3.25 10 - BZgA 53.13 11 - OKFO 4.00 SU 4.00 UD 13.13 13 - LOMBARDY REGION 1.00 MNIPR 9.80 POLIMI 7.50 UNIMIB 7.90 ASST LECCO 7.90 FBF 10.10 14 - SAM 21.13 15 - MFH 20.50 16 - TRIMBOS 1.50 18 - IPHS 10.25 19 - NIJZ 21.13 20 - SMS 9.50 Page 32 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Partner number and short name WP5 effort FFIS 4.13 CatSalut 3.50 Consej- Mujer 5.00 Total 321.96 List of deliverables Due Deliverable Deliverable Title Lead beneficiary Type15 Dissemination level16 Date (in Number14 months)17 A public summary report/ D5.1 executive summary of the 10 - BZgA Report Public 14 SANA Analysis Report on the D5.2 10 - BZgA Report Public 29 pilot implementation A Synthesis Report on the results of the use of indicators for 13 - LOMBARDY D5.3 mental health and the Report Public 28 REGION developed dashboard of MH indicators is elaborated A “training kit” for use of and adaptation by 13 - LOMBARDY D5.4 Other Public 35 interested countries is REGION elaborated Description of deliverables D.5.1. Public summary report/executive summary of the SANA [14] - A Public summary report/executive summary of the main results of the situation analysis and needs assessment for each participating country. D.5.2. Analysis Report on the pilot implementation based on (included) country specific reports and the analytical framework is elaborated [29] - An Analysis and Synthesis Report on the process and results of pilot implementation based on (included) country- specific reports and the analytical framework elaborated under task 5.1. (this will include a public summary of the report). D.5.3. A Synthesis Report on the results of the use of indicators for MH and the developed dashboard of MH indicators is elaborated [28] - A Synthesis Report on the results of the use of indicators for MH, including a dashboard of indicators for assessing the delivery and quality of MH care and prevention. D.5.4. A “training kit” for use of and adaptation by interested countries is elaborated [M35] - A “training kit” for community-based and client-centred MH prevention and care for the use of and adaptation (to local context) by interested countries/institutions. D5.1 : A public summary report/executive summary of the SANA [14] Public summary report/executive summary of the main results of the situation analysis and needs assessment for each participating country D5.2 : Analysis Report on the pilot implementation [29] Page 33 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 An Analysis and Synthesis Report on the process and results of pilot implementation based on (included) country- specific reports and the analytical framework elaborated under task 5.1. (this will include a public summary of the report) D5.3 : A Synthesis Report on the results of the use of indicators for mental health and the developed dashboard of MH indicators is elaborated [28] A Synthesis Report on the results of the use of indicators for MH, including a dashboard of indicators for assessing the delivery and quality of MH care and prevention D5.4 : A “training kit” for use of and adaptation by interested countries is elaborated [35] A “training kit” for community-based and client-centred MH prevention and care for the use of and adaptation (to local context) by interested countries/institutions Schedule of relevant Milestones Due Milestone Milestone title Lead beneficiary Date (in Means of verification number18 months) MS20 kick-off meeting for WP 5 10 - BZgA 2 Two WP Advisory Groups are established and (virtual) MS21 10 - BZgA 3 preparatory country-visit to Belgium is conducted An Analytical Framework for the transfer and piloting of MS22 10 - BZgA 7 (elements) of the Belgian best practice example is elaborated A Situational Analysis and Needs Assessments is carried out and the results are MS23 10 - BZgA 14 compiled by each country into country specific profiles and or reports Pilot implementation of the adapted and defined MS24 10 - BZgA 25 practices is carried out in each implementing country Workshops for cross-country exchange on selected topics MS25 10 - BZgA 23 of common interest are conducted Needs and goals for continued implementation, scaling-up and/or extension of the pilot MS26 practice after completion 10 - BZgA 34 of the JA in each of the participation countries are defined A dashboard of indicators at the country level (or within MS27 the country) and at the central 10 - BZgA 25 level of the JA is established and applied Page 34 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Schedule of relevant Milestones Due Milestone Milestone title Lead beneficiary Date (in Means of verification number18 months) Training (of trainers) among MS28 10 - BZgA 35 stakeholders is delivered Simple implementation roadmaps (for further implementation, scaling- MS29 up and/or extension of the 10 - BZgA 35 pilot practice after the JA duration) are developed for each piloting country Page 35 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Work package number 9 WP6 Lead beneficiary 10 2 - BMSGPK Transfer and pilot implementation of (selected elements of) of the Austrian Best Practce Work package title on Suicide Prevention (SP) “SUPRA” Start month 1 End month 36 Objectives The overall objective is to support improvement in knowledge and quality of suicide prevention services in the participating countries. Specific objectives: Developing or scaling up the suicide prevention strategy on national/regional level based on the best practice example Suicide Prevention Austria (SUPRA) ensuring that the specific components of SUPRA are carefully selected based on their respective context. The WP focuses on: ● recording and assessing the current situation in the field of suicide prevention in each country/region, including in depth understanding of existing stakeholders and their positions, activities, expectations in the field of SP in their country/region as well as knowledge about gaps (situation analysis). ● assessing resources (staff, budget, other) needed to address and implement prioritized activities (aiming to further develop existing activities and/or address identified gaps in their country) (needs analysis). ● obtaining stakeholder commitment for the establishment (or further development) of a national/regional strategy including steps to promote increased awareness for SP of main stakeholders and the general public as well as fighting suicide-related stigma ● promoting learning and cross-country exchange on methods, tools, practices and experiences in the development or improvement of national strategies for suicide prevention ● supporting capacity and competence building of stakeholders for the establishment and operation of suicide prevention services ● supporting the sustainable establishment, improvement and expansion of suicide prevention services by adaption and pilot implementation of SUPRA best practice in the local context of each country. Non-objective 1:1 roll out of SUPRA in participating MS without consideration of the national/regional context/situation. Stakeholders and target groups (at national/regional level) in the participating countries: ● National ministries and other policy makers (national/regional level) ● Health and mental health professionals ● Suicide attempters and survivors of bereavement due to suicide ● Representatives of relevant institutions/organisations (e.g. regarding hotspots: national railway agency; …) ● Media professionals ● General public (awareness/stigma) Description of work and role of partners WP6 - Transfer and pilot implementation of (selected elements of) of the Austrian Best Practce on Suicide Prevention (SP) “SUPRA” [Months: 1-36] BMSGPK, NPHO, NCPHA, CIPH, MHS CYPRUS, MZCR, MSAE, THL, OKFO, DOHI, SAM, MFH, HDIR, IPHS, NIJZ, SMS, FOHM/PHAS This WP aims in particular to develop or scale up a suicide prevention strategy on national/regional level based on the Austrian best practice example Suicide Prevention Austria (SUPRA). Selected elements of SUPRA should be pilot implemented in a defined number of MS for 1) children/adolescents and/or 2) adults (incl. elderly people) in the local contexts of the participating countries, based on the results of the situation analysis and needs assessment (SANA) as well as the priorities within the participating countries. Components of SUPRA include: (i) coordination and organization (aim: suicide prevention is organizationally embedded and co-ordinated). (ii) support and treatment of high risk groups (aim: people at risk of suicide are supported and treated as needed), (iii) restriction of access to means of suicide (aim: rendering access to means of suicide as difficult as possible), (iv) awareness and knowledge (aim: awareness and knowledge of suicidality and about coping with psychosocial crises are widespread among the general population), (iv) to integrate suicide prevention programmes in other health promotion activities (aim: the issue of suicide to be integrated into existing health promotion, addiction and violence prevention measures), (vi) quality assurance and expertise (aim: suicide prevention is quality assured on the basis of scientific expertise). Page 36 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Within this WP participating countriesare supported to develop or refine national/regional strategies as well as to initiate (take first steps towards) pilot-implementation of selected SP-actions by e.g. workshops/trainings, webinars. Task 6.1: Preparatory work: Establishing project structure and content (M1-8) --> link to WP1 and other WPs Lead: AT, Co-lead: CZ, Participants: WP countries, other WP leaders 6.1.1.Web-based-Kick-off-meeting: (lead, co-lead, WP countries) ● Presentation of the overview of the WP 6 and key elements of the SUPRA practice ● Decide on the structure of work incl. project plan, committees, working groups, timetable; ● Define rules of work (meetings, communication format/s) 6.1.2. Establish national/regional working group and advisory board by each participating WP countries Based on experiences from SUPRA and the Czech example ● Organise a national kick-of-meeting based on the EU-level-meeting with all key national stakeholders ● Presentation of the overview of the Joint Action and relevant technical WPs on suicide prevention and mental health reform depending on country’s selection ● Decide on the structure of work incl. project plan, committees, working groups, timetable; ● Define rules of work (meetings, communication format/s) 6.1.3. (Online-) Workshop 1 (2 days); (lead, co-lead, WP countries) --> link to WP1 day 1: presentation of WHO-Framework and use case / best practice model SUPRA with focus on potentially transferable modules (according to the 6 SUPRA-“columns”) ● present an overview of potential SP-actions: o ”Quick Win”-package (actions that can be implemented easily and without a big budget within 1 or 2 years - usually based on existing activities. Can act as motor for political commitment and implementation of further measures of JA) o Additional implementation packages ● To get a first idea which SUPRA actions/packages could be suitable and a priority for participating countries; Development of a plan for the situation analysis day 2: Workshop/training on how to develop a (national/regional) SP strategy, open also for selected further interested experts from participating countries ● Discussion of reflections and ideas of participating countriesso far, based on input from day 1 (WHO-Framework and experiences from SUPRA and the Czech example) 6.1.4. (Online-) Workshop 2 (lead, co-lead, WP countries) --> link to WP 3 (Evaluation) and WP 5 (health care reform) Compilation of a questionnaire for undertaking a comprehensive situation analysis and needs assessment (SANA) as well as compilation of a template for country profiles (output of SANA) ● Joint development of a WP 6-specific questionnaire as basis for SANA using participatory approach/format based on Czech example --> link to WP 3 (Evaluation) and WP 5 (health care reform) ● Presentation (GÖG) and discussion of a draft-template for a country profile Task 6.2: Conducting a country-specific situation analysis & needs assessments in each participating countries(M6-21) Lead: AT, Co-lead: CZ, Participants: WP countries 6.2.1. Situation analysis (WP countries) ● identification of stakeholders and performance of a situation analysis based on defined indicators and existing national/ regional evidence on SP e.g. studies, publications, data (epidemiology, health care resources…) --> link to WP 5 (health care reform) 6.2.2. Needs assessment (WP countries) --> link to link to WP 5 (health care reform) and WP 4 (Sustainability) ● Assessment of resources needed for addressing and implementing selected actions as well as documentation of potential barriers to implementation and enabling factors ● Defining final priorities (Which activities of SP i.e. SUPRA will each participating countryfocus on?)/ first prioritisation of SUPRA actions or packages suggested for national/regional implementation 6.2.3. Workshop 3 (lead, co-lead, WP countries) --> link to WP 4 (Sustainability) Presentation and discussion of results of SANA ● Discussion of the results of SANA and its implications for possible uptake of nationally/regionally prioritized SUPRA- actions while controlling for participating country specific implementation barriers and enabling factors; ● Finalization of template for country profiles describing the results of SANA in each participating countries including specific implementation barriers and enabling factors ● Compilation of a list of common and participating country specific implementation barriers and enabling factors. 6.2.4. Compilation of country profiles (lead, co-lead, WP countries) (D.6.2) --> link to WP 1-4 Compilation of country profiles based on SANA by the participating countries including identification of success factors and barriers to the establishment or improvement of suicide prevention services; drawing lessons and formulating Page 37 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 recommendations that prepare and inform the development and/or scaling-up of suicide prevention services in the participating countries (maybe even after the end of the JA) Task 6.3: (Further) Development of national/regional SP strategies and pilot implementations (M1-M36, conducted in parallel to task 2) Lead: AT, Co-lead: CZ, Participants: WP countries 6.3.1. Development of a use case example for developing and implementing a national/regional SP strategy based on the WHO-framework and Austrian model (SUPRA) (lead, co-lead) (D.6.1). This activity is linked to WP2 (Dissemination). ● Compilation of a SUPRA-handbook: guidance for participating countries, implementation of WHO-framework on national/regional level including barriers, enabling factors and lessons learned as well as a reflection on what actions could potentially be transferred from SUPRA to other country/regional settings, including scientific evidence ● Taking into consideration learnings from the Czech example ● Proposal of a table of contents for a national/regional SP strategy 6.3.2. Prioritisation of SUPRA actions/packages suggested for national/regional implementation (WP countries). This activity is linked to WP 3 (Evaluation) by each participating countriesbased on national/regional context. 6.3.3. Implementation of “quick wins”: Identification, adaptation, development and pilot implementation of selected activities of SUPRA practice and monitoring of implementation” (WP countries) This activity is linked to WP 3 (Evaluation) ● Identifying, adapting and pilot implementing first selected elements of the Austrian best practice in a number of participating countries(“quick wins”). “Quick wins'' are actions that can be implemented easily and without a big budget within 1 or 2 years - usually based on existing activities. These can act as a motor for political commitment and implementation of further measures of JA. Quick wins will most likely be very different in the various countries, in Austria for example it was the roll-out of a national webportal for people seeking help as well as the implementation of an annual suicide prevention report. Quick win actions should always be viewed in the context of any national/ regional strategy, “cherry picking” of individual actions (without embedding these in a comprehensive strategy) should be avoided. 6.3.4. Development of draft strategy or revision or further development of existing strategy (WP countries) (D.6.3) - This activity is linked to WP1 (Coordination), WP 3 (Evaluation) and WP 4 (Sustainability) ● by each participating countries, based on prioritised SUPRA actions or packages and deliverable 1. 6.3.5. Workshop 4/ Training (lead, co-lead, WP countries) on implementation of the developed draft strategy or revision or further development of existing strategy. This activity is linked to WP 4 (Sustainability). This activity focuses on how to transfer the strategy into an implementation concept based on experiences from SUPRA and the Czech examples as well as the experiences of the participating countries-> link to WP 4 (Sustainability). Task 6.4: Training and capacity building (M1-M36, in parallel to other tasks) )This activity is linked to WP 3 (Evaluation), WP4 (Sustainability) and potentially also to WP2 (with regard to harmonization of activities e.g. organization of webinars, workshops). Lead: AT, Co-lead: CZ; Various Experts; Participants: WP countries Taking into account the results of the SANA concerning training aspects in the various participating countries as well as the focus of the implementing countries’spilots and building on the experiences gained by SUPRA, the work under this task will focus on acquiring knowledge and building competences/skills in key features and functions of the SUPRA practice. The scope and content of the training and capacity building measures will be defined, taking into account identified needs, available capacities, resources and time. Furthermore, in view of the restrictions imposed by the development of the Covid-19 pandemic in the participating countries, the development of online and web-based training formats will be considered, especially for training sessions that allow for the participation of a large number of participants across countries. 6.4.1.Training and capacity building will be related to defined actions/packages of SUPRA; (lead, co-lead, various experts, WP countries): This activity includes training and/or thematic webinars on safeguarding hotspots; developing media guidelines selected by participating countries based on results of the needs assessment as well as national/regional draft strategy or on selected “Quick wins”. Such key features and actions may include: (i) coordination and organization (ii) support and treatment of high risk groups (iii) restriction of access to means of suicide iv) awareness and knowledge (iv) integration suicide prevention programmes in other health promotion activities (vi) quality assurance and expertise “Trainings are held by experts (subcontractors) and focus on SUPRA-measures defined within the JA. Experts can be national experts of the respective (participating) country or can be invited experts from other countries, where the respective SUPRA- measure has already been implemented particularly well (e.g. the securing of railway lines is very well implemented in Switzerland or Germany, the establishment of media guidelines is very well implemented in Austria, ...).” Page 38 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Task 6.5. Continuous support on technical activities (M1-M36, in parallel to other tasks) Lead: AT, Co-lead: CZ, Participants: WP countries This task envisages ongoing support needed by implementing MS on various technical activities outlined below: 6.5.1. support of situation analysis e.g. knowledge transfer/exchange and advice by video/telephone-conferences, providing contact information 6.5.2. support of needs assessment (See activity 4.1) 6.5.3. support of country profiles (See activity 4.1) 6.5.4. support of prioritisation of actions (See activity 4.1) 6.5.5. support of national draft strategy / revision/ further development of existing strategy (See activity 4.1) 6.5.6. support for pilot implementation of “quick wins” (See activity 4.1) Cross Cutting tasks: Following cross cutting tasks are an integral part of tasks 1-5. ● Obtain political commitment (national i.e. regional level) at different stages of the JA --> link to WP1 (Coordination), WP 4 (Sustainability) and 2 (Dissemination) ● Increase awareness / address stigma in all stakeholder and target groups --> link to WP 4 (Sustainability) and 2 (Dissemination) ● exchange and learning between participating MS regarding progress/achievements/challenges --> link to WP 1. Participation per Partner Partner number and short name WP6 effort 1 - NPHO 12.00 2 - BMSGPK 0.00 GÖG 35.81 3 - NCPHA 4.00 4 - CIPH 11.85 5 - MHS CYPRUS 11.85 6 - MZCR 8.00 NIMH 15.00 7 - MSAE 8.25 NIHD 3.50 8 - THL 9.50 11 - OKFO 3.35 SU 0.50 UD 8.00 12 - DOHI 11.85 14 - SAM 3.84 15 - MFH 12.00 17 - HDIR 11.85 18 - IPHS 3.84 19 - NIJZ 11.85 20 - SMS 3.85 SERMAS 1.50 FPS 0.50 Page 39 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Partner number and short name WP6 effort Osakidetza 1.50 SNS-O 1.50 FFIS 0.50 CatSalut 1.50 SAS 1.50 21 - FOHM/PHAS 11.00 Total 210.19 List of deliverables Due Deliverable Deliverable Title Lead beneficiary Type 15 Dissemination level 16 Date (in Number14 months)17 D6.1 SUPRA handbook 2 - BMSGPK Report Public 6 Situation analysis and D6.2 needs analysis (SANA) 2 - BMSGPK Report Public 20 profiles Drafted National / D6.3 Regional suicide 2 - BMSGPK Report Public 29 prevention strategies Description of deliverables D.6.1 SUPRA Handbook [6] - SUPRA national use case handbook based on WHO-framework and Czech example. D. 6.2 Situation analysis and needs analysis (SANA) profiles [20] - SANA country profiles on SP activities including list of common and participating country specific implementation barriers and enabling factors. D. 6.3 Drafted National / Regional suicide prevention strategies [29] - (Draft) National/regional strategies (describing prioritized SUPRA-actions which should be rolled out in the implementing countries) and compilation of these strategies (i.e. in a repository). D6.1 : SUPRA handbook [6] SUPRA national use case handbook based on WHO-framework and Czech example D6.2 : Situation analysis and needs analysis (SANA) profiles [20] SANA country profiles on SP activities including list of common and EU MS specific implementation barriers and enabling factors D6.3 : Drafted National / Regional suicide prevention strategies [29] (Draft) National/regional strategies (describing prioritized SUPRA-actions which should be rolled out in the implementing countries) and compilation of these strategies (i.e. in a repository). Page 40 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Schedule of relevant Milestones Due Milestone Milestone title Lead beneficiary Date (in Means of verification number18 months) Web-based Kick-off MS30 2 - BMSGPK 2 Workshop MS31 Workshop 1 (online) 2 - BMSGPK 4 MS32 Workshop 2 (online) 2 - BMSGPK 7 MS33 Workshop 3 2 - BMSGPK 13 MS34 Workshop 4 2 - BMSGPK 29 Page 41 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 1.3.4. WT4 List of milestones Due Milestone WP Milestone title Lead beneficiary Date (in Means of verification number18 number9 months)17 Organisation of kick- off meeting online MS1 completed (meeting, WP1 1 - NPHO 1 agenda & preparatory documents) Project Management MS2 WP1 1 - NPHO 6 platform All governance structures are MS3 established, with WP1 1 - NPHO 4 clear roles and responsibilities Organization of onsite Consortium meetings including MS4 Final Conference WP1 1 - NPHO 12 completed (meeting, agenda & preparatory documents) - 1 Organization of onsite Consortium meetings including MS5 Final Conference WP1 1 - NPHO 24 completed (meeting, agenda & preparatory documents)- 2 Organization of onsite Consortium meetings including MS6 Final Conference WP1 1 - NPHO 36 completed (meeting, agenda & preparatory documents) -3 Member State Policy Committee onsite MS7 meeting completed WP1 1 - NPHO 30 (meeting, agenda & preparatory documents) Organization of General Assembly, Executive board, Member States MS8 WP1 1 - NPHO 36 Policy Committee, Stakeholder forum meetings completed (onsite or online) Launching MS9 WP2 11 - OKFO 5 ImpleMENTAL- Page 42 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Due Milestone WP Milestone title Lead beneficiary Date (in Means of verification number18 number9 months)17 network on the EU Health Policy Platform Launching Landing MS10 WP2 4 - CIPH 3 page of JA Website MS11 Final Conference WP2 4 - CIPH 36 Launching Final Results on the EU MS12 WP2 11 - OKFO 36 Health Policy Platform and specific websites Evaluation framework MS13 for internal evaluation WP3 16 - TRIMBOS 9 of the JA Evaluation framework MS14 for evaluation of the WP3 16 - TRIMBOS 9 two good practices MS piloting good practices have an adapted evaluation plan in place to reflect local contexts and resources MS15 WP3 16 - TRIMBOS 12 for the effective evaluation of the pilot implementation of the good practices in each MS Initial set of prioritised needs and challenges MS16 for sustaining good WP4 11 - OKFO 9 practices are mapped across member states Workshops completed incl. synthesis and MS17 WP4 11 - OKFO 27 Initial set of practical recommendations Short report of the synthesis of the MS18 WP4 11 - OKFO 30 dialogue sessions and roadmap finalized Knowledge to policy MS19 model is validated and WP4 11 - OKFO 34 adopted by MS/C kick-off meeting for MS20 WP5 10 - BZgA 2 WP 5 Two WP Advisory Groups are established MS21 WP5 10 - BZgA 3 and (virtual) preparatory country- Page 43 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Due Milestone WP Milestone title Lead beneficiary Date (in Means of verification number18 number9 months)17 visit to Belgium is conducted An Analytical Framework for the transfer and piloting MS22 WP5 10 - BZgA 7 of (elements) of the Belgian best practice example is elaborated A Situational Analysis and Needs Assessments is carried out and the MS23 results are compiled WP5 10 - BZgA 14 by each country into country specific profiles and or reports Pilot implementation of the adapted and defined MS24 practices is carried out WP5 10 - BZgA 25 in each implementing country Workshops for cross- country exchange MS25 on selected topics of WP5 10 - BZgA 23 common interest are conducted Needs and goals for continued implementation, scaling-up and/or extension of the MS26 WP5 10 - BZgA 34 pilot practice after completion of the JA in each of the participation countries are defined A dashboard of indicators at the country level (or within MS27 the country) and at WP5 10 - BZgA 25 the central level of the JA is established and applied Training (of trainers) MS28 among stakeholders is WP5 10 - BZgA 35 delivered Simple implementation roadmaps (for further MS29 implementation, WP5 10 - BZgA 35 scaling-up and/or extension of the pilot Page 44 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Due Milestone WP Milestone title Lead beneficiary Date (in Means of verification number18 number9 months)17 practice after the JA duration) are developed for each piloting country Web-based Kick-off MS30 WP6 2 - BMSGPK 2 Workshop MS31 Workshop 1 (online) WP6 2 - BMSGPK 4 MS32 Workshop 2 (online) WP6 2 - BMSGPK 7 MS33 Workshop 3 WP6 2 - BMSGPK 13 MS34 Workshop 4 WP6 2 - BMSGPK 29 Page 45 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 1.3.5. WT5 Critical Implementation risks and mitigation actions Risk Description of risk WP Number Proposed risk-mitigation measures number Impact of the COVID Meetings of all partners and Coordinator pandemic (incl. new peaks reallocation of efforts to meet the objectives and and lockdown measures) to deadlines Communication with the Commission WP1, WP2, WP3, WP4, 1 work plan due to disruption if serious threats due to external factors are WP5, WP6 of work programme, affecting the work plan to work on solutions. reallocation of staff in other Responsiveness of all WPs to incorporate or adapt duties, sickness leaves the WP tasks. Appropriate financial control. Financial reporting WP1, WP2, WP3, WP4, 2 Overspending on regular time periods. Adherence to EU WP5, WP6 Financial Guidelines. Efficient internal communication management Partners’ commitment WP1, WP2, WP3, WP4, 3 plan and work with the Coordinator to understand declines WP5, WP6 the reasons and provide solutions Project status meetings at WP level to identify issues on the horizon. Concerned partners commit to provide replacement as soon as possible and WP1, WP2, WP3, WP4, to ensure appropriate briefing and guidance to 4 Staff turnover WP5, WP6 the new staff based, among others, on the main JA documents and tools (Grant Agreement, implementation strategy, monitoring plan, evaluation framework, project handbook, etc.). Involve all partners, personal contacts, Poor response rate from stakeholders and their networks to expand the external experts and pool of experts and stakeholders. Where required, stakeholders to requests/ WP1, WP2, WP3, WP4, adapt/revise the dissemination plan to ensure 5 questionnaires/interviews WP5, WP6 timely information and communication on the (e.g. for SANA in WP5 & 6, JA before requesting input, involvement or evaluation, etc.). collaboration and to ensure reach out to experts and stakeholders WPs leaders /co-leaders: tasks within the WPs Partners cannot continue/ are assigned to lead and co-leaders who shall withdraw from the project work together to reach the defined objectives and for management, financial, WP1, WP2, WP3, WP4, 6 results. In case a leader or co-lead has to drop out political or any other reasons WP5, WP6 of a WP or task, it would be taken over either by (incl. COVID-19 pandemic the co-lead or another WP partner who will be measures). allocated the associated financial resources. Overlapping of start and end dates for WPs’ and tasks have been planned/foreseen as much as possible to decrease the risk of delays in Interdependency between other WPs or other tasks. Regular monitoring of WPs and between partners progress supports the identification of potential within WPs in terms of delays and difficulties at an early stage. All JA (timely) achievement of WP1, WP2, WP3, WP4, 7 artefacts will support the early identification of milestones and delivery of WP5, WP6 risks and careful planning of activities, including outputs. Possible impact the JA workplan, the common implementation on (quality of) outputs and strategy and the Project Handbook Discussion timely delivery. of issues in the ExB trying to find solutions. If needed, review of the time plan for activities, deliverables and milestones. Page 46 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Risk Description of risk WP Number Proposed risk-mitigation measures number All countries early in the procedure will appoint Poor availability of Members for the Member State Policy Committee, policymakers due to who can act as intermediaries between the JA constrained capacities (linked and policy makers. Difficulties encountered and 8 WP1, WP4 to the developments in the potential solutions are discussed in MS Policy Covid19-pandemic or for Committee meetings. Identification of political other reasons) representatives that could act as ambassadors for our JA ImpleMENTAL A careful selection of resources, sites and type of Constrained (financial, staff practice to be implemented could help in reducing and time) capacities and this kind of risk, Type of practice, where the resources of regional or local implementation is taking place to be carefully stakeholders for transfer, selected Attention will be paid to developing 9 pilot implementation and WP1, WP5, WP6 realistic/feasible (local) implementation evaluation of best practices plans, taking into account the results of the (in particular because SANA, available resources and potential room of developments in the for flexibility in adaptation to the needs All Covid19-pandemic). statements applies to all levels of involvement (national, regional, local) use anti-virus, use data backups that include WP1, WP2, WP3, WP4, off-site or remote storage, to secure computers, 10 IT Technologies risk WP5, WP6 servers and wireless networks. All partners comply with GDPR rules Page 47 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 1.3.6. WT6 Summary of project effort in person-months Total Person/Months WP1 WP2 WP3 WP4 WP5 WP6 per Participant 1 - NPHO 93 7 14 11.50 23 12 160.50 2 - BMSGPK 0 0 0 0 0 0 0 · GÖG 2 3.50 10.35 7 0 35.81 58.66 3 - NCPHA 1 1.50 0 2.50 10.50 4 19.50 4 - CIPH 2 33 10.60 11.50 21.13 11.85 90.08 5 - MHS CYPRUS 1 2 9.20 7 21.13 11.85 52.18 6 - MZCR 1 2 3 2 0 8 16 · NIMH 1 1.50 7 5 0 15 29.50 7 - MSAE 1 2 9.80 7 21.10 8.25 49.15 · NIHD 0 0 0 0 0 3.50 3.50 8 - THL 1 1 5 4 0 9.50 20.50 9 - MOH FRANCE 1 1.50 0 0.75 6.75 0 10 · INSERM 0 0 0 0.75 3.25 0 4 10 - BZgA 2 3.50 10.70 7 53.13 0 76.33 11 - OKFO 1 8.50 3.65 14.75 4 3.35 35.25 · SU 0.50 16 0.50 14.75 4 0.50 36.25 · UD 0.50 2 7.75 5 13.13 8 36.38 12 - DOHI 1 1.50 5.40 4 0 11.85 23.75 13 - LOMBARDY REGION 0.50 0 0 0.50 1 0 2 · MNIPR 0 1 1 3.50 9.80 0 15.30 · POLIMI 0 0 2 1 7.50 0 10.50 · UNIMIB 0 0.50 3.50 0 7.90 0 11.90 · ASST LECCO 0.50 1 2 1.75 7.90 0 13.15 Page 48 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Total Person/Months WP1 WP2 WP3 WP4 WP5 WP6 per Participant · FBF 0.50 0.65 1.50 3 10.10 0 15.75 14 - SAM 1 1.50 5.40 4.50 21.13 3.84 37.37 15 - MFH 1 2 7 4 20.50 12 46.50 16 - TRIMBOS 2 3.50 22.05 16 1.50 0 45.05 17 - HDIR 1 1.50 5.40 3 0 11.85 22.75 18 - IPHS 1 1.50 0 2.50 10.25 3.84 19.09 19 - NIJZ 2 2 9.80 7 21.13 11.85 53.78 20 - SMS 1 0.25 2.50 1.80 9.50 3.85 18.90 · SERMAS 0 0.15 0.50 0.55 0 1.50 2.70 · FPS 0 0.15 0.50 0.55 0 0.50 1.70 · Osakidetza 0 0.15 0.50 0.55 0 1.50 2.70 · SNS-O 0 0.15 0.50 0.55 0 1.50 2.70 · FFIS 1 0.70 11.50 1.35 4.13 0.50 19.18 · CatSalut 0 0.15 0.50 0.55 3.50 1.50 6.20 · SAS 0 0.15 0.50 0.55 0 1.50 2.70 · Consej- Mujer 0 0.15 0.50 0.55 5 0 6.20 21 - FOHM/PHAS 1 2 5 3 0 11 22 Total Person/Months 121.50 105.65 179.10 161.25 321.96 210.19 1099.65 Page 49 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 1.3.7. WT7 Tentative schedule of project reviews Review Tentative Planned venue Comments, if any number 19 timing of review RV1 18 by videoconference and emails Mi-term review by the external experts RV2 36 by videoconference and emails Final review by the external experts Page 50 of 50 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 1. Project number The project number has been assigned by the Commission as the unique identifier for your project. It cannot be changed. The project number should appear on each page of the grant agreement preparation documents (part A and part B) to prevent errors during its handling. 2. Project acronym Use the project acronym as given in the submitted proposal. It can generally not be changed. The same acronym should appear on each page of the grant agreement preparation documents (part A and part B) to prevent errors during its handling. 3. Project title Use the title (preferably no longer than 200 characters) as indicated in the submitted proposal. Minor corrections are possible if agreed during the preparation of the grant agreement. 4. Starting date Unless a specific (fixed) starting date is duly justified and agreed upon during the preparation of the Grant Agreement, the project will start on the first day of the month following the entry into force of the Grant Agreement (NB : entry into force = signature by the Agency). Please note that if a fixed starting date is used, you will be required to provide a written justification. 5. Duration Insert the duration of the project in full months. 6. Call (part) identifier The Call (part) identifier is the reference number given in the call or part of the call you were addressing, as indicated in the publication of the call in the Official Journal of the European Union. You have to use the identifier given by the Commission in the letter inviting to prepare the grant agreement. 7. Abstract 8. Project Entry Month The month at which the participant joined the consortium, month 1 marking the start date of the project, and all other start dates being relative to this start date. 9. Work Package number Work package number: WP1, WP2, WP3, ..., WPn 10. Lead beneficiary This must be one of the beneficiaries in the grant (not a third party) - Number of the beneficiary leading the work in this work package 11. Person-months per work package The total number of person-months allocated to each work package. 12. Start month Relative start date for the work in the specific work packages, month 1 marking the start date of the project, and all other start dates being relative to this start date. 13. End month Relative end date, month 1 marking the start date of the project, and all end dates being relative to this start date. 14. Deliverable number Deliverable numbers: D1 - Dn 15. Type Please indicate the type of the deliverable using one of the following codes: R Document, report DEM Demonstrator, pilot, prototype DEC Websites, patent fillings, videos, etc. OTHER ETHICS Ethics requirement ORDP Open Research Data Pilot DATA data sets, microdata, etc. Associated with document Ref. Ares(2021)5882948 - 27/09/2021 16. Dissemination level Please indicate the dissemination level using one of the following codes: PU Public CO Confidential, only for members of the consortium (including the Commission Services) EU-RES Classified Information: RESTREINT UE (Commission Decision 2005/444/EC) EU-CON Classified Information: CONFIDENTIEL UE (Commission Decision 2005/444/EC) EU-SEC Classified Information: SECRET UE (Commission Decision 2005/444/EC) 17. Delivery date for Deliverable Month in which the deliverables will be available, month 1 marking the start date of the project, and all delivery dates being relative to this start date. 18. Milestone number Milestone number:MS1, MS2, ..., MSn 19. Review number Review number: RV1, RV2, ..., RVn 20. Installation Number Number progressively the installations of a same infrastructure. An installation is a part of an infrastructure that could be used independently from the rest. 21. Installation country Code of the country where the installation is located or IO if the access provider (the beneficiary or linked third party) is an international organization, an ERIC or a similar legal entity. 22. Type of access TA-uc if trans-national access with access costs declared on the basis of unit cost, TA-ac if trans-national access with access costs declared as actual costs, and TA-cb if trans-national access with access costs declared as a combination of actual costs and costs on the basis of unit cost, VA-uc if virtual access with access costs declared on the basis of unit cost, VA-ac if virtual access with access costs declared as actual costs, and VA-cb if virtual access with access costs declared as a combination of actual costs and costs on the basis of unit cost. 23. Access costs Cost of the access provided under the project. For virtual access fill only the second column. For trans-national access fill one of the two columns or both according to the way access costs are declared. Trans-national access costs on the basis of unit cost will result from the unit cost by the quantity of access to be provided. 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 2. PART B History of changes SECTION Changes performed May 2021 based on comments from evaluators and 1st consultation with HaDEA List of applicants Changes in the Competent Authority of Cyprus, Hungary, Norway updated Section 2 - Specific Objective(s) of the Project (SPO 7 and 8; SPO 9 and 10) has (Comments of the evaluators Criterion 2) been revised - Outcome impact indicators have been updated (SO 9, 10). Section 4.3 Pertinence of Geographic Section 4.3 has been updated to better clarify the geographical Coverage coverage of the JA ImpleMENTAL and the even wider range of this JA (Comments of the evaluators Criterion 1) in the public health of the European Region. This JA consortium consists of a diverse set of 21 countries, 40 partners (21 Competent Authorities and 19 Affiliated Entities). Netherlands will lead WP3 on evaluation and co-lead Wp4 on Sustainability but will not participate and/or implement the two best practices. At least, 25 implementations of the two best practices in 17 countrie s are anticipated in JA implemental based on the interest expressed by the competent authorities. Of those, 11 implementations relates to the Belgian Best practice on Mental Health Reform and 14 implementation relates to the Austrian best practice on sui cide prevention. In 20 countries, local country teams will be responsible to carry out the actions foreseen on a regional/country level for the technical WPs they participate in as well as actions foreseen for the horizontal WPs. Section 4.4. Context of the project work Section 4.4 Context of the project work has been updated to offer (Comments of the evaluators Criterion 1) specific discussions on the different social, cultural and/or political contexts in which it will operate. Section 4.4. Context of the project work Section 4.4. has also been revised to address the technical (Comments of the evaluators Criterion 2) complementarity with other JAs focusing to implementation of best practices such as CHRODIS PLUS and to stress that the JA will also seek complementarity and/or synergies with past and/or on-going European actions in the area of (mental) health data/indicators (like JA InfAct and JA TEHDAS) and integrated person-centered care (e.g. JADE CARE), including close collaboration with WHO/Europe and building upon the Mental Health Atlas survey, and using linkages/synergies with international projects (OECD quality indicators). Section 5. Means and methods After the first consultation with HaDEA, the Means and Methods (Comments of the evaluators Criterion 2 section has been updated to clearly explain the two best practices, and 1st consultation with HaDEA) the overall implementation strategy and the contribution of WP1 and the other horizontal WPs in the overall project. In this way the effort, strategy and tools used, in order for the JA ImpleMENTAL to achieve the successful implementation of the two best practices into the local context and needs, has been described more clearly. Based on the comment of the evaluator, WP2 description has been updated to make a clear distinction between dissemination plans pertaining to each of the two practices. Section 7.1 Overview of Work Packages Description of WP1 has been updated with more explicit details on 1 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 (WPs) how tasks will be implemented. Section 7.2 Work packages descriptions Based on the comments of the evaluators in Criterion 2, the number (Comments of evaluators criterion 2 &3) of deliverables has been reduced by merging some reports and changing some deliverables to milestones (D3.4, D2.8). Milestones and Deliverables list in WP descriptions have been updated. Based on comments of the evaluators in Criterion 3, description of WP1 has been updated with more explicit details on how tasks will be implemented. Based on comments of the evaluators in Criterion 3 details in the descriptions of WPs (PM per applicant), has been added. Section 7.3 Timetable and Milestones Based on comments of evaluators in Criterion3, WP6 timetable in (Comments of evaluators criterion 2 & 3) Gantt Chart has been added. Milestones listed in section 7.3 have been updated. Section 8. Deliverables Based on the comments of the evaluators in Criterion 2, Deliverables (Comments of evaluators criterion 2) list has been updated. Section 9.(9.1-9.3) Project management In response to the comments of the evaluators on the management (Comments of evaluators criterion 3) structure and in order to make it sufficiently clear, the Section 9. (9.1- 9.3) on Project management has been revised, and the PM2 methodology is currently fully evident in the proposal. A Project Handbook will be developed to establish the high-level approach for implementing the project and will summarize the project objectives and document the selected approach for achieving the project goals and conflict resolution and escalation procedure, policies and rules, and the project mindsets. The existing management structure is considered multifaceted, as the JA Coordinator is sided and supported by all members of the Executive Board, which involves not only WP1 NPHO team but all the leaders and coleaders of all Work Packages (2-6) rather than just the leaders of WP5 and WP6, as suggested in the evaluation report. In this way, substantial communication among the packages is facilitated resulting in great harmony and consistency in the overall approach. Most countries (11/20) will participate in both best practices and we should focus our efforts to work as One Joint Action that implements two best practices with a common implementation strategy described in the means and methods section of the proposal, which will be further developed/operationalized in the first months of the JA. WP1 will prepare the guidelines on the implementation strategy and describe them in the project handbook within the first months of the JA. In WP1, The JA Coordinator is sided 1) by two experienced NPHO teams, 1a) a senior scientific and management NPHO team which apart from the JA Coordinator, will consist from the Senior Mental Health Advisor and 3 senior mental health and public health experts with highly relevant expertise and competencies and 1b ) a senior Legal and Financial NPHO Team with substantial experience in large EU co-funded projects The JA Coordinator is the person responsible for all project management tasks and deliverables. The Head Financial officer in NPHO responsible for task 1.3 on financial management. A Project Management Assistant (PMA) will work fully on the project (36 PMs) on a range of management and supportive tasks as assigned by the JA Coordinator, in order to assist the JA Coordinator and the 2 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 senior NPHO teams in the everyday work of the project. A Financial Officer will be appointed (for 18 PMs) to assist the Senior Financial Officer, in order to meet the needs of this complex JA in response to the request from the evaluators. Section 9.5 Capacity of the staff to carry Updates of staff to the Competent Authority of Germany and Spain. out the project Revision on the name of Competent Authority of Hungary Section 9.6 Risk Analysis and Treatment The risk management plan has been revised based on the comments (Comments of evaluators in Criterion 3) of the evaluators in Criterion 3. Section 10. Budget Based on comments of the evaluators in Criterion 4: (Comments of evaluators in Criterion 4) The Spanish partner has limited the number of staff involved and revised the participation of staff in WPs. Travel costs for participation in meetings of the various JA bodies (GA, Executive Board, etc.) and of the WPs, in particular the two technical WPs, have been minimised as much as possible and a balanced mix of online and onsite meetings/workshops enabling adequate exchange and interaction between participating partners, has been envisaged. All meetings taking place in 2021 are planned as online meetings only, principally due to contact and travel restrictions imposed by the Covid-19 pandemic. In the Detailed budgets per entity (CAs and AEs) the number of staff participating as well as the number of days are indicated. Justification for personnel costs has been updated Partner n.1 NPHO, the cost for external experts for scientific paper has been removed. In Partner n. 17, Norway, the cost for personnel will be covered by national funds from the country; the cost of 894483 euros indicated in the budget of Norway referred on the national funds for the suicide prevention strategy and has been removed. There will be no third party involvement. Norway will cover from national funds the personnel cost. Partner 8, Finland, has provided an explanation for the costs for subcontracting which has been accepted by the Project Officer of HaDEA. Partner 16, Netherlands, has removed the costs of subcontracting for external evaluators and this task will be performed by internal staff of Trimbos Institute. Responding to the evaluators comment that taking into account the COVID pandemic, there should be a clear provision from the beginning for the use of technologies for on-line/virtual meetings, we would like to point that in the budget of NPHO in other goods and services section there is provision for Costs for webex platform for Teleconferences/meetings/conferences and for a Project Management Platform for 25 users. Clerical errors in budget calculations have been corrected Section 14 Updated description of section 14. On Collaborating stakeholders Comments of evaluators in Criterion 3) All sections Proofreading corrections 3 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 SECTION Changes performed June 2021 based on 2nd consultation and comments received from HaDEA and DG SANTE Section 2.1 General Objectives of the The General Objective Section has been modified based on the Project comments from HaDEA and DG SANTE Section 2.2 Specific Objective(s) of the Target values of indicators have been updated to meet the guidance Project by HaDEA to increase the overall target countries which committed to transfer/pilot the Belgian best practice to actually implement it to 90% Section 5. Means and methods Updated description of table “Contribution to the Objectives” of the Joint Action per country Section 6. Expected Outcomes and A paragraph has been added to emphasize that main effort of the Benefits of the Project ImpleMENTAL is expected to be the implementation of the two best practices “Mental health reform in Belgium” and the Austrian best practice on suicide prevention “SUPRA” across 20 participating countries. Section 7.2 Work packages descriptions Descriptions of milestones and deliverables tables in WP1, WP2, WP3, WP4, WP5 and WP6 has been updated based on comments and in the format requested Participation per Partner for WP1, WP2, WP3, WP4, WP5 and WP6 has been updated in the format requested Section 7.3 Timetable and Milestones Based on the guidance from HaDEA, Milestones list in section 7.3 have been updated. Section 8. Deliverables Based on the guidance from HaDEA, the Deliverables list has been updated. Section 9.5 Capacity of the staff to carry Updated of description of the new Competent Authority of Norway out the project Section 10. Budget Updated Detailed Budgets per CAs and AEs provided All sections Proofreading corrections SECTION Changes performed in July 2021 List of applicants Short names of the CAs and the AEs have been added Section 5. Means and methods Updated format of table of the Objectives of the Joint Action per participating country and change of name of the table to “Contribution to the Objectives of the Joint Action per Country” Section 7.2 Work packages descriptions Participation per Partner (CAs and AEs) for WP1, WP2, WP3, WP4, WP5 and WP6 has been updated Description of WP2 & WP4, has been further updated based on comments by HaDEA Section 7.3 Timetable and Milestones Some final editings have been made Section 8. Deliverables Some final editings have been made Section 10. Budget Section 10.2 Section 10.2 Summary of effort has been updated Section 5 Means and Methods, Harmonization, across these sections, of the description of: Section 7.2 WP1 description 1. Project Handbook Section 9.2. Governance, Roles and 2. Governance, management, Performing and advisory bodies Responsibilities Member State Committee was renamed to Member State Policy Committee to emphasize the policy role of this board and the close work and advisory role of the Ministries on implementation and sustainability All sections Proofreading corrections 4 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 SECTION Changes performed in August- September 2021 following organized by HaDEA meetings with WPleaders Section 5. Means and methods Final editings in Means and Methods sections based on comments by WPleaders following meetings organized chaired by HaDEA Section 7.2 Work packages descriptions Final editing in WP1 and WP4 descriptions based on comments by WP leaders following meetings organized chaired by HaDEA. The timeline Consortium meetings has been more clearly described. Section 7.3 Timetable and Milestones Some final editings have been made Section 8. Deliverables Some final editings have been made Section 10. Budget Section 10.2 Section 10.2 Summary of effort has been updated Section 5 Means and Methods, Harmonization, across these sections, of the description of: Section 7.2 WP1 description 1. Project Handbook Section 9.2. Governance, Roles and 2. Governance, management, Performing and advisory bodies Responsibilities Some final editings have been made All sections Proofreading corrections SECTION Detailed Budget 10.4 Changes performed in September 2021 following comments by HaDEA Financial Officer Lump sum Actual costs for the number of events/meetings and the number of persons travelling have been included NPHO a certificate on financial statements for this entity was budgeted and mentioned in the detailed NPHO budget BMSGPK Clarifications provided why there are no PMs and no costs foreseen for this entity, and how exactly this entity will be contributing to this JA, and have been included in Annex 1 Part B GÖG a certificate on financial statements for this entity was budgeted and mentioned in the detailed budget subcontracting costs – clarifications provided on exactly what tasks the subcontractor will provide and why such trainings are necessary for the implementation of the action have been included NCPHA Travel costs – EUR 1000 ‘lump sum for all meetings’- number of meetings number of persons travelling and actual costs have been included CIPH a certificate on financial statements for this entity was budgeted and mentioned in the detailed budget inclusion of justification for each travel cost item, the number of persons travelling and the amount of meetings/events that will take place have been included MHS CYPRUS a certificate on financial statements for this entity was budgeted and mentioned in the detailed budget MSAE For each travel cost the destination/type of event, the number of events/meetings that will take place, the number of persons travelling; have been included other goods and services –in each case the ‘cost of meetings/workshops within country’ entails have been included NIHD For the travel costs the destination, the number of events/meetings that will take place, the number of persons travelling have been included Justification on how exactly this entity will be contributing to this JA –has been included THL Clarification on exactly what tasks the subcontractor will be performing; have been included 5 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 For the travel costs in the amount of EUR 6857, the destination/type of event, the number of events/meetings that will take place, the number of persons travelling; have been included ‘justification’ field for the personnel costs have been included MOH FRANCE Travel costs – EUR 1000 ‘lump sum for all meetings’- the number of events/meetings and the number of persons travelling have been included BZGA a certificate on financial statements for this entity has been budgeted and mentioned in the detailed budget Travel costs – EUR 2000 ‘lump sum for all meetings’- the number of events/meetings and the number of persons travelling have been included other goods and services – EUR 30 150 – justification of ‘expert input’ and tasks they be performing have been included OKFO Travel costs/ other goods and services – corrected Travel costs – EUR 1000 ‘lump sum for all meetings’ the number of events/meetings and the number of persons travelling have been included SU Travel costs/ other goods and services – corrected Travel costs – EUR 1000 ‘lump sum for all meetings’ the number of events/meetings and the number of persons travelling have been included UD Travel costs/ other goods and services – corrected Travel costs – EUR 1000 ‘lump sum for all meetings’ the number of events/meetings and the number of persons travelling have been included LOMBARDY REGION The comment: “ No PMs have been indicated for 5 staff members – please verify this and if appropriate correct the number of PMs for each staff member in the detailed budget and also in Annex 1 Part A, as well as the figures concerning personnel costs: has been addressed and corrected ASST LECCO For all travel costs please the number of persons that will be travelling have been included The comment: “other goods and services - cost items foreseen with zero costs “ has been addressed and these lines were deleted MNIPR staff members mentioned in the detailed budget without any PMs or personnel costs were deleted POLIMI For travel costs please the number of persons travelling, the number of meetings/events that will take place have been included SAM Travel costs – EUR 2000 ‘lump sum for all meetings’- the destination, number of events/meetings and the number of persons travelling have been included MFH a certificate on financial statements for this entity was budgeted and mentioned in the detailed budget Travel costs – EUR 1000 ‘lump sum for all meetings’- the number of events/meetings and the number of persons travelling have been included TRIMBOS a certificate on financial statements for this entity was budgeted and mentioned in the detailed budget IPHS for the travel cost item EUR 1000 ‘lump sum for all meetings’ the number of events/meetings that will take place and the number of persons travelling; have been included SMS for the travel cost item EUR 2000 ‘lump sum for all meetings’ the destination, number of events/meetings that will take place and the number of persons travelling have been included 6 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 TABLE OF ABBREVIATIONS ABBREVIATIONS USED AE Affiliated Entity CA Competent Authority EC European Commission EU European Union ExB Executive Board GA General Assembly HaDEA European Health and Digital Executive Agency (formally known as CHAFEA) JA Joint Action MH Mental Health MH Mental Health MS Member States MS Policy Committee Member State Policy Committee OECD Organisation for Economic Co-operation and Development PCT Project Core Team PO Project Owner PSC Project Steering Committee SANA Situation and Needs Analysis SP Suicide Prevention SUPRA Suicide Prevention Austria WHO World Health Organisation WP Work Package(s) 7 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 TABLE OF DEFINITIONS DEFINITIONS Affiliated Entities or Entity (AE) Affiliated entities to the Competent Authority are "entities that satisfy the eligibility criteria and that do not fall within one of the situations referred to in article 136 (1) and 141 (1) and that have a link with the beneficiary, in particular a legal or capital link, which is neither limited to the action nor established for the sole purpose of its implementation". ELIGIBILITY, SELECTION AND AWARD CRITERIA FOR JOINT ACTIONS 2020 7 Article 187 of the Financial Regulation 2018/1046 of 18 July 2018 Affiliated entities have their own budget in the JA. They participate in the General Assembly but are represented by their Competent Authority for voting. Beneficiaries Those who sign the Grant Agreement. The Competent Authorities of the participating countries. By signing the Agreement or the Accession Form, the beneficiaries accept the grant and agree to implement it under their own responsibility and in accordance with the Agreement, with all the obligations and conditions it sets out. The beneficiaries are jointly and severally liable for the technical implementation of the action Collaborating stakeholders (CS) Plays a role in JA ImpleMENTAL, gets information on project results and may participated in the JA meetings. Collaborating stakeholders have no contractual relationship, nor do they receive any direct EU funding, Stakeholders selected as those with most valuable contribution to the joint action, e.g. significantly increasing the technical and scientific content of the joint action, as well as its relevance for different users in the Union, will be invited to participate in advisory structures, such as the stakeholder forum, for which costs may be reimbursed in the frame of budget funds allocated to Competent Authorities of Affiliated Entities for the purpose. Coordinator The entity entrusted the role and responsibility for coordinating and managing the project. The Coordinator is the Work Package 1 leader-National Public Health Organization Competent Authority (CA) Member States’ and other participating countries’ authorities have nominated one competent authority for this joint action responsible for implementing the action on their behalf. Member States’ and other participating countries’ authorities should confirm that the nominated entity and its affiliated entities are eligible to participate in the action on behalf of the country concerned and under its responsibility. The CA coordinates and shares information with the Affiliated Entities within his or her country and has ONE voting right in the General Assembly of the Consortium Project The project is the Joint Action (JA) on “Joint Action on Support for Member States’ implementation of best practices in the area of mental health” 8 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 LIST OF APPLICANTS Applicant Applicant Organisation Name Short Name Country 1 NATIONAL PUBLIC HEALTH ORGANISATION(Coordinator) NPHO GREECE 2 AUSTRIAN FEDERAL MINISTRY OF SOCIAL AFFAIRS, HEALTH, CARE BMSGPK AUSTRIA AND CONSUMER PROTECTION 2.1 AUSTRIAN NATIONAL PUBLIC HEALTH INSTITUTE - GESUNDHEIT GÖG AUSTRIA ÖSTERREICH GMBH 3 NATIONAL CENTER FOR PUBLIC HEALTH AND ANALYSIS NCPHA BULGARIA 4 CROATIAN INSTITUTE OF PUBLIC HEALTH CIPH CROATIA 5 MENTAL HEALTH SERVICES DIRECTORATE MHS CYPRUS CYPRUS 6 MINISTRY OF HEALTH OF THE CZECH REPUBLIC MZCR CZECHIA 6.1 NATIONAL INSTITUTE FOR MENTAL HEALTH NIMH CZECHIA 7 MINISTRY OF SOCIAL AFFAIRS MSAE ESTONIA 7.1 NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT NIHD ESTONIA 8 FINNISH INSTITUTE FOR HEALTH AND WELFARE THL FINLAND 9 MINISTRY OF SOLIDARITY AND HEALTH MOH-FRANCE FRANCE 9.1 INSERM INSERM FRANCE 10 FEDERAL CENTRE FOR HEALTH EDUCATION BZgA GERMANY 11 ORSZAGOS KORHAZI FOIGAZGATOSAG OKFO HUNGARY 11.1 SEMMELWEIS UNIVERSITY (HEALTH SERVICES MANAGEMENT SU HUNGARY TRAINING CENTRE) 11.2 UNIVERSITY OF DEBRECEN (THE FACULTY OF PUBLIC HEALTH) UD HUNGARY 12 DIRECTORATE OF HEALTH IN ICELAND DOHI ICELAND 13 LOMBARDY REGION LR ITALY 13.1 LOCAL HEALTH AUTHORITY OF LECCO ASST LECCO ITALY 13.2 BICOCCA UNIVERSITY, MILAN – DEPARTMENT OF STATISTICS AND UNIMIB ITALY QUANTITATIVE METHODS 13.3 MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH MNIPR ITALY 13.4 POLITECNICO DI MILANO UNIVERSITY POLIMI ITALY 13.5 FATEBENEFRATELLI CENTER "SAINT JOHN OF GOD"- BRESCIA FBF ITALY 14 MINISTRY OF HEALTH OF THE REPUBLIC OF LITHUANIA SAM LITHUANIA 15 MINISTRY FOR HEALTH - MENTAL HEALTH SERVICES MFH MALTA 16 TRIMBOS INSTITUTE TI NETHERLANDS 17 NORWEGIAN DIRECTORATE OF HEALTH HDIR NORWAY 18 INSTITUTE OF PUBLIC HEALTH OF SERBIA “DR MILAN JOVANOVIC IPHS SERBIA BATUT” 19 NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE - NATIONAL INSTITUTE NIJZ SLOVENIA OF PUBLIC HEALTH 20 SERVICIO MURCIANO DE SALUD SMS SPAIN 20.1 FUNDACIÓN PARA LA FORMACIÓN E INVESTIGACIÓN SANITARIAS FFIS SPAIN DE LA REGIÓN DE MURCIA 20.2 SERVICIO CATALÁN DE SALUD CATSALUT SPAIN 20.3 CONSEJERÍA DE MUJER, IGUALDAD, LGTBI, FAMILIAS Y POLÍTICA CONSEJERIA SPAIN SOCIAL DE LA REGIÓN DE MURCIA DE MUJER 20.4 SERVICIO ANDALUZ DE SALUD SAS SPAIN 20.5 FUNDACIÓN PÚBLICA ANDALUZA PROGRESO Y SALUD FPS SPAIN 20.6 SERVICIO MADRILEÑO DE SALUD SERMAS SPAIN 20.7 SERVICIO NAVARRO DE SALUD-OSASUNBIDEA SNS-O SPAIN 20.8 SERVICIO VASCO DE SALUD –OSAKIDETZA OSAKIDETZA SPAIN 21 PUBLIC HEALTH AGENCY OF SWEDEN FOHM/PHAS SWEDEN 9 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 TABLE OF CONTENTS HISTORY OF CHANGES 1 ABBREVIATIONS USED IN THE PAPER 7 DEFINITIONS 8 LIST OF APPLICANTS 9 TABLE OF CONTENTS 10 2.1 PROBLEM ANALYSIS INCLUDING EVIDENCE BASE 11 2.2 GOALS AND OBJECTIVES OF THE PROJECT 12 2.2.1 General Objectives of the Project 12 2.2.2 Specific Objective(s) of the Project 13 2.3 TARGET GROUPS 19 2.4 POLITICAL RELEVANCE 19 2.4.1 Contribution to the Annual Work Plan 20 2.4.2 Added Value 21 2.4.3 Pertinence of Geographic Coverage 21 2.4.4 Consideration of the social, cultural and political context 22 2.5 METHODS AND MEANS 23 2.6 EXPECTED OUTCOMES OF THE PROJECT 33 2.7.TIMETABLE OF GANTT CHART 35 2.8. PROJECT MANAGEMENT 37 Methods, Governance, Roles, Responsibilities, Processes & Artifacts 2.8.1 Quality of the Partnership 43 2.8.2 Capacity of the staff 44 2.8.3 Financial management 58 2.9. BUDGET 59 2.9.1 Content description and justification 59 2.9.2 Summary of Effort 61 2.9.3 Third-party contribution 62 2.9.2 Detailed Budget 63 2.10. PREVIOUS AND CURRENT GRANTS RELEVANT TO THE PROGRAMME 133 2.11. CURRENT APPLICATIONS RELEVANT TO THE PROGRAMME 138 2.12. EXCEPTIONAL UTILITY 138 2.13 COLLABORATING STAKEHOLDERS 138 10 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 2.1. Problem analysis including evidence base (proposal section 1) More than one in six people across EU countries had a mental health issue in 2016, equivalent to about 84 million people (OECD/EU, 2018). Moreover, in 2016, 165,000 deaths were recorded in EU-27 countries as a corollary of mental and behavioral disorders (including self-harm) resulting in a EU-27 standardized death rate of 36.9 per 100,000 inhabitants (Eurostat, 2020). The burden of mental illness in the European WHO region is estimated to account for 14.4% of years lived with disability (YLDs) and 5.8% of disability -adjusted life-years (DALYs), placing mental illness as the second biggest contributor to YLDs and fourth in t erms of DALYs in the WHO European region (GHDx, 2020). A robust evidence base shows that mental health problems are inextricably linked to social and economic factors such as poverty, are exacerbated by health and social inequities, and are highly co morbid with non-communicable diseases, such as type 2 diabetes (Lund, 2012; Ngo et al., 2013; Silva et al., 2016). The European Mental Health Action Plan 2013-2020 (WHO, 2015) states that mental illness is one of the greatest public health challenges in terms of prevalence, burden of disease and disability and poses a major burden to economies, demanding policy action. Specifically, total costs pertaining to ill mental health have been gauged at more than 4% of GDP- or over EUR 600 billion- across Europe in 2015 (OECD/EU, 2018). EUR 190 billion (1.3%) of GDP relates to direct spending on healthcare, another EUR 170 billion (1.2% of GP) to social security programmes and a further EUR 240 billion (1.6% of GDP) to indirect costs in the labor market (OECD/EU, 2018). Previous research indicates that resources allocated to mental health are scarce when considering the burden ill mental health imposes. In the EU, mental health expenditure as a proportion of total health spending has been estimated to range from <2% to 13.4% (Caldas de Almeida et al. 2016). Addressing mental ill-health and promoting mental health and wellbeing are thus imperative for achieving targets and progress within the health sector as well as in the social, education and labor/economic sectors (OECD/EU, 2018). The importance of strengthening population mental health has been highlighted through the ongoing COVID -19 pandemic. Emerging evidence shows that mental health systems are facing a number of challenges during the pandemic period, including challenges in delivering face-to-face care in the community and in ensuring continuity of care (WHO, 2020). Specifically, community-based services and mental health prevention and promotion programmes, already limited in availability, were found to be disrupted at a time when society needs them the most due to the adverse mental health effects of COVID-19. The recent Eurofound’s COVID-19 e- survey showed the serious impact on young people, as they cope with the lowest levels of mental well -being and high levels of loneliness (Eurofound, 2020). In Europe, a recent pan-European snapshot of mental health services during the early phase of COVID-19 pandemic found that while some challenges are specific to the local context, many challenges were shared across countries (e.g. de-prioritization of psychiatry and focus on infectious diseases, disruption of service delivery, need for and use of modern digital tools, etc.) (Thome et al. 2020). Concerted effort is needed to minimize the adverse impact of the pandemic on m ental health and on mental health care delivery, and to ensure that the mental health of European citizens remains a priority given the impact of mental health on employment, social cohesion and participation, and the economy, all essential components for a recovery from the COVID-19 pandemic. Though many European countries have in place policies and programmes to address mental illness at different ages, implementation remains a challenge and is unequal throughout Europe. About 81% of countries in the European region have a mental health policy in place, though many countries do not have a suicide prevention strategy in place. Globally, two thirds of upper-middle and high-income countries have no suicide prevention strategy (WHO, 2018b). Many countries are seeking ways to improve their national plans and their implementation. In countries participating in this Joint Action that provided data for Mental Health Atlas 2017 survey (18 out of 21; 85%), 89% reported to have a stand-alone policy or plan for mental health, 56% to have a stand-alone law for mental health and 44% to have a suicide prevention strategy (WHO, 2018a). Therefore, 11 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 while progress has been made in countries, there is significant scope to further advance policy development and implementation efforts, in quality improvement, and in mental health promotion and prevention. Mental health service delivery is diverse across Europe. Some countries still rely on provision of the bulk of care in large psychiatric hospitals, while others deliver the bul k of care in community settings (Knapp, McDaid, & Mossialos, 2006). Governance and organization of mental health also varies: in some European countries, mental health care is the responsibility of the Ministry of Health and provision of social care is the responsibility of another ministry such as the Ministry of Labour and Social Affairs; in other countries, there may only be one ministry responsible for all domains of mental health. Financial resources and mechanisms for funding mental health care also vary significantly by country (Dlouhy, 2014; Knapp et al., 2007), and there is a general trend for financing to be dedicated to care rather than on mental health prevention and promotion. Although policies and services addressing mental health are the responsibility of individual EU countries, the need to include mental health among the priorities of the public health agenda has resulted in renewed focus at the EU level. The prior Joint Action for Mental Health and Well -being (Caldas de Almeida et al. 2016) documented uneven progress across countries with regard to the transition of institutional to community -based care, building up of community-based mental health service networks and the delivery of good quality and socially inclusive care. In this reasoning, they recommended the development and implementation of policies and services to address existing insufficiencies and gaps in European mental health care systems, to promote community-based care and the social inclusion of people with long-term mental disorders. These conclusions were replicated by the EU Compass for further action on Mental Health and Wellbeing, which updated progress on transition to community care among Member States. To build upon the 15+ years of EU efforts including the development of the European Framework for Action and the EU Compass (determining best practices for mental health), and strategic WHO documents such as the (European) Mental Health Action Plan 2013 – 2020 and the Mental Health Declaration for Europe in 2005 (WHO, 2005), a new Joint Action to Support Member States’ implementation of best practices in mental health will be implemented. The Members of the Steering Group on Health Promotion, Disease Prevention and Management of Non-Communicable Diseases (SGPP) have selected two best practices (i) the community-based Mental health system reform in Belgium and (ii) multilevel Suicide prevention from Austria to be implemented during this Joint Action with the aim to extend the benefits of these best practices to participating Member States. The two best practices are based on international evidence and recommendations aligning with strategic documents of WHO and EU such as the European Mental Health Action Plan 2013-2020. The best practice related to the mental health service delivery reform in Belgium is based on knowledge that deinstitutionalization of mental health care, broadly defined as the transition from institutional -based care to community-based care, can improve mental health outcomes and quality of life, and avoi ds unnecessary hospitalizations given the associated negative social and economic consequences on the individual, community and societal level. The other important element of this best practice is that is contains strategies for addressing fragmentation in health and social care delivery systems, the integration of which is essential for ensuring mental health, particularly among people with moderate to severe mental ill -health and/or with social and economic needs (Nicaise, Dubois, & Lorant, 2014). The service delivery model focuses on establishing service networks that strengthen community-based care provision, to reduce hospital caseloads and to improve the continuity of care (Lorant et al., 2016). The second best practice implemented in this JA is SUPRA, an evidence-based suicide prevention intervention initially developed and implemented in Austria. Its measures are based on scientific evidence (Mann et al., 2005; Zalsman et al., 2016) and include universal, selective, and indicated prevention measures . This intervention aligns with recommendations of the WHO (WHO, 2014) and preventive approaches recommended in the European Mental Health Action Plan 2013-2020, while respecting the local implementation context and building on existing resources and initiatives. 12 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 2.2 Goals and Objectives of the Project 2.2.1. General Objectives of the Project Investing in mental health has a positive return for the sustained development of populations from an economic, social, and health perspective (WHO, 2013). This Joint Action, JA ImpleMENTAL, a EU-Commission initiative, intends to: 1. support Member States to improve and promote mental health via innovative and sustainable (mental) health system change. 2. reinforce capacity to address system transformation, in particular to support citizen centered and integrated approaches, increase system efficiency, build and maintain healthy alliances across sectors, and reinforce the coordination between national and regional authorities. 3. support the best practice transfer of two best practices in mental health, pre-selected by the Steering Group on Promotion and Prevention (Member States) from the pool of the EU’s Public Health Best Practice Portal the “Mental health reform in Belgium” and the Austrian best practice on suicide prevention “SUPRA”. The effort will be focused on the preparation of the national/regional/local team and environment for the implementation. 4. achieve a strong involvement of national/regional governmental actors to enable such practices to be embedded in health systems. 5. establish sustained cooperation of relevant Member State authorities in the area of Mental Health and involving a wide variety of stakeholders to share a common and global vision about mental health. The scope, scale and extent of these general objectives will be customized for each of the implementation sites tailored to their needs, strategies and local implementation plans. 2.2.2. Specific Objective(s) of the Project Specific Objective 1 Specific Objective Title and Description (WP5) Capturing, understanding and mapping the current situation of mental health and mental health services (including prevention and treatment services), identifying needs and knowledge gaps for the establishment, improvement and/or scale -up of intersectoral community-based and client-centered MH networks and services within the 14 participating countries in the wp5 on Mental health reform in Belgium (Situation and Needs Analysis- SANA) Process Indicator(s) Target value ● Definition of methods and tools for the elaboration of The questionnaires for carrying out SANA are the country-specific SANA in the Analytical Framework elaborated jointly with WP6 for the assessment and transfer of (elements of) the Belgian best practice example At least 90% participating countries attended the ● Participation in workshop and/or exchange with workshop. participating countries for compilation of a questionnaire for conduction of a situation analysis and needs assessment (SANA) Output Indicator(s) Target value Country-specific situation analysis and needs assessment One report per participating country profiles/reports are produced Outcome/Impact Indicator(s) Target value Results of the situation analysis and needs assessments Reported utilization of the SANA results in the are effectively used for and integrated into the respective implementation/action plans (one per development of an implementation/action plan for participating and implementing country) transfer and pilot implementation (of elements) of the Belgian practice, congruent with the emerging mental health needs from the COVID-19 pandemic. 13 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Specific Objective 2 Specific Objective Title and Description (WP5) Supporting the sustainable establishment, further development and/or scale -up of inter- sectoral, community-based and client-centered MH networks and services within and beyond the JA, based on an adaptation, transfer and pilot implementation (of elements) of the Belgian best practice example in the local contexts of the 11 implementing countries. Process Indicator(s) Target value ● Initiated transfer and pilot implementation of (selected ● 10 (90%) countries that had planned to transfer elements of) community-based MH networks and and pilot implement (selected elements of) of services as practised in the Belgian best practice the Belgian best practice example have example in the local contexts of the participating effectively pilot implemented at least one key countries element of the Belgian best practice example ● Workshop(s) of implementing countries for cross- ● At least one workshop of implementing country exchange on the process of pilot countries for cross-country exchange on the implementation process of pilot implementation has taken place ● Process of reflection on needs and goals for continued ● At least 10 (90%) of the countries that pilot implementation, scaling-up or extension of the pilot implemented (elements) of the Belgian best practice after termination of JA in each country practice example identified needs and goals for continuation, scale-up or extension of the pilot implementation after termination of the JA Output Indicator(s) Target value ● Pilot implementation (of elements) of the Belgian best ● All countries that committed to pilot implement practice example was carried out in the various delivered a country-specific report on the pilot involved countries and documented in country-specific implementation process implementation reports ● One cross-country analysis and synthesis report ● A cross-country analysis of the process and results of was produced pilot implementation was undertaken ● At least 90% of the countries that piloted ● Goals, desired outcomes, major steps and milestones (elements) of the Belgian best practice example for continuation, scale-up or extension of the pilot elaborated implementation are synthesized and documented in a simple implementation roadmap Outcome/Impact Indicator(s) Target value Commitment by stakeholders and/or decision-making At least 70% of countries that piloted (elements) of authorities at national, regional or local level within the the Belgian best practice example and elaborated a participating and implementing countries for simple implementation roadmap, concerned continuation, scale-up or extension of pilot stakeholders and/or decision-making authorities at implementation beyond the JA manifested by means of national, regional or local level have concluded formal agreements or expressed publicly. formal agreements or engaged into other forms of formal cooperation or expressed publicly their intention for continuation, scale-up or extension of the pilot implementation. Specific Objective 3 Specific Objective Title and Description (WP5) Supporting the use of information, data and indicators for monitoring, evaluating and improving intersectoral community-based and client-centered MH networks and services and assessing system developments. Process Indicator(s) Target value ● Analysis of health - mental health information systems ● H-MHIS are covered in the SANA of the (H-MHIS) at country level within the frame of the SANA participating countries. ● Set-up of and consultations with a network of country ● Consultations with country experts responsible experts responsible for the collection and use of MH- for the collection and use of MH data -took related data place in at least 90% of the participating 14 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ● Consensus workshop for discussion and agreement on countries the use of existing MH related indicators ● One consensus workshop at central level for discussion and agreement on MH related indicators was conducted (minutes and participants list) Output Indicator(s) Target value ● A dashboard of MH indicators is developed and piloted ● Dashboard of MH indicators is effectively in the participating countries (piloted)/used in 80% of the countries that ● A synthesis report is produced on the use of indicators agreed to apply/activate the dashboard for MH and showing data collected by/in the countries ● One synthesis report on the use of indicators for through the dashboard MH is produced Outcome/Impact Indicator(s) Target value Developed dashboard of indicators is used as a tool for Developed dashboard is piloted/used in at least the collection of data and for monitoring, evaluating and 80% of the participating countries that expressed reporting on mental health care in participating countries willingness to use it Specific Objective 4 Specific Objective Title and Description 4 (WP5) Supporting capacity and competence building of stakeholders for the sustainable establishment and operation of inter-sectoral, community-based and client-centered MH networks in the 14 participating countries for the transfer of the Belgian best practice Process Indicator(s) Target value ● Development of a training and capacity building plan One training and capacity building plan is ● Implementation of the defined training and capacity developed for WP5 building measures At least 90% of the countries interested participated in training programmes. Output Indicator(s) Target value ● Number of training and capacity building measures ● Staff of at least 90% of participating countries conducted during the JA and number of took part in at least one training and capacity staff/professionals in/from the pilot settings trained building measure ● Training kit (including training modules, curricula, ● A training kit is developed and made available materials and/or tools) integrating experiences gained for further adaptation and use in country- through training implemented during the JA developed specific context and ready to be used and adapted by interested institutions/stakeholders Outcome/Impact Indicator(s) Target value Developed training kit is being used by stakeholders in At least one stakeholder in 90% of participating participating (and/or other) countries or stakeholders have countries has expressed interest and willingness to expressed willingness to adapt and use the training kit adapt and use the training kit Specific Objective 5 Specific objective title and description (WP6) Recording and assessing the current situation in the field of suicide prevention in each country/region, including an in-depth understanding of existing stakeholders and their positions, activities and, expectations as well as knowledge about gaps (situation analysis) in 17 participating countries Process indicator(s) Target value Workshop on compilation of a questionnaire for undertaking a 1 workshop has taken place, participants list comprehensive situation analysis and needs assessment and minutes from the workshop are provided (SANA) and on compilation of a template for a country profile Output indicators Target value 15 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Results of the situation analysis are documented in country 1 country profile per MS profile Outcome/impact indicator(s) Target value Results of the situation analysis are used in the respective Reported utilization of the situation analysis country suicide prevention (SP) strategy results in respective SP strategy Specific Objective 6 Specific objective title and description (WP6) Assessing resources (staff, budget, other) needed to address and implement prioritized activities (aiming to further develop existing activities and/or address identified gaps in their country/region) (needs analysis) in 17 participating countries Process indicator(s) Target value Workshop on compilation of a questionnaire for undertaking 1 workshop has taken place, participants list a comprehensive situation analysis and needs assessment and minutes from the workshop are provided (SANA) and on compilation of a template for a country profile Output indicators Target value Results of the needs analysis are documented in country 1 country profile per MS profile Outcome/impact indicator(s) Target value Results of the needs analysis are used in the respective Reported utilization of the needs analysis country SP strategy results in respective SP strategy Specific Objective 7 Specific objective title and description (WP6) Obtaining stakeholder commitment for the establishment (or further development) of a national/regional strategy including steps to promote increased awareness for SP of main stakeholders and the general public as well as fighting suicide -related stigma in 14 implementing countries. Process indicator(s) Target value Workshop on how to develop a (national/regional) SP strategy, 1 workshop has taken place, Participants list presentation of WHO-Framework and use case /best practice and minutes from the workshop are provided model SUPRA with focus on potentially transferable modules (according to the 6 SUPRA-“columns”) Output indicators Target value National/regional working group and advisory board for SP are 1 working group, 1 advisory board per established implementing country/region Outcome/impact indicator(s) Target value National/regional working group and advisory board Reported involvement of the national/regional involvement in strategy formulation (further development) working group and advisory board in strategy development Specific Objective 8 Specific objective title and description (WP6) Promoting learning and cross-country exchange on methods, tools, practices and experiences in the development and/or improvement of national/regional strategies for SP in 17 participating countries. Process indicator(s) Target value Workshop on how to develop and implement a 2 workshops have taken place, Participants list (national/regional) suicide prevention strategy, presentation and minutes from the workshop are provided of WHO-Framework and use case /best practice model 9 trainings have taken place SUPRA with focus on potentially transferrable modules (according to the 6 SUPRA-“columns”) Workshop on implementation of draft SP strategies 16 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Trainings and/or thematic webinars Output indicators Target value Suicide prevention strategies on regional/national level are 1 developed (scaled-up) regional/national SP (further) developed/scaled-up strategy per implementing country/region Outcome/impact indicator(s) Target value Government of the respective MS adopted the Adoption or willingness to adopt the SP strategy regional/national SP prevention strategy or expressed on the regional/national level willingness to adopt under specific circumstances Specific Objective 9 Specific objective title and description (WP3) To assess the JA’s impact by 1) assessing the achievement of project objectives set out in the JA and whether outcomes of the JA meet the needs of and/or within Member States and 2) evaluating the implementation processes and implementation outcomes across MS implementing the best practices, including key ingredients, challenges, and considerations for further implementation and scale-up. Process Indicator(s) Target value Develop and obtain consensus on an evaluation framework for 1) WP leaders are engaged in the development evaluation of the JA and 2) for assessment of implementation of the evaluation framework through online process and implementation outcomes of best practices meetings to secure consensus on aims and WP deliverables/indicators. Output Indicator(s) Target value Evaluation framework is agreed upon by the consortium and One common evaluation framework is in place applied in the internal evaluation to guide the assessment of the JA and of Common evaluation framework and locally adapted version of implementation processes and outcomes the evaluation framework in Member States is complete Outcome/Impact Indicator(s) Target value Evaluation of the JA and best practices is completed, with 1) One meta-synthesis of results across recommendations for further maximizing the impact of the JA implementing MS is complete (in close and 2) Implementation processes and outcomes are evaluated collaboration with efforts in WP5 and 6) across implementing Member States in the format of a meta- synthesis to synthesize implementation barriers, facilitators and key considerations across MS Specific Objective 10 Specific Objective Title and Description WP1 and WP4 Achieve a strong involvement of national/regional governmental actors to enable best practices to be embedded in health systems. Process Indicator(s) Target value ● Number of MoHs representatives participating in Member ●At least 18 of 20 (90%) countries have State Policy Committee representatives in Member State Policy Committee ● Number of DG SANTE and HaDEA representatives ●2 representatives from DG SANTE and HaDEA ● WHO representative ●1 WHO representative Output Indicator(s) Target value ● 2 Member State Policy Committee meetings per year (physical -At least 90% of Member State Policy or by teleconference) Committee Members attend the meetings ● Ministries national/regional policy-makers, reflect on and - Presentation in annual consortium assess the policy relevance and value of JA achievements, and meetings (M12&14) to explore integration of the JA results into national/regional - Minutes of the Members Stake Policy 17 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 policies Committee Meeting in (M30) used in the sustainability plan Outcome/Impact Indicator(s) Target value Level of perception (measured by self-reported data from Member ●Level of utilization of JA ImpleMENTAL State Policy Committee members) that ImpleMENTAL in policy documents on national/regional recommendations and results have impact on mental health services level and strategies in participating countries ●Presentation in final Conference (M36) Specific Objective 11 Specific Objective Title and Description (WP4) To identify opportunities for sustaining the results of the JA beyond its lifespan and embedding lessons learned and knowledge into mental health policy. Process Indicator(s) Target value Create a roadmap for sustaining mental health changes over time and 1 roadmap is developed, and there is create a pathway for lessons learned from the JA to inform policy consensus on its contents (common priorities and planning sustainability plan) Output Indicator(s) Target value ● Policy dialogues are implemented in MS in the JA, which -Policy dialogues are implemented in at generate possibilities/opportunities around a key policy question least 30% of implementing MS (e.g., how to finance multidisciplinary community mental health -Roadmap and sustainability plan are teams for the next 5 years), with a corresponding action plan finalized and implemented (with responsibilities, budget, communication channels). ● A roadmap and sustainability plan are developed and implemented to guide making investments in mental health and the impact of those investments over time Outcome/Impact Indicator(s) Target value Policy makers and key stakeholders in mental health policy have the Policy dialogues are completed and insights from the results of the JA to help support ongoing program sustainability plans are defined and planning work in mental health. completed for each implementing MS Specific Objective 12 Specific Objective Title and Description (WP2) & WP1 To create a community of stakeholders that includes caregivers, healthcare experts, academia, industry, policy makers and /or the general public. Process Indicator(s) Target value ● Number of stakeholder representatives participating in At least 8 stakeholder representatives Stakeholder Forum ● Number of face-to-face and virtual meetings with stakeholders at >25 national and EU level ● Number of presentations at face-to-face and virtual scientific and >40 policy discussion events Output Indicator(s) Target value Two stakeholder meetings per year (physical and by teleconference). Participation of stakeholder forum The Stakeholder Forum has an advisory role and will enable relevant members in annual meetings (8 external stakeholders to follow and contribute to the JA progress and participants) (M12 & M24) discuss with JA partners the topics linked to it. In particular, it allows the stakeholders to bring in their views, interests and expectations into the JA process and advise on issues of practical relevance/importance for achieving the expected results. Estimated audience of ImpleMENTAL dissemination channels > 1,000 18 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Outcome/Impact Indicator(s) Target value ● Level of perception (measured by self-reported data) that > 75% ImpleMENTAL recommendations and results have impact in Presentation of self reported data in the policy setting, and scientific, industrial and general debates and final conference (M36), Broad mental fora health community, MS/C ● Increased awareness of the JA through dissemination actions targeting national and EU stakeholder groups 2.3 Target Groups The Joint Action is a multifaceted policy initiative and has a wide geographical and institutional coverage, and thus has a diverse array of stakeholders that can be informed, engaged and benefit from the lessons learned in the JA. A tailored approach is therefore needed to effectively reach out to them. Primary target groups are: ● Policy and decision makers within and outside the mental health sector, including political authorities and administrators at national/regional/local level (e.g. national/regional health ministries/authorities and other ministries, authorities responsible for social affairs, education, youth, senior citizens, etc.) ; ● Specific institutions/organizations and professionals in the social, educational, employment sectors (and potentially other relevant sectors that will be identified during the JA implementation) with a potential contribution to the psychiatric reform, especially building-up effective community networks, as well as institutions/organizations which are important as hotspots for suicide prevention (e.g. national railway agency); ● Health and mental health professionals; ● Mental health service users, patients and family associations; ● People with lived experience of a suicide attempt and survivors of bereavement due to death by s uicide; ● Media professionals, who play an important role in responsible reporting on mental health and suicide; ● Civil society organizations operating in mental health and/or suicide prevention at local, national or regional level ● The general population, especially as regards the objectives pertaining to raising awareness about suicide and tackling the stigma attached to it. On a more general level, the above-mentioned stakeholders across European countries will be informed about and gain exposure to lessons learned and from the results achieved in the JA and from cross-country exchange through the communication and dissemination activities of the JA, through training and capacity building activities in WP5 and 6, and through evaluation and sustainability acti vities in WP3 and 4. Further, they will be able to use and apply the methods and tools developed and tailored to their needs in the context of the JA, both during the implementation of the JA and after its completion. Finally, non-governmental or other organizations involved in the JA as collaborating partners will benefit indirectly from the results of the JA through their participation as collaborating partners in the JA and through dissemination and communication activities on the JA and its results. It is noteworthy that the final beneficiaries of the Joint Action are children, adolescents and adults (including the elderly) at risk of or affected by mental illness as well as their families. They will benefit from better access and coordination of mental health services in their national/local context, as well as from effective suicide prevention strategies. The Stakeholder analysis at the outset of the Joint Action (described as the second task in WP2) will facilitate effective identification of stakeholder groups that would benefit, advocate for or be potentially less interested or unsupportive of the JA. Tailored engagement, communication and dissemination plans will be shaped accordingly for each type of support level for the JA. 2.4 Political Relevance JA ImpleMENTAL aligns closely to the 3rd Health Programme (2014-20) objectives: 1 (Promote health, prevent disease and foster healthy lifestyles through 'health in all policies'), 3 (Contribute to innovative, efficient and sustainable health systems) and 4 (Facilitate access to high quality, safe healthcare for EU citizens). JA 19 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ImpleMENTAL is concerned with taking actions to ensure that mental health is promoted and protected through implementation of two best practices in suicide prevention and in the p rocess of reform of mental health services, which require engagement with decision-makers across sectors as well as dissemination of knowledge and results to decision-makers and influencers not only in the health sector but also in other sectors includ ing education, employment and social care sectors. Furthermore, one of the two best practices being implemented in this JA concerns the Belgian model of mental health reform, which will contribute to transitions in mental health service delivery systems in 11 Member States, concurring closely with objective 3 of the Health Programme. One of the goals within this practice is to not only facilitate access to mental health services in and around the communities where citizens live but also to improve the quality of mental health services provided at different levels of care, in line with the fourth objective of the Health Programme. 2.4.1. Contribution to meeting the objectives and priorities defined in the annual work programme In total 40 partners (21 Competent Authorities and 19 affiliated entities) from 21 countries, (18 EU Member States, 2 EEA countries and 1 EU candidate country) will be part of the JA ImpleMENTAL Consortium. This JA corresponds to 1.2.1.4 of the 2020 Annual Work Plan (AWP) (Support for the implementation of best practices in the area of mental health) by implementing the two best practices in 17 countries, with at least 25 scheduled implementations, which will generate results and lessons learned across participating countries in terms of th e impact that the implementation of these two best practices has within and across countries on population mental health outcome The results of this JA will not only contribute to furthering knowledge on the implementation process of best practices in mental health, but they will also support policy objectives at national/regional level within MS, as well as contribute to advancing mental health policy efforts at the EU level. The MS implementing the best practices are diverse in their political, social, economic and cultural context, as well as in their mental health system configuration, which will generate rich insights into modifications, considerations and options for implementing these best practices in other contexts throughout Europe during and beyond the lifespan of this Joint Action. This JA is timely in the context of developments in mental health at the EU and international level. There have been numerous strategic and policy documents at the EU level in mental health, including: ● European Commission Green paper "Promoting the Mental Health of the Population. Towards a Strategy on Mental health for the European Union"(2005); ● European pact for mental health and well-being (2008); ● Council conclusions on 'The European Pact for Mental Health and Well-being: results and future action' (2011); ● European framework for action on mental health and wellbeing (2016) and all related thematic documents of the JA. More recently, the previous Joint Action for Mental Health and Wellbeing (2013-2016) and the EU Compass for Further Action on Mental Health and Wellbeing stressed the need for concerted action to implement best practices that can strengthen mental health systems. The JA on Mental Health and Wellbeing additionally emphasized the need of promoting the implementation of e-health approaches, which is very timely given the current situation that emerged due the COVID-19 pandemic, as well as the need for developing community- based and socially inclusive mental health care for people with severe mental disorders. One theme emerging from both the prior Joint Action and the EU Compass was the need f or actual implementation, monitoring and evaluation of transitions in mental health systems, which this JA is focused on, particularly around two best practices in mental health. Further, this JA is aligned with goals set out for Member States in the WHO European Mental Health Action Plan (2013-2020) which specifically sets out targets for Member States to advance efforts to transform their mental health systems: a. To improve the mental health and well-being of the entire population and reduce the burden of mental disorders, ensuring actions for promotion and prevention, and intervention on the determinants of mental health, combining both universal and targeted measures with a special focus on vulnerable groups; b. To respect the rights of people with mental health problems, promote their social inclusion and offer equitable opportunities to attain the highest quality of life, addressing stigma, discrimination and isolation; 20 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 c. To strengthen or establish access to and appropriate use of safe, competent, affordable, effective and community-based mental health services. This JA focuses on implementation of best practices in suicide prevention and also aligns with the Sustainable Development Goals, particularly Target 3.4 (reduce premature mortality attributed to non -communicable diseases) which aims to reduce these deaths by one-third by 2030. As already mentioned, the two best practices chosen for widespread implementation in this JA were selected by the country members of the “Steering Group on Health Promotion, Disease Prevention” among those uploaded in the Best Practice Portal of EU. It is expected that the tailored implementation of these two best practices in a number of Member States will not only result in benefits to mental health services and suicide prevention efforts in implementing Member States but also provide valuable lessons learned for further scale -up and replication of these best practices, as well as ideas for sustaining implementation over time. This will be achieved through exchange of knowledge an d skills between Member States (practice-based, scientific and professional knowledge), which the JA is designed to facilitate as a mechanism for cross-country exchange and cooperation. 2.4.2. Added value at EU level in the field of public health This JA contributes in several ways to ongoing public health efforts at the EU level. First, there remains a demonstrable policy-implementation gap and research-implementation gap, particularly in the field of mental health. This JA builds upon 15 years of efforts at the EU level to identify challenges in mental health systems throughout Europe and narrows the implementation gap in mental health care delivery and pragmatic evaluation strategies by focusing efforts on the implementation of best practices and identif ication of possibilities for improving the implementation process and impact on end beneficiaries. In other words, this JA not only further promotes the best practices in mental health but implements them across and within a diversity of contexts and resource levels in Europe. These lessons learned and understanding of options for implementation based on national/local resources and contexts will not only be visible and beneficial for individual Member States but for Europe as a whole. The frameworks for implementation developed in this JA will be able to be used as a guide or frame of reference for future Member States considering implementation of these two best practices in mental health. These points of added value contribute to EU added value domains ``Long-term effect and potential multiplier effect, such as replicable, transferable and sustainable activities” and “Contribution to complementarity, synergy and compatibility with relevant EU and EU Member States policies and programmes, including compatibility with the European Platform on RD registration and the European Platform on Best Practice Exchange”. In addition, the local, regional and national networks established as part of the implementation of both best practices contributed to strengthening networking activities in mental health not only at the national/local level in MS but also at the European level. The building up of intersectoral networks, between health and the mental health sector as well as across other sectors (social, educational, e tc) will foster a more holistic approach to health and mental health. The networks established in WP6 will also importantly support efforts to combat stigma surrounding death by suicide and suicide attempt, particularly among sectors like the media sector. In WP5, the dashboard of indicators to gauge mental health network development and service delivery will benefit Europe more broadly as it will be publicly available as a support tool to monitor ongoing reform efforts in Member States beyond this JA. Finally, the COVID-19 pandemic has increased the focus on mental health, given the impact that the virus, the lockdown measures, and secondary impacts (e.g. the economic recession) has on our wellbeing and mental health. This JA will consider the impacts of the COVID-19 pandemic in the SANA in WP5 and 6 and also embed evaluation strategies to gauge the effects of the pandemic on mental health systems throughout Europe in WP3. These efforts will support understanding of the mental health system and population mental health impacts of the pandemic for the public health community, which will be crucial in informing eventual recovery plans in Member States. 2.4.3. Pertinence of Geographic Coverage This JA consortium consists of a diverse set of 21 countries, representing different levels of government and key stakeholders necessary to advance efforts in mental health and suicide prevention efforts in Europe, including 21 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 governmental institutions, public health organizations, service delivery organizations, universities, non-profit organizations. Netherlands will lead WP3 on evaluation and co-lead Wp4 on Sustainability but will not participate and/or implement the two best practices. In 20 participating countries, local country teams coordinated by the Competent Authority of each country will be responsible to carry out the actions foreseen on a regional/country level for the technical WPs they participate in, as well as actions foreseen for the horizontal WPs. Local country teams in 11 countries will be involved in activities in both WP5 on Mental Health Reform and WP6 on Suicide prevention. Overall, 14 countries (11 of them implementing the Belgian best practice on Mental Health Reform) will be involved in WP5 and 17 (14 of them implementing the Austrian best practice on Suicide Prevention) in WP6. This will ensure a wide range of reach and diverse contexts for the implementation of the best practices components selected by the individual countries and maximize the transferability of project results to other countries within the European region. More specifically: in WP5 Mental Health Reform the following countries participate under the following categories: -Lead /Implementing: Germany, Colead/ Implementing Italy -Participating and pilot implementing: Croatia, Cyprus, Estonia, Greece, Hungary, Lithuania, Malta, Slovenia, Spain -Participating not implementing: Bulgaria, France, Serbia In WP6 suicide prevention the following countries are participating under the following categories -Lead /Implementing: Austria, Colead/ Implementing Czechia -Participating and pilot implementing: Croatia, Cyprus, Estonia, Finland, Greece, Hungary, Iceland, Malta, Norway, Slovenia, Spain, Sweden. -Participating not implementing: Bulgaria Lithuania Serbia At least 25 implementation instances of the two best practices in 17 countries are anticipated in JA implemental based on the interest expressed by the Competent Authorities. Geographical coverage of countries is broad in this JA consortium and includes EU, EEA, and candidate countries. Importantly, Member States who have developed the two best practices (Belgium and Austria) are also involved in the JA, either as participating Affiliated Entity and WP6 leader (Austria) or as a collaborating partner for WP 5 (Belgium), to guide implementing practices in WP5/6 and ensure that knowledge is transferred and embedded into national/regional/local country contexts. Representatives from the United Kingdom and international stakeholders such as WHO Europe will also be invited to partici pate in the JA to maximize opportunities to disseminate results and lessons learned to an even broader geographical coverage beyond countries represented in this JA consortium. The consortium will also invite service user - and carer organizations active in EU mental health priority setting (e.g. EUFAMI) to advise the JA. Efforts in WP2 (Dissemination) and WP4 (Sustainability) will maintain an extensive list of stakeholders to engage with on lessons learned throughout the lifespan of the JA, who may also be ‘next adopters’ to implement the best practices in countries not included in this JA. The Coordinator (WP1) will ensure close collaboration with Member States, Collaborating Partners, and Governmental bodies throughout the JA to ensure participation of diverse institutions, regions and countries in the JA. 2.4.4. Consideration of the social, cultural and political context This JA focuses on the implementation of two best practices in mental health, a model of mental health service delivery reform in Belgium and a suicide prevention programme from Austria, across a number of MS with marked diversity in terms of their cultural, political and socio-economic contexts and mental health systems configuration (e.g. pathways to care, integration of mental health to primary health care). For example, there are countries where mental health is high in the policy agenda (e.g. Sweden and Finland) or/and with more inclusive social health policies regarding people with mental disorders. Moreover, in certain countries prejudicial attitudes and discrimination surrounding mental disorders and to suicide may be more evident and in other countries strong religious beliefs and affiliations may serve as deterrents to suicide prevention. 22 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Alongside the wider socio-economic, cultural and political context, different countries are at different stages in terms of deinstitutionalization and the mental health service delivery reform as well as the implementation of a national strategic plan for suicide prevention. Hence, at the onset of the JA, they are at different starting points with respect to the two best practices. An illustration of this point is the presence of multifarious national strategies for the prevention of suicide. The JA will contribute to the development of a national /regional suicide prevention strategy in some countries (e.g. Greece); it will complement/scale-up existing activities in countries like Slovenia or Spain; and it will strengthen and support ongoing national suicide prevention plans in countries like Finland. Further, heterogeneity in the stages of deinstitutionalization, community care and mental health service delivery reform as well as suicide prevention activities are not only different between Member States. Even within the same country especially in countries with more decentralized (or/and fragmented) mental health care systems, like Italy and Germany, different regions might have varying approaches to community - based care and suicide prevention and may be be at different levels of implementation. It merits noting that the ongoing COVID-19 pandemic also impinges on the mental health of the population and the mental health care system in different ways and to a different degree in various countries introducing greater diversity among MS. It is therefore anticipated that MS will necessitate a tailored approach concerning the existing practices, the scale of implementation and field preparation. To this end, WP5 and WP6 have already allowed for flexibility regarding which elements of the best practices can and will be pilot implemented by MS, consonant with their needs, priorities, resources as well as their socio-economic and political context. Moreover, by acknowledging, understanding and addressing this heterogeneity, the JA may facilitate transferability and applicability of results in many contexts, widen competence, increase innovation and ensure sustainable implementation of best practices in mental health. Discussions in the consortium of partners, in the MS Policy Committee and in the Stakeholder Fo rum (WP1), the stakeholders analysis (WP2) and the situation and needs assessment analysis (SANA) in WP5 and WP6, will address this diversity, the hindrances it may introduce and possible solutions for overcoming them. These in turn will inform WP4 to ensure sustainability of implementation after the end of this Joint Action. In order to achieve successful implementation of a best practice the approach used has to be adapted to local context and needs, so that the intervention reaches the expected results. Existing evidence indicates that a structured process facilitates implementation of pilot- and innovative practices in existing services. The aim is that the transfer and spread of innovation from their sites of origin to other regions will accelerate the progress in Europe. The EU has launched a series of initiatives to support facing these challenges, such as in the Project INTEGRATE, a European Commission FP7 funded collaborative research project (2012–2016) and in the Joint Actions CHRODIS, CHRODIS Plus, and eHAction, and EU-funded projects such as SCIROCCO, SCIROCCO Exchange, among others. Building on this knowledge, JA ImpleMENTAL will use a common implementation strategy and structured processes to promote the uptake of the two best practices by the MH (services) systems and/or policies in the implementing countries. The JA will also seek complementarity and/or synergies with past and/or on-going European actions in the area of (mental) health data/indicators (like JA InfAct and JA TEHDAS) and integrated person-centered care (e.g. JADE CARE), including close collaboration with WHO/Europe and building upon the Mental Health Atlas survey, and using linkages/synergies with international projects (OECD quality indicators). 2.5 Methods and Means This EU-Commission initiative focuses on the transfer of two best practices in mental health, pre-selected by the Steering Group on Promotion and Prevention (Member States) from the pool of the EU’s Public Health Best Practice Portal. ORIGINAL BEST PRACTICES Best practice “Mental health reform in Belgium” 23 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 The first best practice “Mental health reform in Belgium” focuses on establishing local networks for mental health that strengthen community-based provision of preventive, promotive and care services across sectors, with the aim to improve access to continuity and quality of care. The basic concepts of this practice are: user-centered approach, psycho-social rehabilitation, ‘health in all policies’, proximity care (home setting) and continuity of care (link between the institution – the ambulatory and medico-social) and decreasing the length of institutional stays with the objective of a global and integrated policy. This policy is incorporating all relevant domains and coordinated actions: 1. Prevention and promotion of mental health care, early detection, screening and diagnostic activities 2. Rehabilitation teams focusing on recovery and social inclusion 3. Residential intensive treatment for both acute and chronic mental health problems, if hospitalization is necessary 4. Specific residential facilities allowing an offer of care, when necessary care at home or at a home substitution is not possible 5. Mobile or ambulatory teams offering intensive treatment for both acute and chronic mental health problems. Thus, the integration of the new practice within the existing network of services (communities and medical- social) is achieved, while ensuring the re-organization of help and care according to the needs of people and their entourage and keeping people as much as possible in their own environment. Best practice on suicide prevention “SUPRA” Austria The second best practice “SUPRA” initially developed in Austria is a multi-level suicide prevention strategy that integrates universal, selective and indicated prevention interventions, based on the local implementation context and building upon existing resources and initiatives. The objectives of Suicide Prevention Austria were to coordinate suicide prevention in Austria at the national and regional levels, to ensure support for risk groups, to develop standards for access to means of suicide, to develop media support for suicide prevention, to integrate suicide prevention programmes into other health promotion activities, and to support research on suicide. Components of SUPRA include: (i) ensuring that suicide prevention is organizationally embedded and co-ordinated (ii) support and treatment of high risk groups for suicide according to their needs (iii) restriction of access to means of suicide with an aim of making access as difficult as possible (iv) ensuring that awareness and knowledge of suicidality and about coping with psychosocial crises are widespread among the general population, (v) integrating suicide prevention programmes in other health promotion activities and to addiction and violence prevention measures (vi) quality assurance and expertise (aim: suicide prevention is quality assured on the basis of scientific expertise). Participating countries will be supported in developing or upgrading draft national/regional strategies and in initiating (first steps towards) pilot-implementation of selected suicide prevention interventions through workshops, training sessions and webinars. JA ImpleMENTAL, will mainly focus to support the transfer of the two best practices in mental health, pre - selected by the Steering Group on Promotion and Prevention (Member States) from the pool of the EU’s Public 24 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Health Best Practice Portal. The “Mental health reform in Belgium” and the Austrian best practice on suicide prevention “SUPRA”. We anticipate at least 25 implementation instances across Europe, within the 17 countries that have committed to implement one (9 countries) or both ( 8 countries) best practices. Even for the three countries that will not implement the best practices, the participation in the selected technical WPs will reinforce their capacities to address system transformation through their participation in SANA Activities, workshops and training sessions This partially meets the objectives of this Joint Action and may promote future implementation of elements of the two best practices in the specific countries. A strong involvement of national/regional governmental actors and/or local authorities across all 20 countries will enable such practices to be embedded in health systems at national/regional/local level. This is anticipated to be achieved through the participation in the Member State Policy Committee (WP1) and sustainability activities in (WP4). Last but not least, sustained cooperation and involvement of a wide variety of stakeholders to share a common and global vision about mental health and vast dissemination of joi nt action scope vision and results will be established through the work of (WP1) and (WP3) in all 21 participating countries. The table below summarizes the participation of each country in the above mentioned activities. Table 5. CONTRIBUTION TO THE OBJECTIVES OF THE JOINT ACTION PER COUNTRY Country Competent Involvement of Stakeholders Contact SANA Contact SANA Implement BP: Implement BP: Authority Representatives of Engagement and Capacity and Capacity "Mental Reform "Suicide Short name Ministries of Health and building through building through Belgium" Prevention- and Sustainability Dissemination training for BP: " training for BP: SUPRA- activities Activities Mental Reform "Suicide Austria" Belgium" Prevention- SUPRA" 1. GREECE NPHO . 2.AUSTRIA BMSGPK 3.BULGARIA NCPHA 4.CROATIA CIPH 5.CYPRUS MHS SHSO 6.CZECHIA MoHCZ 7.ESTONIA MoSAE 8.FINLAND THL 9.FRANCE FR-MoH 10.GERMANY BZgA 11.HUNGARY OKFO 12.ICELAND DOHI 13.ITALY LR 14.LITHUANIA SAM 15.MALTA MFH-MHS 16.NETHERLANDS TI 17.NORWAY HDIR 19.SERBIA IPHS 19.SLOVENIA NIJZ 20.SPAIN SMS 25 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 21.SWEDEN PHAS P articipating P articipating but not implementing No t Participating and not I mplementing the I mplementing the indicated BP in dicated BP t h e indicated BP 26 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 IMPLEMENTATION OF THE BEST PRACTICES In order to achieve successful implementation of the two best practices, adapted to the national/local context and needs, JA ImpleMENTAL will use an overall PROJECT implementation strategy, based on the one previously used in CHRODIS Plus. The strategy will include the following phases: ● Pre-implementation phase: planning and preparation for the implementation. At the project level all WP leaders/co-leaders will perform planned activities according to the work plan. Implementing sites in each country, organized with support of the country competent authority and the WP5 & 6 leaders/co- leaders, will study the best practices, inform and engage stakeholders, prepare and perform a Situation Analysis and Needs Assessment (SANA), define implementation plans, expected outcomes per countries and across countries in terms of expectations from the JA, etc. In this frame, the Scirocco Maturity Model developed within the European Innovation Partnership on Active and Healthy Ageing, is an example of an additional, optional tool that can be used for self-assessment of the region’s readiness for integrated care and for assistance in the development of local implementation plans. ● Implementation phase: countries implement (elements of) the best practices, and participate in capacity building activities with support from technical WP5 & 6 leaders /co-leaders. Regular monitoring, implementation of QA/QI tools (PDSA cycles) and coordinated evaluation will take place. ● Post-implementation phase: assessment of processes and outcomes and learning (implementing sites will deliver implementation reports and the process of the JA will be evaluated ). The strategy will include a series of methods and techniques to enhance the adoption, implementation an d sustainability of Practices. WORK PACKAGES Overall, WP1 Coordination will be responsible for the smooth, coordination and management of the JA ImpleMENTAL, ensuring that the JA workplan across all wps and all performing layers, is implemented as planned and that progress is consistently monitored against project objectives and deliverables, making adjustments where necessary in line with the workings of the Consortium. The management approach of the JA is based on the PM2 methodology of the European Commission, adapted to the context of the JA ImpleMENTAL. The JA Work Plan will be used as the baseline but also will be kept up-to-date during the life of the project and capture all project related work as identified during planning phase or emerged during the executing phase (e.g. risks, issues, corrective actions etc.) During the pre-implementation phase, WP1 will establish the directing, managing and performing layers and advisory bodies & committees that will have diverse functions and roles, with the aim of ensuring that the activities are in line with the work plan, EU- and national strategies during the whole period of the JA. The project coordination by WP1 includes allocating project resources to activities, performing regular quality checks of interim results, maintaining ongoing communication with all project team members, and keeping everyone involved in the project motivated by means of leadership, negotiations, conflict resolution and the application of appropriate management techniques. WP1 will contribute to the scientific aspects of the project, in close cooperation with all WP leaders, especially WP5 & WP6, during the whole implementation period of the JA ImpleMENTAL, will ensure its scientific integrity, robust methodology, evidence-based policy implications and effective scientific communication among the work packages, including between the two technical ones, since there are overlapping areas between them (e.g. SANA, see below). By addressing the scientific interlinkages among the WPs, including between the two technical ones. Scientific coherence and effective management of the JA will be fostered. Quality assurance activities will include the review and acceptance of deliverables and dissemination documents. The JA Coordinator, will be sided and supported by all members of the Executive Board, which involves not only the WP1 team which includes: 1a) a senior scientific and management NPHO team and 1b) a senior legal and financial NPHO Team with substantial experience in large EU co-funded projects, but also all the leaders and co- leaders of all work packages. A Project Management Assistant (PMA) will work on a range of management - and supportive tasks as assigned by the JA Coordinator in order to assist the JA Coordinator and the senior NPHO teams in the everyday work of the project. In this way, multifaceted management strategy, and substantial communication among the packages is facilitated resulting in great harmony and consistency in the overall 27 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 approach. Executive Board Members meet in person or via teleconference every six months and hold short teleconferences on a bi-weekly or monthly basis. These meetings allow the board to have ov ersight of the project’s current and future activities and results and to discuss progress and difficulties encountered as well as potential solutions. Short Executive board meetings chaired by the JA Coordinator will be scheduled on a bi- weekly or monthly basis, to check the status of the work within each WP, discuss interlinkages between wps, approve actions and schedule next steps. PDSA tools will be used also on the project level to ensure monitoring and early initiation of quality improvement actions. General Assembly meetings will be organized every six months to discuss the project progress, for a coherent coordination and project planning. WP1: WP1 will organize the (online) kick-off-meeting of the JA in month 1 of the JA. The kick-off will aim to build consensus on the governance and working structures (working and/or advisory groups, etc.) for the JA and individual WPs, the definition of cooperation- and communication principles and formats as well as the definition of rules of work. It will include dedicated sessions for the individual WPs, thereby providing the basis for a first exchange on the two selected Austrian and Belgian best practice examples and on the planned activities of the WPs. Annual Consortium meetings will be organized (by WP1 with the support of WP2) in month 12, 24 & 36. The Annual Consortium meeting in M36 is also defined as the Final Conference . In these meetings, participants will share their progress, results/outcomes, and receive information on next steps. The Member State Policy Committee, which will include representatives of the Ministry of Health of the participating countries, will be organized every six months to support successful design and implementation of the two best practices in the implementing sites, to further reinforce capacities of national/regional/local mental health services and alignment with national/regional/local policies. Near the end of the implementation phase, WP1 in collaboration with WP4 will organize the Member State Policy Committee meeting, to review progress of the work and provide advice on the sustainability plan for keeping the mental health issues at the forefront of the political agenda for health during and after the completion of the Joint Action. In the first months of the JA, WP1 will also develop the Project Handbook to establish the high-level approach for implementing the project objectives. The Project Handbook is one of the main artefacts of the JA and summarizes the project objectives and documents the selected approach for achieving the project goals. It also highlights the Critical Success Factors (CSFs), documents the key controlling processes, the resource allocation, the conflict resolution and escalation procedure, policies and rules, and the project mindsets. The Project Handbook also describes the project organizational structure, the key stakeholders, and their roles and responsibilities. It documents the plans necessary for managing the project Processes which include: 1. Requirements Management Plan, 2. Project Change Management Plan, 3. Risk Management Plan, 4. Quality Management Plan, 5. the deliverable acceptance plan, 6. Issue Management Plan and 7. Communications Management plan, as well as any methodology-tailoring decisions. It determines which plans guidelines and other documents) are necessary for the project, including the guidelines of the implementation strategy. It also documents the key project progress measurements to be use for monitoring and controlling activities. The Project Handbook is based on the Grant Agreement which includes the agreed project work plan, as well as the Consortium Agreement. The Project Handbook will be the reference document for all project members and stakeholders, and along with the Project Work Plan, is the basis on which the project is managed and executed. The Project Handbook will be kept up to date by the Coordinator. WP1 will develop the guidelines on the common implementation strategy to facilitate the uptake of the two best practices in the existing mental health (services) systems or policies. It will include a series of methods and techniques, concrete procedures and recommendations to enhance the adoption and sustainability of the original two best practices and to contribute to monitoring (WP1) and evaluation activities (WP3). The monitoring framework developed by WP1 will use the JA Work Plan as a reference for monitoring the project performance; a regular exchange of information about the project’s current status and next steps will be conducted with the Executive Board at periodic onsite and online meetings. The monitoring framework will gather data on, and monitor the progress of tasks, key outputs (i.e. completed and verified deliverables and milestones) achieved as planned, resource utilization, risks management and people productivity. The framework of process and output monitoring indicators will be prepared by WP1, discussed within the Executive 28 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Board, presented in the General Assembly meeting in month 6 and used for monitoring all actions during the steps of the implementation of the JA. The monitoring framework will be closely aligned with the evaluation framework to avoid duplication of work. Ongoing monitoring data will be strategically used to ensure that the JA ImpleMENTAL achieves desired results. WP2: WP2 will interact with all other WPs, to align activities and to ascertain dissemination of all project results. This WP aims to facilitate knowledge transfer and exchange of processes, experiences, and evidence in the course of best practices implementation by different communication channels to stakeholders, interested bodies, beneficiaries, and the wider audience of the action. WP2 aims to raise awareness about project findings as well as to discuss the translatability and applicability of findings for other contexts and the Member States in Europe. The dissemination activities will start with mapping the stakeholders involved in mental health in all MS/partners involved in the JA and development of the visual identity of the JA including logo and website w ith information about the project, news and updates in the field of mental health. A dissemination strategy will be developed to ensure the dissemination of the project’s results to competent authorities and experts. The overall dissemination strategy will be specified in a communication and dissemination plan developed at the early stages. Specific needs of the 2 technical WPs will be taken into account. The stakeholder analysis and the communication and dissemination plan will take into account the specif ic dissemination approaches, target groups, and dissemination purposes needed for each of the technical WPs of the project. Identifying communication channels and networks will be the next step. The project results will be shared on the database of health projects managed by the European Commission's European Health. Using the EU Health Policy Platform (EU HPP) throughout the JA will support the virtual exchange management of stakeholders. The JA will create a network dedicated to this project at the Agora Network of the EU HPP and publish news related to the project on the Agora Network of the EU HPP. Communication tools that will be used in JA are a leaflet at the beginning of the JA and a layman version of the final report at the end of the JA. Other comm unication tools that will be used are newsletters, posters, press releases, presentations, blogs, personal and/or online events (meetings, conferences, workshops, exhibitions), and a press communication kit. The main language will be English and, when appropriate, translations will be made into other languages in cooperation with MS. More than one social media platform will be used as there may be differences in what is predominantly used in specific age groups and countries, like Facebook, Instagram, Twitter and WhatsApp. The organization of webinars and online policy dialogues would additionally support the visibility and accessibility of the outputs and results of the JA. Dissemination events will be organized as a cost-effective means of engaging policymakers and stakeholders in the EU in order to discuss JA developments, challenging policy issues, and recommendations at the strategic level. The final conference will disseminate country-specific evidence on the effectiveness and the implementation process of the best practices. WP3: The aim of WP3 is two-fold: to support evaluation of the JA in its aim to serve as a vehicle to advance mental health and suicide prevention efforts in Europe and to support the assessment and evaluation of implementation processes and outcomes of the best practices in WP5 and WP6. To achieve the first aim, an evaluation framework to guide evaluation of the JA will be developed by the WP leaders (i.e. the Executive Board), and carried out by WP3 task leaders. This internal evaluation will conclude with a set of recommendations for the Coordinator and the EC to further improve the process and potential impact of the JA. To achieve the second aim, an overall evaluation framework will be defined in WP3, with a core set of metrics to evaluate the implementation process and outcomes of the best practices (in WP5 and 6) and tools for Member States to support evaluation of the implementation process over time. The overall evaluation framework will also select a guiding implementation science framework to help clarify which implementation constructs will be evaluated. Each implementing country will then adapt the evaluation framework to their own local resources, to ensure that the evaluation approach remains feasible. This may include a choice for a particular methodology (e.g. focus group discussion over individual interviews) or may include locally adapted tools already translated to the local language. WP3 will serve as a hub for questions or help to solve challenges related to evaluati on practices in each implementation country. Alongside pilot implementation, each implementing country will carry out evaluation activities defined and supported within the frame and under responsibility of WP3. WP4: WP4focuses on distilling methods and strategies for sustaining the results for the implementation of best practices, and embedding these insights into ongoing policy and planning in mental health. The WP will focus on 29 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 creating a plan for sustaining the results from the JA after its lifespan and on integrating the results from the JA into ongoing mental health policy- and planning priorities throughout Member States. Member States and WP leaders play an important role in defining, shaping and steering the content covered in WP3 and WP4. Following the guidelines for the implementation strategy and the overall JA workplan, WP5 & WP6 with support of the horizontal WPs that will provide coordination, management and monitoring of the JA (WP1), dissemination and communication of activities and results of the JA (WP2), evaluation of the action’s outcomes and potential impact (WP3) and sustainability of the JA results and their integration into policies (WP4), will ensure the successful transfer adaptation and implementation of the two best practices. The actions of WP5 &WP6 are included in a four steps approach within the three phases of the implementation strategy: 1) The preparatory step. The preparatory step is included in the pre-implementation phase. During the preparatory step the establishment of two WP Advisory Groups (WPAGs) of European experts on mental health for 1) children/adolescents, 2) adults (incl. older people) is envisaged for WP5. The WPAG’s function will be crucial in supporting a regular review of the ongoing work of WP5, with regular dialogue and feedback on the different tasks and results of WP5. The experts of the WPAGs will provide additional knowledge and expertise on key aspects and support the WP leaders and participating countries in identifying issues, alternative approaches, and/or priorities. The composition of the WPAGs, their specific functions and organization of work will be defined in the preparatory phase at the beginning of the JA. The experts involved in the WPAGs shall represent a variety of institutions (e.g. research, patients/family organizations, international organizations, regional/local MH service networks, etc.) and will/can be recruited from participating institutions/countries, from collaborating partners/stakeholder organizations (e.g. WHO) as well as from other organizations/institutions not involved in the JA ("external experts"). Recruitment criteria and process will be discussed among the WP5 partners in the preparatory phase of the JA. For WP6, a national/regional working group and advisory board will be set-up by each participating country (MS). Within WP5, a virtual country “visit” to Belgium will be organized to exchange with and learn from the leaders and representatives of the Belgian best practice example on core elements of the practice, establis hed structures and operations, and lessons learned. WP5 will also develop an Analytical Framework to build the conceptual basis for activities carried out in WP5 and guide transfer of elements from the Belgian best practice example to the contexts of each MS. In particular, the framework will: ❖ integrate findings from a rapid review of international literature (on community-based (mental) health care and prevention networks), lessons learned from the Belgian best practice example, outcomes from the previous JA on Mental health and Wellbeing and key EU and WHO strategic documents; ❖ outline collection and use of data and indicators to inform and support the building, monitoring and evaluation of community-based MH networks and services; ❖ identify key factors, (potential) enablers and obstacles for the (sustainable) establishment of community - based and client-centered inter-sectoral MH networks, based on the experience of the Belgian practice and, possibly, other countries participating in the JA as well as on reviewed literature (which will also inform inputs in WP3 and WP4) and, ❖ identify and frame common elements/topics that might be considered during the pilot implementation, for monitoring and evaluation (WP1 & WP3) and topical cross-country exchange (WP5 and 4); ❖ elaborate on methods and tools for the country-specific situation analysis and needs assessment. Common elements/topics will be identified, specified and selected during the JA in consultation with the participating countries. Potential examples include : 1) the use of digital tools (e.g. to support the network building processes and/or to identify appropriate measures and/or decision -making, etc.); 2) A focus on prevention, health promotion, early detection and screening services; 3) Methods, strategies and tools for inter- sectoral and multi-disciplinary network building and cooperation in mental health; 4) sustainable funding for community-based mental health networks. In WP6, the preparatory step will include carrying out workshops with all participating countries with the aim to obtain a first idea of potentially transferable modules and/or packages of the best practice (SUPRA) that 30 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 could be suitable and align with priorities of the participating MS. These modules and packages relevant for each MS will be used to develop a plan for the situation analysis 1 and needs assessment (SANA). The preparatory step also entails the construction of a questionnaire as a basis for undertaking SANA as well as the development and discussion of a template for country-specific profiles/reports as a joint activity of WP5 and WP6 (with input from WP1 and WP3). In doing so, the involved partners will draw on recent experience made by the Czech partners in conducting a SANA in collaboration with WHO experts within a participatory approach/format. Further existing tools/formats like the WHO Mental Health Atlas profiles and/or the EU COMPASS will also be taken into account or used for the development of the template of the country profile/report. 2) A Situation Analysis & Needs Assessment (SANA) will be conducted in each of the participating countries. This step is also a part of the pre-implementation phase. The SANA aims to capture and record the current mental health situation and structures in both prevention and care systems in the fields covered by WP5 and WP6 within each country and/or region. It also aims to understand the positions of the stakeholders within the local contexts of the countries and at identifying and assessing priorities and opportunities, expectation and needs, as well as knowledge about gaps and potential barriers for pilot implementation. The structure of the SANA will be divided into two parts. The first component will encompass a general overview of the main building blocks and key features of each country’s mental health system (i.e. policy and legislation, governance, financing, workforce, organization and care deliv ery at mental health service level, information system, etc.). Data sources will include relevant available national/regional data and indicators (e.g. from health registries, regular studies/surveys and publications). The purpose is 1) to provide a clear foundation for the transfer of the community-based approach to MH services (WP5) and the prospective suicide prevention strategy (WP6) while respecting the recommendations for evidence -based policy making and 2) to provide evidence for prioritizing and sel ecting elements of the Belgian and Austrian best practices. The results of this preliminary analysis will already support the identification of potential knowledge gaps. The second component will include a more detailed analysis of the situation and an assessment of needs will be undertaken in WP5 and WP6, taking into account the individual focus and needs of each WP. The detailed analysis in WP5 will be conducted at a level (national, regional, local) chosen by each country and relevant for pilot implementation of the (adapted) Belgian best practice example. This analysis will include: an overview of potential national/regional/local framework(s), characteristics of target groups, details of existing community - based networks and services, mental health services availability for different target groups, involved stakeholders, structures, scope and potential of/for intersectoral and multi -disciplinary cooperation, training and support needs of stakeholders and professionals, key elements and potential sustaini ng networks. Results will inform the introduction, extension or scale-up of community-based, client-centered and integrated care and prevention mental health networks at the chosen level in the Member States. For WP6, the needs assessment will involve gathering, analyzing and assessing available resources (staff, budget, other) in the respective participating countries in order to inform the contextualization of the SUPRA best practice by each country working group/advisory board, to address and implement prioritized activities (for further development of existing activities and/or for responding to identified gaps in the country). The SANA will include issues relating to the impact of the COVID-19 pandemic on the population’s mental health and the mental health care system as far as possible. The results of the SANA will be compiled into country profiles/reports elaborated by each participating country. 3) The third step involves the adaptation, development and pilot implementation of (selected) elements of the Belgian best practice example (WP5) and the (further) development of national/regional suicide prevention strategies as well as the pilot implementation of first selected elements of the Austrian best practice (WP6). This step will be conducted within the national/regional/local context of each implementing country, thus enabling a piloting that takes into account existing structures and priorities at the level chosen by each country. 1 The situation analysis is an activity shared across the two technical WPs. It will have a common base and additional components regarding the specific technical WPs. 31 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Activities carried out under WP5 will include the development of a simple and logical transfer/change model for adaptation of (elements of) the Belgian best practice example to the local contexts of each country. This will describe which features/elements of the Belgian practice will be transferred, why and how, based on t he findings of the SANA and taking into account potential opportunities for implementation at the chosen level. This will inform the development of an implementation/action plan for the pilot in each implementing country that will correspond to the nature and level of the pilot, local contexts and constraints, capacities and resources and describe the involvement and (inter-sectoral) cooperation with stakeholders. This will involve cooperation with and involvement of associated entities and other stakeholders to define the objectives of the pilot, inputs, activities, outputs, expected effects, etc. It is expected that the logical transfer/change model and the implementation/action plan developed by the MS will support the classification of each country into categories or clusters of countries that will either focus on a) piloting the same key elements of the Belgian best practice b) follow similar approaches or c) face common challenges. It is further assumed that these categories/clusters will inform and facilitate the fine-tuning of tasks and activities under this WP during the JA, in particular the specifications of approaches and contents for the training and capacity building activities under task 5.5. The process and outputs of the pilot implementation will be documented in country-specific implementation reports elaborated by each country, based on a common template developed within WP5 and with input and support from WP1 and WP3. These country-specific reports will feed into the elaboration of a short cross- country Analysis Report on pilot implementation that will build on the analytical framework for WP5. This Analysis Report will be realized as a first deliverable of WP5, towards the end of the second year of the JA (see JA time plan). Following the implementation process, an exercise will be conducted at the level of each pilot site to reflect on the experiences gained during the pilot implementation and findings from the evaluation (WP3) with the aim of identifying needs for continued implementation, scaling-up or extension of the pilot practice after the JA. The results of this exercise will feed into the development of a simple implementation roadmap to be used as a strategic plan for further action after the JA and link into sustainability activiti es in WP4. Within WP6 the third step will involve developing a use case example for elaboration and implementation of a national/regional SP strategy, including the compilation of a handbook for guidance of the participating countries and the development of an outline for a national/regional SP strategy by each country. Selected elements of the Austrian best practice will be adapted into “Quick Wins” for Member States. Following the implementation of SUPRA components/packages, a national/regional draft strategy (or steps for its development) for suicide prevention implementation will be elaborated in each country. Alongside the aforementioned steps, WP5 and WP6 will carry out additional horizontal activities that will support the four-step process and contribute to strengthening sustainability of the results beyond the JA: First, the transfer, adaptation and pilot implementation of the Belgian and Austrian best practice examples in each technical WP will be backed through workshop(s) of participating countri es in each WP, during the different phases of the four-step approach. Workshops will enable consultations and agreement on key elements of the working process (e.g. analytical framework, SANA, etc.) and promote learning and cross -country exchange on methods, tools, practices and experiences in the development and implementation of the pilot implementation and the elaboration or improvement of national/regional strategies. Further, thematic workshops will enable the sharing of expertise and information on se lected and specific topical areas of relevance for each WP across countries. Further, WP5 will initiate a process of analysis and cross-country exchange on the collection and use of data and mental health system indicators that will support the establishment and development of community-based networks and the assessment of (the delivery and quality of) MH services. This process will be based on an analysis of the health/mental health Information systems (H and MH-IS) of participating countries (carried out as part of the SANA described above) leading to the development and pilot implementation of a dashboard of mental health indicators to monitor services (delivery and quality, i.e. appropriateness, intensity, continuity, safety of care and system effectiveness). Consultations will be carried out with a network of experts from affiliated entities and/or collaborating partners responsible for the collection and use of data within the participating countries, and a consensus workshop with participating countrie s will be organized to discuss and 32 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 agree on the indicators. A manual for building an indicator set will also be drafted, covering issues linked to the harmonization of definitions and description of indicators, the list of variables for structuring an indi cator set and the processing of data. Required data will be extracted from computerized mental health and health care databases and, finally a dashboard of indicators will be built-up for (pilot) application either at the country level or within the country (e.g. at regional/local level) and at the JA level. This set of indicators will also be streamlined into the evaluation framework for implementation of best practices in WP3. As an added value of this work, the finalized dashboard will be made publicly available to serve as a support tool that can be used by/within each country after termination of the JA. It might also support countries in answering periodical requests for data by international bodies (e.g. WHO, EU and OECD). This process will take into account ongoing projects at international and national levels that aim to develop and/or compile mental health indicators with the aim of avoiding any potential duplication of work between these projects and the JA. The results of this task will be compiled in a Synthesis Report with a cross-country analysis of the indicators, including recommendations for improvement. Complementary to this deliverable, WP3 will be responsible for synthesizing key findings from the implementation process of a) the mental health reform model from Belgium and b) the suicide prevention model from Austria from across implementing Member States. To facilitate the implementation of the two best practices in mental health, training and capacity building activities will be developed and carried out within WP5 and WP6. This training and capacity building is envisaged to support cultural, attitudinal and institutional changes that are important in the shift towards community-based and client-based mental health care as well as regional or national strategies for suicide prevention. The content of the training and capacity building activities will be informed by the findings from the SANA for both WP5 and WP6, the individual focus/needs of the pilots in different MS, and as guidelines and tools developed by the WHO. A training and capacity building plan will be elaborated for WP5, which will integrate (international) academic and practical knowledge, foresee diverse formats of training/capacity building measures adapted to defined categories of participants, and envisage the development of a “training kit” consisting of training modules, curricula, materials and/or tools. The scope and content of the training and capacity building measures will be defined in the plan, under consideratio n of identified needs, available capacities, resources and time. Training modules and capacity building activities will also be tailored for potential online delivery, depending on developments in the COVID-19 pandemic. Training and capacity building within WP5 will focus on acquiring knowledge and building competences/skills linked to the core features and functions of the Belgian best practice example, covering three main areas: ● Development and operation of local inter-sectoral mental health care and prevention networks, with a focus on network governance, design, strategic management, networking tools, main roles and responsibilities, participatory dynamics and participation of users and relatives, strategies for inter-sectoral cooperation, etc. The training might address various stakeholders and partner roles (e.g. network coordinator, professional network partners, “case manager”, users and relatives, stakeholders outside the health sector, etc.); ● Use of methodologies and tools supporting and shaping the development and coordination of needs/client- centered health promotion, care and or prevention services and interventions. Examples for relevant topics include the collection and use of (routine) data for network and intervention planning, the concept an d use of individualized care/services plans, the development and deployment of mobile teams and outreach measures, methods and tools for evaluation of interventions, etc. ● Thematic modules of specific relevance for both target groups of children/adolescents and adults. This might include topical training on recovery and rehabilitation-oriented approaches and practices, transition from child mental health services to adult mental health services, the promotion of child health and well -being in families with mentally ill parents, mental health promotion and prevention for elderly persons, services for adults with complex mental health needs, etc.) Training and capacity building within WP6 will be related to defined actions/packages of SUPRA and are further defined under the description of WP6 in Chapter 7 in this proposal. The training and capacity building measures will adopt a train-the-trainer approach, i.e. implementation of training will target experts/specialists from various participating countries who can be deployed and act as multipliers/trainers in their respective countries or who hold core function(s) within the national/regional/local 33 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 networks and working structures established within WP5 and 6. Likewise, the training kit foreseen in WP5 will be developed with the aim of being adapted for (further) training and capacity building and used in the respective country context. Finally, obtaining stakeholder commitment for the establishment or scale-up of intersectoral community-based MH networks (WP5) or the establishment (or further development) of national/regional suicide prevention strategies will be part of the continuous efforts undertaken within WP5 and 6, with support of WP2 and 4. This will include, among others, the implementation of information and exchange meetings with regional and/or national ministries/authorities within the defined tasks of WP 5 and 6 in preparation and support of pilot implementation as well as consultations and discussions at the level of the JA Member States Policy Comm ittee to ensure commitment to the JA’s objectives and to support sustainability of results beyond the lifespan of the JA. Within WP5, steps to promote and ensure commitment of local mental health stakeholders will be embedded into the local implementation/action plans developed in each piloting country. Within WP6 the work will focus on promoting increased awareness of main stakeholders (and the general public) for suicide prevention as well as fighting suicide-related stigma. Stakeholder engagement within WP6 will be realized mainly through involvement in the work of the regional/national working groups/advisory boards, which will be established in each participating country of WP6. 4) A fourth and final step taking place alongside pilot implementation are monitoring and evaluation activities in each implementing country, defined and supported within the framework elaborated by WP3 (Evaluation) via a consultative process with endorsement and active involvement of WP1,5, and 6 leaders, and under responsibility of WP3 (see developments above). WP3 will also be responsible for synthesizing key findings from the implementation processes of implemented best practices in WP 5/6 across member States. During the post- implementation phase, this information will be compiled into a meta synthesis of local evaluations, with the aim to distil success factors and barriers to implementation across countries, noting considerations and differences in mental health system structure and resources. This meta-synthesis will provide important input for WP4 (Sustainability) which will customize the findings from the local evaluations and the meta-synthesis and use it for input in WP4 activities such as policy dialogue sessions. Policy dialogue sessions are a methodology where in policy makers and key stakeholders that influence the policy process are brought together to generate possibilities/opportunities around a key policy question (e.g., how to finance community mental health services for the next 5 years) with a corresponding action plan (with responsibilities, budget, communication channels). WP4 will also select a framework for embedding knowledge into policy and practice that will help frame constructs assessed to be most relevant for advancing mental health systems and polici es. The work of WP4 will culminate to a sustainability plan, which together with W5 and 6 leaders, will elaborate on how mental health system indicators can be continuously monitored and flag up new mental health system developments or challenges. The sustainability plan will also estimate costs, benefits and risks of investing in certain implementation strategies employed in WP5 and 6. 2.6 Expected Outcomes JA ImpleMENTAL is expected to contribute to improvement and promotion of mental health via innov ative and sustainable (mental) health system change that the implementation of the two best practices “Mental health reform in Belgium” and the Austrian best practice on suicide prevention “SUPRA” across 20 participating countries will accomplish. The Joint Action is expected to result in: 1) the effective establishment, improvement, expansion or scale -up of inter-sectoral community-based mental health networks and provision of integrated client-centered mental health services and/or in pilot settings across participating countries (WP5); 2) the activation, promotion and strengthening of intersectoral cooperation for the delivery of community - based and client/user-centered MH services (WP5); 34 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 3) stakeholders in participating countries applying the dashboard of indi cators as a support tool for the assessment (in terms of delivery and quality) and improvement of community-based mental health services as well as long-term outcomes of mental health reform (WP5); 4) the development of training modules, curricula and/or tool s in the participating countries, to enhance the capacities and competencies of staff and stakeholders with respect to the establishment and operation of community-based networks and the organization and delivery of services and care pathways within the country (WP5); 5) national/regional working groups, advisory boards, stakeholders and partners in the pilot settings are involved in strategic development and jointly define goals and necessary steps for continuation, extension or scale-up of the pilot implementation beyond the JA duration (WP5 and WP6); 6) a deep contextual understanding from the SANA, that will inform a country’s suicide prevention strategy (WP6); 7) obtaining stakeholder commitment for the establishment/further development of a national/regional suicide prevention strategy (WP6); 8) raising awareness about suicide and to fight suicide-related stigma (WP6); 9) an in-depth understanding of implementation processes and strategies employed across Member States that are implementing best practices in WP5/6 (WP5,6,3); 10) a set of key indicators to measure and evaluate the implementation process and implementation outcomes of large-scale mental health system transformations and suicide prevention efforts (WP3); 11) an understanding of how results and lessons learned from WP3, 5 and 6 can be translated into messages and formats relevant for policymakers at regional and national level (WP4); 12) a sustainability plan containing key consideration, case studies, and what is required in terms of investments (financial, human resources, institutional, political, cultural needs) to make changes in mental health and suicide prevention efforts at a local and regional level (WP4). Short- and medium-term benefits are: ● Improved knowledge and understanding on the key elements, facilitators and barriers to the sustainable development, organization and management of community-based mental health promotion, prevention and care networks in the local contexts of the participating countries; ● Enhanced knowledge on the role, success factors and barriers for inter-sectoral stakeholder cooperation for the delivery of effective and efficient community-based and client/user-centered mental health services; ● Improved knowledge and skills of stakeholders, professionals and multipliers involved in the man agement and operation of community-based mental health networks and in the delivery of client-centered mental health services in participating countries; ● Improved knowledge on activities, expectations, facilitators, barriers, methods and tools for establis hing or further developing effective suicide prevention strategies; Expected long-term benefits are: ● Expansion of intersectoral community-based and client-centered mental health networks in European countries and cross-country exchange of experiences and best practices; ● Greater adoption and implementation within Member States of mental health promotion and prevention interventions and strategies, as well as care services at community level; ● Greater number of Member States with suicide prevention strategies in place, as well as plans for implementing and scaling-up effective suicide prevention strategies; ● Persons with mental health problems have access to services and care needed close to where they live, work and study; 35 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 2.7. Timetable or Gantt Chart Task Description Year 1 Year 2 Year 3 Month 1/ 3/ 5/ 7/ 9/ 11 13 15 17 19 21 23 25 27 29 31 33 35 2 4 6 8 10 / / / / / / / / / / / / / 12 14 16 18 20 22 24 26 28 30 32 34 36 WP1 Coordination and Management of the JA T1.1 Establishing, maintaining and managing the organizational structure and the relevant directing, management, performing layers and advisory bodies of the Consortium T1.2 Ensure smooth management and implementation of the project T1.3 Coordination of the project communication management plan T1.4 Financial management Leader T1.5 Scientific contribution in the scientific aspects of the JA in order to ensure its scientific integrity, robust methodology, policy implications and deliverable acceptance WP2 Dissemination T2.1 Development Of the Visual Identity of the Project T2.2 Stakeholder analysis T2.3 Development of the Dissemination strategy T2.4 Identifying Dissemination Channels and Networks T2.5 Development of Communication Tools T2.6 EU Level Dissemination Events and Final Conference WP Evaluation 3 T3.1 Develop an evaluation framework for evaluation of the JA, to assess the output from all WP’s T3.2 Evaluate the Joint Action (all WPs) T3.3 Evaluation of the implementation of pilot practices in WP5/6 T3.4 Develop a meta-synthesis of local evaluations in MS in order to identify success factors and barriers in implementation WP4 Sustainability T4.1 Develop a unified conceptual model to guide the process of translating knowledge into policy & practice. T4.2 Support the process of embedding knowledge gained from the implementation of the good practices through thematic workshops to facilitate 36 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 networking, and support stakeholders in understanding how changes/results from pilots can be sustained T4.3 Policy dialogues in MS/C to jointly develop a roadmap to advance mental health policy priorities in Europe beyond the JA T4.4 Elaboration of a common sustainability plan (CSP), built on the results achieved at the previous milestones of the WP and the cooperation with all WPs. T4.5 Support next adopters (i.e. outside of this JA) identified through the stakeholder analysis practices(s) by informing them about key ingredients and processes for scale-up WP Transfer and pilot implementation of 5 (selected elements of) the Belgian best practice of community-based mental health service networks T5.1 Preparatory work: establishing WP structures and content T5.2 Conduction of a situation analysis and needs assessment T5.3 Adaptation, development and pilot implementation of (selected elements) of the Belgian best practice T5.4 Adaptation, development and (pilot) application of a dashboard of MH indicators T5.5 Training and capacity building WP Transfer and pilot implementation of 6 BP “SUPRA”-Austria T6.1 Preparatory work: Establishing project r structure and content T6.2 Conducting a country-specific situation analysis & needs assessments in each participating countries T6.3 (Further)Development of national/regional SP strategies and pilot implementations (M1-M36, conducted in parallel to task 2) T6.4 Training and capacity building (M1-M36, in parallel to other tasks) T6.5 Continuous support on technical activities (M1-M36, in parallel to other tasks) 37 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 2.8. Project management structure Methods Close collaboration between the European Commission, the HaDEA and DG Sante officers and the JA ImpleMENTAL Consortium is anticipated. The Governance and Organizational Structure of this close collaboration is presented in the Graph presented in 9.2., which defines the bodies in the Steering, Directing, Managing and Performing layers, based on the PM² Methodology. The PM2 methodology considers that the project team has roles both from the requestor’s side (HaDEA) and the provider’s side (JA ImpleMENTAL Consortium). Steering Layer The Steering Layer provides general project direction and guidance. It keeps the project focused on its objectives. It reports to the European Commission. The Project Steering Committee (PSC) is composed of the roles defined in the Directing (HaDEA and JA ImpleMENTAL General Assembly) and Management Layers (HaDEA Project Officer and the JA Coordinator). Directing Layer The Directing Layer mobilizes the necessary resources and monitors the project’s performance in order to realize the project’s objectives. The Directing Layer comprises the roles of Project Owner (PO) which in JA ImpeMENTAL is assumed by -HaDEA and Solution Provider (SP) –which in the JA ImpleMENTAL is assumed by the JA ImpleMENTAL General Assembly. Managing Layer The Managing Layer focuses on day-to-day project management. It organizes, monitors and controls work to produce the intended deliverables and implement them in the business organization. Members of the Managing Layer report to the Directing Layer. The Managing Layer comprises the roles of Business Manager (BM)which in the JA ImpleMENTAL is assumed by the HaDEA Project Officer) and Project Manager (PM) which in the JA ImpleMENTAL is assumed by the JA Coordinator. It is of utmost importance for the success of the project that there is close collaboration and good communication between these two roles. Performing Layer The Performing Layer carries out the project work. It produces the deliverables and implements them in the business organization. Members of the Performing Layer report to the Managing Layer. The Performing Layer comprises the roles of the Business Implementation Group (BIG) which is assumed by the HaDEA Group and the Project Core Team (PCT) - which is assumed by JA ImpleMENTAL Executive Board. 38 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Governance, Roles and Responsibilities EUROPEAN COMMISSION Business Governing Layer Project Steering Committee (PSC) Advi s ory role Steering Layer Ha DEA G eneral Assembly JA MS Pol i cy Im pl eMEN TA L Com m i ttee Directing Layer Sta kehol der Ptoj ect Of f i cer J A Coordi na tor f orum Collaboration Ha DEA & Communication Managing Layer Bus iness Implem enta ti on ExB G roup- Ha DEA Project Core Team (PCT) Coordinator NPHO JA Coordinator Senior Administrative /Legal /Financial Team Senior Scientific Team Performing Layer Work package (co-) Leaders WP WP WP WP 3 1 2 4 Wp5 Wp6 Governance Some decision power Operational Project Operational technical wps Core Team ExB Advices Acts Operational Horzontal Wps 39 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 JA IMPLEMENTAL CONSORTIUM PROJECT MANAGEMENT The management approach of the JA ImpleMENTAL Consortium is based on the PM2 methodology of the European Commission, tailored to the needs of the JA ImpleMENTAL The management structure of JA has been designed to respond to the needs of a large -scale consortium that involves a broad range of Competent Authorities and Affiliated Entities at European level for the implementation and sustainability of the two best practices. The management structure of JA ImpleMENTAL Consortium has been defined to: ● Define clearly the governance and organization structure of the Consortium. ● Deliver the project work plan. ● Plan, organize and monitor the effort and manage risks in order to achieve the JA ImpleMENTAL objectives within constraints of time schedule and budget and tackle the challenges on work plans because of the COVID-19 pandemic. ● Manage the relationships among partners, including conflict resolution. ● Run performance quality control procedures using QI/QA tools and making continuous quality improvements in order to arrive to the expected achievements and deliverables described in the work plan. ● Provide information to the partners and EU Commission on the project status and progress. ● Drive the project implementation in accordance with administrative, financial and legal issues defined by the European regulations ● Guarantee that the rights and obligations of the partners are kept compliant with the Grant Agreement signed with the Commission and the Consortium Agreement. ● A consortium agreement will be signed between the partners to specify the project governance, the internal organization of the consortium, the management of the project, and any other critical aspects such as liability and confidentiality ● The Project Handbook will also summarize the project’s objectives, will document the selected approach for achieving the project goals and will establish the guidelines and standards for the project. It will also highlight the key controlling processes to be used, the project policies and rules, and the overall management approach. Directing, managing, performing layers and advisory bodies of the JA ImpleMENTAL Consortium General Assembly: Chaired by the JA Coordinator, the General Assembly (GA) is the directing and major decision-making body of the consortium where JA partners meet to discuss the progress and results of the JA. It represents the interests of those who design, manage and implement the project’s deliverables. It takes decisions on the strategic orientation and execution of the JA and provides overall strategic guidance. It also takes major decisions about the implementation and revision of the work plan. Decisions are taken by means of majority votes. The European Commission, DG SANTE and the European Health and Digital Executive Agency (HaDEA) representatives, participate as observers. The General Assembly shall consist of one representative of each Competent Authority. AEs can participate but have no voting rights. The body meets at least bi-annually. Online GA meetings will be held during the online Kick off meeting (M1) and in M6,18 &30. Physical meetings of the General Assembly will take place at the same dates as the Annual Consortium meetings in M12, M24, 36. Onsite GA meetings are coinciding with Annual Consortium meetings but are considered separate events. The following decisions shall be made by the General Assembly: -overall accountability for the project deliverables and services. -critical decisions as to the implementation of the Action and its deliverables, as proposed by the Coordinator and the Executive Board. -decisions on the overall development of the project based on input from the Coordinator and the ExB. -review the progress of the Action based on the report of the Coordinator and the Executive Board. -Mobilize the required resources from the provider side. -Validate major re-allocation of budget whenever changes need to be done. 40 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 -Take the necessary actions and corrective measures in case of the default of a partner. - Approval and changes to the Consortium Agreement. Coordinator: is the legal entity that acts as the intermediary between the members of the Parties of the Consortium, the HaDEA and DG SANTE. The Coordinator shall perform the tasks assigned to it as described in the Grant Agreement and the Consortium Agreement. The Coordinator shall report to and be liable to the General Assembly. The role of the Coordinator is entrusted to the National Public Health Organization of Greece (NPHO) which will be responsible for overall coordination and management of the JA ImpleMENTAL. The responsibilities of JA Coordinator are to: • execute the project plans as approved by the Project Steering Committee (PSC) (please see above Steering Layer). • coordinate the ExB (Project Core Team - PCT). • ensure the effective use of the allocated resources. • ensure that project objectives are achieved within the identified constraints, taking preventive or corrective measures where necessary. • manage stakeholder expectations. • oversee the creation of all management artefacts and secures approval from the Project Owner (PO) - HaDEA or the Project Steering Committee (PSC). • ensure the controlled evolution of products delivered, through proper change management. • perform risk management activities for project-related risks. • monitor project status and report to the General Assembly and the Project Steering Committee (PSC) on project progress at regular predefined intervals. • ensure conflict solution. Conflicts will be solved at the lowest level possible, and preferably amicably. If an agreement cannot be reached at the task or WP level, then the JA Coordinator will mediate. When required, conflicts are discussed at the ExB Meetings. If that is not satisfactory, it is the JA Coordinator responsibility to escalate unresolvable project issues to GA who will decide and, if necessary, will ask for the authorization of the European Commission for any envisaged changes. • Liaise between the Directing and Performing Layers of the project. NPHO team Structure: The appointed JA Coordinator, is sided 1) by two experienced NPHO teams 1a) a senior scientific and management NPHO team which apart from the JA Coordinator, will consist from the Senior Mental Health Advisor and 3 senior mental health and public health experts with highly relevant expertise and competencies and 1b) a senior Legal and Financial NPHO Team with substantial experience in large EU co-funded projects. The JA Coordinator is the person responsible for all project management tasks and deliverables The Head Financial officer in NPHO responsible for the financial management. A Project Management Assistant (PMA) will work full time on a range of management and supportive tasks as assigned by the JA Coordinator, in order to assist the JA Coordinator and the senior NPHO teams in the everyday work of the project. A Financial Officer will be appointed part time on the JA to assist the Senior Financial NPHO Team . A part time communication officer will also contribute to the work of the NPHO team. The main tasks of WP1 include: ● Task 1.1: Establishing, maintaining and managing the organizational structure and the relevant governing, management performing and advisory bodies. ● Task 1.2 Ensure smooth management and implementation of the project. ● Task 1.3: Financial management ● Task 1.4: Coordination of internal and external communication of the project ● Task 1.5: Scientific contribution in the scientific aspects of the JA in order to ensure its scientific integrity, robust methodology, policy implications and deliverable acceptance The tasks are described in detail in WP1 description. 41 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Executive Board (ExB): Chaired by the JA Coordinator, it is composed of the JA Coordinator, the senior scientific technical management NPHO team, the senior Legal and Financial NPHO Team and all WP leaders/co-leaders. It is the project core team which comprises the specialist roles responsible for creating the project deliverables, thus collaborating with the JA Coordinator in executive decisions and implementation of the work plan on a daily basis. The European Commission, DG SANTE and European Health and Digital Executive Agency (HaDEA) representatives participate as “advisors”. Executive Board Members meet in person or via teleconference every six months and hold short teleconferences on a bi-weekly or monthly basis. These meetings allow the board to have oversight of the project’s current and future activities and results and to discuss progress and difficulties encountered as well as potential solutions. Bi-annually meetings will take place online in M6, 18 and onsite, in M12, M24, M30 & M36. In M12, M24 & M36 ExB meetings are coinciding with Annual Consortium meetings and in M30 with Member State Policy Committee meeting in M30, but are considered separate events. Decisions will be taken based on consensus whenever possible. I n case no consensus can be reached, decisions will be taken by majority votes. Coordinated by the JA Coordinator, the Executive Board shall: ● Participate in developing the project scope and planning project activities. ● Carry out project activities based on the Project Work Plan and schedule. ● Produce project deliverables. ● Provide the JA Coordinator with information on the progress of activities. ● prioritize the projects objectives and outcomes. ● support the Coordinator in organizing the GA meetings and in the preparation of the draft decisions to be presented by the Coordinator to the GA. ● formulate risk management strategies and ensure that risks are regularly reassessed. ● propose re-allocation of budget whenever changes need to be made. ● support the Coordinator in preparing meetings with the Funding Authority and in preparing related data and deliverables. ● help the Coordinator resolve potential conflicts and disputes. ● prepare the content and timing of press releases and joint publications by the Action or propose d by the Funding Authority. WP (Co-) Leaders: Coordination and implementation roles and activities are performed by Competent Authorities (CAs) and Affiliated Entities (AEs). All activities will be coordinated at the Work Package (WP) level, under the responsibility of WP leader and co-leaders. WP (co-) leaders will coordinate the work within the individual WPs, ensuring that the work plan is executed as expected, in close collaboration with the participating WP partners. Additionally, the WP leaders will be responsible for the timely implementation of the Joint Action decisions within their WP. They will also report WP progress to the Coordinator and to the ExB. WP leaders’ specific tasks include: ● coordinate and supervise their respective WP on daily basi s; ● follow-up the WP deliverables and milestones as defined in the work plan and ensure their timely achievement. ● ensure that each participant fulfills its commitment to the WP. ● present progress reports on the state of advancement of the WP. ● make proposals on the allocation of WP tasks and financial needs. ● draft and validate WP deliverables to be submitted to the EC. ● identify potential risk(s),as early as possible, within the WP and propose contingency plans. ● organize WP meetings with the WP teams whenever necessary. ● solve conflicts at the lowest level possible, and preferably amicably. If an agreement cannot be reached at the task or WP level the JA Coordinator will be informed. 42 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ● inform the Coordinator and the GA of any work plan modification, adjustment or other difficulty arising in connection with the WP. Competent Authorities -Local Country Teams: Each Competent Authority will be responsible to execute the relevant actions described in the proposal, the Consortium and Grant Agreement and the project handbook for itself and its linked third parties. Each Competent Authority must: (i) keep information stored in the Participant Portal Beneficiary Register up to date (ii) inform the coordinator immediately of any events or circumstances likely to affect significantly or delay the implementation of the action (iii) submit to the coordinator in good time: - individual financial statements for itself and its affiliated entities and, if required, certificates on the financial statements - the data needed to draw up the technical reports - any other documents or information required by the Agency or the Commission under the Agreement, unless the Agreement requires the beneficiary to submit this information directly. Each Competent Authority will be responsible for the work of its Affiliated Entities. In each country the competent authority will coordinate and be responsible for organizing local implementation teams and sites and conducting the actions with the structured way described in the implementation strategy. The Competent Authority within the country will be responsible to solve conflicts at the lowest level possible, and preferably amicably. If an agreement cannot be reached at the country level the JA Coordinator will be informed. Advisory bodies of the Consortium The Member State Policy Committee and the Stakeholder Forum have an advisory role of political and scientific relevance also ensuring that the project reaches its objectives and expected impact. Member States Policy Committee: Chaired by the Coordinator, the Member States Policy Committee is composed of representatives nominated by the political/governmental authorities at national/regional level in participating countries. The Members of the Steering Group on Health Promotion, Disease Prevention and Management of Non-Communicable Diseases (SGPP) have selected two best practices (i) the community - based Mental health system reform in Belgium and (ii) the multi level Suicide prevention from Austria to be implemented during this Joint Action with the aim to extend the benefits of these best practices to participating Member States. The Member States Policy Committee will ensure the engagement of National Ministries in the implementation of the two best practices. The aim is to reach out to and engage Ministries national/regional policy-makers, to reflect on and assess the policy relevance and value of JA achievements, and to explore integration of the JA results into national/regional policies. Ministries will be consulted and informed on the implementation process (in collaboration with WP5 and WP6) and on the sustainability work (in collaboration with WP4). This will ensure keeping mental health issues at the forefront of the political agenda for health during and after the completion of the Joint Action. The members will be nominated at the start of the project. Representatives from DG SANTE, HaDEA, WHO-Europe will participate in the meetings. Executive board members will participate in the meetings. The body meets at least bi-annually. The meetings of the Member States Policy Committee are scheduled online in M6 & M18 and onsite in M12, M24, 30 & M36. The meetings in M12, M24 & M36 are coinciding with Annual Consortium Meetings but are considered separate events. A one standalone special Member State Policy committee meeting will take place onsite in M30. Member States Policy Committee members will also be invited to attend the Kick off meeting in M1 and the Annual Consortium meetings. 43 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Stakeholder Forum: Chaired by the JA Coordinator, will be composed by representatives of DG SANTE, HaDEA, WHO-Europe, OECD and representatives of major stakeholders e.g.: Associations of users and family/relatives, Health and mental health professionals, media professionals. Executive board members will participate in the meetings. Recruitment criteria and process will be discussed and decided in the initial phase of the JA. The Stakeholder Forum will enable the relevant external stakeholders to follow and contribute to the JA progress and discuss with JA partners the topics linked to it. In particular, it allows the stakeholders to bring in their views, interests and expectations into the JA process and advise on issues of practical relevance/importance for achieving the expected results. The body meets at least annually, onsite meetings are scheduled in M12, M24, & M36, coinciding with Annual Consortium Meetings but are considered separate events. Representatives of the stakeholder forum will also be invited to attend the Annual Consortium meetings. The stakeholder forum along with the Member States Policy Committee has an advisory role on political and scientific relevance and that the project reaches its objectives and expected impact. Processes and artefacts The main artefacts will be: ● The Project Handbook: In the first months of the JA, WP1 will also develop the Project Handbook to establish the high-level approach for implementing the project objectives. The Project Handbook is one of the main artefacts of the JA and summarizes the project objectives and documents the selected approach for achieving the project goals. It also highlights the communication management plan, documents the Critical Success Factors (CSFs), defines the key controlling processes, the resource allocation, the conflict resolution and escalation procedure, policies and rules, and the project mindsets. The Project Handbook also documents the project governance roles and their roles and responsibilities, and defines the plans necessary for managing the project as well as any methodology-tailoring decisions including the establishment of the implementation strategy as well as the management and monitoring framework. The Project Handbook is based on the Grant Agreement which includes the agreed project work plan, as well as the Consortium Agreement. The Project Handbook will be the reference document for all project members and stakeholders, and along with the Project Work Plan, is the basis on which the project is managed and executed. The Project Handbook will be kept up to date by the Coordinator. ● The Project work plan: it includes the project scope and identifies and organizes the project work and deliverables needed to achieve the project goals. It will be used as the basis to monitor the progress and control the project. It will document all project activities needed to achieve the project goals along with their detailed effort/cost estimates, their schedule and resulting project duration and resource requirements. ● The Project Stakeholder Matrix will list all the people, groups or organizations involved in the project, contact details and clarification of their roles. 2.8.1. Quality of the partnership (proposal section 9.4) All the participants of the JA ImpleMENTAL have been nominated by the respective MS for their involvemen t in the field of public health and mental health and their capacity to run the activities foreseen in this joint action. The partners are not only from Ministries but also Public Health institutes and their affiliated entities and seconded experts are Universities and clinics with substantial experience in the field. All partners are experienced professionals and many have collaborated before in relevant projects. Despite the obstacles faced because of the pandemic which prevented them from organizing any onsite meeting during the Joint Action preparation they have successfully collaborated during the joint action preparation. Partners have substantial experience in the field of Public Health and Mental Health and proven capacities in project management in national European and international level. 44 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 2.8.2. Capacity of the staff (proposal section 9.5) 1. Coordinator: Greece – NHPO: NPHO’s mission is to provide services that contribute to the protection and improvement of health and increase the life expectancy of the population by enhancing the capacity of the National Healthcare System, with particular focus on public health services, to effectively respond to threats to human health through the early detection, monitoring and evaluation of risks, reportin g and submission of evidence-based proposals and intervention measures. The main functions of the NPHO include activities such as epidemiological surveillance, risk assessment, scientific consultation, preparedness and response, provision of reliable and comparable epidemiological data and statistics to national, European and International authorities; education and training in the field of public health, informing the public and health professionals about the risks of serious health threats and promoting public awareness-raising actions. NPHO is the operational centre for the planning and implementation of public health protection actions, maintaining readiness to respond to emergency health risks and adjusting its operations to the needs of the country and the international organizations with which NPHO collaborates. NPHO develops and promotes actions aimed at promoting health, preventing chronic diseases and reducing, in general, the burden of non-communicable diseases. Mental health is among the priorities of the public health agenda under the new national public health legislation. Key Staff: Vasileia Konte, MD, the appointed JA Coordinator, is the nominated contact person of the National Public Health Organization for the Joint Action on Mental Health. Vasileia Konte, is the Head of the Directorate of Epidemiology and Prevention of Non-Communicable Diseases and Injuries at the National Public Health Organization in Greece. She is a Senior Public Health Expert, an Infectious Disease Specialist clinician and a highly skilled project/program manager, with more than 20 years of experience in public health research, participation in many international projects and public health surveillance networks, including participation as national focal point in various positions to the European Center for Disease Prevention and Control and the WHO. She has served as the nominated national contact point for the EU Joint Action on Quality Improvement of HIV prevention. Charalabos C. Papageorgiou MD, PhD will participate as a senior advisor and seconded expert. He is the Professor of Psychiatry at University of Athens Medical School and Chairman of the 1nd Department of Psychiatry University of Athens Medical School, Eginition Hospital (since September 2014). He was chairman of the 2nd Department of Psychiatry, University of Athens Medical School, UGH Attikon Hospital (2013-2014). He is the Head of the Psychophysiology Laboratory, 1st Department of Psychiatry, University of Athens, Greece, and the Head of the Psychophysiology Laboratory at the University Mental Health Research Institute (UMHRI) Athens, Greece. Dr. Papageorgiou’ research activities have focused on psychophysiology, psychosomatic, and clinical studies in psychiatry. He has participated in various Research Programs in Germany Greece and Europe. He has participated, also, in several projects concerning the prevention of Psychological / Psychiatric problems for the general population and recently for the covid -19 lockdown. He is a member of various scientific and professional Societies and Boards. He is the author or co-author of more than 200 articles in peer-reviewed journals and invited chapters in edited books. He is reviewer in many Scientific Journals. Maria Stamou, PhD, is the alternate nominated contact person of the National Public Health Organization for the Joint Action on Mental Health. She is a social and organizational psychologist with almost 10 years’ experience in the area of mental health. She has participated as a trainee in the EU Joint Action on Quality Improvement of HIV Prevention and as an expert in Joint Action on Integrating Prevention, Testing and Linkage to Care Strategies Across HIV, Viral Hepatitis, TB and STI’s in Europe-INTERGRATE. Stathis Papachristou, M.Sc., is psychologist in National Public Health Organization in Greece with postgraduate studies and almost 10 years’ experience in the field of Mental Health Promotion – Prevention of Psychiatric Disorders. He has participated in many research projects in the field of public health and mental health promotion as well as in intervention programs to the general population in the context of the National Strategic Reference Framework (NSRF). He is also a research fellow in the Institute of Social and Preventive Medicine, member of the Association of Greek Psychologists and member of the Delinquency Prevention Council in Papagos – Cholargos Municipality, Athens, Greece. Part of his work has been published in Greek and International Conferences. Lily E. Peppou MSc, will participate as senior advisor and seconded expert. She is a psychologist with an MSc on Psychiatric Epidemiology, while she is upon completing her PhD on the determinants of compulsory admissions in Greece. She is currently the coordinator of the Unit of Social Psychiatry and Psychosocial Care at the University Mental Health, Neurosciences and 45 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Precision Medicine Research Institute “Costas Stefanis”, and a Scientific Collaborator of the First Department of Psychiatry, University of Athens. She has vast research and clinical experience in the field of mental health as well as patient participation in health policy, patient empowerment and stigma. She has been among the leading researchers on the mental health effects of the financial crisis in Greece and she has presented her work at numerous national and international conferences. She has worked as a researcher on many international and multicentre projects and she has more than 40 international publications at peer-reviewed journals, including the Lancet, BMJ Open, Health Expectations, etc. Georgios Anastopoulos, is a Health Economist and the Head of Finance Department of National Public Health Organization since 2018. He holds a PhD degree in Health Services Management. He has worked for the National Public Health Organization since 2008 in various job roles such as the Head of International and Public Relations Office and the Head of Management and Finance Office on Specialized Issues, planning and managing EU funded projects in the fields of public health and migration. 2. Austria – BMSGPK: The Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection (BMSGPK) is the federal authority responsible for policy-making in the areas of social affairs, public health, long- term care and consumer protection. It is the leading authority in Austria to negotiate European legislation and assure its national implementation in the policy fields mentioned above, among others the EU4Health programme. Key Staff: Constantin Zieger is a health and nursing scientist and deputy head of the department for Non- Communicable Diseases, Mental Health and Geriatric Medicine in the Federal Ministry of Social Affairs, Health, Care and Consumer Protection (BMSGPK). He is responsible for various topics in the field of mental health, including the coordination of the suicide prevention programme Austria (SUPRA) activities for the Federal Ministry of Social Affairs, Health, Care and Consumer Protection. He is also responsible for all issues relating to ageing and various matters relating to non-communicable diseases. Affiliated entity: Austrian National Public Health Institute (Gesundheit Österreich GmbH, GÖG) The Austrian National Public Health Institute (Gesundheit Österreich GmbH, GÖG) is the institution responsible for researching and planning public healthcare in Austria, and also acts as the national competence and funding centre for the health promotion and prevention as well as facilitator for health-care related research. Set up by federal law on 1 August 2006, GÖG is a public non-profit limited liability company fully owned by the Republic of Austria, represented by BMSGPK. Key Staff: Alexander Grabenhofer-Eggerth is a psychologist and head of the department Psychosocial Health at the Austrian National Public Health Institute (Gesundheit Österreich GmbH/GÖG). He is also head of the national coordinating centre for suicide prevention at the GÖG. The coordinating centre developed the SUPRA - programme on behalf of the BMSGPK together with a panel of leading national experts. Alexander Grab enhofer- Eggerth is member of the advisory board on mental health of the BMSGPK. In addition to suicide prevention, he is active as a project manager in health services research and strategy development in the field of psychotherapeutic care in particular and psychosocial care in general. Furthermore, he has experience in several EU projects in the field of addiction and addiction prevention. Joy Ladurner works for the department of Psychosocial Health. She has a background in business administration, health economics and health policy (University of Vienna, LSE, LSHTM/London). She has gained considerable experience in the field of international health system comparison during various international projects. Within the field of psychosocial health Joy has a special (research) interest in involuntary placement, child- and adolescent mental health and anti-stigma work. Joy also works for OEKUSS, the Austrian competence - and service-institution for self-help focusing on the promotion of patient participation. Further current research interests include health equity and barriers to health (care) systems. Joy is trained in moderation and mediation and has moderated/facilitated a large number of workshops, expert group meetings, conferences and other events. Sylvia Gaiswinkler works at the Austrian National Public Health Institute in Vienna. She is the researcher and author of the 1st Austrian Gender Health Report with a focus on depression and suicide, published by the Ministry of Labour, Social Affairs, Health and Consumer Protection in 2018. She is part of the project team on suicide prevention in Austria and focuses in her work on mental health and wellbeing. She also leads the National Focal Point for Women's Health and is the strategic process manager for the implementation of the Austrian Action Plan for Women's Health. As a 46 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 sociologist her interests concern socio-economic effects – especially of vulnerable groups - on (mental) health and wellbeing. 3. Bulgaria – National Center of Public Health and Analyses (NCPHA):NCPHA as a health institution is engaged in conducting state healthcare policy. It provides the MoH with expertise, consultation and analyses in the field of public health as well as with information regarding the healthcare management and medical and statistical information at national and international levels. It continues to be a major contractor in a number of international projects and programs both within the EU Public Health Program and under the EU's Joint Actions mechanism (currently participating in six joint actions). NCPHA is the collaborative center of WHO for health and safety at work. Only in 2019 the NCPHA experts have 105 scientific articles in prestigious national and international publications, participated in 213 scientific forums and in over 80 media events. Mental health is among its main concerns. The specialists working in this field have amounted to wide experience in different projects and programs. Team members: Asoc. Prof. HristoHinkov MD, PhD; Vladimir Nakov, MD, PhD; Maya Li utskanova; RumyanaDinolova, MD, PhD; Stefani Nikolova; ZahariZarkov, MD, PhD. The NCPHA team has professional experience and expertise in the following areas: Health policy analysis for the prevention of the most common chronic mental health disorders; Studying the experiences of others countries and organizations in the field of mental health promotion, the fight against stigma in mental disorders, the prevention of mental illness; Development and implementation of programs and projects for prevention of mental diseases; Scientific activity and publications; Development and implementation of information campaigns and projects related to the prevention of suicides, reducing the stigma of mental disorders; University teaching and training of specialists from the primary health network for early detection of mental health problems; Development of manuals and guidelines for good practices for professionals and other specialists in the field of health and mental health; Analyses of the effectiveness of national policies for mental health; Development of modern innovative technologies and methods for the management and financing of psychiatric institutions. The team members have professional competencies in the field of the administration and management of processes in healthcare, in the field of public health, in psychiatry, psychology, public communications and campaigns. The team has organized and conducted two epidemiological studies of common mental disorders in Bulgaria. The team also has experience in management and participation in national and international projects. 4. Croatia – CIPH: The Croatian Institute of Public Health (CIPH) is a central public health institute in the Republic of Croatia. CIPH maintains national public health registries and coordinates the network of regional public health institutes, actively participates in the creation of health policy and public health regulations, and engages in international co-operation to improve public health and welfare. CIPH’s Division of School Medicine, Mental Health & Addiction Prevention has a coordinating role in the health system for all mental health institutions in Croatia, develops mental health strategy and other health measures and interventions in mental health care on primary, secondary and tertiary level, improves health literacy in population, supports psychiatric care users organizations, raises awareness on mental health and implements mental health in the community. Key Staff: Prof. Danijela Štimac Grbić, MD, Ph.D., MPH, specialist of public health, Head of the Department for Mental Health and prevention of Addiction at CIPH, and Associate Professor at the University of Zagreb, School of Medicine, at the Department of Social Medicine and Organization of Health Care, member of the Working Group of the Croatian Ministry of Health for the Mental Health Strategy, co-chair of the National Working Group for Mental Health Care and the Croatian Association of Public Health, member of the Scientific Board and Governing Board of the European Public Health Association. Primarius Ivana Pavić Šimetin, MD, Ph.D., Deputy Director of CIPH and Head of Division for School Medicine, Mental Health, and Addiction Prevention at CIPH, project leader of RECOVER-e (LaRge-scalE implementation of COmmunity based mental health care for people with seVere and Enduring mental ill health in EuRopE), national coordinator of HBSC. Dijana Mayer, MD, Ph.D., a specialist in Epidemiology, Head of Department for Monitoring and Improving School and Youth Health at CIPH, national coordinator of GYTS. Bojana Raičković, MA, Psychologist, Head of Programme and Project Management Department, National Focal Point for Third Health Programme 2014-2020 and EU4Health 2021-2027, Data 47 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Protection Officer at the Croatian Institute of Public Health. She was a project leader of the ESF project “Self- employment subsidy”. She is currently national coordinator of 3HP project NFP4Health, CIPH’s leader of 3HP project JA TEHDAS and participates in H2020 project RECOVER-e. Ana Ištvanović, MD, resident of public health at the Department for Mental Health and Addiction Prevention at the Croatian Institute of Public Health. Anja Belavić, MD, resident in school and adolescent medicine at the Department of School and Adolescent Medicine Addiction and Mental Health at CIPH. Mišela Žehaček Živković, MD, resident in school and adolescent medicine at the Department of School and Adolescent Medicine Addiction and Mental Health at CIPH. Roberto Mužić, MD, resident of psychiatry at the Department for Mental Health and Addiction Prevention at the Croatian Institute of Public Health. Maja Valentić, MA, Sociologist, consultant in the Department of School and Adolescent Medicine Addiction and Mental Health at CIPH and analyst on the Registry of Persons Treated for Psychoactive Drug Abuse. 5. Cyprus – MHS: Mental Health Services Directorate offers lifelong mental care to the population needs, from childhood and adulthood, to psychogeriatric care, all around Cyprus (Nicosia, Limassol, Larnaca, Ammochostos, Pafos). The fundamental objective of the mental health policy is to continue the psychiatric reform in transferring the services from the Mental Hospital to the Community. The services are directed to four main axes: a) Mental Health Services for Adults, b) the Child and Adolescent Mental Health, c) the Prevention and Treatment of Drug Dependence, and d) Mental Health Services in Prison. Key Staff: Dr Anna Paradeisioti, MD MSc PhD, Child and Adolescent Psychiatrist, Dr Lampros Samartzis, MD MSc PhD, Psychiatrist, Dr Andreas Hodjitofis, MD MSc PhD, Psychiatrist 6. Czechia – MoHCZ: Ministry of Health of the Czech Republic (MoHCZ) is responsible for the health of the citizens of the Czech Republic. The reform of mental health care is ongoing since 2013 with satisfactory results, and the government adopted the policy on suicide prevention in 2020.MoHCZ has a leading role in mental health care and has an influential role on the national level also as a chair of the Government Council for Mental Health. Key Staff: PhDr. Ing. Pavel Mička is a director of the Department of Mental Health Reform at MoHCZ. He is responsible for coordinating several programs and actions conducted as a part of an ongoing mental health care reform. Mudr. Dita Protopopová, PhD. is chairing the Government Council for Mental Health. Besides that, she is an experienced psychiatrist and member of the executive committee for mental health care reform. Mgr. Eva Tuškováhas several years of experience in the field of mental health. She deals mainly with the topic of (de)stigmatization of mental illness in various contexts. Affiliated entity: National Institute for Mental Health (NIMH) National Institute for Mental Health (NIMH) is a leading research center in the field of mental health in Czechia. The scope of the research spans from neurobiology to public mental health. NIMH is providing expertise for Czech government and MoHCZ in the mental health area and is involved in the reform of mental health care system and national suicide prevention policy implementation. Key Staff: Mgr. Alexandr Kasal is a junior researcher at NIMH. He has several years of experience in participative policy making on national level gathered, namely by the preparation of the National Action Plan for Suicide Prevention. Alexandr has a background in Public and Social Policy. Mgr. Laura Bechyňováis a psychologist and research assistant at NIMH. In her work, she focuses on suicide and its prevention and child and adolescent mental health. Ph.Dr. Petr Winkler, PhD. is head of Public Mental Health Research Program at NIMH. He is an experienced researcher in the epidemiology of mental disorders, and he has been involved in the reform of mental health care since its beginning. Mgr. Roksana Vintoniv is a psychologist and research assistant at NIMH. As a researcher she works in The Czech Technical University in Prague on a project, which aims to explore factors that influence successful integration of young people who left institutional care. She also focuses on prevention in primary and secondary schools. 7. Estonia – MoSA: Ministry of Social Affairs of Estonia (MoSA) is responsible for developing strategies and coordinates the implementation of policies in the field of health. Its competencies include the leading role in 48 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 coordination of public health policies, prevention of no communi cable diseases and development of respective strategies. Key Staff: KäthlinMikiver (MsC) – Chief Specialist of the Public Health Department of the MoSA of Estonia. Main competences include coordination of policies and strategies in the field of mental health, 7 years of experience in the field of mental health. Affiliated entity: National Institute for Health Development (NIHD) The National Institute for Health Development (NIHD) is a government established research and development body collecting, connect ing and providing reliable national information from a multitude of sources, related to the health of the Estonian population. Main areas of activity are evaluation and assessment of population health and health determinants, health promotion, organization of public health services and social services, consultations on and influence of health policy. Key Staff: Tiia Pertel (MD) – Head of the Centre for Health and Welfare Promotion, 19 years’ experience in the public health and health promotion field. Karin Streimann (MA) is an early-stage researcher and works in the Children and Youth Unit, National Institute for Health Development for the last 10 years. She is mainly involved with mental health promotion and substance use prevention activities. 8. Finland – THL: The Finnish Institute for Health and Welfare (THL) carries out extensive research on population health and social welfare and provides evidence-based information to support the decision-makers and experts of the governmental and health and social welfare sectors. Mental health unit at THL studies population mental health and develops ways to promote mental health and prevent mental health problems. It also implements the National Mental Health Strategy and Suicide Prevention Agenda 2020–2030. Key Staff: A chief specialist in Mental Health Unit, (THL) has also been a director of WHO Collaborating Centre for Mental Health since 2013. Her expertise areas are mental health promotion, suicide prevention and positive mental health. Her PhD thesis in 2011 dealt with the role of mental health in health policy making. Currently she leads a four year project funded by the Academy of Finland concentrating on those living alone in Finland, positive mental health, quality of life and social support. She is also working with implementation of National Mental Health Strategy and Suicide Prevention Programme launched 2020. A senior specialist in Mental Health Unit (THL) has expertise also in mental health promotion, suicide prevention and positive mental health. She is currently working on her PhD thesis on mental health promotion competencies. Both have expertise in several international projects. An adjunct professor of psychiatry and research professor in Mental Health Unit (THL)His expertise areas are mental health and psychiatry, suicide prevention, sleep and circadian rhythm and the effect of polar nights on mood. He also works with National Mental Health Strategy and Suicide Prevention Programme launched 2020. 9. France – MoH: The Ministry of Solidarity and Health (MoH) leads across health, social affairs, solidarity and social cohesion by creating national policies and legislation, providing the long-term vision and ambition to meet current and future challenges, putting health and solidarity at the heart of gov ernment. Within the MoH, the Directorate General for Health is responsible for the elaboration of Public Health policies, disease prevention and health promotion. The Directorate General for Health is currently involved as a partner in several Joint Action and action supporting the health reform. Key Staff: Frank Bellivier received his medical degree at the University of Paris (René Descartes). His current roles include Professor of Adult Psychiatry at University Denis Diderot in Paris, Head of the Departme nts of Psychiatry and Addiction at Saint-Louis - Lariboisière – F. Widal hospitals in Paris. He is also director of a research team on neuropsychopharmacology of bipolar disorders and addictions at the Institut National de la Santé et de la RechercheMédicale (INSERM UMRS_1144, www.umrs1144.com). In May 2019, Frank Bellivier was appointed Ministry’s Delegate for mental health and psychiatry at the Ministry of Health and Solidarities in charge of the governmental roadmap for mental health and psychiatry. Simon Vasseur-Bacle is a clinical and systemic psychologist at the EPSM (public mental health hospital) Lille Metropole since 2008, in a community based mental health service, recognized by WHO as a good practice laboratory. Simon Vasseur-Bacle is also in charge of international affairs at the WHO Collaborating Center for Research and Training in Mental Health (CCOMS, Lille, France). He’s currently leading the development of the WHO Quality Rights program in France and F rench- 49 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 speaking countries, and participates in strengthening mental health systems at the international level (Burkina Faso, Turkey, Tunisia, …). Simon Vasseur-Bacle is also project manager at the Ministerial Delegation for Mental Health and Psychiatry (DMSMP, Ministry of Health and Solidarities). Mrs Roxane Berjaoui is a Public Health medical doctor (MD) with twenty five years of experience in this field, working for regional state Institutions dealing with programs for disabled and elderly persons and dealing with regulation of the French health system at a regional level. Since 2019, she is working as an International Affairs advisor on health promotion and prevention at the French Ministry of Health near the Director General. She is involved in an international program and network on nutritional labeling, in national collaboration on physical activity with the technical expert team developing the "Sport and Health" strategy and in the follow up of NCDs at a national level in relationship with WHO Geneva, WHO Europe (focal point) and with ΟCED. She is involved in a joint action newly launched - Joint Action Best Remap (implementation of validated best practices in nutrition). Affiliated entity:INSERM Inserm is a nationwide public scientific and technological institute which operates under the joint authority of the French Ministries of Health and Research. The institute is dedicated to biomedical research and human health, and is involved in the entire range of activities from the laboratory to the patient’ s bedside. It is in close partnership with hospital and university department, e.g. the UHG-Paris Neuroscience and psychiatry, the largest psychiatric hospital offering community based MH Care, > 76000 patients/ years and covering 90% of Parisian population and including the C’JAAD (Evaluation Centre for Young Adults and Adolescents) that pioneered Early Detection and Intervention in France. Inserm will also be involved through the ‘Institut de Psychiatrie‘(IdP, https://www.institutdepsychiatrie.org/), a National consortium for translational research in Psychiatry, and especially the Transition Network that launch a task force for defining recommendation for early intervention at the National level. Key Staff: Prof MO Krebs (F) is a MD PhD, trained in psychiatry and Neuroscience She is a leader in clinical and translational research in schizophrenia and developmental disorders (>8000 citations, web of science H factor 44; google scholar h55). Her team has recently been awarded an ‘Avenir investment’ grant for the PsyCARE project for preventive and personalized psychiatry in adolescents and young adults. She is member of the ECNP Prevention of Mental Disorders – Promotion of Mental Health (PMD-PMH) TWG Group and in the EPA: member of the Section Prevention of Mental Disorders of EPA. She is an expert for the ITMO Neuroscience entity, an advisory board for defining research and strategies in Psychiatry and Neurosciences for Inserm. 10. Germany – BZgA:The Federal Centre for Health Education is a public health authority at federal level, founded in 1967, with the responsibility for prevention, health promotion and education (incl. mental health)Main tasks of BZgAinclude 1)Developing concepts, strategies and measures on the contents and methods of prevention, health promotion and education; 2) Planning, implementing and evaluating campaigns and programmes of prevention and health promotion and contributing to national action plans. BZgA has long standing experience in the assessment, dissemination and transfer of good practice in prevention and health promotion in supporting local community-based networks in promoting integrated health approaches through the development and dissemination of instruments and measures for quality assurance and capacity development. BZgA is currently engaged in elaborating analysis reports on the mental health of the adult population and on children and adolescents in Germany. For the present JA BZgA will cooperate with affiliated entities which will be identified and nominated until and/or during implementation of the JA. Key Staff: Prof. Dr. Freia De Bock (f) is Head of Research and Head of the Department for Effectiveness and Efficiency in Health Education. She is a pediatrician and professor of public health with a research backgrou nd in implementation and evaluation of complex PH interventions and mixed methods, mostly applied in everyday life settings (of children) and in local communities. She has a strong research track-record and experience in early prevention and health promotion, gained as head of a dedicated research program at the Mannheim Institute of PH, Social and Preventive Medicine. As somatic and mental health and development are closely intertwined during childhood, much of her work is related to outcomes that are an essential part of mental health (e.g., patient-centered outcomes, subjective wellbeing etc.). She also built up the German national platform for mental health during the COVID-19 crisis and is the lead or senior author of numerous peer-reviewed articles. Yvette Shajanian Zarneh (f) joined the BZgA as Scientific Project Officer in 2014 and has been heading the BZgA 50 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 unit for International Relations since 2018. She holds Master’s degrees in Political Science and in Management of Health and Social Services and brings in 18 years of experience as a researcher and project manager in the field of public health, health care system development and long-term care at international level. She has been managing the input of the BZgA and other German partners in several Horizon 2020 projects and Joint Actions. Nathalie Bélorgey(f) has joined the unit for International Relations of the BZgA in 2017 where she has been working as Senior Scientific Project Officer on issues of sexual and reproductive health, early prevention an d health promotion, health inequalities, migration and health. She holds Master’s Degrees in Applied Languages and in Law and has a longstanding experience as a research and project manager in the field of social and (public) health systems and policies in an international context. She has been leading Germany’s contribution to the WPs on migration and health and monitoring in the Joint Action “Health Equity Europe”. Mirja Otten (f) joined the BZgA in 2018 and is a member of the Research and Quality Improve ment unit. After obtaining a Diploma of Law and a Master’s Degree in Psychology, she completed her Ph.D. at the University of Hamburg. She specialized in evaluation of health promotion measures, campaigns and complex interventions, survey research, evidence synthesis, development of recommendations for actions and consults on various research projects. At BZgA, her research projects focused on sexual and reproductive health as well as mental health. Verena Grau (f) graduated with a master's degree in German language and literature and in Islamic studies in 2010. She worked for an international exchange organization in higher education for ten years and gained profound experience in the management of third-party projects and grants in the public sector. In early 2019 she started to work as administrative officer of the BZgA’s National Centre for Early Childhood Prevention before joining the team of the International Relations’ unit in Autumn 2019. Since then she has been responsible for the administrative and financial management of BZgA’s input to the EU-Joint Action “Health Equity Europe” (2018 - 2021). 11. Hungary – OKFO: ORSZAGOS KORHAZI FOIGAZGATOSAG (National Directorate General for Hospitals) is legal successor of the National Healthcare Service Centre (ÁEEK) since 01.01.2021. OKFO is a central governmental office in Hungary with nation-wide competence. It represents both the public (GOV) and End User side (care providers). "Its tasks range from hospital planning, care coordination, licensing of medical professionals and management of external funding to implementation of national strategies and communication with international research organizations" [OECD]. Key Staff: István CSIZMADIA, MSc in Economics and Health Care Management (male): István leads international programmes and projects at OKFO, Hungary. He has extensive (30+ years’) experience in Preparing, planning and managing EU funded programmes, implementing and coordinating EU projects. Robert LANG, MBA, CFA (male): Senior advisor and consultant at ÁEEK. He has extensive experience in strategic and financial planning, learning solutions and implementing EU projects. Dr. Béla MUZSIK MD (male): Béla is Director for Monitoring, Management, Data Analysis and Data Supply at ÁEEK, Hungary. He has extensive 18 years’ experience in primary care, occupational medicine and occupational rehabilitation, healthcare quality management and audit, training and education. Peter BEZZEGH (male) is a sociologist and a health policy expert at ÁEEK. He has 5 years’ experience in strategic planning, implementing EU projects and network building. Olga DÁNYI (female), financial coordinator, has 18 years of experience in the financial management of EU funded projects. Affiliated entity: 1. Semmelweis University, Health Services Management Training Centre (SU, HSMTC). Semmelweis University (SU) is the largest medical university in Hungary. The Institute of Health Services Management Training Centre (HSMTC) is part of the Faculty of Health- and Public Services. HSMTC is engaged in development of knowledge management and of HRH management, with focus also placed on the physical and mental safety of HRH as well as of patients. The institution gained a wide variety of expertise from previous projects inter alia in dissemination, communication, evaluation and sustainability activities. Key Staff: The team of Semmelweis University will be composed of experts experienced in the field of health workforce and HRH management, and additional competencies of project management and PR as wel l. Eszter Kovacs, PhD – senior expert, highly experienced in the field of health workforce research, including mental health and behavioural aspects, managing planning and forecasting projects, with many years of experience in EU level project design, coordination and implementation. Marianna Makai – senior expert in the field of PR, communication and dissemination at national and international levels. Marta Sziklai – communication and 51 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 dissemination expert. The team will also involve colleagues in part-time, including Livia Langner – psychologist; Zoltan Cserhati, MD – senior lecturer, experienced in designing mental health care projects and organizational management; Szilvia Adam, PhD – expert of issues of work-life balance and burnout; Reka Kovacs D.Jur. – policy expert in the field of HWF development and social issues. All of the team members have affiliation and relevant expertise in different areas of mental health research and policy. Szilvia Kerekes – administrative and financial affairs. 2. University of Debrecen, The Faculty of Public Health (UD, FPH) The University of Debrecen is more than four hundred and fifty years old, it is one of the largest educational centers of the country and it is a central player in Hungarian higher education. It has outstanding educational, research, and innovation capacities. It is one of the top 500 universities in the world. The student community of 30,000 can study in 14 faculties including the Faculty of Public Health, the Faculty of Medicine and it hosts two university hospitals that offer comprehensive outpatient and inpatient care in the full spectrum of medical disciplines including mental health and psychiatry Key Staff: Judit ZSUGA MD PhD (female) graduated as a medical doctor at the University of Debrecen in 1998. She acquired an MSc in Health System Management in 2005, University of Debrecen in 2008. She is a board - certified neurologist, clinical pharmacologist and cognitive behavior therapist with 8 years of clinical practice and 10 years of experience in health system management. She defended her PhD in 2007 in the field of clinical medicine, her habilitation was absolved in 2013 in the field of health sciences. She possesses language skills in English (level C1). Attila NAGY MD PhD (male) graduated as a medical doctor at the University of Debrecen in 2005. He also graduated, as an epidemiologist at the Faculty of Public Health, University of Debrecen in 2008. He obtained his medical specialization in preventive medicine in 2009 and he defended his PhD in 2015 (University of Debrecen). He possesses language skills in English (level C1) and German (level B1). Csaba E. MORE (male) is the Head of the Department of Psychiatry of the Kenezy University Hospital of the University of Debrecen. He is a board-certified psychiatrist, addictologist and psychiatry rehabilitation specialist. Csaba PAPP (male) is the Head of the Department of Health Promotion of the Clinical Center of the University of Debrecen. He is a board - certified general practitioner. He received his PhD in the field of health sciences. 12. Iceland – DOHI: As stated in the Medical Director of Health and Public Health Act No. 41/2007 the Directorate of Health in Iceland (DOHI) is a government agency that serves under the Ministry of Health and is headed by the Director of Health. Its principal role is public health promotion and prevention, including disease prevention, and promoting accessible, safe, high-quality health care in Iceland. Among its functions are: To advise the Minister of Health and other Government bodies, health professionals and the public on matters concerning health, disease prevention and health promotion. To sponsor and organize public health initiatives. To promote improvements of health care quality. To supervise the health care serv ices and health care professionals. To monitor prescription medicines and promote their prudent use. To collect and process data on health and health care services and promote research in that field. To handle complaints from health care users. To issue licenses to practice to health care professionals and ensure that their education meets requirements at all times. The management of DOHI consists of six Heads of Division as well as the Director of Health. These Divisions are: Health Care Supervision and Quality, Supervision and Incidents, Health Information, Communicable Disease Control, Public Health, and Finance and Administration. In the department of Public Health there are specialists on determinants of health (tobacco-, alcohol and drug, - violence prevention, nutrition, physical activity and mental health) who are all participating in various networks and programmes on national, nordic and European levels. Hopefully we can strengthen our networking and relation with other funding and managing authorit ies with our participation in this project. Key Staff: Dora Gudrun Gudmundsdottir PhD, a licensed clinical psychologist is the director of Public Health at the Directorate of Health in Iceland, where she coordinates national efforts to promote health and w ellbeing. Her expertise lies in mental health promotion. She has served as the governmental expert on mental health from Iceland for the EU. She has been involved with several projects on health promotion and chronic disease prevention e.g., JA MHWB, JA CHRODIS, DataPrev, Move Europe and Healthy Together. She was the WP leader 52 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 for dissemination for JA MHWB. Sólveig Karlsdóttir MA, is a project manager at the Division of Public Health at the Directorate of Health in Iceland. She has been involved in several EU projects and the work regarding NFP. Sólveig is currently working on DOHI participation in the UPRIGHT H2020 project. A project manager on suicide prevention at the Directorate of Health will also participate in this JA. 13. Italy – LR: Lombardy Region, Competent Authority for Italy, has a particular expertise and direct planning and organizational responsibility in the mental health field. The psychiatric reform in Italy in 1978 entrusted the Italian regions to implement the psychiatric reform. In the years following the reform, the Lombardy Region has implemented a vast network of territorial services that today serves roughly 150,000 adult patients and 130,000 children and adolescents. Lombardy Region has also acquired expertise in managing health/men tal health information collected in administrative databases and in using this information for planning and evaluating MH services. Key Staff: Paola Sacchi MD, psychiatrist, is Head of the Department of Mental Health & Substance Abuse, General Direction Welfare - Lombardy Region. She has a long-time expertise in the organization of health services, having been previously Health & Social Director in the Local Health Unit in Milan, Director of Mental Health Services and Substance Abuse Services in the City of Milan. Affiliated entities: 1. ASST LECCO: Local Health Authority of Lecco (ASST, Azienda Socio Sanitaria Territoriale) public provider for health services in the Province of Lecco (Lombardy) and in the JA has in charge the coordination and management issues on behalf of Lombardy Region. 2. MNIPR: Mario Negri Institute for Pharmacological Research – IRCSS – Research Institute for pharmacological research and public health and has in charge training in the JA. 3. FBF: " Saint John of God '' Fatebenefratelli Center – IRCSS – Institute for mental health research and care that will implement the best practice at country level. 4. UNIMIB: Bicocca University, Milan - Department of Statistics and Quantitative Methods specialized in the use of health databases for epidemiological research and has in charge the epidemiological issues of the dashboard of mental health indicators for the JA. 5. POLIMI: Politecnico di Milano University specialized in software and in implementing e-health has in charge the technical issues of the dashboard of mental health indicators for the JA. Key Staff: Antonio Lora MD, psychiatrist, is Head of the Department of Mental Health and Substance Abuse of the Local Health Unit di Lecco. He is senior consultant for mental health services evaluation in DG Welfare of Lombardy Region, in the Italian Ministry of Health and in WHO Department of Mental Health and Substance Abuse (Geneva).Teresa Di Fiandra, psychologist, has been working at the Ministry of Health in the General Directorate for Health Prevention, where she has been in charge for planning in the areas of mental health, dementia, health in prison and forensic hospitals. She has been officially appointed as the Italian National Counterpart for WHO Europe in the field of mental health (from 2001 to 2019, when she retired), she has also been the Italian Governmental expert to the European Commission for both Mental health and Dementia, as well as member of OECD Mental Health Care Quality Indicators group. She has been an expert consulta nt on several EU projects in the mentioned fields, and coordinator of the Italian participation in three EC Joint Actions (ALCOVE and DEM2 on dementia, and the JA on Mental health and well -being). 14. Lithuania – SAM: Overall responsibility for general supervision of the entire health system is held by the Ministry of health (MoH). The MoH is strongly involved in drafting legal acts and issuing regulation for the health sector. It also runs health care facilities and public health institutions and has the overall responsibility of health system performance. The main aims of the MoH are the development, organization, coordination and control over the implementation of state policy in four fields: individual health care, public health, pharmaceutical activities and health insurance. Other major functions of the ministry of health include drafting legal acts, licensing, implementing state policy in subordinated institutions, formulating and implementing health strategies and programs, international collaboration, analysing and disseminating information, and handling patients’ complaints. Mental health is one of the fields of MoH concern. The Ministry of Health prepares legal acts regulating the provision of outpatient and inpatient mental health services (for ex ample: by order of MoH 53 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 was established, that the maximum number of registered citizens for each team member providing primary outpatient mental health care services is 17 000 citizens.). MoH is responsible for the prevention of mental health disorders at the national level (for example: Since 2019, the MoH started financing municipal Public Health Bureaus to promote mental health prevention in schools, since 2020 MoH started financing municipal Public Health Bureaus to provide psychological help to the indi viduals experiencing difficult life situations (such as job loss, divorce and etc.) Key Staff: Edita Bishop Graduated Vilnius University, Faculty of Medicine, holds a master’s degree, professional qualification of occupational medicine. Edita Bishop has over 20 years working at the different governmental institutions. Edita Bishop was Director of the Food, Tourism and Recreation Services Department at the State Consumer Rights Protection Authority, Director of Gaming Control Authority under the Ministry of Finance of the Republic of Lithuania, Head of Primary Coordination Division at the Ministry of Health and since 2018 – Adviser at the Mental Health Division of the Ministry of Health. Edita Bishop was responsible for organizing and controlling the activities of the Authority, Department or Division, preparing legal acts concerning consumer rights, gaming control and health (implemented at the national level) and also leading different working group members, who represent various different institutions. Si nce 2018 Edita’s Bishop main duty is policy making in the field of primary mental health care. Renata Beržanskienė, expert, Head at Financial Management and Control Division. Graduated from Vilnius Gediminas Technical University in 2004, holds a master’s d egree in Business Management. Renata Beržanskienė is working at Financial Management and Control division of the Ministry of Health of the Republic of Lithuania since 2018. Renata has 18-years’ experience in coordinating and managing European projects. Marija Oleškevičienė has a Master’s degree of Science in Mechanical (Biomechanical) Engineering (Medical equipment, prosthetic engineering). Marija Oleškevičienė has 1,5 years’ experience as Chief specialist at the Ministry of health of the Republic of Lithuania (Policy making in the field of mental health, secondary and tertiary mental health services, actions against stigma); 19 years of experience at the Department for the affairs of disabled under the ministry of Social affairs and labour of Lithuania, 9 years of these as head of monitoring and control division (implementation of deinstitutionalisation policy in Lithuania, strategical planning, implementation, control and monitoring of policy measures in the field of integration of disabled people (management and control of more than 450 projects every year). 15. Malta – MHS: Mental Health Services seek to deliver patient centred care through a multidisciplinary team to patients with a mental disorder guided by evidence-based science. Mental Health services are guided by the provisions of the Mental Health Act (Cap 525) 2012, MHS has contributed towards the drafting of the Act and its implementation. MHS was part of the drafting team of the Mental Health Strategy 2020-2030 and is currently in the process of implementing it. Mental Health Services have participated in the Joint Action on Mental Health and Wellbeing (Feb 2013-Jan 2016) and have also collaborated with WHO on several projects. Key Staff: Dr Stephanie Xuerebis the CEO of Mental Health Services and is also a Consultant in Public Health Medicine. Past Chair of the Mental Health Reform Team, which was instrumental to steer change in Mental Health Services. Dr Xuereb was also responsible for the implementation of the new Mental Health Act 2012. In her prior role as lead of the National Cancer Screening Programmes in Malta she participated in a number of EU projects including iPAAC Join Action (Innovative Partnership for Action Against Cancer) and EU-TOPIA (Towards improved screening for breast, cervical and colorectal cancer in all of Europe), a five year project (2015-2020) funded by the European Union. Dr Anton Grech is a Consultant Psychiatrist who works in Adult General Psychiatry both in community and hospital settings. He has been Clinical Chairman of the Department of Psychiatry within the Ministry of Health, Malta, since September 2011. He has experience in working on large projects. During his training in the UK, he was responsible for the further development of the Maudsley Family Study, a large study on the biological markers on Schizophrenia. He has published papers that were written in collaboration with other European colleagues. Dr Grech was one of the main contributors towards the Mental Health Strategy. Dr Antonella Sammut is a Consultant in Public Health with special interest in Public Mental Health and has been working within Mental Health Services since March 2018. She spent 5 years working within the office of the Commissioner of Mental Health during which she was part of the team revising the Mental Health Act 2012 and monitoring its implementation. She was one of the main authors of the Mental Health 54 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Strategy, Malta. She has participated in the EU Joint Action Integrate and was the National Contact Point during the initial phases for Patient Safety and Quality of Care. Dr Elaine Claire Lautier is a Public Health Medicine Specialist. She has worked in the area of Mental Health as a Public Health Specialist since 2016. She was part of the team for the drafting of the Mental Health S trategy. She has been involved in a number of Joint Actions and currently is participating in BEST REMAP JA. She also leads the EU JAV on behalf of the Ministry for Health in Malta. 16. Netherlands – TI: TheTrimbos Institute is the national knowledge institute for mental health and addiction in the Netherlands. Its aim is to contribute to improving the mental health and wellbeing of the Dutch population, and contribute to advancing mental health efforts nationally and internationally. Trimbos is a WHO Collaborating Centre for Mental Health Services and Interventions across the Life Course. Trimbos has a track record in implementation research on service delivery models and substantial experience in mental health implementation projects internationally. In addition, core activities include policy advice to Ministries of Health and Social Welfare, research, development and evaluation of new treatment methods, clinical guideline development and capacity building of health professionals for their implementatio n, monitoring of the health status of the population, monitoring the quality of care of service provider organizations. Key Staff: Dr. Laura Shields‐Zeeman, Head of Department, Trimbos Mental Health and Prevention Department. Dr. Shields‐Zeeman is the thematic lead for mental health at Trimbos, leads the Department of Mental Health and Prevention at the Trimbos Institute and is the Director of the WHO Collaborating Centre for Mental Health Services and Interventions across the Life Course, as well as a Visiting Scholar at the University of California, San Francisco in the area of social determinants of health and social policy and epi demiology. She was a 2018-19 Harkness Fellow for the Commonwealth Fund in the United States working with leading health and social policy experts. She is currently project leader and co-lead of various international projects, such as the Horizon 2020 project RECOVER-E involving 16 partners from 11 Member States. She has specific expertise on the development, implementation and evaluation of service delivery transformations in mental health care, in policy analysis, and in implementation science. She has been closely involved in policy development processes at the national and international level and has experience in working with expert working groups in the European Region and in coordinating processes and management of activities and projects. Prof. Dr. Filip Smit, Chief Scientist of the Trimbos Institute, Professor of Public Mental Health at VU University, Amsterdam, Expert in Advanced Statistics, Health Economist. Filip Smit, PhD, is professor of evidence -based public mental health at University Medical Centres Amsterdam (location VUmc) department of Epidemiology and Biostatistics and the department of Clinical, Neuro and Developmental Psychology. He also holds a position as Chief Scientist at the Netherlands Institute of Mental Health and Addiction (Trimbos Institute), Utrecht. Filip obtained his PhD with distinction (cum laude) in 2008 and was appointed professor in 2009. His Google Scholar H-index is 59. Filip’s fields of expertise are epidemiology, randomised trials, meta-analysis, and health-economic evaluation with applications in preventive psychiatry. Drs Lotte Voorham, Senior Project Manager, Department of Mental Health and Prevention. Lotte Voorham is a senior project manager with a background in Psychology and over 10 years’ experience in project management and research and good communication skills. Since 2008 she has been involved in coordinating and participating in several EU projects. She fulfilled the role of coordinator and project manager in the STAD in Europe project (finished in 2019). 17. Norway – HDIR:The Norwegian Directorate of Health aims to better the quality in the health service and to promote factors that bring good health to the population. The Directorate is a competent authority, subordinated to the Norwegian Ministry of He alth and Care Services. The Directorate has long-term experience working with suicide prevention and campaigns. The Directorate launched and implemented the national action plan for prevention of suicide and self -harm 2014-2017. The National Institute of Public Health may also contribute to the Norwegian participation. Key Staff: Wenche Øiestad Competence: Senior adviser at The Norwegian Directorate of Health and coordinator for the new national action plan for suicide prevention. 55 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Åste Herheim: Competence: Specialist on clinical and community psychology and head of department at The Norwegian Directorate of Health. Lars Mehlum: Competence: Specialist in psychiatry and head of the National Centre for Suicide Prevention 18. Serbia – IPHS: Institute of Public Health of Serbia “Dr Milan Jovanovic Batut” (IPHS) is the leading institution in the area of public health in Serbia which functions as the national research institute in the public health with the important role in coordination of public health programs through the network of 24 regional institutes of public health. IPHS conducts all its activities in close cooperation with the Ministry of Health of Serbia, and serves as the main monitoring institution for public health related issues which supports evide nce-based decision making. Institute´s main areas of activity are: analysis, planning and organization of health care, informatics with biostatistics, health promotion, prevention and control of communicable and non - communicable diseases, hygiene and human ecology and microbiology. Activities of the IPHS are implemented through multisectoral cooperation from national to local level. IPHS has long experience in international cooperation and implemented various projects with many EU and non-EU member states funded by WHO, European Union etc. Key Staff: Verica Jovanovic, MD, PhD, Associate Professor, specialist in social medicine/public health has rich experience in project management, research and monitoring and evaluation in the public health area. She participated and contributed to development of many public health strategic documents and as director of the IPHS she has proven her leadership skills. Milena Vasic, DMD, MSc, PhD, Professor, specialist in social medicine/public health, master in Health Services Management is a Head of Department for International Cooperation and Project Management at the Institute of Public Health of Serbia. She has more than 25 years of experience in public health. She has been working on projects preparation, implementation, (including dissemination, visibility and exploitation), monitoring and evaluation. Biljana Kilibarda, DMD, PhD is a public health expert, mostly focused on health promotion, prevention of non-communicable diseases, and monitoring and prevention of risky behaviour. Her activities include research such as general population surveys, and needs assessments in various public health domains. Perisa Simonovic, MD, MSc, specialist in psychiatry, Assistant Director of the IPHS, with experience both in treatment of mental health illnesses and in organization and coordination of various programs from the public health perspective. 19. Slovenia – NIJZ: National Institute of Public Health of the Republic of Slovenia (NIJZ) is the central Slovenian institution for public health practice, research and education. Being centred on all aspects of public health, NIJZ presents a capable partner in practically all health-related projects. At the same time, NIJZ could engage in wide- ranging dissemination of the project results and knowledge gained in the project implementation process. Inclusive engagement and promotion of lessons learnt could ensure better national and transnational transferability and applicability of the project results, and other outputs generated by the proj ect partners. Key Staff: Matej Vinko, male. Medical doctor, public health specialist, head of the mental health expert group at the NIJZ. He is the WHO’s Slovenian collaborator in Mental Health Atlas project. He is a member of the public mental health section at the European Public Health Association. MV was a member of the scientific group to prepare the Resolution on the National Mental Health Programme and is currently involved in its implementation as the head of the interdisciplinary working group for mental health promotion and prevention of mental disorders in child and adolescent population. SaškaRoškar, female. Psychologist, PhD, Assist Prof. at University of Ljubljana, National Expert of Public Health at the NIJZ. SRs’ main expertise is in the field of mental health promotion, prevention of mental health diseases and suicide prevention. She coordinated the NIJZ part in the 7th Framework Programme EU funded OSPI project and was the leader of the project STRENGHT (Norway Grants). SR was National Representative for Slovenia in the International Association of Suicide Prevention (IASP). She was Assistant Project Leader in several national Mental Health related projects and was part of the scientific group to prepare the Resolution on the National Mental Health Programme. She authored and co- authored several scientific papers in national and international peer reviewed journals. 20. Spain – SMS: The ServicioMurciano de Salud (SMS)is responsible for health care in the Region of Murcia, integrating a total of 11 hospitals, with 3,651 beds and 508 outpatient appointments of primary care, and 56 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 providing healthcare to 1.47 million inhabitants. In the exercise of its functions, the SMS provides services and develops the following actions: Health Promotion, Prevention of the disease, Comprehensive Primary Care health, Specialized Healthcare as well as the management of the public health services that it integrates. SMS, through the Mental Health and Drug Addiction network, is the competent entity at the regional level for assistance in Mental Health. Murcia has got the award of “Reference site 3 stars in EIP -AHA” (European Innovation Partnership on Active & Healthy Ageing. Key Staff: Bartolomé Ruiz Periago. Psychologist. Master in Management and Public Administration. Clinical Management in Mental Health. Director of the Center of Attention to People with Intellectual Disabilities Seriously Affected. Head of the Management Service for Specialized Care Centers. Institute of Social Services Region of Murcia. Deputy Director General of Social Services Management. Institute of Social Services Region of Murcia. Jose Martinez Serrano. Psychiatry. Master "Prevention and Treatment of Addictive Behaviors”. Coordinator of the Mental Health Center. Head of Service of the Short Stage Unit of the Psychiatric Hospital (HPRA). Loreto Medina Garrido. Psychiatry. Expert in autolytic behaviors for mental health management and suicide prevention actions. Head of the Suicide Prevention Service at the HPRA and several Health Areas, in charge of training trainers in suicide prevention. Beatriz Martinez-Lozano Aranaga Economist studies in Public Health. Advisor for coordinating European Health issues in the Region of Murcia. Coordinates the EIP in the region, responsible for the EUROEMPLEO-Mental Health program. Affiliated Entities:1. Fundación para la Formación e Investigación Sanitarias de la Región de Murcia/FFIS is a foundation of the public sector, non-profit organization, constituted by the Autonomous Community of the Region of Murcia, which depends on the Ministry of Health of the Region. The profile of the FFIS matched with the proposal through their expertise in management of European projects and his performance in training, and the contribution of this institution will be essential to support activities mainly in management throughout the project development process becoming a support for scientific coordination. It has wide experience in Joint Actions and has performed in them, management, research, promotion and evaluation actions . Besides in other Joint Actions it has participated in the analysis, implementation and evaluation of the implementation of Good Practices. Key Staff: Maria del Pilar López Acuña, Expert in Promotion and Management of International R & D & I Projects and Actions. Public Health. Dentistry and Specialist in Orthodontics and Orthopaedics. In charge of the Direction of the National Cancer Registry of Mexico. Experience in evaluation of healthcare European Project Researcher and Senior Manager of (FFIS/SMS/Consejería de Salud). Researcher in 9 European Projects, 4 of them Joint Actions Research member of the Murcian Institute for Bio Sanitary Research Virgen de la Arrixaca. Designated to the ServicioMurciano de Salud (SMS) to support European health projects i n the Region of Murcia. Rosa Fernández Tarazaga. Master in European Projects management and Search for Grants. Project management technician of European Projects. 2. Consejería de Mujer, Igualdad, LGTBI, Familias y Política Social de la Región de Murcia/CARM Consejería de la Mujer is in charge of proposal, development and execution of the general guidelines of: assistance and social welfare; development community; family and childhood, people with disabilities, old people, personal autonomy and care for people in situations of dependency and risk or exclusion social, it is the institution to coordinate the primary social affairs provided by Councils and Murcia Region. Key Staff: Mercedes Guillén Torres, Social Worker, promoting Social Services and on Europe an operational programs. Working in the Socio-Health Coordination Teams for Attention to people with Serious Mental Disorder. Gloria González Lucas, Adviser on Social Affairs, Law Degree and belongs to the Civil Servant Murcia Region. 3. Servicio Andaluz de Salud / SASis part of the Regional Ministry of Health and Families of Andalusia and is responsible for health care provision in one of the largest regions in Spain. The Regional Mental Health Office coordinates the Comprehensive Mental Health Plan for Andalusia. Its main purpose is to align mental health care services according to mental health needs of people living in the region, improving coordination with social health care and increasing the commitment of health professionals and the general public t o mental health. Key Staff: Manuel Prado Cala. Law. Postgraduate in healthcare management. Currently Director of the Regional Mental Health Office of the Andalusian Health Service (SAS), of the Regional Ministry of Health of Andalusia. It participated as a partner in the Joint Action for Mental Health and Well -being (2013-2016). Evelyn Huizing. 57 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Nurse Specialist in Mental Health. Bachelor of Science in Nursing. Currently Senior Advisor for the Regional Mental Health Office and Coordinator of the European Community based Mental Health Service Providers Network (EUCOMS) of SAS. Partner in the European Regions Enforcing Actions against Suicide project (EUREGENAS). 4. Fundación Pública Andaluza Progreso y Salud/ FPS is a non-for-profit organization which belongs to the Andalusian Regional Ministry of Health and Families. FPS provides services to the Andalusian Public Health System through three lines of activity: R&I, which manages research and innovation in Health; Information and Communication Technologies (ICT) and IAVANTE, which includes training and evaluation of professional expertise. Key Staff: Sonia Basulto Pardo. Economist. Master in European Union Law, Promotion and Management of International Projects by the Polytechnic University of Madrid. More than 15 years working as a financial manager of European projects. Currently working at Fundación Progreso y Salud as project manager. 5. Servicio Navarro de Salud-Osasunbidea/ SNS-O responsibility for health care in the specialty of mental health lies with the Navarra Mental Health Network. Its mission is to promote mental health, prevent mental disorders and associated disability, as well as provide specialized healthcare of quality in mental health to the population of Navarra. Is responsible for the mental health policy and strategy that is explained in Navarra's III Mental Health Plan 2019-2023. This Plan includes different objectives for suicide approach. Key Staff: Adriana Goñi Sarriés. Clinical Psychology. Clinical and management. Responsible for the Community Area and Mental Health Centers. Head of service for the Intermediate Mental Health Resources Area. Belongs to the Interinstitutional Commission on Suicide Prevention. Co-author of the Protocol on the Prevention of Suicidal Behaviors. Chair of the Technical Suicide Working Group. Responsible for the suicide line of inquiry. 6. Servicio Catalán de Salud / CatSalud. The Master Plan for Mental Health and Addictions (PDSMiAd) drawn up in 2006 by the Department of Health of the Generalitat de Catalunya (Catalan government) defined a mental health care model that considered the entire health system from a wide perspective. The Master Plan contributes to the design of policies and implementation of actions for mental health promotion, disease prevention, diagnosis, treatment, rehabilitation, and the social and labour inclusion of affected people, based on evidence, ethics and experience. Key Staff: Jordi Blanch Andreu, MD PhD, psychiatrist, chair of the Master Plan for Mental Health and Addictions, Department of Health, Generalitat de Catalunya. Consultant in Psychiatry, President of the European Association of Psychosomatic Medicine. Researcher in CIBERSAM – Spain. 7. Servicio Vasco de Salud –Osakidetza Is a public entity under private law attached to the De partment of Health of the Basque Government and its purpose is to provide health services to the population through a public, universal and quality health system. It is made up of different organizations that lead the clinical care of people with mental illness in the region. During the last 5 years, Osakidetza has led the development of suicide prevention activities within the territory, including research. Key Staff: AndreaGabilondo Cuéllar. Psychiatrist and researcher at Biodonostia. PhD in Biomedicine Public Health. Master in Mental Health Policies and Services. Experience in the development of programs for the prevention of mental disorders and suicide and in research on the epidemiology of suicide and depression. Participation in different suicide prevention projects in Gipuzkoa Region. Team of the Suicide Prevention Strategy for the Basque Country. 8. ServicioMadrileño de Salud/ SERMAS Madrid Health Department its competences in the matter of education, promotion, prevention and assistance in mental he alth through the Network of Psychiatry and Mental Health Services depending on Madrid Health Service (SERMAS) and the Mental Health Plan. Key Staff: Mª Mercedes Navío Acosta. Psychiatrist. Regional Office of Mental Health and Addictions Coordinator. Central managing of Outpatient Mental Health Care and coordinating Inpatient Psychiatric Services. Head of Action Plan in Mental Health and Suicide Prevention Programs. Beatriz Baón Pérez. Psychiatrist. Regional Office of Mental Health and Addictions Coordinator, belonging to SERMAS. Senior Technical responsible for the development, monitoring and evaluation of Action Plan in Mental Health and Suicide Prevention Programs in adolescents and adults. Collaborative Entities: a) Consejería de Salud (DGPIFyC CARM). The Ministry of Health of the Region of Murcia and the General Directorate of Planning, Research, Pharmacy and Citizen Services, assumes the competences of 58 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Planning and Coordination of Regional Health and Social Health of the Region of Murcia. Key Staff: Jesus Cañavate, General Director, Senior Political and Scientific Officer, is the Chair Manager in charge of the Creation and Implementation of the Socio-sanitary strategy in mental health at the political level of The Area of the Ministry of Health of Murcia Region. b) Instituto Murciano de Acción Social (IMAS).The General Directorate of people with disabilities is responsible for the management of services, canters and programs for the care of people with physical, intellectual or sensory disabilities and chronic mental illness. Key Staff:Catalina Sánchez, Head of the service for people with disabilities. Pedagogy Senior Scientific Officer. Maria Carmen Saura, Department for people with intellectual, physical and serious mental disabilities, Psychology, Scient ific Researcher. Both in charge to support SMS and Consejerías for all the implemental activities in the Mental Health Reform good practice. 21. Sweden – PHAS: The Public Health Agency of Sweden (PHAS) is an expert authority with responsibility for public health issues at a national level. The Agency develops and supports activities to promote health, prevent illness and improve preparedness for health threats. Our mission from the government is also to monitor the health status of the population and the factors that affect this. Important partners are other governmental agencies, regions and municipalities. The PHAS also has in its instruction from the Swedish Parliament the mandate and responsibility to monitor and actively participate in public health work within the European Union (EU) and internationally, and be the national focal point for the EU Health Program/s and Non -Communicable Diseases (NCDs) within the EU since 2014. Within the field of mental health and suicide prevention, the PHAS is responsible for several commissions from the Ministry of Health and Social Affairs. National coordination of suicide prevention in Sweden is one of the main tasks within these commissions. Key Staff: Johanna Ahnquist/female. Johanna Ahnquist, B.A in Sociology, MPH in Public Health, Ph.D. in Social Epidemiology, is head of the Unit for Mental Health, Children and Youth at the PHAS. Johanna has been employed at the PHAS since 2003. She has been head of the unit since 2013. Before 2013, she was responsible for several government commissions e.g., concerning parental support. She has also been responsible for data analysis and literature reviews concerning health inequalities. Johanna has been involved in previous international collaborations, e.g., as expert in the EU Expert Group on Social Determinants and Health Inequalities. Jenny Telander/female. Jenny Telander, B.A. in Social Anthropology, MPH in Health Promotion, is a Public Health Policy Analyst and Project Manager employed at the PHAS since 2007. For the past 6 years she has been working in the field of suicide prevention as National coordinator. 2.8.3. Financial management (proposal section 9.7) The EC financial contribution will be distributed amongst the beneficiaries, based on the allocated budget to each beneficiary for: ● the effort necessary to perform the JA on the implementation of best practices in the area of Mental Health ● travel and subsistence to JA on mental health meetings (GA, WP meetings or workshops) ● logistic costs for the organisation of meetings (catering) ● other costs necessary for perform the WP tasks (printing costs, communication costs) The Coordinating institution, NPHO, has extensive experience in the financial management of research collaborative projects and public health actions (INTEGRATE, EU-JAV, EU-JAMRAI, SHARP). NPHO will perform these tasks through the Coordinator and the financial and project management team of NPHO for the JA ImpleMENTAL. The financial and project management team of NPHO will also provide continuous direct suppo rt to all beneficiaries. It will check all data reported by beneficiaries before submission to the EC. In particular, they will verify: ● the quality and accuracy of financial reports submitted (in relation to the work performed), ● the on time uploading of reports to the participant portal, ● the use of funding according to existing guidelines, ● that costs actually incurred are consistent with those initially budgeted, ● that sufficient justification is provided in case of significant deviation, 59 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ● that the banking information from the beneficiaries is kept up to date. The financial and project management team of NPHO will instruct the beneficiaries on proper time recording practices and prepare comprehensive reporting templates that will be sent to all beneficiaries well before the EC reporting deadline, to allow timely submission of reports. After validation of periodic reports by the EC, distribution of co-funding to beneficiaries will be made by the Coordinator’s financial officer without unjustified delay. Permanent supervision on financial balance of the action will allow the financial and project management team of NPHO to alert promptly the Coordinator and Executive Board as to whether or not resources are being used effectively and efficiently and to give sugge stions and recommendations for proper reactions, such as reallocation between partners or WPs. 2.9. Budget 2.9.1. Content description and justification The EC financial contribution has been carefully distributed amongst the beneficiaries, based on: • th e effort necessary to perform the JA tasks • travel and subsistence to JA meetings (GA, WP meetings or workshops) • logistic costs for the organization of meetings (catering) • other costs necessary for perform the WP tasks such as printing costs or communication costs • other costs necessary for external experts for training and working groups on mental health• other costs for project management software, platform for training, conferences and meetings and the evaluation software. Allocation of effort was categorized based on the level of participation: wpleaders-coleaders, implementing best practices (1 or 2 Best practices), participating in technical wp in SANA and workshops but not implementing a pilot. More specifically: Travel costs for participation in meetings of the various JA bodies (GA, Executive Board, etc.) and of the WPs, in particular the two technical WPs, have been minimized as much as possible and a balanced mix of online and onsite meetings/workshops enabling adequate exchange and interacti on between participating partners, has been envisaged. All meetings taking place in 2021 are planned as online meetings only, principally due to contact and travel restrictions imposed by the Covid-19 pandemic. Within WP5, travel and subsistence costs have been budgeted for following onsite meetings/workshops: • Internal meetings with relevant stakeholders within the participating countries • Four on -site meetings/workshops of all WP5 participating countries in 2022 and 2023 (one person only per country) as part of the activities to be performed under WP5 (any other necessary meeting will be online) • Four on -site training sessions (for two participants per country) as part of task 5.5 on training and capacity building (any other training will be implemented online) • Travel costs for the trainers who will perform the onsite meetings (two trainers for each of the four training sessions) • Three on-site meetings for each of the two WP5 Advisory Groups (for eight experts per group) - three other meetings of the WPAGs will be held online. Within WP 6 besides two online-workshops and three online-trainings travel and subsistence costs have been budgeted for two onsite-workshops and six onsite-trainings. The onsite workshops and training focus on complex strategy developments and practical parts that cannot be developed and discussed in the same quality in an online-format. Nevertheless, these formats will be held online if the epidemiological situation should require it. Allocation of effort was categorized based on the level of participation wp-leaders/co-leaders, wp-task leaders/co-leaders, implementing best practices (1 or 2 Best practices), participating in technical wp in SANA and workshops but not implementing a pilot. More specifically: In WP5 Mental Health Reform the following countries participate under the following categories: -Lead /Implementing: Germany, Colead/ Implementing: Italy -Participating and pilot implementing: Croatia, Cyprus, Estonia, Greece, Hungary, Lithuania, Malta, Slovenia, Spain -Participating not implementing: Bulgaria, France, Serbia In WP6 suicide prevention the following countries are participating under the following categories: -Lead /Implementing: Austria, Colead/ Implementing: Czechia 60 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 -Participating and pilot implementing: Croatia, Cyprus, Estonia, Finland, Greece, Hungary, Iceland, Malta, Norway, Slovenia, Spain, Sweden. -Participating not implementing: Bulgaria, Lithuania, Serbia Budget was first discussed individually with WP leaders through mail discussions. WP l eaders work on the allocation of effort for each task and an estimated budget where formulated using the average monthly cost of each applicant and the indicated effort as well as the all costs in budget category C (only in exceptional cases category b costs are accommodated). WP leaders recognized the effort needed for horizontal package work and allocated effort and travel costs to all applicants for the work in all horizontal wps (wp1, wp2, wp3, wp4). An estimated overall budget was then sent to all applicants (applicants are the competent authorities who are responsible for providing a country level budget which incorporate the effort and costs of the competent authority and the affiliated entities) with: • The indicative Person-Month per applicant (one country budget for competent authority and affiliated entities) per WP and the associated tasks • Number of meetings/workshops expected to take place during the project (when possible, we have tried to combine WP workshops with annual General Assembly mee tings to minimize travel costs). • Allocation of other costs for other goods and services including allocation for printing, translation, within country meetings and evaluation software licenses. Applicants took these estimations into account to calculate their travel and subsistence costs, according to their involvement in each of the WPs and all agreed to the allocation of effort estimated by the wp leaders/ co leaders• Personnel costs represent the highest cost item (75,6%). Most of the effort (>50%), an d thus most of the JA costs, concentrates on the two technical work packages (wp5 & wp6): Other Direct Costs in wp1 are mainly allocated to travels for governance structure meetings (annual meetings, executive board meetings and Member State Policy committee meetings) and most direct costs in wp2 are allocated to the travel costs for attending the final conference. 61 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 2.9.2 Summary of Effort Per Beneficiary WP1 WP2 WP3 WP4 WP5 WP6 TotalPMs Per Country 1.GREECE 1.NPHO 93,00 7,00 14,00 11,50 23,00 12,00 160,50 2.AUSTRIA 2.BMSGPK 2,00 3,50 10,35 7,00 0,00 35,81 58,66 3.BULGARIA 3. NCPHA 1,00 1,50 0,00 2,50 10,50 4,00 19,50 4.CROATIA 4.CIPH 2,00 33,00 10,60 11,50 21,13 11,85 90,08 5.CYPRUS 5.MHS SHSO 1,00 2,00 9,20 7,00 21,13 11,85 52,18 6.CZECHIA 6. MoHCZ 2,00 3,50 10,00 7,00 0,00 23,00 45,50 7.ESTONIA 7. MSAE 1,00 2,00 9,80 7,00 21,10 11,75 52,65 8.FINLAND 8.THL 1,00 1,00 5,00 4,00 0,00 9,50 20,50 9.FRANCE 9. FR-MOH 1,00 1,50 0,00 1,50 10,00 0,00 14,00 10.GERMANY 10. BzgA 2,00 3,50 10,70 7,00 53,13 0,00 76,33 11.HUNGARY 11. OKFO 2,00 26,50 11,90 34,50 21,13 11,85 107,88 12.ICELAND 12. DOHI 1,00 1,50 5,40 4,00 0,00 11,85 23,75 13.ITALY 13. LR 1,50 3,15 10,00 9,75 44,20 0,00 68,60 14.LITHUANIA 14. SAM 1,00 1,50 5,40 4,50 21,13 3,84 37,37 15.MALTA 15. MHS 1,00 2,00 7,00 4,00 20,50 12,00 46,50 16.NETHERLANDS 16.TRIMBOS 2,00 3,50 22,05 16,00 1,50 0,00 45,05 17.NORWAY 17. HDIR 1,00 1,50 5,40 3,00 0,00 11,85 22,75 19.SERBIA 18. IPHS 1,00 1,50 0,00 2,50 10,25 3,84 19,09 19.SLOVENIA 19. NIJZ 2,00 2,00 9,80 7,00 21,13 11,85 53,78 20.SPAIN 20. SMS 2,00 2,00 17,50 7,00 22,13 12,35 62,98 21.SWEDEN 21. PHAS 1,00 2,00 5,00 3,00 0,00 11,00 22,00 Total per WP 121,50 105,65 179,10 161,25 321,96 210,19 1.099,65 62 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Summary of Effort Per Beneficiary and Affiliated entity (CA and AE) Country ShortName WP1 WP2 WP3 WP4 WP5 WP6 Total PMs per CA and AE 1.GREECE NPHO 93,00 7,00 14,00 11,50 23,00 12,00 160,50 2.AUSTRIA BMSGPK 0,00 0,00 0,00 0,00 0,00 0,00 0,00 2.1.AUSTRIA GÖG 2,00 3,50 10,35 7,00 0,00 35,81 58,66 3.BULGARIA NCPHA 1,00 1,50 0,00 2,50 10,50 4,00 19,50 4.CROATIA CIPH 2,00 33,00 10,60 11,50 21,13 11,85 90,08 5.CYPRUS MHS CYPRUS 1,00 2,00 9,20 7,00 21,13 11,85 52,18 6.CZECHIA MZCR 1,00 2,00 3,00 2,00 0,00 8,00 16,00 6.1. CZECHIA NIMH 1,00 1,50 7,00 5,00 0,00 15,00 29,50 7.ESTONIA MSAE 1,00 2,00 9,80 7,00 21,10 8,25 49,15 7.1. ESTONIA NIHD 0,00 0,00 0,00 0,00 0,00 3,50 3,50 8.FINLAND THL 1,00 1,00 5,00 4,00 0,00 9,50 20,50 9.FRANCE MOH-FRANCE 1,00 1,50 0,00 0,75 6,75 0,00 10,00 9.1. FRANCE INSERM 0,00 0,00 0,00 0,75 3,25 0,00 4,00 10.GERMANY BZgA 2,00 3,50 10,70 7,00 53,13 0,00 76,33 11.HUNGARY OKFO 1,00 8,50 3,65 14,75 4,00 3,35 35,25 11.1. HUNGARY SU 0,50 16,00 0,50 14,75 4,00 0,50 36,25 11.2. HUNGARY UD 0,50 2,00 7,75 5,00 13,13 8,00 36,38 12.ICELAND DOHI 1,00 1,50 5,40 4,00 0,00 11,85 23,75 13.ITALY LR 0,50 0,00 0,00 0,50 1,00 0,00 2,00 13.1. ITALY ASST LECCO 0,50 1,00 2,00 1,75 7,90 0,00 13,15 13.2. ITALY UNIMIB 0,00 1,00 1,00 3,50 7,90 0,00 15,30 13.3. ITALY MNIPR 0,00 0,00 2,00 1,00 9,80 0,00 10,50 13.4. ITALY POLIMI 0,50 0,65 1,50 3,00 7,50 0,00 15,75 13.5. ITALY FBF 0,00 0,50 3,50 0,00 10,10 0,00 11,90 14.LITHUANIA AM 1,00 1,50 5,40 4,50 21,13 3,84 37,37 15.MALTA MFH 1,00 2,00 7,00 4,00 20,50 12,00 46,50 16.NETHERLANDS TRIMBOS 2,00 3,50 22,05 16,00 1,50 0,00 45,05 17.NORWAY HDIR 1,00 1,50 5,40 3,00 0,00 11,85 22,75 18.SERBIA IPHS 1,00 1,50 0,00 2,50 10,25 3,84 19,09 19.SLOVENIA NIJZ 2,00 2,00 9,80 7,00 21,13 11,85 53,78 20.SPAIN SMS 1,00 0,25 2,50 1,80 9,50 3,85 18,90 20.1. SPAIN FFIS 1,00 0,70 11,50 1,35 4,13 0,50 19,18 20.2. SPAIN CATSALUT 0,00 0,15 0,50 0,55 3,50 0,00 6,20 20.3. SPAIN CONSEJ-MUJER 0,00 0,15 0,50 0,55 5,00 1,50 2,70 20.4. SPAIN SAS 0,00 0,15 0,50 0,55 0,00 0,50 1,70 20.5. SPAIN FBS 0,00 0,15 0,50 0,55 0,00 1,50 2,70 20.6. SPAIN SERMAS 0,00 0,15 0,50 0,55 0,00 1,50 6,20 20.7. SPAIN SNS-O 0,00 0,15 0,50 0,55 0,00 1,50 2,70 20.8. SPAIN OSAKIDETZA 0,00 0,15 0,50 0,55 0,00 1,50 2,70 21.SWEDEN FOHM/PHAS 1,00 2,00 5,00 3,00 0,00 11,00 22,00 Total Person - Months per WP 121,50 105,65 179,10 161,25 321,96 210,19 1.099,65 2.9.3 Third-Party Contributions No third-Party Contributions declared. 63 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 2.9.4. Detailed budget (proposal section 10.3) 1.NATIONAL PUBLIC HEALTH ORGANISATION- NPHO Applicant No. & Short Name (Coordinator)-Greece (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) Months WP1. Head Scientific Officer/JA Coordinator € 3.214,81 12,00 38.577,72 € WP1. Senior Scientific Officer A € 2.792,72 4,00 11.170,88 € WP1.Junior Scientific Officer € 1.803,91 4,00 7.215,64 € WP1.Professor/Senior Researcher € 4.000,00 3,00 12.000,00 € WP1.Researcher/Scientific Officer 00222022 € 4,00 8.000,00 € WP1.Legal Officer € 2.642,00 3,00 7.926,00 € WP1.Chief Financiial Officer € 3.064,87 3,00 9.194,61 € WP1.Financial Officer B € 2.000,00 18,00 36.000,00 € WP1.Financial Officer A € 2.457,00 2,00 4.914,00 € WP1.Project Manager (Assistant to the Coordinator) € 2.200,00 36,00 79.200,00 € WP1. Communication Officer € 1.800,00 4,00 7.200,00 € WP2.Head Scientific Officer/JA Coordinator € 3.214,81 1,00 3.214,81 € WP2. Senior Scientific Officer A € 2.792,72 2,00 5.585,44 € WP2.Communication Officer € 1.800,00 4,00 7.200,00 € WP3.Head Scientific Officer/JA Coordinator € 3.214,81 3,00 9.644,43 € WP3.Senior Scientific Officer A € 2.792,72 3,00 8.378,16 € WP3.Junior Scientific Officer € 1.803,91 4,00 7.215,64 € WP3.Researcher/Scientific Officer € 2.000,00 4,00 8.000,00 € WP4. Head Scientific Officer/JA Coordinator € 3.214,81 3,00 9.644,43 € WP4. Senior Scientific Officer A € 2.792,72 3,00 8.378,16 € WP4. Junior Scientific Officer € 1.803,91 1,50 2.705,87 € WP4. /Senior Researcher € 4.000,00 3,00 12.000,00 € WP4. Researcher/Scientific Officer € 2.000,00 1,00 2.000,00 € WP5.Head Scientific Officer/JA Coordinator € 3.214,81 2,00 6.429,62 € WP5.Senior Scientific Officer A € 2.792,72 6,00 16.756,32 € WP5.Junior Scientific Officer € 1.803,91 5,00 9.019,55 € WP5.Professor/Senior Researcher € 4.000,00 5,00 20.000,00 € WP5.Researcher/Scientific Officer € 2.000,00 5,00 10.000,00 € WP6.Head Scientific Officer/JA Coordinator € 3.214,81 1,00 3.214,81 € WP6.Senior Scientific Officer A € 2.792,72 3,00 8.378,16 € WP6.Junior Scientific Officer € 1.803,91 2,00 3.607,82 € WP6.Professor/Senior Researcher € 4.000,00 3,00 12.000,00 € WP6.Researcher/Scientific Officer € 2.000,00 3,00 6.000,00 € Total costs (€) Total Person-month for (A) Average monthly costs: 160,50 400.772,07 € 64 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Justification Scientific Officers will be involved in coordination WP1 Dissemination WP2 (, Evaluation WP3 and Sustainability activities WP4. The two Officers will participate in all activities, meetings and training in WP5 and implement the best practice. They will also participate in WP6 ,activities meeting and trainings The Administrative and/or Financial Officer will be responsible for financial management, administration and reporting in all WPs. Concluding, each officer will work In total: Head Scientific Officer/ Ja Coordinator (22PM), Senior Scientific Officer A (21,5PM), Junior Scientific Officer (16,5PM), Professor/Senior Researcher (14PM),Researcher/Scientific Officer (17PM),Chief Financial Officer (3PM),Financial Officer A (2PM),Financial Officer B (18PM),Legal Officer (3PM),Project Manager (Assistant to the Coordinator) (36PM), Communication Officer (8PM) (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00 Justification (C) Other Direct costs (C.1) Travel for ONSITE MEETINGS Costs (€) Justification WP1. Travel and subsistence for participation in (on- 2 meetings x 6 persons x 1.000€ site) annual Consortium /GA meetings in M12 & 12.000,00 € Member State Committee Delegate (1) & M24 Coordination Team (5 persons)) WP1. Annual meetings, implementers (1 for each 2 meetings x 2 persons (1 implementer 4.000,00 € best practice) in M12 & M24 per each BP) x 1.000€ WP1. Executive board meetings back to back to 2 meetings x 4 persons (to 2 extra nights) Annual Consortium/GA Meetings in M12 & M24 4.000,00 € x 500€ WP1. Coordinator attendance of European events 5 meetings x 1X persons X 1.000€ related to Mental Health to disseminate and 5.000,00 € communicate about the Joint Action WP1.Travel and subsistence costs of the Coordinator 7 meetings x 1 person X 1.000€ to attend meetings and workshops of the Joint 7.000,00 € Action WP1. Other staff of NPHO scientific team, attendance at European events related to Mental 3.000,00 € 3 meetings x 1 person X 1.000€ Health to disseminate and communicate about the Joint Action WP1. Participants of Stakeholder forum members. 2 meetings x 7 persons (Members of Travel and subsistence for participation in Annual Stakeholder forum) x 1.000€ 20.000,00 € Consortium meetings: in M12 & M24 & M36 1 meeting x 6 persons (Members of Stakeholder forum) x 1.000€ WP 5 Travel and subsistence costs for Participations of stakeholders of WP5 in 2.000,00 € meetings/workshops with stakeholders within meetings and workshops within the 65 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 countries country approx. 3 meetings with stakeholders in Greece 6 persons per meeting). Travel and subsistence costs of EUR 100 per person. Participation of 1 staff member in 4 WP5. Travel and subsistence costs -European level 4.000,00 € (onsite) 2-days WP workshops in 2022 & 2023 WP5. Travel and subsistence costs of participants to 2 persons per country participating in 8.000,00 € 4 on-site training- European level WP5 on site training : 2 x 4 X 1.000€ WP6. Travel and subsistence costs for 2 workshops - 1 person x 2 travels X 1.000€ 2.000,00 € European level WP6. Travel and subsistence costs for training - 4.857,00 € 1 person x 6 trainings European level Total C.1 Travel: 75.857,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification WP1- Financial costs 7.000,00 € Certificate of Financial Statement WP1. Translation and english proof reading 5.000,00 € quality of deliverables WP1. Costs for webex platform 5.000,00 € Teleconferences /meetings/conferences WP1. Project Management Platform 18.000,00 € 25 users x36 months x18 -20 €per user WP1. Print/publications 3.000,00 € WP1. Renting of venue for Member State Policy Committe incl. technical equipment (2 days) in M30 1.500,00 € 1 meeting x 2-days = 1.500€. The meeting wil ltake place in Athens. WP1.Catering costs Member State Policy committee 3.200,00 € meeeting in M30 40 personsX2 daysx40 euros per person WP2. 0rganizational costs for Annual Costs of renting the venue+ Technical 7.000,00 € Consortium(Final conference ) /GA Meeting in M36 equipment + catering WP2. Translation of dissemination materials 1.500,00 € translation of JA dissemination materials WP3. Costs evaluation software (WP3) 500,00 € User licences esp. for training curricula/materials, WP5. Translation and proof reading 2.142,43 € training tools, reports, other country- specific materials. WP5 Costs of meetings/workshops within countries 1.500,00 € Costs of renting the venue + catering WP6. Costs of meetings/workshops within countries 1.050,00 € Costs of renting the venue + catering 56.392,43 € Total Costs of C.2 Other goods and services Total Costs (€) of (C) 132.249,43 Total Costs (D) Indirect costs (€) (Max 7% on A, B, and C) 37.311,50 Flat rate of 7% on A, B, and C. Total estimated eligible costs 570.333,00 0 66 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 2. AUSTRIAN FEDERAL MINISTRY OF SOCIAL AFFAIRS, Applicant No. &Short Name HEALTH, CARE AND CONSUMER PROTECTION -BMSGPK– AUSTRIA (If affiliated entity: Affiliated to which Applicant number/Short name) Total estimated eligible costs=0 € All budgets for Austria will be included to the affiliated entity of BMSGPK (2.1. GÖG). Please see the detailed budget of GÖG). “The travel/accommodation costs of the representative of the ministry will be billed through GÖG.” “There are no further PMs foreseen as SUPRA (and in direct connection this JA) is conducted by GÖG on behalf of the ministry and it is part of the regular job of the ministry’s representative to be informed and involved in all actions of SUPRA. 2.1.GÖG- Gesundheit Österreich GmbH - Austrian National Applicant No. &Short Name Public Health Institute- AUSTRIA (If affiliated entity: Affiliated to which 2.BMSGPK-AUSTRIA Applicant number/Short name) (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Senior mental Health Expert, head of 19,66 168.908,89 € department € 8.591,50 Senior Health Expert € 7.543,99 19,50 147.107,81 € Mental Health Expert € 6.964,67 19,50 135.811,07 € Total costs (€) Total Person-month for (A) Average monthly costs: 7.700,05 € 58,66 451.827,76 € Justification one head of department and two health experts: lead and coordination of WP6 (B) Direct costs of Subcontracting Costs (€) Task(s) justification Costs of Sub-contracting 14.400,00 € 2 external experts for 9 trainings, 800.- for each per training (1,5 days) TotalCosts (€) of (B) 14.400,00 Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification WP1.Travel and subsistence for € 4.000,00 2 meetings x 2 persons x 1.000€. participation in (on-site) Annual During these Annual Consortium Consortium/General Assembly (GA) Meetings, the meeting of the MS Policy 67 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 meetings in M12 & M24 Committee will be held. Participation of Member State Policy Committee Delegate (Federal MoH Austria) & GÖG WP1.Participation of pilot implementers of € 2.000,00 Participation of staff member of pilot WP6 in the annual Consortium implementers in 2 Consortium meetingsM12 & M24 meetings = 2 meetings x 1 person x 1.000€ WP1. Executive board meetings back to € 2.000,00 2 persons X 2 extra nights X2 annual back to Annual Consortium/GA Meetings in meetings x250 € per extra night M12 & M24 subsistence WP1. Travel and subsistence for € 1.000,00 Participation of 1 staff member 1 participation in Member States Policy meeting Committee meeting in M30: Participation of = 1 person x 1.000€ staff member from Federal MoH Austria delegate (in 1 meeting co-organized with WP4) Wp1.Travel and subsistence for € 2.000,00 Participation of 2 staff members in 1 participation in Member States Policy meeting Committee meeting in M30 in Athens. = 2 persons x 1.000€ Participation of WP leaders (GÖG staff members ) in 1 meeting co-organized with WP4 in M30 WP1.ExB meeting in M30. Participation of € 1.000,00 1meeting X2 persons X2 extra nights GÖG staff members (meeting back-to-back x250 € per extra night subsistence with the MS Policy Committee meeting) Wp2.Travel and subsistence for participation in Annual Consortium/GA 3 persons x 1.000€ /Final Conference meeting in M36: Participation Member State Policy Committee Delegate (Federal MoH Austria) & GÖG € 3.000,00 Wp2,Travel and subsistence for WP(co-) 2 extra persons x 1 travel for each WP Leading countries: Participation of staff (co)leader members/stakeholders € 2.000,00 WP2, Participation in Annual Consortium/ Participation of 1 staff member Final Conference meeting in M36 = 1 person x 1.000€ Participation of staff members from pilot practice implementers € 1.000,00 ExB meeting in M36 back to back to Final € 1.000,00 2 persons 2 extra nights x250 € per conference/extra costs extra night subsistence WP6. Travel and subsistence costs for WP for 2 persons (2 workshops and 6 lead € 16.000,00 trainings) WP6. Travel and subsistence costs for 2 1 person for 2 workshops workshops for implementing countries € 2.000,00 WP6. Travel and subsistence costs for 6 6 trainings for implementing countries trainings for implementing countries € 4.857,00 for 2 persons Total C.1 Travel: 41.856,57 € (C.2) Equipment Costs (€) Justification 68 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 - (C.3) Other Goods and Services Costs (€) Justification Translation of dissemination materials Translation of JA dissemination materials € 2.000,00€ Costs evaluation software (WP3) 500,00 € User license Travel and subsistence costs for external 6 trainings with 2 external experts in experts € 12.000,00 2022 and 2023 Catering workshops € 2.000,00 1.000 per workshop Catering trainings € 2.400,00 400 per training Room rent € 4.000,00 English proof reading of deliverables 3.000,00 € Print/publications 1.500,00 € Certificate on financial statements € 3.000,00 WP6Costs of stakeholder meetings/workshops within Austria :Renting Costs of renting the of venue incl. technical equipment € 1.000,00 venue WP6 Costs of stakeholder meetings/workshops within Austria :catering € 500,00 Costs of catering Total Costs of C.2 Other goods and services 31.900,00 € Total Costs (€) of (C) 73.756,57€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 37.798,91€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 577.783,24€ 69 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 3. NCPHA - NATIONAL CENTER FOR PUBLIC HEALTH AND Applicant No. &Short Name ANALYSIS BULGARIA (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Staff function Monthly Estimated Sum Cost (€) Cost Person-month Head of Department 1.700,00 € 5,75 9.775,00€ Senior Scientific Officer 1.400,00 € 9,25 12.950,00€ Administrative and/or Financial Officer 1.100,00 € 4,50 4.950,00€ Others: Total costs (€) Total Person-month for (A) Average monthly costs: 1.400,00 € 19,50 27.675,00€ Justification Participation in: WP1:1 PM; WP2: 1,5PM; WP3: 0 PM, WP4:2,5 PM, WP5: 10,5 PM, WP6: 4 PM Bulgaria will participate in Situation Analysis & Needs Assessment as well as training activities in WP5 &WP6, in dissemination activities (WP2), and in policy dialogues and sustainability planning (WP1&WP4). (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€)Justification 2 meeting x 2 persons x 1.000€ Participation of Member State Policy WP1 Travel and subsistence for Committee Delegate Ministry of participation in (on-site) Annual Consortium 4.000,00 € Bulgaria& Competent Authority NCPHA General Assembly (GA) meetings in M12 Meetings of the MS Policy Committee and M24 will be held in a dedicated session of the Annual Consortium Meetings WP1 Participation of staff member from MoHBulgaria in themeeting of the Participation of 1 staff member 1 Member State Policy Committee in Athens 1.000,00 € meeting in M30. This meeting is organized by WP1 in = 1 person x 1.000€ collaboration with WP4 3 persons x 1.000€ WP2 Travel and subsistence for Participation Member State Policy participation in Annual Consortium/ (GA) / 3.000,00 € Committee Delegate & Competent Final Conference in M36 Authority WP5 Stakeholder meetings/workshops 1.000,00 € Participations of stakeholders of WP5 in within Bulgaria meetings and workshops within the 70 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 country approx. 3 meetings with stakeholders (3 persons per meeting). Travel and subsistence costs of EUR 100 per person. WP5 Four on-site workshops (2022 & 2023) 4.000,00 € Participation of staff members in 4 on- (In 2021 only virtual/online workshops) - site workshops = 4 workshops x 1.000€ European Level WP5 Four on-site training sessions- 8.000,00 € Participation of 2 persons in 4 on-site European Level training WP6 Travel and subsistence costs for 2 2.000,00 € 2 workshopsX1 workshops -European Level person WP6 Travel and subsistence costs for 6 trainings for 2 persons -European Level 4.857,00 € 6 trainings X 2 persons average Total C.1 Travel: 27.857,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification Translation of JA dissemination 2.000,00 € WP2 Translation of dissemination materials materials WP5 Renting of venue incl. technical equipment for within the country meetings 500,00 € Costs of renting the venue Wp5.Catering for within the country meetings 230,00 € Costs of catering WP5.Translation and proofreading: esp. for training curricula/materials, training tools, 2.142,43 € reports, other country-specific materials. WP6. Costs of meetings/workshops within countries 1.050,00 € Costs of renting the venue + catering Total Costs of C.2 Other goods and services 5.923,00 € Total Costs (€) of (C) 33.780,00€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 4.301,85€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 65.756,85€ 71 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Applicant No. &Short Name 4. CIPH- CROATIAN INSTITUTE OF PUBLIC HEALTH -CROATIA (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Staff function Monthly Cost Estimated Sum Cost (€) Person-month Senior Scientific Officer/lead € 3.375,34 17,00 57.380,72 Senior Scientific Officer € 4.340,49 19,00 82.469,33 Senior Scientific Officer €3.750,37 18,00 67.506,74 Junior Scientific Officer €1.656,24 6,98 11.552,27 Junior Scientific Officer €1.640,08 9,00 14.760,72 Junior Scientific Officer €1.656,24 7,00 11.593,67 Junior Scientific Officer/Project manager €2.035,26 10,00 20.352,6 Administrative Officer € 1.514,40 3,10 4.694,65 Total Total Costs (€) for Person month (A) 90,08 270.310,67 Justification WP1: Coordination at MS level, reporting, participation in relevant steering and management bodies and activities; WP2: Leader of WP2, reporting, leader of Task 2.1, 2.4, 2.6 and 2.7, participation in the tasks of WP2; WP3: Participation in WP3 activities; WP4: Participation in WP4 activities; WP5: Implementation of the knowledge transfer at MS level, reporting, participation in WP5; WP6: Implementation of the knowledge transfer at MS level, reporting, participation in WP6. (B) Direct costs of sub-contracting Costs Task(s)/Justification (€) N/R €0 N/R Total Costs (€) of (B) €0 (C) Other direct costs (C.1) Travel Costs (€) Justification Wp1 Travel and subsistence for € 2.000,00 1 meetings x 2 persons x 1.000€ participation in (on-site) annual Consortium/ General Assembly (GA) meetings: Participation of Member State Committee Delegate & Competent Authority (Annual Consortium meetings will be organized by WP1 in collaboration with HR and HU, in Croatia M12 and Hungary M24. So for Croatia travel costs are included only for the meeting in Hungary ) WP1 Participation of pilot implementers € 2.000,00 Participation of staff member of pilot implementers 72 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 of 2 Best Practices in 2 Annual Consortium meetings = 2 meetings x 2 persons per meeting) x 1.000€ WP1 Participation of pilot implementers € 1.000,00 Participation of 1 extra staff member of pilot implementers in Annual Consortium meeting in Hungary = 1 meeting x 1person x 1.000€ WP1 Annual Meetings / extra costs for € 1.000,00 2 persons X 2 extra nights X1 annual meeting in back to back executive board meeting in Hungary x250 € per extra night subsistence Hungary WP1 Participation of CA staff members € 1.000,00 2 persons X 2 extra nights x250 € per extra night (in 1 meeting back-to-back with the MS subsistence Committee meeting) M30 for attending the ExB meeting WP1 Travel and subsistence for € 2.000,00 Participation of 2 staff members in 1 meeting participation in Member States = 2 persons x 1.000€ Committee meeting: Participation of staff members (in 1 meeting co-organised with WP4 meeting) M30 WP1 Participation of member State € 1.000,00 Participation of 1 staff member in 1 meeting Committee delegate (in 1 meeting co- = 1 person x 1.000€ organised with WP4 meeting ) WP2 Travel and subsistence for participation in Annual Consortium 3 persons x 1.000€ Meetings/ Final Conference: € 3.000,00 Participation Member State Committee Delegate & Competent Authority WP2 Participation of staff 2 extra persons x 1 travel for each WP (co) leader € 2.000,00 members/stakeholders WP2 Final conference/extra costs for € 1.000,00 2 persons X 2 extra nights x250 € per extra night back to back executive board meetings subsistence WP2 Participation of staff members from € 2.000,00 Participation of 2 staff member pilot practice implementers in Final Conference M36 WP2 Invitation of european level € 8.000,00 Invitation of 8 stakeholders in final conference 8 stakeholders in Annual consortium persons x 1000€ x 1 meeting meeting /Final Conference M36 WP2 Attending dissemination conferences € 4.000,00 2 persons x 2 travels X100 euros WP5 Stakeholder meetings/workshops 3 meetings X 6 stakeholders x 100euros per within Croatia € 2.000,00 partcipant WP5 Four on-site workshops (2022 & Participation of staff members in 4 on-site 2023) (In 2021 only virtual/online workshops = 4 workshops x 1.000€ workshops) € 4.000,00 WP5 Four on-site training sessions Participation of 2 persons in 4 on-site trainings € 8.000,00 = 2 persons x 4 sessions x 1.000€ WP6 Travel and subsistence costs for 2 workshops for implementing countries € 2.000,00 2 workshops X1 person X1000 euros WP6 Travel and subsistence costs for 6 trainings for implementing countries for 2 persons € 4.856,57 6 trainings x1 person 73 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Total C.1 Travel: 50.856,57 € (C.2) Equipment Costs (€) Justification € 0,00 N/R (C.3) Other goods and services Costs (€) Justification WP1 3.000,00 € Certificate of Financial statement WP2 Dissemination materials design and print 2.600,00 € WP2 Visual design and website development 2.600,00 € WP2 Co-organization of Annual meeting M12 in Croatia 2.600,00 € WP2 Translation of the dissemination materials 2.000,00 € WP2 co -0rganization of Final conference M36 Athens 2.000,00 € WP3 Costs evaluation software (WP3) 500,00 € user license Translation and proof reading): esp. for training curricula/materials, training tools, reports, other WP5 2.142,86 € country-specific materials. WP5 Costs of meetings/workshops 1.500,00 € Costs of renting the venue + catering within countries WP6 Venue & Catering 1.050,00 € renting venue and catering costs Total Costs of C.2 Other goods and 19.992,86 € services Total Costs (€) of (C) 70.849,43 (D) Indirect Costs Total Costs (€) (Max. 7% on A, B and C) 23.881,21€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 365.041,31€ 74 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 5.MENTAL HEALTH SERVICES DIRECTORATE- MHS Applicant No. & Short Name CYPRUS (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Staff function (Please repeat line for each staff function Estimated Person- Monthly Cost Sum Cost (€) category. You do not need to fill staff names month here) Senior Scientific Officer - MHS SHSO € 4.672 14,75 68.910,82 € Senior Scientific Officer - MHS SHSO € 4.672 14,15 66.107,67 € Senior Scientific Officer - MHS SHSO € 4.672 11,55 53.960,68 € Head Officer - MHS SHSO € 7.949 11,73 93.207,18 € Total costs (€) Total Person-month for (A) Average monthly costs: 7.321,73 € 52,18 282.186,35 € Justification 382.011,44 € Scientific Officers will be involved in coordination WP1 Dissemination WP2, (Evaluation WP3 and Sustainability activities WP4. The two Officers will participate in all activities, meetings and training in WP5 and implement the best practice. They will also participate in WP6 ,activities meeting and trainings The Administrative and/or Financial Officer will be responsible for financial management, administration and reporting in all WPs (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00 Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification 2 meetings x 2 persons x 1.000€ WP1 Annual Consortium /GA meetings,M12 & During these Annual Consortium 4.000,00 € M24. Meetings, the meeting of the MS Policy Committee will be held. WP 1 Annual Consortium meetings, 2 meetings x 2 persons (1 for each best 4.000,00 € implementers in M12 & M24 practice) x 1.000€ WP1 Participation of staff member from MoH in 1 meeting of the Member State Policy 1.000,00 € Participation of 1 staff member 1 meeting Committee. This meeting is organized by WP1 in collaboration with WP4 in M30 3 persons x 1 meeting x 1.000€ WP2 1 meeting: Annual Consortium (Final 3.000,00 € Member State Policy Committee Conference) /GA meetings M36 Delegate (1) & Competent Authority (2) 75 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 WP2 Final Conference, implementers (1 for 2 persons x 1 travel for each 2GP 2.000,00 € each best practice) M36 implementer Meetings and workshops for country stakeholders involved in pilot WP 5 Travel and subsistence costs for implementation approx. 3 meetings with meetings/workshops with stakeholders within 2.000,00 € stakeholders in Germany (6 persons per countries meeting). Travel and subsistence costs of EUR 100 per person. WP5 Travel and subsistence costs of 4 (onsite) 2-days WP workshops in 2022 4.000,00 € participating countries for participation in… & 2023 WP5 Travel and subsistence costs of 2 persons per country participating in 8.000,00 € participants to 4 on-site training WP5: 2 x 4 WP6 Travel and subsistence costs for 2 2.000,00 € 1 person x 1 travel workshops for implementing country 6 trainings for implementing countries WP6 Travel and subsistence costs for 4.857,00 € for 2 persons Total C.1 Travel: 34.857,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification Cost for certificate for financial WP1–Financial Costs 3.000,00 € statements WP2 2.000,00 € Translation of dissemination materials WP3 Costs evaluation software (WP3) 500,00 € User licences esp. for training curricula/materials, WP5 Translation and proof reading 1.946,15 € training tools, reports, other country- specific materials. WP5 Costs of meetings/workshops within 1.500,00 € Costs of renting the venue + catering countries Costs of renting the WP6 Venue & Catering 1.050,00 € venue + catering Total Costs of C.2 Other goods and services 9.996,15 € Total Costs (€) of (C) 44.853,15 (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 22.892,77 Flat rate of 7% on A, B, and C. Total estimated eligible costs 349.932,27 76 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 6. MINISTRY OF HEALTH OF THE CZECH REPUBLIC-MZCR Applicant No. &Short Name CZECHIA (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Staff function Estimated Monthly Cost Sum Cost (€) Person-month Senior Scientific Officer MoHCZ 5.475,00 6,00 32.850,00 € Junior Scientific Officer MoHCZ 4.295,00 4,00 17.180,00 € Administrative and/or Financial Officer MoHCZ 2.056,21 6,00 12.337,26 € Total Person- Total costs month (€) for (A) Averagemonthlycosts: 3.256,67 € 16,00 62.367,26 € Justification Co-leading of WP6; participating also partly in horizontal WPs 1-4. Two senior scientific officer positions, one junior scientific officer and administrative/financial officer support (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Travel and subsistence for participation in (on- 1.000,00 € 1 meeting x 1 person x 1.000€ site) annual General Assembly (GA) meetings: Participation of Member State Committee Delegate & Competent Authority Participation of pilot implementers 1.000,00 € Participation of staff member of pilot implementers in 1 GA meetings = 1 meeting x 1 person x 1.000€ Annual Meetings / extra costs for back to back 1.000,00 € 2 persons X 2 extra nights X1 executive board meetings annual meeting x250 € per extra night subsistence Participation of executive board members from 500,00 € 1 person X 2 extra nights x250 € Czechia (in 1 meeting back-to-back with the MS per extra night subsistence Committee meeting) M30 Travel and subsistence for participation in 1.000,00 € Participation of 1 executive board Member States Committee meetings: member from Czechia in 1 Participation of staff members (in 1 meeting co- meeting organized with WP4 in M30) = 1 person x 1.000€ 77 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Participation of staff member from MoHCZ (in 1 1.000,00 € Participation of 1 staff member 1 meeting co-organized with WP4 meeting ) meeting = 1 person x 1.000€ Travel and subsistence for participation in Final 1.000,00 € Conference: 1 person x 1.000€ Participation Member State Committee Delegate & Competent Authority Participation of staff members/stakeholders 1.000,00 € 1 extra person x 1 travel for each WP (co-) leader Final conference/extra costs for back to back 500,00 € 1 person X 2 extra nights x250 € executive board meetings per extra night subsistence 1.000,00 € Travel and subsistence costs for 1 workshop for implementing countries for 1 person (14 Traveltoworkshops countries) 2.000,00 € Travel and subsistence costs for 2 trainings for implementing countries for 2 persons (1/3 of 15 Traveltotrainings countries) 2.523,24 € Czechia is co-leader of WP6 and with that function, extra travels are anticipated on the basis of Travel expenses for co-leaders the previous experience Total C.1 Travel: 13.523,24 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification 500,00 € Costs evaluation software (WP3) User licence WP6 Venue & Catering Meetings within the Costs of renting the venue + country 1050,00 € catering Total Costs of C.2 Other goods and services 1.550,00 € Total Costs (€) of (C) 15.073,24€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 5.420,84€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 82.861,34€ 78 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 6.1 NATIONAL INSTITUTE FOR MENTAL HEALTH- NIMH Applicant No. & Short Name CZECHIA (If affiliated entity: Affiliated to which 6. MZCR Applicant number/Short name) (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month NIMH Senior Scientific Officer 5.475,00€ 15,00 82.125,00 € NIMH Junior Scientific Officer 4.295,00€ 10,50 45.097,50 € NIMH Administrative and/or Financial Officer 2.056,21€ 4,008.224,84 € Totalcosts (€) TotalPerson-month for (A) Average monthly costs: 3.256,67 € 29,50 135.447,34 € Justification Co-leading of WP6; participating also partly in horizontal WPs 1- 4. Two senior scientific officer positions, one junior scientific officer and administrative/financial officer support (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Wp1 Travel and subsistence for participation 3.000,00 € 1 meeting x 2 person x 1.000€ in (on-site) annual General Assembly (GA) 1 meeting x 1 person x 1.000€ meetings: Participation of Member State Committee Delegate & Competent Authority Wp1 Participation of pilot implementers 1.000,00 € Participation of staff member of pilot implementers in 1 GA meetings = 1 meeting x 1 person x 1.000€ Wp1 Annual Meetings /extra costs for back 1.000,00 € 2 persons X 2 extra nights X1 annual to back executive board meetings meeting x250 € per extra night subsistence Wp1 Participation of executive board 500,00 € 1 person X 2 extra nights x250 € per members from Czechia (in 1 meeting back- extra night subsistence to-back with the MS Committee meeting) M30 Wp1 Travel and subsistence for participation 1.000,00 € Participation of 1 executive board in Member States Committee meetings: member from Czechia in 1 meeting Participation of staff members (in 1 meeting = 1 person x 1.000€ co-organized with WP4 in M30) 79 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Wp2 Travel and subsistence for 2.000,00 € participation in Final Conference: 2 persons x 1.000€ Participation Member State Committee Delegate & Competent Authority Participation of staff members/stakeholders 1.000,00 € 1 extra person x 1 travel for each WP (co-) leader Final conference/extra costs for back to back 500,00 € 1 person X 2 extra nights x250 € per executive board meetings extra night subsistence Participation of staff members from pilot 1.000,00 € Participation of 1 staff member of practice implementers implementers = 1 person x 1.000€ 1.000,00 € Travel and subsistence costs for 1 workshop for implementing countries Traveltoworkshops for 1 person (14 countries) 3.000,00 € Travel and subsistence costs for 4 trainings for implementing countries Traveltotrainings for 2 persons (1/3 of 15 countries) 5.333,33 € Czechia is co-leader of WP6 and with that function, extra travels are anticipated on the basis of the Travel expenses for co-leaders previous experience Total C.1 Travel: 20.333,33 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification Translation of dissemination materials 2.000,00 € Translation of JA dissemination materials Total Costs of C.2 Other goods and services 2.000,00 € Total Costs (€) of (C) 22.333,33€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 11.044,65€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 168.825,32€ 80 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 7. MINISTRY OF SOCIAL AFFAIRS-MSAE Applicant No. &Short Name ESTONIA (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Estimated Staff function Monthly Cost Sum Cost (€) Person-month Senior Officer (WP5); MoSA 3.221,24 € 16,20 52.184,09 € senior researcher (WP5) MoSA-A 3.292,82 € 3,50 11.524,87 € Senior Officer 2 -WP5 2.863,32 € 4,70 13.457,60 € Senior Officer 3-WP5 2.863,32 € 3,30 9.448,96 € Senior Officer 4-WP5 2.863,32 € 3,30 9.448,96 € Senior Officer (WP6-A); MoSA 3.221,24 € 15,00 48.318,60 € Senior Officer (WP6-B ) MoSA 2.934,90 € 2,30 6.750,27 € senior researcher (WP6) MoSA-B 3.292,82 € 0,85 2.798,90 € TotalPM Total costs (€) for (A) Average monthly costs: 2.455,30 € 49,15 153.932,47 € Justification Participation in: WP1:1 PM; WP2: 2 PM; WP3 10PM, WP4:7PM, WP5: 21,125 PM; WP6: 11,85 PM (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00 Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification 4.000,00 € 2 meetings x 2 persons (1 member of the CA and 1 representative of the Ministry) x 1.000€ WP1: Annual Consortium /GA meetings, During these Annual Consortium M12 & M24. Meetings , the meetings of the General Assembly and of the MS Policy Committee will be held as a coinciding events WP1: Annual Consortium meetings, 4.000,00 € 2 meetings x 2 persons (1 for each best implementers in M12 & M24 practice ) x 1.000€ WP1: Participation of staff member from 1.000,00 € Participation of 1 staff member 1 MoH in 1 meeting of the Member State meeting Policy Committee. This meeting is organized by WP1 in collaboration with WP4 in M30 3.000,00 € 3 persons x 1 Annual consortium/Final WP2: 1 meeting: Annual Consortium /GA Conference meeting x 1.000€ meetings Final Conference M36 Member State Policy Committee Delegate (1) & Competent Authority (2) 81 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 the meetings of the General Assembly and of the MS Policy Committee will be held as a coinciding events WP2: Annual Consortium./ Final 2.000,00 € 2 persons x 1 travel for each 2BP Conference, implementers (1 for each best implementer practice) M36 2.000,00 € meetings and workshops for country stakeholders involved in pilot WP5: Travel and subsistence costs for implementation approx. 3 meetings meetings/workshops with stakeholders with stakeholders (6 persons per within countries meeting). Travel and subistence costs of EUR 100 per person. WP5: Travel and subsistence costs of 4.000,00 € 4 (onsite) 2-days WP workshops in 2022 participating countries for participation in… & 2023 WP5: Travel and subsistence costs of 8.000,00 € 2 persons per country participating in participants to 4 on-site training WP5: 2 x 4 WP6: Travel and subsistence costs for 2 2.000,00 € 1 person x 2 travels workshops WP6: Travel and subsistence costs 2.428,50 € 3 trainings Total C.1 Travel: 32.428,50 € (C.2) Equipment Costs (€) Justification NA (C.3) Other Goods and Services Costs (€) Justification Cost of meetings/workshops within WP5 3.642,43 € county/translation materials WP3 500,00 € Cost of evaluation software WP2 2.000,00 € Translation of dissemination materials Cost of meetings/workshops within Wp6 1050,00 € county Total Costs of C.2 Other goods and services 7.192,43 € Total Costs (€) of (C) 39.621,50€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 13.548,78€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 207.102,75€ 82 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 7.1 NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT -NIHD Applicant No. &Short Name ESTONIA (If affiliated entity: Affiliated to which 7. MSAE Applicant number/Short name) (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Senior Scientific Officer 2 3.435,99 € 1,756.012,98 € Juniorscientificofficer 1; 2.491,09 € 1,754.359,41 € Total costs (€) Total Person-month for (A) Average monthly costs: 2.963,54 € 3,50 10.372,39 € Justification Participation in: WP6 NIHD is essential partner to support activities from scientific coordination and implementation of the best practice. Developing strategy and measures on the contents and methods of prevention and health promotion. (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification WP6: Travel and subsistence costs 2.428,50 € 3 trainings X 1 person Total C.1 Travel: 2.428,50 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification Total Costs of C.2 Other goods and services 0,00 € Total Costs (€) of (C) 2.428,50€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 896,06€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 13.696,95€ 83 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 8.FINNISH INSTITUTE FOR HEALTH AND WELFARE-THL Applicant No. &Short Name FINLAND (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Estimated Person- Staff function Monthly Cost Sum Cost (€) month Chief Specialist/ THL € 9.000 7,00 63000,00 Senior Specialist/THL € 7.200 9,00 64800,00 Research professors/THL € 10.500 4,50 47250,00 Average monthly costs: 2.670,00 € 20,50 175.050,00 € Justification (B) Direct costs of Subcontracting Costs (€) Task(s) justification Consultation wp2 20.000,00€ NGO has networks which THL does not have Mieliry is Finnish Mental Health Association, which has a suicide prevention centre and SOS crisis centre. Modified: Surunauhary is NGO, focusing on those friends and family that are left behind after suicide. Their role is 1) provide information from the grassroot Consultation wp6 9.000,00€ level: the networks of the local NGO’s, mental health service users, and family members of users and suicide victims. Furthermore, the NGO’s will 2) connect and involve these subgroups to our work, 3) they will disseminate JA work in their networks and 4) support the implementation of the JA work. Total Costs (€) of (B) 29.000,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification 6.000,00 € 2 annual meetings in M12,14 X 3 Wp 1. Travel and subsistence for persons (1 Competent Authority staff+ 1 participation in (on-site) annual member state Policy Committee Consortium /General Assembly (GA) / representative+1 implementer )X 1000 Policy Member State Committee meetings euros in M12,24 WP 1 Participation of staff member from 1.000,00 € Participation of 1 person in 1 meeting MoH France (in 1 meeting of the Policy x 1.000€ Member State Committee. This meeting isorganised by WP1 in collaboration with 84 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 WP4 in M30 4.000,00 € Final conference (final annual consortium meeting) X 4 persons (2 Competent Authority staff+ 1 Member WP2. Travel and subsistence costs State Policy Committee representative+1 implementer ) x1 meeting x 1000 euros WP6. Travel and subsistence costs for 2 2.000,00 € 1 person x 1 travel X 1.000€ workshops -European level WP6. Travel and subsistence costs for 4.857,00 € 6 persons x 1 travel X 809.5 euros in 6 training -European level trainings Total C.1 Travel: 17.857,00 € (C.2) Equipment Costs (€) Justification - n/a (C.3) Other Goods and Services Costs (€) Justification WP3 500,00 € Cost of evaluation software Dissemination materials translation and wp2 2.000,00 € print WP6. Costs of meetings/workshops within countries 1.050,00 € Costs of renting the venue + catering Total Costs of C.2 Other goods and services 3.550,00 € Total Costs (€) of (C) € 21.406,57€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) € 15.781,96€ Flat rate of 7% on A, B, and C. Total estimated eligible costs € 241.238,53€ 85 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 9. MINISTRY OF SOLIDARITY AND HEALTH- Applicant No. & Short Name MoHFRANCE (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Staff function Monthly Cost Estimated Person-month Sum Cost (€) Senior Scientific Officer A 8.300,00 € 2,00 16.600,00 € Senior Scientific Officer B 8.300,00 € 4,00 33.200,00 € JuniorScientificOfficer 8.300,00 € 4,00 33.200,00 € Total Person-month Total costs (€) for (A) Averagemonthlycosts: 8.300,00 € 10,00 83.000,00 € Justification Participating country Wp5 .Participation of Staff in all WPs except WP6. Senior Scientific Officer A: WP1 X 0,5PM &WP5 X1, 5 PM Senior Scientific Officer B: WP1X 0,5PM, WP2 X 1 PM, WP4 X 0, 75 PM &WP5 X1, 75 PM. Junior Scientific Officer :WP2 X0,5PM & WP5X3,5 PM (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00 Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Wp 1. Travel and subsistence for participation 4.000,00 € 2 meetings x 2 persons x 1.000€ in (on-site) annual Consortium /General Assembly (GA) meetings: Participation of Policy Member State Committee Delegate of Ministry of France & Competent Authority in M12 and M24 WP 1 Participation of staff member from MoH 1.000,00 € Participation of 1 person in 1 meeting France (in 1 meeting of the Policy Member x 1.000€ State Committee. This meeting is organized by WP1 in collaboration with WP4 in M30 Participation of 2 staff members in Final WP2 2.000,00 € Conference x 1.000€ 2.000,00 € Participation of 1 staff member on 2 -site WP5. workshops - European level 6.000,00 € Participation of staff member on 6-site trainings= 6 WP5. x 1.000€- European level WP5.Stakeholder meetings/workshops within 1.000,00 € Travel and subsistence costs for approx. 3 meetings France with stakeholders (3 persons per meeting). Travel 86 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 and subsistence costs of EUR 100 per person. Total C.1 Travel: 16.000,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification translation of dissemination materials, printing and WP2. 1.500,00 € lay, publishing costs renting of technical equipment, catering for WP5. 750,00 € meetings in France WP5. 2.142,86 € translation for training Total Costs of C.2 Other goods and services 4.392,86 € Total Costs (€) of (C) 20.392,86€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 7.237,50€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 110.630,36€ 87 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Applicant No. & Short Name 9.1 INSERM-FRANCE (If affiliated entity: Affiliated to which 9. MoH FRANCE Applicant number/Short name) (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Head of Department 0,00 € Senior Scientific Officer 8.300,00 € 4,00 33.200,00 € Total costs (€) for Total Person-month (A) Average monthly costs: 8.300,00 € 4,00 33.200,00 € Justification Senior Scientific Officer participates in: WP4 X 0,75 PMs & WP5 X 3,25 PMs (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00 Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Participation of 1 staff member in Final WP2 1.000,00 € Conference x 1.000€ Participation of 1 staff member on 2 -site WP5 2.000,00 € workshops 2 x 1.000€ Participation of 1 staff member on 2-site WP5 2.000,00 € trainings= 2 x 1.000€ Total C.1 Travel: 5.000,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification translation of dissemination materials, WP2 500,00 € printing and lay, publishing costs Total Costs of C.2 Other goods and services 500,00 € Total Costs (€) of (C) 5.500,00€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 2.709,00€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 41.409,00€ 88 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 10. FEDERAL CENTRE FOR HEALTH EDUCATION- BZgA Applicant No. & Short Name GERMANY (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Staff function Estimated Person- Monthly Cost* Sum Cost (€) month Head of Unit and/or Department, BZgA wp1 € 9.347,00 0,10 934,70 € Senior Scientific & Project Officer, BZgAwp1 € 8.182,17 1,40 11.455,04 € Administrative and Financial Officer,BZgAwp1 € 6.724,78 0,50 3.362,39 € Head of Unit and/or Department, BZgA wp2 € 9.347,00 0,18 1.635,73 € Senior Scientific & Project Officer, BZgAwp2 € 8.182,17 2,45 20.046,32 € Administrative and Financial Officer,BZgAwp2 € 6.724,78 0,88 5.884,18 € Head of Unit and/or Department, BZgAwp3 € 9.347,00 0,54 5.000,65 € Senior Scientific & Project Officer, BZgAwp3 € 8.182,17 7,49 61.284,45 € Administrative and Financial Officer,BZgAwp3 € 6.724,78 2,68 17.988,79 € Head of Unit and/or Department, BZgAwp4 € 9.347,00 0,35 3.271,45 € Senior Scientific & Project Officer, BZgAwp4 € 8.182,17 4,90 40.092,63 € Administrative and Financial Officer,BZgAwp4 € 6.724,78 1,75 11.768,37 € Head of Unit and/or Department, BZgAwp5 € 9.347,00 2,66 24.863,02 € Senior Scientific & Project Officer, BZgAwp5 € 8.182,17 37,19 304.294,90 € Administrative and Financial Officer,BZgAwp5 € 6.724,78 13,28 89.305,08 € Total costs (€) Total Person-month for (A) Average monthly costs: 40.423,25 € 76,33 601.187,69 € Justification One head of Unit and/or Department: participation in WP5 and WP5 meetings and workshops, scientific advice and support to leading officers, participation in stakeholder meetings within Germany, participation in GA and Two Senior Scientific & Project Officers: lead and coordination of WP5, input to all WP5 activities and other WPs; participation in all JA meetings. One Administrative and Financial Officer: financial administration, reporting and controlling, technical and administrative support, management of contracting issues (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00 € Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification 89 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Two annual meetings X 2 people / 2x2 ExB WP1 Travel and subsistence costs 10.000,00 € meetings + 1 MSC meeting M30 1 x1 person Final conference ( 5 staff members x1 WP2 Travel and subsistence costs 7.000,00 € meetings )+( 1 implementer) x 1000 &ExB meeting Travel and subsistence costs for approx. 6-7 WP 5 Stakeholder meetings/workshops within meetings with stakeholders in Germany (3 2.000,00 € Germany persons per meeting). Travel and subsistence costs of EUR 100 per person WP5 Two on-site workshops (2022 & 2023) - in Participation of staff members in 2 on-site Italy (two other on-site workshops in Germany 2.000,00 € workshops = 2 workshops x 1.000€ and any additional workshop only online) Participation of 2 persons (BZgA and/or AEs and/or pilot implementing institution staff) in WP5 Four on-site training sessions 8.000,00 € 4 on-site training = 2 persons x 4 sessions x 1.000€ Participation of 4 staff members (BZgA and/or WP 5 Three on-site meetings of WP Advisory AEs and/or pilot implementing institution 12.000,00 € Groups staff) for 3 onsite Advisory Groups meetings in Italy = 4 persons x 3 meetings = 12 x 1.000€ Total C.1 Travel: 41.000,00 € (C.2) Equipment Costs (€) Justification (C.3) Other Goods and Services Costs (€) Justification Dissemination materials translation and wp2 500,00 € printing wp3 500,00 € Evaluation software Renting of venues for 4 workshops/training wp5 8.000,00 € sessions for 2-days each = 4 x 2.000€. Catering = 20 persons X 2 days x 4 wp5 6.400,00 € meetings/sessions x 40€ wp5 100,00€ Copying: 200€ x 4 meetings 500,00 wp5 Renting of venue incl. technical equipment 100,00 wp5 Catering Fee rates for external contracted experts for 42 working days: Fee rates for working days of contracted external expert members of the WP5 Advisory Group for participation in meetings and additional work input/expertise provided on specific issues (to be specified during JA wp5 30.150,00 € implementation according to effective needs). Fee rates for contracted experts in WPAG meetings: 4 experts x 6 one-day meetings (= 24 working days (wd) x 450€/day) and 6 additional wd per year for needed additional expert input (=3 wd x 3 years = 18 wd) => 24 wd + 18wd = 42 wd 90 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Fee rates for working days of contracted external training experts for preparation and implementation of training sessions under Task 5.5 Training and capacity buidling2 experts x 5 training days x 2 trainings) = 20 working days) + 5 additional reserve training days = 25 wd TOTAL: 67 wd x 450€/day For WP5 Advisory Groups' meetings (on-site): 1 WPAG x 4 experts x 3 on-site meetings wp5 16.000,00 € = 12 x 1.000€ For WP5 training sessions (on-site): 2 trainers X 2 training sessions = 4 x 1.000€ 1.000,00 € wp5 Translation and proofreading wp5 Print/publications costs 1.245,00 € Cost for financial Audit (certificate for financial All WPs 8.000,00 € statements) Total C.3 Other goods and services 72.495,00 € Total Costs (€) of (C) 113.495,00€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 50.027,79€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 764.710,47€ 91 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 11. ORSZAGOSKORHAZIFOIGAZGATOSAG-OKFO Applicant No. &Short Name HUNGARY (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Country Coordinator / Senior Scientific 3.800,00 € 17,65 67.070,00 € Officers/Experts Financial Project Manager / Scientific 2.800,00 € 17,60 49.280,00 € Officers/Experts Total costs (€) Total Person-month for (A) Average monthly costs: 3.300,71 € 35,25 116.350,00 € Justification WP1: Coordination at MS level, reporting, participation in relevant steering and management bodies and activities WP2: Co-Leader of WP2, reporting, leader of Task 2.2, 2.3 and 2.6, participation in the tasks of WP2 WP3: Participation in WP3 activities WP4: Co-Leader of WP4, reporting, leader of Task 4.3, co-lead of Task 4.1, 4.2, 4.4 and 4.5, participation in the tasks of WP4 WP5: Implementation of the knowledge transfer at MS level, reporting, participation in WP5 WP6: Implementation of the knowledge transfer at MS level, reporting, participation in WP6 (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00 Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Travel and subsistence for participation in € 2.000,00 1 meetings x 2 persons x 1.000€ (on-site) annual Consortium/General Assembly (GA) meetings: Participation of Member State Policy Committee Delegate representative of MoH Hungary (EMMI) & Competent Authority (GA meetings will be organized by WP1 in collaboration with HR and HU, in Croatia M12 and Hungary M24. So for Hungary travel costs are included only for the meeting in Croatia ) Participation of pilot implementers of 2 Best € 2.000,00 Participation of staff member of pilot Practices implementers in 2 GA meetings = 2 meetings x 2 persons per meeting) x 1.000€ Executive board meetings back to back to € 1.000,00 2 persons X 2 extra nightsX1 annual meeting Annual Meetings /extra costs for in Croatia x250 € per extra night subsistence 92 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Participation of executive board members (in € 1.000,00 2 persons X 2 extra nights x250 € per extra 1 meeting back-to-back with the MS Policy night subsistence Committee meeting) M30 Travel and subsistence for participation in € 2.000,00 Participation of 2 staff members in 1 Member State Policy Committee meeting: meeting Participation of executive board members (in = 2 persons x 1.000€ 1 meeting co-organized with WP4 meeting) M30 Participation of representative of MoH € 1.000,00 Participation of 1 staff member 1 meeting Hungary (in 1 meeting co-organized with = 1 person x 1.000€ WP4 meeting ) Travel and subsistence for participation in € 1.000,00 Final Conference: 1 person x 1.000€ x 1 travel Participation Member State Policy Committee Delegate representative of MoH Hungary (EMMI) & Competent Authority Participation of staff members/stakeholders € 1.600,00 2 extra persons x 1 travel for each WP (co) leader Final conference/extra costs for back to back € 700,00 2 persons X 2 extra nights x250 € per extra executive board meetings night subsistence Attending policy level meetings outside the € 1.000,00 WP leadership members, €1000/a/travel x 1 JA person x 1 travel Travel and subsistence for participation in: Travel and subsistence costs for workshop € 1.000,00 1 workshop x 1 person x 1000€ for implementing countries Travel and subsistence costs for 6 trainings € 2.428,00 6 trainingsx2 persons average for implementing countries for 2 persons Total C.1 Travel: 20.728,29 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification Total Costs (€) of (C) 20.728,29€ (D) In directcosts Total Costs (€) (Max 7% on A, B, and C) 9.595,48€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 146.673,76€ 93 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 11.1. SEMMELWEIS UNIVERSITY (HEALTH SERVICES Applicant No. &Short Name MANAGEMENT TRAINING CENTRE)-SU HUNGARY (If affiliated entity: Affiliated to which 11. OKFO Applicant number/Short name) (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Country Coordinator / Senior Scientific 3.800,00 € 18,35 69.730,00 € Officers/Experts Financial Project Manager / Scientific 2.800,00 € 17,90 50.120,00 € Officers/Experts Total costs (€) Total Person-month for (A) Average monthly costs: 3.306,21 € 36,25 119.850,00 € Justification WP1: Coordination at MS level, reporting, participation in relevant steering and management bodies and activities WP2: Co-Leader of WP2, reporting, leader of Task 2.2, 2.3 and 2.6, participation in the tasks of WP2 WP3: Participation in WP3 activities WP4: Co-Leader of WP4, reporting, leader of Task 4.3, co-lead of Task 4.1, 4.2, 4.4 and 4.5, participation in the tasks of WP4 WP5: Implementation of the knowledge transfer at MS level, reporting, participation in WP5 WP6: Implementation of the knowledge transfer at MS level, reporting, participation in WP6 (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00 Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Participation of pilotimplementers € 1.000,00 Participation of 1 extra staff member of pilot implementers in GA meetings in Croatia = 1 meetings x 1persons x 1.000€ Travel and subsistence for participation in € 1.000,00 Final Conference: 1 person x 1.000€ Participation Member State Policy Committee Delegate representative of MoH Hungary (EMMI) & Competent Authority 94 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Participation of staff members from pilot € 1.000,00 Participation of 2 staff member x 1 practice implementers travel x EUR 500 € 2.000,00 1 person x 2 travels WP2 Attending dissemination conferences Attending policy level meetings outside the JA € 2.000,00 WP leadership members, €1000/a/travel WP5Stakeholder meetings/workshops within € 1.000,00 Travel and subsistence costs for approx. Hungary 3 meetings with stakeholders in Hungary 2-4 persons per meeting). Travel and subsistence costs of EUR 100 per person Four on-site workshops (2022 & 2023) (In € 2.000,00 Participation of staff members in -2 on- 2021 only virtual/online workshops) site workshops = -2 workshops x 1.000€ Four on-site training sessions € 4.000,00 Participation of 1 person in 4 on-site training= 1 person x 4 sessions x 1.000€ Total C.1 Travel: 14.000,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification € 5.500,00 2nd annual meeting (M24), HU, Costs of event co-organization with WP1 of organisation (incl, venue, catering, annual meeting in Hungary technology) € 2.000,00 Translation Translation of dissemination materials Costs evaluation software (WP3) € 500,00 User licence € 2.100,00 Policy dialogue sessions for all the 21 Policy dialogues, organization MS/C and stakeholders on online platform/services € 6.300,00 Thematic workshops for all the 21 MS/C Thematic workshops, organization and stakeholders on online platform/services Renting of venue incl. technical equipment € 1.000,00 Participating AND implementing country Catering Participating AND implementing € 500,00 country Translation and proof reading): esp. for € 2.143,00 training curricula/materials, training tools, reports, other country-specific materials. WP6. Costs of meetings/workshops within Costs of renting the venue technical countries 1.050,00 € equipment &catering( Total Costs of C.2 Other goods and services 21.092,86 € Total Costs (€) of (C) 35.092,86€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 10.846,00€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 165.788,86€ 95 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 11.2 UNIVERSITY OF DEBRECEN (THE FACULTY OF PUBLIC HEALTH) ApplicantNo. &ShortName UD HUNGARY (If affiliated entity: Affiliated to which 11. OKFO Applicant number/Short name) (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Country Coordinator / Senior Scientific 3.800,00 € 17,93 68.115,00 € Officers/Experts Financial Project Manager / Scientific 2.800,00 € 18,45 51.660,00 € Officers/Experts Total costs (€) for Total Person-month (A) Average monthly costs: 3.292,78 € 36,38 119.775,00 € Justification WP1: Coordination at MS level, reporting, participation in relevant steering and management bodies and activities WP2: Co-Leader of WP2, reporting, leader of Task 2.2, 2.3 and 2.6, participation in the tasks of WP2 WP3: Participation in WP3 activities WP4: Co-Leader of WP4, reporting, leader of Task 4.3, co-lead of Task 4.1, 4.2, 4.4 and 4.5, participation in the tasks of WP4 WP5: Implementation of the knowledge transfer at MS level, reporting, participation in WP5 WP6: Implementation of the knowledge transfer at MS level, reporting, participation in WP6 (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00 Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Participation of pilot implementers of 2 € 2.000,00 Participation of staff member of pilot Best Practices implementers in 2 GA meetings = 2 meetings x 2 persons per meeting) x 1.000€ Travel and subsistence for participation € 1.000,00 in Final Conference: 1 person x 1.000€ Participation Member State Policy Committee Delegate representative of MoH Hungary (EMMI) & Competent Authority Participation of staff members from pilot € 1.000,00 Participation of 2 staff members x 1 travel x practice implementers EUR 500 Attending policy level meetings outside € 1.000,00 WP leadership members, €1000/a/travel the JA 96 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 WP5 Stakeholder meetings/workshops € 1.000,00 Travel and subsistence costs for approx. 3 within Hungary meetings with stakeholders in Hungary 2-4 persons per meeting). Travel and subsistence costs of EUR 100 per person Four on-site workshops (2022 & 2023) (In € 2.000,00 Participation of staff members in 2 on-site 2021 only virtual/online workshops) workshops = 2 workshops x 1.000€ Four on-site training sessions € 4.000,00 Participation of 1person in 4 on-site training = 1 person x 4 sessions x 1.000€ Travel and subsistence costs for € 1.000,00 1 workshop x 1 person x 1000 workshop for implementing countries Travel and subsistence costs for 6 € 2.428,00 6 trainings x2 persons average trainings for implementing countries for 2 persons Total C.1 Travel: 15.428,29 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification Total Costs (€) of (C) 15.428,29€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 9.464,23€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 144.667,51€ 97 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 12. DIRECTORATE OF HEALTH IN ICELAND- DOHI Applicant No. &Short Name ICELAND (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Staff function Monthly Cost Estimated PMs Sum Cost (€) DOHI Senior Scientific Officer 7.000,00 € 23,75 166.250,00 € Total PMs Total costs (€) for (A) Average monthly costs: 2.333,33 € 23,75 166.250,00 € Justification In WP1 and WP2 the main activities are carried out by the national project coordinator. In WP2 there is also a communications officer involved. In WP3 and WP4 the project coordinator will receive assistance from an expert responsible for some of the national activities. WP6 which involves the greatest amount of work will be completed by the project coordinator together with the national expert and the communications officer. (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00 Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification 10.500,00 € 2 annual consortium meetings M12,M24 : 1500€ X3 persons (Member State Policy WP1 Committee Delegate & Competent Authority& Implementing partner1 Member State Policy Committee meeting M30: 1500€X1 person 6.000,00 € Annual Consortium Meeting/ Final Conference M36 : 1500 €X 4 persons Member State Policy Committee Delegate WP2 (1person) & Competent Authority (2 persons); Participation of staff member from pilot practice implementers (1 person) 7.857,00 € Travel and subsistence costs for 2 workshops for implementing countries (1500€X1 person WP6 per workshop); Travel and subsistence costs for 6 trainings for 2 persons. Total C.1 Travel: 24.357,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification WP 2 2.000,00 € Translation of materials WP 3 500,00 € License evaluation software WP6. meetings/workshops within 1.050,00 € Costs of renting the venue + catering countries Total Costs of C3 3.550,00 € 98 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Total Costs (€) of (C) € 27.907,00€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) € 13.590,99 € Flat rate of 7% on A, B, and C. Total estimated eligible costs € 207.747,99€ 99 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 13.LOMBARDY REGION- LR Applicant No. &Short Name ITALY (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Senior Scientific Officer 8.000,00 € 2,00 16.000,00 € Total costs (€) Total Person-month for (A) Average monthly costs: 6.333,33 € 2,00 16.000,00 € Justification RL is the Competent Authority for Italy and participates in WP1 (0,5 PM ): coordination at MS level, reporting, participation in relevant steering and management bodies and activities; in sustainability activities in WP4 (0,5 PM) and WP5 (1 PM), where is co-leader of the WP5. (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Total C.1 Travel: 0,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification Total Costs of C.2 Other goods and services 0,00 € Total Costs (€) of (C) 0,00€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 1.120,00€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 17.120,00€ 100 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Applicant No. &Short Name 13.1LOCAL HEALTH AUTHORITY OF LECCO- ASST LECCO (If affiliated entity: Affiliated to which 13. LR Applicant number/Short name) ITALY (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Senior Scientific Officer 8.000,00 € 8,65 69.200,00 € Senior Researcher 7.000,00 € 1,00 7.000,00 € Junior Scientific Officer 4.000,00 € 1,00 4.000,00 € Senior Administrative 8.000,00 € 1,00 8.000,00 € and/or Financial Officer Junior Senior Administrative and/or 4.000,00 € 1,50 6.000,00 € Financial Officer Total Person-month Total costs (€) for (A) Average monthly costs: 6.333,33 € 13,15 94.200,00 € Justification ASST LECCO is the Italian AE that is in charge for the organization and management of the Joint Action on behalf of Lombardy Region. The main activities are developed in WP5 (PM 7,9), but it is present in all the WPs (except WP6 where Italy doesn't participate): WP1 (PM 0,5), WP2 (PM 1), WP3 (PM 2) and WP4 (PM 1,75) (B) Direct costs of Costs (€) Task(s) justification Subcontracting Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification 2 on-site WP5 workshops (2022 &2023) in Germany (participation 2.000,00 € of 1 person in 2 on-site workshops X 1000 euros) (two other on site workshops in Italy and any additional workshop on line) 3 on site meetings of WP5 Advisory Working Groups in Germany 6.000,00 € (participation of 2 persons X 3 onsite meetings X1000) WP1 General Assembly, Executive Board and Member States 10.000,00 € Committee meetings (travel and subsistence costs) (participation of 2 persons X 5 onsite meetings X1000) 6.000,00 € WP2 Final Conference meetings (travel and subsistence costs) Total C.1 Travel: 24.000,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Costs (€) Justification Services 101 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 cost for contracting external experts for WP5 working groups (training, working groups, others if needed) . Fee rates for four external experts for WP5 Working Groups. For WG meetings: 4 experts X 6 one-day meetings= (12 days X 450 euros) and 6 18.900,00 € additional wd per year for needed additional expert input (3wd X 3 years= 18wd) 24 wd + 18 wd = 42 wd. Fee rates for external contracted training experts : 2 experts X 5 training days X 2 trainings) = 20 wd + 5 additional reserve training days = 25 wd costs of 4 on-site workshops in 2002 &2023 : 1) renting venues for workshops and training (incl.technical equipment) (renting of venues for 4 workshops/training sessions for 2 days each) = 4 X 8.700,00 € 2000 euros 2) catering (max. 20 persons per workshop/training of 2 days)=20 persons X 2 days x 4 meetings X 40 euros) 3) copying (200 euros X 4 meetings) Travel and subsistence costs of contracted experts for participation in meetings/trainings (for WP5 WG meetings on- 12.000,00 € site; 1 meeting WPAG X 4 experts X 3 onsite meetings =12.000 X 1000 euros. For WP5 training sessions: 2 trainees X 2 on-site training sessions =4 X 1000 euros) Translation and proof reading) for training curricula/materials, training tools, reports, other country-specific materials. 2.142,86 € Translation from any foreign language of participating country into English) 5.500,00 € Costs for Print/publications of WP5 WP2 materials, articles Total Costs of C.2 Other goods and services 47.242,86 € Total Costs (€) of (C) 71.242,86€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 11.581,00€ Flat rate of 7% on A, B, and C. Total estimated eligible 177.023,86€ costs 102 13.2. BICOCCA 101035969 UNIVERSITY, MILAN – DEPARTMENT OF - JA – 02 -2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Applicant No. & Short Name STATISTICS AND QUANTITATIVE METHODS UNIMIB (If affiliated entity: Affiliated to which 13. LR Applicant number/Short name) ITALY (A) Direct personnel costs Staff function Monthly Estimated PMs Sum Cost (€) Cost Senior Scientific Officer 8.000,00 € 7,40 59.200,00 € Senior Consultant 6.000,00 € 2,50 15.000,00 € Junior Scientific Officer 4.000,00 € 2,00 8.000,00 € Total Person- Total costs (€) for (A) month Average monthly costs: 6.333,33 € 11,90 82.200,00 € Justification Bicocca University is the Italian AE that will develop a dashboard of indicators for evaluating community mental health services in MSs and will analyze the collected data (Task 5.4) (WP5 PM 7, 9). It is involved also in WP3 (3.5 PM) and WP2 (0,5 PM) (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification 2.000,00 € on site meetings of WP5 Advisory Working Groups in Germany (participation of 1 persons X 2 onsite meetings X1000) Total C.1 Travel: 2.000,00 € (C.2) Equipment Costs (€) Justification 0,00€ NA (C.3) Other Goods and Services Costs (€) Justification costs of 2 on-site workshops in 2002 & 2023 for dashboard : 1) renting venues for workshops and training (incl.technical equipment) (renting of venues for 4 workshops/training sessions for 2 3.000,00 € days each) = 4 X 2000 euros 2) catering (max. 20 persons per workshop/training of 2 days)=20 persons X 2 days x 4 meetings X 40 euros) 3) copying (200 euros X 4 meetings) Total Costs of C.2 Other goods and services 3.000,00 € Tota lCosts (€) of (C) 5.000,00€ Total Costs (D) Indirect costs (€) (Max 7% on A, B, and C) 6.104,00€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 93.304,00€ 103 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 13.3MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH Applicant No. &Short Name IPRMN (If affiliated entity: Affiliated to which 13. LR Applicant number/Short name) ITALY (A) Direct personnel costs Staff function Estimated Monthly Cost Sum Cost (€) Person-month Senior Scientific Officer 8.000,00 € 4,80 38.400,00 € Senior Researcher 7.000,00 € 4,00 28.000,00 € Senior Consultant 6.000,00 € 2,50 15.000,00 € Junior Scientific Officer 4.000,00 € 4,00 16.000,00 € Total Person- Total costs (€) for (A) month Average monthly costs: 6.333,33 € 15,30 97.400,00 € Justification IPRMN is the Italian AE that in WP5 will develop SANA for RL and will deliver training for all the MSs implementing the best practices for mental health system reform (Task 5.5) (9,8 PM); it participates also to the activities delivered in WP2 (1 PM), WP3 (1 PM) and WP4 (3,5 PM). (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification 2.000,00 € on site meetings of WP5 Advisory Working Groups in Germany (participation of 1 persons X 2 onsite meetings X1000) 8.000,00 € Four on-site training sessions (participation of 2 persons in 4 on site training = 2 persons X 4 sessions X1000) Total C.1 Travel: 10.000,00 € (C.2) Equipment Costs (€) Justification costs for web platform for Working Task "training" 5.000,00 € (C.3) Other Goods and Services Costs (€) Justification Cost for contracting external experts for WP5 working groups (training, working groups, others if needed) . Fee 11.250,00 € rates for external contracted training experts : 2 experts X 5 training days X 2 trainings) = 20 wd + 5 additional reserve training days = 25 wd X 450 euros 104 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 costs of 2 on-site workshops in 2002 &2023 : 1) renting venues for workshops and training (incl.technical equipment) (renting of venues for 4 workshops/training 3.500,00 € sessions for 2 days each) = 4 X 2000 euros 2) catering (max. 20 persons per workshop/training of 2 days)=20 persons X 2 days x 4 meetings X 40 euros) 3) copying (200 euros X 4 meetings) Travel and subsistence costs of contracted experts for participation in meetings/trainings ForWP5 training 4.000,00 € sessions: 2 trainees X 2 on-site training sessions =4 X 1000 euros) Total Costs of C.2 Other goods and services 18.750,00 € Total Costs (€) of (C) 33.750,00€ Total Costs (D) Indirect costs (€) (Max 7% on A, B, and C) 9.180,50€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 140.330,50€ 105 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 13.4 POLITECNICO DI MILANO UNIVERSITY Applicant No. & Short Name POLIMI (If affiliated entity: Affiliated to which 13. LR Applicant number/Short name) ITALY (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Senior Scientific Officer 8.000,00 € 5,50 44.000,00 € Senior Researcher 7.000,00 € 2,50 17.500,00 € Junior Scientific Officer 4.000,00 € 2,50 10.000,00 € Total Person- Total costs (€) for (A) month Average monthly costs: 6.333,33 € 10,50 71.500,00 € Justification Politecnico University is the Italian AE that will develop the software used in the dashboard of indicators for evaluating community mental health services in MSs (Task 5.4) and collaborate with Bicocca University in data extraction and analysis (WP5 PM 7,5). It is involved also in WP3 (2 PM) and WP4 (1 PM) (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00 Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification 2.000,00 € on site meetings of WP5 Advisory Working Groups in Germany (participation of 1 persons X 2 onsite meetings X1000) Total C.1 Travel: 2.000,00 € (C.2) Equipment Costs (€) Justification software for the WP5 working task "indicator 10.000,00 € dashboard" (C.3) Other Goods and Services Costs (€) Justification Total Costs of C.2 Other goods and services 0,00 € Total Costs (€) of (C) 12.000,00€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 5.845,00€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 89.345,00€ Applicant No. &Short Name 13.5. FATEBENEFRATELLI CENTER "SAINT JOHN OF GOD"- BRESCIA 106 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 FBF (If affiliated entity: Affiliated to which 13. LR Applicant number/Short name) ITALY (A) Direct personnel costs Staff function Estimated Monthly Cost Sum Cost (€) Person-month Senior Scientific Officer 8.000,00 € 6,00 48.000,00 € Senior Researcher 7.000,00 € 4,65 32.550,00 € Senior Consultant 6.000,00 € 2,70 16.200,00 € Junior Scientific Officer 4.000,00 € 2,40 9.600,00 € Total Person- Total costs (€) for (A) month Average monthly costs: 6.333,33 € 15,75 106.350,00 € Justification FBF is the Italian AE that in WP5 will manage the implementation of the best practice in mental health services of Lombardy Region (PM 10.1). It is also involved in WP1 (0, 5 PM), WP2 (0.65 PM), WP 3 (1, 5 PM) and WP4 (3 PM). (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00 Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification 2.000,00 € Participation of staff member of stakeholders/pilot implementers in 2 WP1 General Assembly meetings = 2 meetings x 1 person x 1.000€ 1.000,00 € WP2 Final Conference meetings (travel and subsistence costs) 2.000,00 € WP5 Meetings/workshops with stakeholders within Italy Total C.1 Travel: 5.000,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification costs of WP5 stakeholder meetings/workshops 1.500,00 € within Italy: 1) renting a venue (incl.technical equipment) 1000 euros 2) for catering 500 euros Total Costs of C.2 Other goods and services 1.500,00 € Total Costs (€) of (C) 6.500,00€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 7.899,50€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 120.749,50€ 107 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 14 MINISTRY OF HEALTH OF THE REPUBLIC OF LITHUANIA-SAM ApplicantNo. &ShortName LITHUANIA (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Estimated Person- Staff function Monthly Cost Sum Cost (€) month Project Coordinator 2.468,00 € 16,84 41.561,12 € Project Communicator 1.905,00 € 10,90 20.764,50 € Financial Officer 2.782,29 € 9,63 26.779,54 € Total Person-month Total costs (€) for (A) Average monthly costs: 1.457,67 € 37,37 89.105,16 € Justification Lithuania will be taking part in WP 5 technical work packages with a view to implement /pilot at least 1 best practice and participate in SANA and training in WP5 put will not implement the activities of formulating or updating national suicide prevention strategy during the JA. Lithuania will take part in the activities of the horizontal wps (1-4). (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Travel and subsistence for participation in (on- 4.000 € 2 meetings x 2 persons x 1.000€ site) annual General Assembly (GA) meetings: Participation of Member State Committee Delegate Ministry of Lithuania &Competent Authority in M12 and M24 Participation of stakeholders/pilot implementers 2.000 € Participation of staff member of stakeholders/pilot implementers in 2 GA meetings = 2 meetings x 1 person x 1.000€ Participation of staff member from MoH 1.000 € Participation of 1 staff member 1 Lithuania (in 1 meeting of the Member State meeting Committee. This meeting is organized by WP1 in = 1 person x 1.000€ collaboration with WP4 Travel and subsistence for participation in Final Conference: 3 persons x 1.000€ Participation Member State Committee Delegate & Competent Authority 3.000 € Participation of staff members from pilot Participation of 1 staff member practice implementers x1 person x 1.000€ 1.000 € 108 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Travel and subsistence for participation in: Stakeholder meetings/workshops within the We are planning 3 meetings and country workshops with stakeholders in Lithuania (6 persons per meeting). We are calculating, that travel and subsistence costs an average of 100 euros per person, taking into account that the meeting will be 2.000 € within the country. Four on-site workshops (2022 & 2023) (In 2021 Participation of staff members in 4 on- only virtual/online workshops) site workshops = 4 workshops x 1.000€ 4.000 € Four on-site training sessions Participation of 2 persons in 4 on-site training 8.000 € = 2 persons x 4 sessions x 1.000€ Travel and subsistence costs for 1 workshop for participating countries for 1 person (3 countries) 2.000 € 2 workshopsX1 person Travel and subsistence costs for 6 trainings for 6 trainings x 2 personsaverage implementing countries for 2 persons 4.857 € Total C.1 Travel: 31.857,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification Dissemination materials design and print 2.000 € Costs evaluation software (WP3) userlicence 500 € Wp5Renting of venue incl. technical equipment Participating AND implementing country 1.000 € WP5 Catering Participating AND implementing country 500 € WP5 Translation and proof reading): esp. for training curricula/materials, training tools, reports, other country-specific materials. 2.143 € WP6. meetings/workshops within countries 1.050,00 € Costs of renting the venue + catering Total Costs of C.2 Other goods and services 7.192,86 € Total Costs (€) of (C) 39.049,86€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 8.970,85€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 137.125,87€ 109 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 15. MINISTRY FOR HEALTH - MENTAL HEALTH SERVICES Applicant No. &Short Name MFH-MALTA (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Senior Scientific Officer A 9005,00 13,00 117.065,00 Senior Scientific Officer B 8272,00 3,00 24.816,00 Senior Scientific Officer C 11995,00 4.5 53.977,50 Senior Scientific Officer D 5269,00 12,00 63.228,00 Administrative officer 3128,00 7,00 21.896,00 Financial Officer 2375,00 7,00 16.625,00 Total Person- Total costs (€) for (A) month Average monthly costs: 6.674,00 € 47,00 297.607,50 € Justification Malta will be taking part in both technical work packages with a view to implement /pilot at least 1 best practice and to draft a national suicide prevention strategy. Senior Scientific Officer A will work WP1 x1PM, WP2X1PM, WP3X1PM, WP4X1PM, WP5X5PM & WP6X4PM. Senior Scientific Officer B will work in WP5X2PM & WP6X1PM Senior Scientific Officer C will work in WP3X1PM, WP5X3PM & WP6X1PM. Senior Scientific Officer D will work in WP2X1PM, WP3X1PM, WP4X1PM, WP5X5PM & WP6X4PM. Administrative officer will work in WP3X2PM, WP4X1PM, WP5X3PM & WP6X1PM. Financial Officer will work in WP3X2PM, WP4X1PM, WP5X3PM & WP6X1PM. (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00 Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification WP1.Travel and subsistence for participation € 4.800 2 meetings x 2 persons x 1.200€ in (on-site) annual Consortium/ General Participation of Policy Member State Assembly (GA) meetings in M12 and M24 Committee Delegate MFH - MHS Malta & Competent Authority in M12 and M24 WP1. Participation of stakeholders/pilot € 4.800 Participation of staff member of implementers (Malta is implementing both stakeholders/pilot implementers of the 2 Best Best Practices) Practices in 2 Consortium/GA meeting in M12 and M24 = 2 meetings x 2 person x 1.200€ 110 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 WP1. Participation of staff member from MFH € 1.200 Participation of 1 staff member 1 meeting - MHS (in 1 meeting of the Member State = 1 person x 1.200€ Committee. This meeting is organized by WP1 in collaboration with WP4 in M30 WP2. Travel and subsistence Participation Policy Member State Committee Delegate & Competent Authority in Final Conference € 3.600 3 persons x 1.200€ WP5. Stakeholder meetings/workshops within Travel and subsistence costs for approx. 6-7 the country- Malta meetings with stakeholders or 3 meetings X 6 persons. Travel and subsistence costs of EUR 1.000,00 € 100 per person. WP5. Four on-site workshops (2022 & 2023) Participation of staff members in 4 on-site (In 2021 only virtual/online workshops)- workshops = 4 x 1.200€ European level 4.800,00 € WP5. Four on-site training sessions- European Participation of 2 persons in 4 on-site training level = 2 persons x 4 sessions x 1.200€ 9.600,00 € WP6. Travel and subsistence costs for 2 workshops - European level € 2.400 2 workshopsX1 person x 1,200 WP6. Travel and subsistence costs for 6 training for implementing countries for 2 persons -European level € 14.400 6 trainings x 2 persons average x 1,200 Total C.1 Travel: 49.000,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification WP1. Auditing of Project €5000 Auditing of project for Certification WP2. Translation of dissemination materials €2.000 translation of JA dissemination materials WP3.Costsevaluationsoftware €500,00 User license WP5 Renting of venue incl. technical Venue and catering are around 30 euro per equipment () & Catering (lump-sum)Malta is person exc VAT, if 2workshops are done with implementing country 50 people per workshop = 3000 Euro exc VAT € 3.540 or 3540Euro inc VAT WP6. Renting of venue incl. technical Venue and catering are around 30 euro per equipment & Catering Malta is implementing person exc VAT, if 2workshops are done with country 50 people per workshop = 3000 Euro exc VAT € 3.540 or 3540 Euro inc VAT WP5. Translation and proof reading ): esp. for training curricula/materials, training tools, reports, other country-specific materials. € 3.500 Total Costs of C.2 Other goods and services 13.080,00 € Total Costs (€) of (C) 67.080,00€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 25.528,13€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 390.215,63€ 111 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 16. TRIMBOS INSTITUTE-TI Applicant No. &Short Name NETHERLANDS (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Senior Scientific Officer 8.792,84 € 15,55 136.728,66€ Junior Scientific Officer 4.678,14 € 16,50 77.189,26€ Administrative and/or Financial Officer 6.522,24 € 1,00 6.522,24€ Head of department 9.943,61 € 12,00 119.323,28€ Total costs (€) for Total Person-month (A) 7.675,05€ 45,05 339.763,43€ Justification Head of Department: WP 1, WP3 (lead) WP4 (co-lead) and WP 5. Senior Scientific Officers: WP1, WP 2, WP 3 (lead), WP4 (co-lead) Junior Scientific Officer: WP1, WP2, WP3 (lead), WP4 (co-lead) Administrative and Financial Officer: WP1 (administrative and financial management (for all other WPs). (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C.1) Travel Costs (€) Justification Travel and subsistence for participation in 2 meetings x 2 persons x 1.000€ (on-site) annual General Assembly (GA) meetings: Participation of Member State Policy Committee Delegate & Competent Authority -Trimbos , M12 M24 4.000,00 € Annual Meetings /extra costs for back to 2 persons X 2 extra nightsX2 back two executive board meetings back to annual meetings x250 € per back with the annual meetings M12 M24 2.000,00 € extra night subsistence 2 persons X 2 extra nights x250 € Participation of Trimbos staff members (in 1 per extra night subsistence meeting back-to-back with the MS Policy Committee meeting) M30 1.000,00 € Travel and subsistence for participation in Participation of 2 staff members Member States Policy Committee in 1 meeting This meeting is co-organized with WP4 ) Participation of Trimbos staff M30 2.000,00 € Participation of staff member from MoH Participation of 1 staff member Netherlands (in 1 meeting co-organized with 1 meeting WP4 meeting - reduced costs) 1.000,00 € 112 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Travel and subsistence for participation in Final Conference: Participation Member State Policy Committee Delegate Ministry & Competent Authority -Trimbos 1.000,00 1 person x 1.000€ 1 extra person x 1 travel for Participation of staff members/stakeholders 1.000,00 each WP (-co) leader Final conference/extra costs for executive 1 person x 2 extra nights board meeting back to back with the final X 300€ per extra night conference 600, 00 subsistence Attending two conferences with two persons Travel for dissemination of research results (2x2x1000) incl conference fee (2 x 250,-) and data at conferences (WP3) 4.500,00 € Attending two meetings with two persons Attending policy level meetings outside the (2x2x1000) JA (WP4) 4.000,00 € Four on-site workshops (2022 & 2023) - Participation of staff members in partly outside Germany 4 on-site workshops = 4 (In 2021 only virtual/online workshops) 4.000,00 € workshops x 1.000€ Participation of 2 persons in 2 on-site training Participation in at least two on-site training = 2 persons x 4 sessions x 1.000€ sessions 4.000,00 € Travel and subsistence costs for 2 workshops for implementing countries 2.000,00 € 2 workshopsX1 person Travel and subsistence costs for at least 2 trainings for implementing countries for 2 persons 4.857,00 € 2 trainingsx2 persons (average) Total C.1 Travel: 35.957,00 € (C.2) Equipment Costs (€) Justification (C3) Other Goods and Services Costs (€) Justification The licencing fees of evaluation software to run Costs evaluation software (WP3) 2.000,00 € the higher level analyses Printing and lay-out (WP3) 800,00 € Publishing costs (WP3) 5.000,00 € certificate of financial statements 3.400,00€ Translation and dissemination of materials 2.000,00 € (WP2) Total Costs of C.3 Other goods and services 13.200,00 € Total Costs (€) of (C) 49.157,00€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 27.224,43€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 416.144,86€ 113 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 17. NORWEGIAN DIRECTORATE OF HEALTH- HDIR Applicant No. &Short Name NORWAY (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Estimated Staff function Monthly Cost Sum Cost (€) PMs Senior Officer wp1 1,00 Senior Officer wp2 1,50 Senior Officer wp3 5,40 Senior Officer wp4 3,00 Senior Officer wp6 11,85 Total Person- Total costs (€) for month (A) Average monthly costs: 22,75 Justification *The competent Authority of Norway will cover the salary costs for the Norwegian participation through its own budget. The Norwegian team will participate: in WP1-WP4 activities and inWP6: Implementation of WP6 best practice, SANA, participation in workshops and capacity building activities, and reporting (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification 2 meetings x 2 persons x 1.000€ WP1 Annual Consortium /GA meetings,M12 & During these Annual Consortium M24. Participation from the Ministry (MS Policy 4.000,00 € Meetings, the meeting of the MS Committee Delegate) and Competent Authority Policy Committee will be held. WP 1 Annual Consortium meetings, in M12 & 2.000,00 € 2 meetings x 1 person x 1.000€ M24participation of BP implementer WP1 Participation of staff member from MoH in Participation Participation from the 1 meeting of the Member State Policy Ministry (MS Policy Committee 1.000,00 € Committee. This meeting is organized by WP1 Delegate) 1meeting x 1 person x in collaboration with WP4 in M30 1.000€ WP2 Travel and subsistence costs Final 4.000,00 € 1 MS Policy Committee Delegate+ 2 conference/Annual Consortium/GA meeting in staff members +1 Implementer M30 1meeting x 4 persons x 1.000€ 6.856,57 € Travel and subsistence costs for WP6Travel and subsistence costs workshops and training Total C.1 Travel: 17.857,00 € (C.2) Equipment Costs (€) Justification n/a 114 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 (C.3) Other Goods and Services Costs (€) Justification WP3 500,00 € Cost of evaluation software Dissemination materials translation wp2 2.000,00 € and printing WP6. Costs of meetings/workshops within countries 1.050,00 € Costs of renting the venue + catering Total Costs of C.2 Other goods and services 3.550,00 € Total Costs (€) of (C) 21.406,57€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 1.498,46€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 22.905,03€ 115 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 18. INSTITUTE OF PUBLIC HEALTH OF SERBIA Applicant No. &Short Name “DR MILAN JOVANOVIC BATUT”-IPHS SERBIA (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Staff function Estimated Monthly Cost Sum Cost (€) Person-month Public Health Expert 1.803,00 € 19,09 34.419,27 0,00 € Total Person- Total costs (€) for month (A) Average monthly costs: 19,09 34.419,27 € Justification Participation in: WP1:1 PM; WP2: 1,5PM; WP3 0 PM, WP4:2,5 PM, WP5: 10,5 PM; WP6: 4 PM Serbia will participate in Situation Analysis & Needs Assessment as well as training activities in WP5 &WP6 , in dissemination activities (WP2), and in policy dialogues and sustainability planning (WP1&WP4) (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00 Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification WP1 Travel and subsistence for participation 4.000,00 € 2 meetings x 2 persons x 1.000€ in (on-site) annual Consortium meetings: Participation of Member State Policy Committee Delegate Ministry of Serbia or other relevant institution/body+ Competent Authority in M12 and M24 WP1 Participation of staff member from 1.000,00 € Participation of 1 staff member 1 Ministry of Serbia or other relevant meeting institution/body (in 1 meeting of the Member = 1 person x 1.000€ State Policy Committee. This meeting is organized by WP1 in collaboration with WP4 M30 WP2 Travel and subsistence for participation 3.000,00 € in Final Conference: 3 persons x 1.000€ Participation Member State Policy Committee Delegate & Competent Authority WP5 Stakeholder meetings/workshops within For the travel cost EUR 1000 for 3 Serbia 1.000,00 € persons to participate at 3 stakeholder 116 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 meetings. WP5 Four on-site workshops (2022 & 2023) Participation of staff members in 4 on- (In 2021 only virtual/online workshops) site workshops = 4 workshops x 4.000,00 € 1.000€ WP5 Four on-site training sessions Participation of 2 persons in 4 on-site training 8.000,00 € = 2 persons x 4 sessions x 1.000€ WP6 Travel and subsistence costs for 1 workshop for participating countries for 1 person (3 countries) 2.000,00 € 1 workshopsX1 person WP6 Travel and subsistence costs for 6 4.857,00 € trainings for implementing countries for 2 persons 6 trainings x2 persons average Total C.1 Travel: 27.857,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification (WP2)Translation of dissemination materials Dissemination materials translation 2.000,00 € and printing WP5 Renting of venue incl. technical equipment for within the country meetings 500,00 € Wp5. Catering for within the country meetings 230,00 € WP5. Translation and proofreading): esp. for training curricula/materials, training tools, 2.142,43 € reports, other country-specific materials. WP6. Costs of meetings/workshops within 1.050,00 € Costs of renting the venue + catering countries Total Costs of C.2 Other goods and services 5.922,86 € Total Costs (€) of (C) 33.779,86€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 4.773,94€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 72.973,07€ 117 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 19.NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE - NATIONAL Applicant No. &Short Name INSTITUTE OF PUBLIC HEALTH NIJZ- SLOVENIA (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Head of Department 0,00 € Senior Scientific Officer 4.000,00 € 17,98 71.920,00 € Junior Scientific Officer 3.000,00 € 27,59 82.770,00 € Administrative and/or Financial Officer 3.000,00 € 8,21 24.630,00 € Total costs (€) Total Person-month for (A) Average monthly costs: 3.333,33 € 53,78 179.320,00 € Justification Scientific Officers will be involved in coordination WP1, Dissemination WP2, Evaluation WP3 and Sustainability activities WP4. The two Officers will participate in all activities, meetings and training in WP5 and implement the best practice. They will also participate in WP6 ,activities meeting and trainings The Administrative and/or Financial Officer will be responsible for financial management, administration and reporting in all WPs (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification WP1 Annual meetings,M12 & M24 4.000,00 € 2 meetings x 2 persons x 1.000€ WP 1 Annual meetings, implementers (1 for 4.000,00 € 2 meetings x 2 persons x 1.000€ each best practice) M12 & M24 WP1 Participation of staff member from MoH in 1 meeting of the Member State Policy 1meetings x 1 person x 1.000€ 1.000,00 € Committee. This meeting is organized by WP1 in collaboration with WP4 M30 WP2 Final Conference Member State Policy Committee Delegate & Competent Authority 3.000,00 € 3 persons x 1 travel x 1.000€ M36 WP2 Final Conference, implementers (1 for 2 persons x 1 travel for each 2GP 2.000,00 € each best practice) M36 implementer 118 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Meetings and workshops for country stakeholders involved in pilot WP 5 Travel and subsistence costs for implementation approx. 3 meetings meetings/workshops with stakeholders 2.000,00 € with stakeholders (3 persons per within countries meeting). Travel and subsistence costs of EUR 100 per person. WP5 Travel and subsistence costs of participating countries for participation in... (1 person per country) = 1 x 4 x 14 4 (onsite) 2-days WP workshops in 4.000,00 € Host countries (Germany, Italy, and possibly 2022 & 2023 other European participating MS). For 2021 only virtual/online workshops. WP5 Travel and subsistence costs of 2 persons per country participating in 8.000,00 € participants to 4 on-site training WP5: 2 x 4 WP6 Travel and subsistence costs for 2 2.000,00 € 1 person x 1 travel workshops for implementing country 6 trainings for implementing countries WP6 Travel and subsistence costs for 4.857,00 € for 2 persons Total C.1 Travel: 34.857,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification WP2 2.000,00 € Translation of dissemination materials esp. for training curricula/materials, WP5 Translation and proofreading 2.143,00 € training tools, reports, other country- specific materials. WP5 Costs of meetings/workshops within 1.500,00 € Costs of renting the venue + catering countries Costs evaluation software (WP3) 500,00 € User licenses WP6. Costs of meetings/workshops within 1.050,00 € Costs of renting the venue + catering countries 7.193,00 € Total Costs of C.2 Other goods and services 42.050,00€ Total Costs (€) of (C) (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 15.495,90€ Flat rate of 7% on A, B, and C. Total estimated eligible costs € 236.865,90€ 119 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 20.SERVICIO MURCIANO DE SALUD-SMS Applicant No. &Short Name SPAIN (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Project Manager /Senior Scientific Officer -SMS € 6.558,00 9,85 64.596,30 € Project Manager /Senior Scientific Officer -SMS € 9.006,00 4,00 36.024,00 € Senior Researcher - SMS € 8.721,00 4,30 37.500,30 € Project Manager&Advisor-SMS € 5.649,00 0,75 4.236,75 € Total Person- Total costs (€) month for (A) Average monthly costs: 7.071,00 € 18,90 142.357,35 € Justification Project Manager and Senior Scientific Officer - Regional Coordinator of WP5 Responsible for coordinating all the activities of the wp5 of all the affiliated entities of Spain that participate in this WP/ Project Manager, Scientific Officer - Regional coordinator of WP6 suicide prevention, responsible for the implementation of the project in each regional health area in Murcia and in affiliated entities in Spain /Senior Researcher - design the healthcare process to be implemented in the pilot areas of health and developing the suicide prevention implementation/Project Manager- Technician advisor of implementation and responsible of dissemination activities (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00 Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Travel and subsistence for participation in (on-site) € 4.000,00 2 meetings x 2 persons x 1.000€ annual General Assembly (GA) meetings: Participation of Member State Committee Delegate & Competent Authority THL in M12 amd M24 € 4.000,00 Participation of staff member of stakeholders/pilot implementers in 2 Participation of stakeholders/pilot implementers GA meetings = 2 meetings x 2 person x 1.000€ 120 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Member State Policy Committee Meeting This € 1.000,00 Participation of 1 staff member 1 meeting is organized by WP1 in collaboration with meeting= 1 person x 1.000€ WP4 in M30 Travel and subsistence for participation in Final Conference: 3 persons x 1.000€ Participation Member Stat Policy Committee Delegate & Competent Authority € 3.000,00 Participation of staff members from pilot practice Participation of 1 staff member implementers = 2 person x 1.000€ € 2.000,00 Stakeholder meetings/workshops within the In this concept we are planning to country have a meeting in Murcia for the professionals from the affiliated entities of Spain, with the professionals of the Beneficiary Entity SMS, and the rest of the entities in Murcia. We are planning 6 people, one of each of the affiliated entities. We are calculating an average of 330 euros per person, taking into account that the meeting will be within the country, the date could be in the middle of the project. This meeting will be to make an evaluation of the actions in the middle of the project and to plan the responsibilities of spreading the knowledge of the project as better as possible within the 2.000,00 € different communities of Spain. Four on-site workshops (2022 & 2023) (In 2021 only Participation of staff members in 4 virtual/online workshops) on-site workshops = 4 workshops x 4.000,00 € 1.000€ Four on-site training sessions Participation of 2 persons in 4 on-site training 8.000,00 € = 2 persons x 4 sessions x 1.000€ Travel and subsistence costs for 2 workshops for 2 workshopsX1 implementing countries € 2.000,00 person Travel and subsistence costs for 6 trainings for 6 trainings x2 implementing countries for 2 persons € 4.857,00 persons average Total C.1 Travel: 34.856,57 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification 121 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 We will prepare brochures, promotional and prevention material, posters, banners. We will 2.000,00 € reproduce strategy documents for dissemination. Renting of venue incl. technical equipment 1.000,00 € Costs for renting Participating AND implementing country Catering Participating AND implementing country 500,00 € Costs for catering Translation and proof reading ): esp. for training curricula/materials, training tools, reports, other 2.142,86 € country-specific materials. WP6. Costs of meetings/workshops within countries 1.050,00 € Costs of renting the venue + catering Total Costs of C.2 Other goods and services 6.692,86 € Total Costs (€) of (C) 41.549,43€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 12.873,47 € Flat rate of 7% on A, B, and C. Total estimated eligible costs 196.780,25€ 122 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 20.1 FUNDACIÓN PARA LA FORMACIÓN E INVESTIGACIÓN Applicant No. & Short Name SANITARIAS DE LA REGIÓN DE MURCIA FFIS -FFIS (If affiliated entity: Affiliated to which 20. SMS Applicant number/Short name) SPAIN (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Senior Project Manager& Researcher-FFIS € 4.923,00 13,90 68.429,70 € Project ManagementTechnician-FFIS € 2.909,00 5,28 15.342,34 € Total costs (€) Total Person-month for (A) Average monthly costs: 2.610,50 € 19,18 83.772,04 € Justification Senior Project Manager and Researcher, Coordinate and support for the SMS, all the activities related to all the WPs in which Spain participates in the Joint Action, communication and evaluation activities / Project Management Technician, support financial, reporting and evaluation activities of the affiliated entities of Spain, communication activities. (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00 Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Total C.1 Travel: 0,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification Total Costs of C.2 Other goods and services 0,00 € Total Costs (€) of (C) 0,00€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 5.864,04€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 89.636,08€ 123 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 20.2 SERVICIO CATALÁN DE SALUD Applicant No. & Short Name CATSALUT (If affiliated entity: Affiliated to which 20. SMS Applicant number/Short name) SPAIN (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Senior Scientific Officer -CatSalut € 6.000,00 6,20 37.200,00 € Total costs (€) Total Person-month for (A) Average monthly costs: 2.000,00 € 6,20 37.200,00 € Justification WP5 & WP6 Senior Scientific Officer, responsible for the implementation of the project in each health area of Catalunya, responsible of the suicide prevention strategy on the Region of Catalunya based on the best practice Suicide Prevention. (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Total C.1 Travel: 0,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification Total Costs of C.2 Other goods and services 0,00 € Total Costs (€) of (C) 0,00€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 2.604,00€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 39.804,00€ 124 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 20.3. CONSEJERÍA DE MUJER, IGUALDAD, LGTBI, FAMILIAS Y Applicant No. & Short Name POLÍTICA SOCIAL DE LA REGIÓN DE MURCIA CONSEJERIA DE MUJER (CARM) (If affiliated entity: Affiliated to which 20. SMS Applicant number/Short name) SPAIN (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Scientific Researcher- Consejeria de la Mujer € 4.544,00 1,65 7.497,60 € Legal Advisor-Consejeria de la Mujer € 5.506,00 4,55 25.050,48 € Total costs (€) Total Person-month for (A) Average monthly costs: 3.349,87 € 6,20 32.548,08 € Justification Scientific Researcher, collaborate to design the healthcare process to be implemented in the pilot areas of Health, integrating the public network of Social Services in the region, responsible for the implementation of the project in each area of health in the Region, from the field of social services./Legal Adviser, legal advice on all aspects of implementation best practice in WP5in the field of Social Services in the region (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Total C.1 Travel: 0,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification Total Costs of C.2 Other goods and services 0,00 € Total Costs (€) of (C) 0,00€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 2.278,37€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 34.826,45€ 125 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 20.4. SERVICIO ANDALUZ DE SALUD Applicant No. &Short Name -SAS (If affiliated entity: Affiliated to which 20. SMS Applicant number/Short name) SPAIN (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Senior Political Officer- SAS € 5.460,00 1,55 8.463,00 € Scientific Officer and Researcher- SAS € 3.500,00 1,15 4.025,00 € Total costs (€) Total Person-month for (A) Average monthly costs: 2.986,67 € 2,70 12.488,00 € Justification WP6 Senior Political Officer - Coordinate actions for the dissemination of the project at the policy level in the Andalusia Region /Scientific Officer and Researcher, developing the suicide prevention strategy at regional level (Andalusia Region) based on the best practice, Suicide Prevention. (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Total C.1 Travel: 0,00 € (C.2) Equipment Costs (€) Justification < - (C.3) Other Goods and Services Costs (€) Justification Total Costs of C.2 Other goods and services 0,00 € Total Costs (€) of (C) 0,00€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 874,16€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 13.362,16€ 126 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 20.5 FUNDACIÓN PÚBLICA ANDALUZA PROGRESO Y SALUD Applicant No. & Short Name -FPS (If affiliated entity: Affiliated to which 20. SMS Applicant number/Short name) SPAIN (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Project Manager- FPS € 4.291,00 1,70 7.294,70 € Total costs (€) Total Person-month for (A) Average monthly costs: 1.430,33 € 1,70 7.294,70 € Justification Project Manager, coordinate and support for the Andalusia Region in all the activities related of the Joint Action. (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Total C.1 Travel: 0,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification Total Costs of C.2 Other goods and services 0,00 € Total Costs (€) of (C) 0,00€ (D) Indirect costs TotalCosts (€) (Max 7% on A, B, and C) 510,63€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 7.805,33€ 127 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 20.6 SERVICIO MADRILEÑO DE SALUD Applicant No. & Short Name SERMAS (If affiliated entity: Affiliated to which 20. SMS Applicant number/Short name) SPAIN (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Senior Scientific Officer - SERMAS € 5.250,00 1,35 7.087,50 € Senior Technical Researcher- SERMAS € 4.614,00 1,35 6.228,90 € Total costs (€) Total Person-month for (A) Average monthly costs: 3.288,00 € 2,70 13.316,40 € Justification WP6 Senior Scientific Officer and researcher, Head of Action Plan in Mental Health and Suicide Prevention Programs Coordinate actions for the dissemination of the project at the policy level. Support to Suicide Prevention Program / Senior Technical Researcher, responsible for the development, monitoring and evaluation of Action in the Region of Madrid. (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Total C.1 Travel: 0,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification Total Costs of C.2 Other goods and services 0,00 € Total Costs (€) of (C) 0,00€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 932,15€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 14.248,55€ 128 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 20.7 SERVICIO NAVARRO DE SALUD-OSASUNBIDEA Applicant No. &Short Name - SNS-O (If affiliated entity: Affiliated to which 20. SMS Applicant number/Short name) SPAIN (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Scientific Researcher -SNS-O € 4.881,00 2,70 13.178,51 € Total costs (€) Total Person-month for (A) Average monthly costs: 1.626,98 € 2,70 13.178,51 € Justification Scientific Researcher, in charge of the suicide prevention strategy on the Navarra Region, based on the best practice Suicide Prevention, coordinate actions for the dissemination of the project at the policy level in Navarra Region. (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Total C.1 Travel: 0,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification Total Costs of C.2 Other goods and services 0,00 € Total Costs (€) of (C) 0,00€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 922,50€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 14.101,00€ 129 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 20.8 SERVICIO VASCO DE SALUD –OSAKIDETZA Applicant No. &Short Name OSAKIDETZA (If affiliated entity: Affiliated to which 20. SMS Applicant number/Short name) SPAIN (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Scientific Researcher- OSAKIDETZA € 6.825,00 2,7018.427,50 € Total costs (€) Total Person-month for (A) Average monthly costs: 2.275,00 € 2,70 18.427,50 € Justification WP6 Scientific Researcher, in charge of the suicide prevention strategy on Basque Country Region based on the best practice Suicide Prevention. (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Direct costs (C.1) Travel Costs (€) Justification Total C.1 Travel: 0,00 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification Total Costs of C.2 Other goods and services 0,00 € Total Costs (€) of (C) 0,00€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 1.289,93€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 19.717,43 130 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 21.PUBLIC HEALTH AGENCY OF SWEDEN- Applicant No. &Short Name FOHM/PHAS SWEDEN (If affiliated entity: Affiliated to which Applicant number/Short name) (A) Direct personnel costs Staff function Estimated Person- Monthly Cost Sum Cost (€) month Project Coordinator 6.800,00 € 13,00 88.400,00 € 1 Expertise responsible for national 6.800,00 € 6,00 40.800,00 € activities Communications officer 5.700,00 € 3,00 17.100,00 € Total Person-month Totalcosts (€) for (A) Average monthl ycosts: 6.433,33 € 22,00 146.300,00 € Justification In WP1 and WP2 the main activities are carried out by the national project coordinator. In WP2 there is also a communications officer involved. In WP3 and WP4 the project coordinator will receive assistance from an expert responsible for some of the national activities. WP6 which involves the greatest amount of work will be completed by the project coordinator together with the national expert and the communications officer. (B) Direct costs of Subcontracting Costs (€) Task(s) justification Total Costs (€) of (B) 0,00€ Justification (C) Other Directcosts (C.1) Travel Costs (€) Justification 7.000,00 € 2 annual consortium meetings M12,M24 X 3 people WP1 1 Member State Policy Committee meeting M30 X 1 person 4.000,00 € Travel and subsistence for participation in Final Conference M36 : Participation Member State Policy Committee Delegate & Competent WP2 Authority (3 persons); Participation of staff member from pilot practice implementers (1 person) 6.856,47 € Travel and subsistence costs for 2 workshops for implementing countries (1 person per WP6 workshop); Travel and subsistence costs for 6 trainings for 2 persons. 131 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Total C.1 Travel: 17.856,47 € (C.2) Equipment Costs (€) Justification - (C.3) Other Goods and Services Costs (€) Justification WP 2 2.000,00 € Translation of materials WP 3 500,00 € License evaluation software WP6. Costs of meetings/workshops Costs of renting the venue technical equipment within countries 1.050,00 € & catering Total Costs of C.2 Other goods and services 3.550,00 € Total Costs (€) of (C) 21.406,57€ (D) Indirect costs Total Costs (€) (Max 7% on A, B, and C) 11.739,46€ Flat rate of 7% on A, B, and C. Total estimated eligible costs 179.446,03€ 132 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 2.10 Previous and current grants relevant to the programme Name/title, number and Institution(s)/beneficiaries involved Total amount of EU contribution duration of the grant Strengthened International NPHO, Greece BMSGPK, Austria HeAlth Regulations and CIPH, Croatia MoSA, Estonia THL, Preparedness in the EU - Joint € 7 900 000,00 Finland MOH, France SAM, Lithuania Action [SHARPJA] 01/04/2019 - MHS, Malta HDIR, Norway NIPH, 31/03/2022 No 848096 HP-JA- Norway IPHS, Serbia PHAS, Sweden 2018 European Joint Action on NPHO, Greece, CIPH, Croatia, THL, € 3 530 231,97 Vaccination [EU-JAV] Finland, INSERM, France, SAM, 01/08/2018 - 31/07/2021 Lithuania, MHS, Malta, PHAS, No 801495 HP-JA-2017 Sweden Joint Action on integrating NPHO, Greece, CIPH, Croatia, NIHD, € 1 999 877,08 prevention, testing and linkage Estonia, MHS, Malta to care strategies across HIV, viral hepatitis, TB and STIs in Europe (INTEGRATE) [INTEGRATE]01/09/2017 - 28/02/2021, No 761319 HP-JA-2016 European Joint Action on NPHO, Greece, GÖG, Austria, CIPH, € 4 178 162,75 antimicrobial resistance and Croatia MOH, France, INSERM, associated infections [EU- France, HDIR, Norway, NIPH, JAMRAI] Norway, Norwegian Medical Agency, 01/09/2017 - 28/02/2021 Norway, NIJZ, Slovenia, FFIS, Spain, No 761296 HP-JA-2016 SERMAS, Spain, PHAS, Sweden Joint Action on HIV and Co- NPHO, Greece CIPH, Croatia € 2 999 747,09 infection Prevention and Harm NIHD, Estonia THL, Finland MHS, Reduction [HA-REACT] Malta 01/10/2015 - 31/01/2019 No 677085 HP-JA-2014 Common Approach for REfugees NPHO, Greece CIPH, Croatia MHS, € 1 689 045,11 and other migrants' health Malta [CARE] 01/04/2016 - 31/03/2017 No 717317 HP-HA-2015 Tobacco Cessation Guidelines NPHO, Greece € 541 890,80 For High Risk Groups [Tob-G] SU - HSMTC, Hungary Coordinator 01/06/2015 - 30/11/2017 No. 664292 HP-PJ-2014 InfAct (Information for Action) BMSGPK, Austria, CIPH, Croatia, MHS 01/03/2018 – 31/05/2021 SHSO, Cyprus, MoSA, Estonia, THL, € 3 999 191,48 No 801553 HP-JA-2017 Finland, UNIMIB,Italy, MHS, Malta, HDIR, Norway, NIPH, Norway, NIJZ, Slovenia; PHAS, Sweden Preparedness and action at BMSGPK, Austria; CIPH, Croatia €3 000 000,00 points of entry [Healthy MHS, Malta; PHAS, Sweden GateWays]; 01/05/2018 – 133 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 30/04/2021 No 801493 HP-JA-2017 Joint Action supporting the BMSGPK, Austria; MHSSHSO, Cyprus; € 2 699 978,06 eHealth Network [eHAction] MoHCZ, Czechia; MoSA, Estonia; 01/06/2018 - 31/05/2021 THL, Finland; MOH, France; ÁEEK, No 801558 HP-JA-2017 Hungary; SU - HSMTC, Hungary; SAM, Lithuania; MHS, Malta Supporting Member States GÖG, Austria € 299 994,00 voluntary cooperation in the area of pricing through the Eu- ripid Collaboration [EURIPID] 01/02/2019-31/01/2022 No 826652 HP-JA-2018 European Network for Health GÖG, Austria; NCPHA, Bulgaria; € 11 999 798,74 Technology Assessment – Joint CIPH, Croatia; MHSSHSO, Cyprus; Action 1- 3, EUnetHTA JA1, JA2 MoHCZ, Czechia; THL, Finland and JA3 (HP), SU - HSMTC, Hungary; MHS, Malta 01/06/2016 - 31/05/2021 HDIR, Norway No 724130HP-ADHOC-2014- 2020-JA-2015 Joint Action to support the GÖG, Austria THL, Finland MOH, € 2 400 000,00 eHealth Network [JAseHN], France ÁEEK, Hungary SU - HSMTC, 01/05/2015 - 30/06/2018 Hungary MHS, Malta HDIR, Norway No 677102HP-JA-2014 Promoting Implementation of GÖG, Austria MOH, France INSERM, € 4 379 979,00 Recommendations on Policy, France HDIR, Norway Information and Data for Rare Diseases [RD-ACTION], 01/06/2015 - 31/07/2018 No 677024HP-JA-2014 Joint Action on Implementation GÖG, Austria; NCPHA, Bulgaria; € 6 000 000,00 of Validated Best Practices in CIPH, Croatia; MHS SHSO, Cyprus Nutrition [Best-ReMaP] MoSA, Estonia THL, Finland SAM, 01/10/2020 - 30/09/2023 Lithuania MHS, Malta NIJZ, Slovenia No 951202HP-JA-2019 Joint Action Health Equity NCPHA, Bulgaria CIPH, Croatia MHS € 2 499 997,02 Europe [JAHEE] SHSO, Cyprus NIHD, Estonia/ THL, 01/06/2018-30/11/2021 Finland No 801600 HP-JA-2017 MOH, France / BZgA, Germany IPHS, Serbia/ NIJZ, Slovenia ;PHAS, Sweden Innovative Partnership for NCPHA, Bulgaria/ CIPH, Croatia € 4 500 000,00 Action Against Cancer [iPAAC] MHS SHSO, Cyprus/ THL, Finland 01/04/2018-31/03/2021 SAM, Lithuania/ MHS, Malta IPHS, No 801520 HP-JA-2017 Serbia NIJZ, Slovenia Joint Action on Tobacco Control NCPHA, Bulgaria/ MHSSHSO, Cyprus € 1 995 334,21 [JATC] DOHI, Iceland /MNIPR, Italy 1/10/2017-15/12/2020 MHS, Malta/ PHAS, Sweden No 761297 HP-JA-2016 Implementing good practices for NCPHA, Bulgaria/ CIPH, Croatia € 4 999 999,56 134 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 chronic diseases [CHRODIS- THL, Finland/ SU - HSMTC, Hungary PLUS] DOHI, Iceland/ MHS, Malta 01/09/2017 - 30/11/2020 NIJZ, Slovenia/ SAS, Spain No 761307HP-JA-2016 Managing Frailty. A NCPHA, Bulgaria/ CIPH, Croatia € 3 442 455,01 comprehensive approach to MHS SHSO, Cyprus/ MoHCZ, Czech promote a disability-free THL, Finland/ MOH, France/ NIPH, advanced age in Europe: the Norway ADVANTAGE initiative Norwegian National Advisory Unit on [ADVANTAGE] Ageing and Health (Ageing and 01/01/2017-31/12/2019 Health), Norway/ NIJZ, Slovenia/ No 724099HP-JA-2015 SERMAS, Spain Joint Action on Nutrition and NCPHA, Bulgaria/ CIPH, Croatia € 1 200 000,00 Physical Activity [JANPA] NIHD, Estonia/THL, Finlan/ MOH, 01/09/2015-30/11/2017 France/ MHS, Malta/ HDIR, Norway/ No 677063 HP-JA-2014 NIJZ, Slovenia Joint Action on implementation CIPH, Croatia/ MoHCZ, Czechia/ € 3 999 226,00 of digitally enabled integrated MoSA, Estonia/ ÁEEK, Hungary/ SU - person-centred care [JADECARE] HSMTC, Hungary/ LR, Italy 01/10/2020-30/09/2023 SMS and FFIS,Spain No 951442 HP-JA-2019 Joint Action on Rare Cancers CIPH, Croatia/ MHS SHSO, Cyprus/ € 1 499 848,04 [JARC] MoHCZ, Czechia/ INSERM, France 01/10/2016-30/09/2019 MHS, Malta/ FFIS-CARM, Spain No 724161 HP-JA-2015 Efficient response to highly CIPH, Croatia. THL, Finland. NSERM, € 3 499 873,00 dangerous and emerging France. PHAS, Sweden pathogens at EU level [EMERGE] 01/06/2015 - 31/03/2019 No 677066HP-JA-2014 facilitatinG the Authorisation of MHS SHSO, Cyprus € 1 199 824,37 Preparation Process for blood MHS, Malta and tissues and cells [GAPP] SAS, Spain 01/05/2019-30/04/2021 No 785269 HP-JA-2016 Market surveillance of medical MHS SHSO, Cyprus € 849 487,69 devices [JAMS] 17/10/2016- 16/01/2020 No 723964 HP-JA-2015 Local Strategies to Reduce MoHCZ, Czechia € 745 979,00 Underage and Heavy Episodic Drinking [Localize It] [738055] – Project 01/04/2017-30/09/2019 No 738055 HP-PJ-2016 BRidging Information and Data THL, Finland € 3 473 044,23 Generation for Evidence-based INSERM, France Health Policy and Research [BRIDGE Health] 01/05/2015-31/10/2017 No 664691 HP-PJ-2014 VASCERN Registries [VASCERN INSERM, France € 393 922,26 135 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Registries] 01/05/2020-30/04/2023 No 947651 HP-PJ-2019 Codification for Rare Diseases INSERM, France € 749 884,35 [RDCODE] MHS, Malta 01/01/2019-30/06/2021 No 826607 HP-PJ-2018 Orphanet Network [ONW] INSERM, France € 2 639 245,52 01/06/2018-30/06/2021 No 831390 HP-PJ-2018 EUropean Refugees - HUman UD, FPH, Hungary € 1 251 841,13 Movement and Advisory Network [EUR-HUMAN] 01/01/2016-31/12/2016 No 717319 HP-HA-2015 Frailty management MNIPR, Italy € 1 427 779,00 Optimisation through EIP AHA Commitments and Utilisation of Stakeholders input [FOCUS] [664367] – Project 01/05/2015- 30/04/2018 No 664367 HP-PJ-2014 RESPOND H2020 Improving the LR, Italy € 6.265.778 Preparedness of Health Systems to Reduce Mental Health and Psychosocial Concerns resulting from the COVID-19 Pandemic 1/12/2020-- 30/11/2023 N° 101016127 Remote Assessment of Disease FBF Italy € 11.000.000 and Relapse in Central Nervous System Disorders 1/4/2016 -31/3/2022 N° 115902 H2020-EU.3.1.7. Vigilance and Inspection for the SAM, Lithuania € 2 328 664,00 Safety of Transfusion, Assisted HDIR, Norway Reproduction and Transplantation [VISTART], 10/10/2015 - 09/02/2019 No 676969HP-JA-2014 EUPAP – An European Physical MHS, Malta € 1 346 154,90 Activity on Prescription model PHAS, Sweden [EUPAP] 01/03/2019-28/02/2022 No 847174 HP-PJ-2018 TRANSfusion and MHS, Malta € 522 170,23 transplantation: PrOtection and SElection of donors [TRANSPOSE] 01/09/2017-29/02/2020 No 738145 HP-PJ-2016 136 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 STAD in Europe [SIE] [709661] – TI, Netherlands € 698 416,59 Project 01/06/2016 – 31/05/2019 No 709661 HP-PJ-2015 Joint Action on Dementia 2015- HDIR, Norway, € 1 498 710,30 2018 [DEM 2] TI, Netherlands 01/03/2016-31/10/2019 No 678481 HP-JA-2014 Joint Market Surveillance HDIR, Norway € 199 999,00 Actions on medical devices intended to be re-sterilized focusing on information in the Instruction for use and validation data necessary for the re-sterilisation by the user [COENJA2014] 01/11/2015-30/04/2017 No 676988 HP-JA-2014 CANCON - European Guide on NIJZ, Slovenia €5.999.985,00 Quality Improvement in Comprehensive Cancer Control; 24.2.2014 - 23.4.2017; JA 2012 2203 PARENT - Cross Border Patient NIJZ, Slovenia €3.360.548,01 Registries Initiative 2.5.20112 - 1.2.2016 JA 20122 23 02 HepCare Europe: [HEPCARE SAS, Spain € 1 069 977,67 EUROPE] [709844] – Project 01/05/2016-31/10/2019 No 709844 HP-PJ-2015 PaEdiatric Transplantation SERMAS, Spain € 399 962,84 European Registry [PETER] 01/07/2020-30/06/2023 No 947629 HP-PJ-2019 Personalized Knowledge Osakidetza, Spain € 1 589 751,69 Transfer and Access to Tailored Evidence-Based Assets on Integrated Care: SCIROCCO Exchange [SCIROCCO Exchange] 01/01/2019-31/08/2021 No 826676 HP-PJ-2018 Advancing Care Coordination Osakidetza, Spain € 2 072 432,18 and Telehealth deployment at Scale [ACT-at-Scale] 04/03/2016-03/03/2019 No 709770 HP-PJ-2015 LaRge-scalE implementation of Netherlands (Trimbos), Bulgaria € 3 500 000 COmmunity based mental (NCPHA), Croatia (CIPH), Germany, health care for people with North Macedonia, Montenegro, seVere and Enduring mental ill Romania, Moldova, Spain 137 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 health in EuRopE, RECOVER-E. 01/01/2018-31/12/2012. No 779362. EU Compass for Mental Health All Member States were involved. € 800 000 and Wellbeing 2015-2018 Commissioned by CHAFEA. Consortium consisted of the Netherlands (Trimbos), Belgium, Portugal and Finland 2.11. Current applications relevant to the programme CIPH is involved in JATC2 and NFP4HEALTH as competent authority and in TEHDAS as aff. Entity NPHO is involved in JATC2. CIPH is involved in JATC2, NFP4HEALTH, JA TERROR, JADECARE, IPAAC, Best-ReMap, SHARP JA, U-JAV, InfAct, Integrate, EUnetHTA and JA Healthy Gateways as competent authority and in JA TEHDAS as aff. Entity NPHO is involved in JATC2 2.12 Exceptional Utility All Criteria for exceptional utility of grants Articles 7(2), 7(3) and 8(1) of the Programme Regulation, for Joint actions may receive co-funding of 80% of the total eligible cost, provided that the proposals meet the relevant eligibility and selection criteria for the type of grant as described under its headi ng (see below) and the following specific criteria for exceptional utility: For Actions co-financed with Member State authorities: 1. at least 30% of the budget must be allocated to Member States whose GNI per inhabitant is less than 90% of the EU average. This is to encourage the participation of Member States with a low GNI; Almost 52% of the budget is allocated to Member States whose GNI per inhabitant is less than 90% of the EU average. 2. actions must involve bodies from at least 14 countries participati ng in the programme, of which at least four must have a GNI per inhabitant less than 90% of the EU average. This is to promote wide geographical coverage and the participation of national authorities of Member States with a low GNI JA ImpleMental involves 21 countries, 12 meet the criteria of a GNI per inhabitant less than 90% of the EU average. 2.13 .Collaborating stakeholders The Joint Action is a multifaceted policy initiative and has a wide geographical and institutional coverage, and thus has a diverse array of stakeholders that can be informed, engaged and benefit from the lessons learned in the JA. A tailored approach is therefore needed to effectively reach out to them. The JA ImpleMENTAL Coordinator and Executive Board is in the process of contacti ng and engaging with the following stakeholders identified as main stakeholders: Mental health user and family associations, People with lived experience of a suicide attempt and survivors of bereavement due to death by suicide, Specific institutions/organizations in the area of Mental Health, Health and Mental Health Professionals, Media professionals, Policy makers within and outside the mental health sector. This list of target groups of stakeholders should be considered provisional, as one specific task that will be dedicated to the mapping of stakeholders in wp2, will be used to complete this list at the very beginning of the Joint Action. As the list of involved stakeholders should not be too long, so as to ensure effective communication and collaboration, priority will be assigned to specific stakeholder groups and their role will be delineated. As the list of involved stakeholders should not be too long, so as to ensure effective communication and collaboration, priority will be assigned to specific stakeholder groups and their role will be delineated. Priority will be assigned to patients and families associations (e.g. EUFAMI, GAMIAN), consonant with the patient-centered care paradigm and the two best practices (the one on mental health service delivery reform is explicitly centered on recovery and patient- centered care). The associations should be active on a European level. Moreover, civil society organizations operating at the EU level will also be prioritized so as to ensure dissemination and sust ainable 138 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 implementation of the two best practices. Recruitment criteria and process will be discussed in the initial phase of the JA. Below is a table summarizing all countries, international organizations, stakeholders and experts already participating in the joint action. Institution Contract Person (full name) Country & City WHO Regional Office for Europe Dr Dan Chisholm Copenhagen, Division of NCDs and Promotion of Health Programme Manager for Mental Health Denmark through the Life-course +45 45 33 67 84 (office) WHO Regional Office for Europe + 45 29 10 89 59 (mobile) UN City, Marmorvej 51, DK-2100 Copenhagen, [email protected] Denmark Skype: chisholmd Federal public service Jacob Bernard HEALTH,FOOD CHAIN SAFETY AND [email protected] Belgium ENVIRONMENThttps://www.health.belgium.b Sarah Morsink e/en/food [email protected] Central Denmark EU Office CDEU Maria Heilskou Pedersen Central Denmark [email protected] Specialkonsulent/ Senior EU-advisor EU Office [email protected] Bruxelles Tel: + 32 2 880 34 16 tel:+32478782483 Public Health England Nicolas Ventosa UK [email protected] Gregor Henderson<[email protected]. uk References Caldas de Almeida, Mateus, P., & Tome, G. (2016). Joint Action on Mental Health and Well-being: Towards Community-based and Socially Inclusive Mental Health Care. Situation Analysis and Recommendations for Action. Available at: https://ec.europa.eu/health/sites/health/files/mental_health/docs/2017_towardsmhcare_en.pdf CHRODIS. Guidelines CHRODIS Implementation Strategy - http://chrodis.eu/official-reports/ Dlouhy, M. (2014). Mental health policy in Eastern Europe: a comparative analysis of seven mental health systems. BMC health services research, 14(1), 1-8. Eurofound (2020), Living, working and COVID-19 dataset, Dublin, http://eurofound.link/covid19data Eurostat (2020). Mental Health and Related Issues Statistics. Available at: https://ec.europa.eu/eurostat/statistics-explained/pdfscache/37380.pdf GHDx. (2020). Global Health Data Exchange: GBD Results Tool. Retrieved from http://ghdx.healthdata.org/gbd- results-tool Knapp, M., McDaid, D., Amaddeo, F., Constantopoulos, A., Oliveira, M. D., Salvador–Carulla, L., Zechmeister, I., & Group, M. (2007). Financing mental health care in Europe. Journal of Mental Health, 16(2), 167-180. Knapp, M., McDaid, D., &Mossialos, E. (2006). Mental Health Policy and Practice across Europe: McGraw-Hill Education (UK). Lorant, V., Grard, A., Van Audenhove, C., Helmer, E., Vanderhaegen, J., & Nicaise, P. (2016). Assessment of the priority target group of mental health service networks within a nation-wide reform of adult psychiatry in Belgium. BMC health services research, 16(1), 187. Lund, C. (2012). Poverty and mental health: a review of practice and policies. Neuropsychiatry, 2(3), 213. 139 101035969 - JA – 02 -2020Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Mann, J. J., Apter, A., Bertolote, J., Beautrais, A., Currier, D., Haas, A., Hegerl, U., Lonnqvist, J., Malone, K., & Marusic, A. (2005). Suicide prevention strategies: a systematic review. Jama, 294(16), 2064-2074. Ngo, V. K., Rubinstein, A., Ganju, V., Kanellis, P., Loza, N., Rabadan-Diehl, C., & Daar, A. S. (2013). Grand challenges: integrating mental health care into the non-communicable disease agenda. PLoS Med, 10(5), e1001443. Nicaise, P., Dubois, V., & Lorant, V. (2014). Mental health care delivery system reform in Belgium: the challenge of achieving deinstitutionalisation whilst addressing fragmentation of care at the same time. Health Policy, 115(2-3), 120-127. OECD/EU. (2018). Health at a Glance: State of Health in the EU Cycle. OECD Publishing. Silva, M., Loureiro, A., & Cardoso, G. (2016). Social determinants of mental health: a review of the evidence. The European Journal of Psychiatry, 30(4), 259-292. Thome, J., Deloyer, J., Coogan, A.N., Bailey-Rodriguez, D., et al. (2020). The impact of the early phase of the COVID-19 pandemic on mental-health services in Europe. World Journal of Biological Psychiatry. DOI: 10.1080/15622975.2020.1844290. WHO. (2005) Mental Health Declaration for Europe - Facing the Challenges, Building Solutions. Geneva: WHO Regional Office for Europe. WHO. (2013) Investing in mental health: evidence for action. Geneva:WHO Regional Office for Europe. WHO. (2014). Preventing suicide: a global imperative. Geneva: World Health Organization. WHO. (2015). The European Mental Health Action Plan 2013-2020. Geneva:WHO Regional Office for Europe. WHO. (2018a). Mental Health Atlas-2017 Country Profiles. WHO. (2018b). Mental Health Atlas 2017. Geneva: World Health Organization. WHO. (2020). The Impact of COVID-19 on Mental, Neurological and Substance Use Services: Results of a Rapid Assessment. Geneva: WHO. Zalsman, G., Hawton, K., Wasserman, D., van Heeringen, K., Arensman, E., Sarchiapone, M., Carli, V., Hoschl, C., Barzilay, R., Balazs, J., Purebl, G., Kahn, J. P., Saiz, P. A., Lipsicas, C. B., Bobes, J., Cozman, D., Hegerl, U., & Zohar, J. (2016). Suicide prevention strategies revisited: 10-year systematic review. Lancet Psychiatry, 3(7), 646-659. doi:10.1016/S2215-0366(16)30030-X 140 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 ESTIMATED BUDGET FOR THE ACTION Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Estimated eligible1 costs (per budget category) EU contribution Action's estimated receipts Financial B. Direct D. Indirect Reimbursement Maximum EU Maximum Income contributions A. Direct C. Other Action’s costs of Total costs generated given by third personnel costs direct costs costs2 rate %3 contribution4 grant amount5 total receipts subcontracting by the action parties to the beneficiaries A.1 Employees C.1 Travel (or equivalent) C.2 Equipment A.2 Natural persons under C.3 Other goods direct contract and services and seconded persons Cost form6 Actual Actual Actual Flat-rate7 7% d= a b c e = a+b+c+d f g=e*f h i j k=i+j 0.07 * (a+b+c) 1. NPHO 400 772.07 0.00 132 249.43 37 311.51 570 333.01 80.00 456 266.41 456 266.41 0.00 0.00 0.00 2. BMSGPK 0.00 0.00 0.00 0.00 0.00 80.00 0.00 0.00 0.00 0.00 0.00 - GÖG 451 827.76 14 400.00 73 756.57 37 798.90 577 783.23 80.00 462 226.58 462 226.58 0.00 0.00 0.00 Σ beneficiary 451 827.76 14 400.00 73 756.57 37 798.90 577 783.23 462 226.58 462 226.58 0.00 0.00 0.00 3. NCPHA 27 675.00 0.00 33 780.00 4 301.85 65 756.85 80.00 52 605.48 52 605.48 0.00 0.00 0.00 4. CIPH 270 310.67 0.00 70 849.43 23 881.21 365 041.31 80.00 292 033.05 292 033.05 0.00 0.00 0.00 5. MHS CYPRUS 282 186.35 0.00 44 853.15 22 892.77 349 932.27 80.00 279 945.82 279 945.82 0.00 0.00 0.00 6. MZCR 62 367.26 0.00 15 073.24 5 420.84 82 861.34 80.00 66 289.07 66 289.07 0.00 0.00 0.00 - NIMH 135 447.34 0.00 22 333.33 11 044.65 168 825.32 80.00 135 060.26 135 060.26 0.00 0.00 0.00 Σ beneficiary 197 814.60 0.00 37 406.57 16 465.49 251 686.66 201 349.33 201 349.33 0.00 0.00 0.00 7. MSAE 153 932.47 0.00 39 621.50 13 548.78 207 102.75 80.00 165 682.20 165 682.20 0.00 0.00 0.00 - NIHD 10 372.39 0.00 2 428.50 896.06 13 696.95 80.00 10 957.56 10 957.56 0.00 0.00 0.00 Σ beneficiary 164 304.86 0.00 42 050.00 14 444.84 220 799.70 176 639.76 176 639.76 0.00 0.00 0.00 8. THL 175 050.00 29 000.00 21 406.57 15 781.96 241 238.53 80.00 192 990.82 192 990.82 0.00 0.00 0.00 9. MOH 83 000.00 0.00 20 392.86 7 237.50 110 630.36 80.00 88 504.29 88 504.29 0.00 0.00 0.00 FRANCE - INSERM 33 200.00 0.00 5 500.00 2 709.00 41 409.00 80.00 33 127.20 33 127.20 0.00 0.00 0.00 Page 1 of 4 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 ESTIMATED BUDGET FOR THE ACTION Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Estimated eligible1 costs (per budget category) EU contribution Action's estimated receipts Financial B. Direct D. Indirect Reimbursement Maximum EU Maximum Income contributions A. Direct C. Other Action’s costs of Total costs generated given by third personnel costs direct costs costs2 rate %3 contribution4 grant amount5 total receipts subcontracting by the action parties to the beneficiaries A.1 Employees C.1 Travel (or equivalent) C.2 Equipment A.2 Natural persons under C.3 Other goods direct contract and services and seconded persons Cost form6 Actual Actual Actual Flat-rate7 7% d= a b c e = a+b+c+d f g=e*f h i j k=i+j 0.07 * (a+b+c) Σ beneficiary 116 200.00 0.00 25 892.86 9 946.50 152 039.36 121 631.49 121 631.49 0.00 0.00 0.00 10. BZgA 601 187.69 0.00 113 495.00 50 027.79 764 710.48 80.00 611 768.38 611 768.38 0.00 0.00 0.00 11. OKFO 116 350.00 0.00 20 728.29 9 595.48 146 673.77 80.00 117 339.02 117 339.02 0.00 0.00 0.00 - SU 119 850.00 0.00 35 092.86 10 846.00 165 788.86 80.00 132 631.09 132 631.09 0.00 0.00 0.00 - UD 119 775.00 0.00 15 428.29 9 464.23 144 667.52 80.00 115 734.02 115 734.02 0.00 0.00 0.00 Σ beneficiary 355 975.00 0.00 71 249.44 29 905.71 457 130.15 365 704.13 365 704.13 0.00 0.00 0.00 12. DOHI 166 250.00 0.00 27 907.00 13 590.99 207 747.99 80.00 166 198.39 166 198.39 0.00 0.00 0.00 13. LOMBARDY 16 000.00 0.00 0.00 1 120.00 17 120.00 80.00 13 696.00 13 696.00 0.00 0.00 0.00 REGION - ASST LECCO 94 200.00 0.00 71 242.86 11 581.00 177 023.86 80.00 141 619.09 141 619.09 0.00 0.00 0.00 - UNIMIB 82 200.00 0.00 5 000.00 6 104.00 93 304.00 80.00 74 643.20 74 643.20 0.00 0.00 0.00 - MNIPR 97 400.00 0.00 33 750.00 9 180.50 140 330.50 80.00 112 264.40 112 264.40 0.00 0.00 0.00 - POLIMI 71 500.00 0.00 12 000.00 5 845.00 89 345.00 80.00 71 476.00 71 476.00 0.00 0.00 0.00 - FBF 106 350.00 0.00 6 500.00 7 899.50 120 749.50 80.00 96 599.60 96 599.60 0.00 0.00 0.00 Σ beneficiary 467 650.00 0.00 128 492.86 41 730.00 637 872.86 510 298.29 510 298.29 0.00 0.00 0.00 14. SAM 89 105.16 0.00 39 049.86 8 970.85 137 125.87 80.00 109 700.70 109 700.70 0.00 0.00 0.00 15. MFH 297 607.50 0.00 67 080.00 25 528.13 390 215.63 80.00 312 172.50 312 172.50 0.00 0.00 0.00 16. TRIMBOS 339 763.43 0.00 49 157.00 27 224.43 416 144.86 80.00 332 915.89 332 915.89 0.00 0.00 0.00 Page 2 of 4 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 ESTIMATED BUDGET FOR THE ACTION Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Estimated eligible1 costs (per budget category) EU contribution Action's estimated receipts Financial B. Direct D. Indirect Reimbursement Maximum EU Maximum Income contributions A. Direct C. Other Action’s costs of Total costs generated given by third personnel costs direct costs costs2 rate %3 contribution4 grant amount5 total receipts subcontracting by the action parties to the beneficiaries A.1 Employees C.1 Travel (or equivalent) C.2 Equipment A.2 Natural persons under C.3 Other goods direct contract and services and seconded persons Cost form6 Actual Actual Actual Flat-rate7 7% d= a b c e = a+b+c+d f g=e*f h i j k=i+j 0.07 * (a+b+c) 17. HDIR 0.00 0.00 21 406.57 1 498.46 22 905.03 80.00 18 324.02 18 324.02 0.00 0.00 0.00 18. IPHS 34 419.27 0.00 33 779.86 4 773.94 72 973.07 80.00 58 378.46 58 378.46 0.00 0.00 0.00 19. NIJZ 179 320.00 0.00 42 050.00 15 495.90 236 865.90 80.00 189 492.72 189 492.72 0.00 0.00 0.00 20. SMS 142 357.35 0.00 41 549.43 12 873.47 196 780.25 80.00 157 424.20 157 424.20 0.00 0.00 0.00 - FFIS 83 772.04 0.00 0.00 5 864.03 89 636.07 80.00 71 708.86 71 708.86 0.00 0.00 0.00 - CatSalut 37 200.00 0.00 0.00 2 604.00 39 804.00 80.00 31 843.20 31 843.20 0.00 0.00 0.00 - Consej- Mujer 32 548.08 0.00 0.00 2 278.37 34 826.45 80.00 27 861.16 27 861.16 0.00 0.00 0.00 - SAS 12 488.00 0.00 0.00 874.16 13 362.16 80.00 10 689.73 10 689.73 0.00 0.00 0.00 - FPS 7 294.70 0.00 0.00 510.63 7 805.33 80.00 6 244.26 6 244.26 0.00 0.00 0.00 - SERMAS 13 316.40 0.00 0.00 932.15 14 248.55 80.00 11 398.84 11 398.84 0.00 0.00 0.00 - SNS-O 13 178.51 0.00 0.00 922.50 14 101.01 80.00 11 280.81 11 280.81 0.00 0.00 0.00 - Osakidetza 18 427.50 0.00 0.00 1 289.93 19 717.43 80.00 15 773.94 15 773.94 0.00 0.00 0.00 Σ beneficiary 360 582.58 0.00 41 549.43 28 149.24 430 281.25 344 225.00 344 225.00 0.00 0.00 0.00 21. FOHM/PHAS 146 300.00 0.00 21 406.57 11 739.46 179 446.03 80.00 143 556.82 143 556.82 0.00 0.00 0.00 Σ consortium 5 124 301.94 43 400.00 1 138 868.17 441 459.93 6 748 030.04 80.007 5 398 424.04 5 398 424.04 0.00 0.00 0.00 1 See Article 6 for the eligibility conditions. Page 3 of 4 Grant Agreement number: 101035969 — JA-02-2020 — HP-JA-2020 / HP-JA-2020-2 ESTIMATED BUDGET FOR THE ACTION Associated with document Ref. Ares(2021)5882948 - 27/09/2021 2 The indirect costs claimed must be free of any amounts covered by an operating grant (received under any EU or Euratom funding programme). A beneficiary that receives an operating grant during the action's duration cannot claim any indirect costs for the year(s)/reporting period(s) covered by the operating grant (see Article 6.2.D). 3 See Article 5.2 for the reimbursement rate. 4 This is the theoretical amount of the EU contribution, if the reimbursement rate is applied to all the budgeted costs. This theoretical amount is capped by the 'maximum grant amount'. 5 The 'maximum grant amount' is the maximum grant amount decided by the Agency. It normally corresponds to the requested grant, but may be lower. 6 See Article 5 for the cost forms. 7 Flat rate : 7% of eligible direct costs. Page 4 of 4 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES BUNDESMINISTERIUM FUER SOZIALES, GESUNDHEIT, PFLEGE UND KONSUMENTENSCHUTZ (BMSGPK), established in Radetzkystrasse 2, WIEN 1030, Austria, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘2’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-999467243_75_210--] Christina Dietscher with ECAS id n002d83d signed in the Participant Portal on 05/10/2021 at 13:48:58 (transaction id SigId-35028-Cze7A x36J3a73XPmzfZJQcfWSMJ9lMyX5KlTswIUmKzq0jFWkoH0A9ggBGi8 HnWOK1isHMFvAUIFuu1wNAFHPhW-yntOf97TTHq7ktbp37lfAm-9E EiRdKP5hcLCpKyA1UtQDtMuIUXeHgqsNVkOfv0Xd6EHxTgoI2QOIK GOptop7kJaqhYVv5ckwKrzoJQZiyKiu). Timestamp by third party at 2021.10.05 14:49:06 CEST 1 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES NATSIONALEN CENTAR PO OBSHTESTVENO ZDRAVE I ANALIZI (NCPHA), established in ACAD IVAN GESHOV BLVD 15, SOFIA 1431, Bulgaria, VAT number: BG176094665, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘3’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-986300754_75_210--] Plamen DIMITROV with ECAS id ndimipam signed in the Participant Portal on 29/09/2021 at 10:05:26 (transaction id SigId-18177-K1jcQz h1FalvHw7rM4AdjDVY6OqzptnzRgiNxTXvcQpicgyxy38lUdSvvhBDx9 wrbJdPlvBhgAbZt21ofk9nXAG-jpJZscgsw0KwfOyDFdfrEC-nXzv4wAG RB80IDzbfRRgndNdOtsnKyK5LnRudJoQDYv5kFnJVRNWPd7mIzYdCd ATzodchPHrSgkd02mWYTqzU42). Timestamp by third party at 2021.09.29 11:05:31 CEST 2 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO (CIPH), established in ROCKEFELLEROVA 7, ZAGREB 10000, Croatia, VAT number: HR75297532041, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘4’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-998128255_75_210--] Krunoslav Capak with ECAS id n003ph9b signed in the Participant Portal on 29/09/2021 at 15:07:04 (transaction id SigId-23072-7fyll0d DDtdEO1bpTzhssdvmzZpNC97EAWJIzQ9qczXaGY8zcxGd9vW2XwrO Z71S32DkCVIx9Au0pxBAGWzSwLbW-jpJZscgsw0KwfOyDFdfrEC-dJL wAMbQIdtYFVdyqwslFQjP4Y5vFaYCGzyVyFhWCKbwvqwPyD4COHzx 2hDNyY6L7uK4jet4wppv08X6W2rvBL). Timestamp by third party at 2021.09.29 16:07:09 CEST 3 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES ORGANISMOS KRATIKON YPIRESION YGEIAS (MHS CYPRUS), established in PRODROMOU 1 AND CHILONOS 17, NICOSIA 1448, Cyprus, VAT number: CY18007761X, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘5’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-891074787_75_210--] 4 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES MINISTERSTVO ZDRAVOTNICTVI CESKE REPUBLIKY (MZCR), established in PALACKEHO NAMESTI 375/4, PRAHA 12801, Czech Republic, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘6’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-924144512_75_210--] Pavel Micka with ECAS id n006fx70 signed in the Participant Portal on 08/10/2021 at 08:08:08 (transaction id SigId-67978-NJnZMENXf B0ZcOEZHLa6UUDx72XHmGok6J3lRXfs6T4lb8WxluZ71yObNvzVzO yLbJk3uxfLjAwzGozPzGB520O-yntOf97TTHq7ktbp37lfAm-vSziSefK tjGaHtoGuwhzq175ed6M2GBJCeHLJ1Z1NPjT01X5xN26ZIx9RwZzjS HCEWSPNSDUsgu0AVpB2eR09ze). Timestamp by third party at 2021.10.08 09:08:18 CEST 5 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES SOTSIAALMINISTEERIUM (MSAE), established in Suur-Ameerika 1, TALLINN 10122, Estonia, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘7’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-998429731_75_210--] 6 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES TERVEYDEN JA HYVINVOINNIN LAITOS (THL), established in MANNERHEIMINTIE 166, HELSINKI 00271, Finland, VAT number: FI22295006, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘8’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-996697893_75_210--] Markku Tervahauta with ECAS id n002iyzh signed in the Participant Portal on 01/10/2021 at 07:45:33 (transaction id SigId-5598-GzJdq9 MN285rhA3GQemoVduuapeUQ9bzbqd65I1263kDvokXJ6TJlODl00zP 9iXC1rZSpARa2c2JsNIOxOWjzvW-yntOf97TTHq7ktbp37lfAm-EXY2Oc ZEdMa01i6O3A2vPajVc3sUllv4zuzNpCRQULfBvtUpeaGEHCHAVJursC gKIkWInjPNAXVmAahEQODQWm). Timestamp by third party at 2021.10.01 08:45:38 CEST 7 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES MINISTERE DES AFFAIRES SOCIALES ET DE LA SANTE (MOH FRANCE), established in AVENUE DUQUESNE 14, PARIS CEDEX 75350, France, VAT number: N/A, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘9’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-998887377_75_210--] 8 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES BUNDESZENTRALE FUR GESUNDHEITLICHE AUFKLARUNG (BZgA), established in MAARWEG 149-161, KOLN 50825, Germany, VAT number: DE122948246, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘10’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-998190723_75_210--] Martin Dietrich with ECAS id n006fgzy signed in the Participant Portal on 29/09/2021 at 13:04:38 (transaction id SigId-20973-sb1Hz rLntIdgapszS26VosDHKhK2iVCRC8KFFyzlDrmpxNCccOImv1zKqiQR TxlF8XO7JghJTYZd8twBxBzlQzgG-jpJZscgsw0KwfOyDFdfrEC-qNAjLI byeNaYMKLkIExR8qmCaWUS9hR2jVK3WKrC9Gzds2LzyU6pCg85Nz nFKOztvMdF6AjzeEabgwdKdLlrZPK). Timestamp by third party at 2021.09.29 14:04:42 CEST 9 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES ORSZAGOS KORHAZI FOIGAZGATOSAG (OKFO), established in DIOS AROK 3, BUDAPEST 1125, Hungary, VAT number: HU15845883, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘11’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-891516331_75_210--] 10 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES EMBAETTI LANDLAEKNIS (DOHI), established in BARONSSTIG 47, REYKJAVIK 101, Iceland, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘12’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-955430213_75_210--] Halla Thorhallsdottir with ECAS id n002nudw signed in the Participant Portal on 28/09/2021 at 14:47:24 (transaction id SigId-57248-BCzoXlFI L3mWiFt6YRXFe9ja3YpdsVDmfMzNRgJ0gqpHa7U9SueVhIpnX51JCxPh HtuEp2aC19zYnexdp6jZzu0-rS0vSrmBGYCagVEG22GDby-acGONueHo cOUeqXhWWWSfWspT2ohpYrbkjRgxh0sX8qWHHdoQNOeYCAOb0Xh hmitzJI2iF85zJCzSTzqMstPW4K). Timestamp by third party at 2021.09.28 15:47:28 CEST 11 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES REGIONE LOMBARDIA (LOMBARDY REGION), established in PIAZZA CITTA DI LOMBARDIA 1, MILANO 20124, Italy, VAT number: IT12874720159, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘13’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-999654065_75_210--] Giovanni Pavesi with ECAS id n006g7xj signed in the Participant Portal on 05/10/2021 at 09:07:23 (transaction id SigId-30287-eMktX R8iS8b6kXSfj6VnWMs56Z4S1iTi65a7lkD0pvMQuxPfOmw6zapzLG0 YLzc5qXth1Uzou3aflcxCzleD5SI-yntOf97TTHq7ktbp37lfAm-cw9zOy hGZIxkdac0R6SD6SzpuLidSodfgBzKarfMwqUpdUm192e6zQMOeA SD8RPZD4VjiZf0vzLSqrzypU2kQvzS). Timestamp by third party at 2021.10.05 10:07:30 CEST 12 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJA (SAM), established in VILNIAUS G 33, VILNIUS LT 01506, Lithuania, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘14’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-933839468_75_210--] Edita BISHOP with ECAS id nbishoed signed in the Participant Portal on 29/09/2021 at 09:33:20 (transaction id SigId-17537-7H5EmZa8O9 VCIq7dQjkhCJSLszt3285Mvc6pYUqyzp9UUpzaY9OzjKnu0uuX6375R KGZIXMmHzGTBU7e2kotZL1-jpJZscgsw0KwfOyDFdfrEC-F9sa6WjzYk L5qoAaMAJkBUzZjAD11fjlRzcggKp4I1PdlgTuQtepX73xzsMp6S22tbw VDiAmhwZZoGT69ZNw1NS). Timestamp by third party at 2021.09.29 10:33:25 CEST 13 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES Ministry for Health - Government of Malta (MFH), established in Palazzo Castellania, Merchants Street 15, Valletta VLT 200, Malta, VAT number: MT12979127, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘15’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-974144423_75_210--] Joseph RAPA with ECAS id nraparjo signed in the Participant Portal on 01/10/2021 at 11:56:51 (transaction id SigId-9669-BVUsVsrRzdY FA8UZK3xGp10xD7jRch0ry5kklFnafSYmRcFaMb7DS5scBhgZ8CU2 mzpkr8LOYlQ7RdpZ6YAIth-yntOf97TTHq7ktbp37lfAm-aNpHSNWm T2DKvsTKkloNthTXYBhVX6EdwGmWgjXzZgMZqu8V0SJ2vTU5cU7hZ rASi30dmbIvbfpHA7MjoLEKgK). Timestamp by third party at 2021.10.01 12:56:59 CEST 14 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES STICHTING TRIMBOS- INSTITUUT, NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION (TRIMBOS), established in DA COSTAKADE 45, UTRECHT 3521 VS, Netherlands, VAT number: NL805514806B01, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘16’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-998923073_75_210--] John Hoebe with ECAS id n0029p7n signed in the Participant Portal on 28/09/2021 at 15:34:37 (transaction id SigId-58146-L5onD3yKDF Six0hwdwbjp73NHqWB43xS3OQzPEzv2zu4zg0o4e2rzNGLvtqzZqFT CuVzkTFi9H09XCOQ6zKPmgm5-rS0vSrmBGYCagVEG22GDby-b6Of H1ghXZri3KbQv9za2aaKmN60CKm6JcetePzoePaqqJ3oudIbyCIBfqx GoEihrhiwrierSOnLNtV2Xuf3S7). Timestamp by third party at 2021.09.28 16:34:41 CEST 15 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES HELSEDIREKTORATET (HDIR), established in VITAMINVEIEN 4, OSLO 0213, Norway, VAT number: NO983544622, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘17’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-974772304_75_210--] Åste Herheim with ECAS id n0072hlx signed in the Participant Portal on 29/09/2021 at 09:39:58 (transaction id SigId-17652-JSZGZq9hH4a adpwAewrXqu8dpNKzvCcWDSQxaDUzMfd6XdnsuE5MwR4s8adDku VX4ykQwSXA3GYFVl23CbWcJo-jpJZscgsw0KwfOyDFdfrEC-rQlsVkwid dzhsGCc28urbmwmPH2FuzXXPgTn5v2LtRVzvEeXMEzj7y6GMKHqm rrNL0uSVDAE7P52szUpfqwDwII). Timestamp by third party at 2021.09.29 10:40:02 CEST 16 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES INSTITUT ZA ZASTITU ZDRAVLJA SRBIJEDR MILAN JOVANOVIC BATUT (IPHS), established in DR SUBOTICA STREET 5, BEOGRAD 11000, Serbia, VAT number: RS102000930, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘18’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-941063349_75_210--] Verica JOVANOVIC with ECAS id njovveri signed in the Participant Portal on 28/09/2021 at 15:37:29 (transaction id SigId-58187-ChFqRl rsWeZ8t7hsyq7OzYRtDw5eV6uleIEAnnPA2gOxue01RbkMNzf1zjiobF FeXiYTETV70frAzQwgUOydbUm-rS0vSrmBGYCagVEG22GDby-s1bzN rhLW4GYiqP3ncMk4ZspINqPiHRUik9wXLMf3f8AzKkxcJXlWpLQE453 zx0CYU5T8bQRgA65mbVFnATssZG). Timestamp by third party at 2021.09.28 16:37:34 CEST 17 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES NACIONALNI INSTITUT ZA JAVNO ZDRAVJE (NIJZ), established in TRUBARJEVA CESTA 2, LJUBLJANA 1000, Slovenia, VAT number: SI44724535, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘19’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-948891346_75_210--] Milan Krek with ECAS id n003bif0 signed in the Participant Portal on 08/10/2021 at 13:00:32 (transaction id SigId-73504-sbLAAGXvK Ujj9g2eo6Uzk9kwnbEOSb6or3XKadNEj4EymA6CUOuPHauIEjjUAU DOjREAUa1dWVt2Wf2dy6aA4e-yntOf97TTHq7ktbp37lfAm-87TQdC nfVwuzdOUUarzkcOyNuJ96vDzNBZhzXeo0pQdctj5YGpG50Evt62Vv 452eDSmVQcoUU3CIOnk4kn2hDzb). Timestamp by third party at 2021.10.08 14:00:36 CEST 18 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES SERVICIO MURCIANO DE SALUD (SMS), established in C CENTRAL 7, MURCIA 30100, Spain, VAT number: ESQ8050008E, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘20’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-934953804_75_210--] Gorka SANCHEZ with ECAS id nsangork signed in the Participant Portal on 29/09/2021 at 05:10:36 (transaction id SigId-15426-zXdR 2VhTJZARYpOIM6hPlsEyRpCSvPT1qUy5rZDmO1GnPvXq9UGugxEk lTafYEAPcfoO4AY8JQgg7GeMpDBRfK-jpJZscgsw0KwfOyDFdfrEC-ll okzSElsFy0TJhVFVziiTQcoebKAkJPp75mYBaoeZVcdawLrTS7mRAfd oIKDciJ8TxahSpl92trDtG9lMdj3V). Timestamp by third party at 2021.09.29 07:10:56 CEST 19 Grant Agreement number: 101035969 — JA-02-2020 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 3 ACCESSION FORM FOR BENEFICIARIES FOLKHALSOMYNDIGHETEN (FOHM/PHAS), established in NOBELS VAG 18, SOLNA 171 82, Sweden, VAT number: SE202100654501, (‘the beneficiary’), represented for the purpose of signing this Accession Form by the undersigned, hereby agrees to become beneficiary No (‘21’) in Grant Agreement No 101035969 (‘the Grant Agreement’) between ETHNIKOS ORGANISMOS DIMOSIAS YGEIAS and the European Health and Digital Executive Agency (‘the EU’), represented by the European Commission ('the Commission'), for the action entitled JA on Implementation of Best Practices in the area of Mental Health (JA-02-2020). and mandates the coordinator to submit and sign in its name and on its behalf any amendments to the Agreement, in accordance with Article 39. By signing this Accession Form, the beneficiary accepts the grant and agrees to implement it in accordance with the Agreement, with all the obligations and conditions it sets out. SIGNATURE For the beneficiary/new beneficiary/new coordinator [--TGSMark#signature-949789954_75_210--] Patric Wither with ECAS id n006nguk signed in the Participant Portal on 30/09/2021 at 15:07:04 (transaction id SigId-35692-mmK zikCkzi2ZrcnrQRCKR9U3K52m3mgiHVJ6F4nLNYlzIdnQ7lwKUgCSoG AU2R4mwmkuHPqMI9G85sogXIvKehW-jpJZscgsw0KwfOyDFdfrEC- AvUlL6TGl5JacsdiF6jjXViMzQcgh1CN339AhPfIEbU3QpdIWVmJYNH HG3XcEcM8ypOuiCbFhfliackvCzjj9P). Timestamp by third party at 2021.09.30 16:07:12 CEST 20 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 i print format A4 MODEL ANNEX 4 CHAFEA MGA — MULTI landscape FINANCIAL STATEMENT FOR [BENEFICIARY [name]/AFFILIATED ENTITY [name]] FOR REPORTING PERIOD [reporting period] 1 Receipts EU contribution Eligible costs (per budget category) Financial contributions Reimburseme Maximum EU A. Direct personnel B. Direct costs of C. Other direct 2 Income generated Requested EU D. Indirect costs Total costs given by third Total receipts 3 4 costs subcontracting costs by the action nt rate % constribution contribution parties to the beneficiaries A.1 Employees (or C.1 Travel equivalent) A.2 Natural persons C.2 Equipment under direct contract and seconded persons C.3 Other goods and services 6 5 Actual Actual Actual Flat-rate Cost form 7% d= e= a b c f g h= f + g i j k 0,07 * (a + b + c) a+ b + c + d [short name beneficiary / affiliated entity] The beneficiary/affiliated entity hereby confirms that: The information provided is complete, reliable and true. The costs declared are eligible (see Article 6). The costs can be substantiated by adequate records and supporting documentation that will be produced upon request or in the context of checks, reviews, audits and investigations (see Articles 12, 13 and 17). For the last reporting period: that all the receipts have been declared (see Article 5.3.3). i Please declare all eligible costs, even if they exceed the amounts indicated in the estimated budget (see Annex 2). Only amounts that were declared in your individual financial statements can be taken into account lateron, in order to replace other costs that are found to be ineligible. 1 See Article 6 for the eligibility conditions. 2 The indirect costs claimed must be free of any amounts covered by an operating grant (received under any EU or Euratom funding programme). A beneficiary that receives an operating grant during the duration of the action cannot claim any indirect costs for the year(s) covered by the operating grant (see Article 6.2.D). 3 See Article 5.2 for the reimbursement rate 4 This is the theoretical amount of EU contribution that the system calculates automatically (by multiplying the reimbursement rate by the total costs declared). The amount you request (in the column 'requested EU contribution') may have to be less. 5 See Article 5 for the cost forms. 6 Flat rate : 7% of eligible direct costs. Associated with document Ref. Ares(2021)5882948 - 27/09/2021 ANNEX 5 MODEL FOR THE CERTIFICATE ON THE FINANCIAL STATEMENT (CFS) This document sets out: - the objectives and scope of the independent report of factual findings on costs declared under a EU grant agreement financed under the Health Programme (2014-2020) or Consumer Programme (2014-2020) and - a model for the certificate on the financial statement (CFS). 1. Background and subject matter [OPTION 1 for actions with one RP and NO interim payments: Within 60 days of the end of the reporting period, the coordinator must submit to the Commission a final report, which should include (among other documents and unless otherwise specified in Article 15 of the Grant Agreement) a certified financial statement (CFS; see proposed model below) for each beneficiary and (if applicable) each affiliated entity, if: - it requests an EU contribution of EUR 150 000 or more as reimbursement of actual costs and - the maximum EU contribution indicated for that beneficiary/affiliated entity in the estimated budget (see Annex 2) as reimbursement of actual costs is EUR 200 000 or more.] [OPTION 2 for actions with several RPs and interim payments: Within 60 days of the end of each reporting period, the coordinator must submit to the Commission a periodic report, which should include (among other documents and unless otherwise specified in Article 15 of the Grant Agreement) a certified financial statement (CFS; see proposed model below) for each beneficiary and (if applicable) each affiliated entity, if: - the cumulative amount of EU contribution the beneficiary/affiliated entity requests as reimbursement of actual costs is EUR 150 000 or more and - the maximum EU contribution indicated for that beneficiary/affiliated entity in the estimated budget (see Annex 2) as reimbursement of actual costs is EUR 200 000 or more. The CFS must be submitted every time the cumulative amount of payments requested (i.e. including in previous financial statements) reaches the threshold (i.e. a first certificate once the cumulative amount reaches 150 000, a second certificate once it reaches 300 000, a third certificate once it reaches 450 000, etc.). Once the threshold is reached, the CFS must cover all reporting periods for which no certificate has yet been submitted.] 1 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 The beneficiary must provide the CFS for itself and, if applicable, for its affiliated entity(ies). The purpose of the audit on which the CFS is based is to give the Agency ‘reasonable assurance’1 that costs declared as eligible costs under the grant (and, if relevant, receipts generated in the course of the action) are being claimed by the beneficiary in accordance with the relevant legal and financial provisions of the Grant Agreement. The scope of the audit is limited to the verification of eligible costs included in the CFS. The audit must be conducted in line with point 3 below. Certifying auditors must carry out the audits in compliance with generally accepted audit standards and indicate which standards they have applied. They must bear in mind that, to establish a CFS, they must carry out a compliance audit and not a normal statutory audit. The eligibility criteria in the Grant Agreement always override normal accounting practices. The beneficiary and the auditor are expected to address any questions on factual data or detailed calculations before the financial statement and the accompanying certificate are submitted. It is also recommended that the beneficiary take into account the auditor’s preliminary comments and suggestions in order to avoid a qualified opinion or reduce the scope of the qualifications. Since the certificate is the main source of assurance for cost claims and payments, it will be easier to consider amounts as eligible if a non-qualified certificate is provided. The submission of a certificate does not affect the Agency’s right to carry out its own assessment or audits. Neither does the reimbursement of costs covered by a certificate preclude the Agency or the Commission, the European Anti-Fraud Office or the European Court of Auditors from carrying out checks, reviews, audits and investigations in accordance with Article 17 of the Grant Agreement. The Agency expects the certificates to be issued by auditors according to the highest professional standards. 2. Auditors who may deliver a certificate The beneficiary is free to choose a qualified external auditor, including its usual external auditor, provided that: - the external auditor is independent from the beneficiary and - the provisions of Directive 2006/43/EC2 are complied with. 1 This means a high degree of confidence. 2 Directive 2006/43/EC of the European Parliament and of the Council of 17 May 2006 on statutory audits of annual accounts and consolidated accounts or similar national regulations (OJ L 157, 9.6.2006, p. 87). 2 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Independence is one of the qualities that permit the auditor to apply unbiased judgement and objective consideration to established facts to arrive at an opinion or a decision. It also means that the auditor works without direction or interference of any kind from the beneficiary. Auditors are considered as providing services to the beneficiary/affiliated entity under a purchase contract within the meaning of Article 9 of the Grant Agreement. This means that the costs of the CFS may normally be declared as costs incurred for the action, if the cost eligibility rules set out in Articles 6 and 9.1.1 of the Grant Agreement are fulfilled (especially: best value for money and no conflict of interests; see also below eligibility of costs of other goods and services). Where the beneficiary/affiliated entity uses its usual external auditor, it is presumed that they already have an agreement that complies with these provisions and there is no obligation to find new bids. Where the beneficiary/affiliated entity uses an external auditor who is not their usual external auditor, it must select an auditor following the rules set out in Article 9.1.1. Public bodies can choose an external auditor or a competent public officer. In the latter case, the auditor’s independence is usually defined as independence from the audited beneficiary ‘in fact and in appearance’. A preliminary condition is that this officer was not involved in any way in drawing up the financial statements. Relevant national authorities establish the legal capacity of the officer to carry out audits of that specific public body. The certificate should refer to this appointment. 3. Audit methodology and expected results 3.1 Verification of eligibility of the costs declared The auditor must conduct its verification on the basis of inquiry and analysis, (re)computation, comparison, other accuracy checks, observation, inspection of records and documents and by interviewing the beneficiary (and the persons working for it). The auditor must examine the following documentation:  the Grant Agreement and any amendments to it;  the periodical and/or final report(s);  for personnel costs o salary slips; o time sheets; o contracts of employment; o other documents (e.g. personnel accounts, social security legislation, invoices, receipts, etc.); o proofs of payment;  for subcontracting o the call for tender; o tenders (if applicable); o justification for the choice of subcontractor; o contracts with subcontractors; o invoices; o declarations by the beneficiary; o proofs of payment; 3 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 o other documents: e.g. national rules on public tendering if applicable, EU Directives, etc.;  for travel and subsistence costs o the beneficiary’s internal rules on travel; o transport invoices and tickets (if applicable); o declarations by the beneficiary; o other documents (proofs of attendance such as minutes of meetings, reports, etc.); o proofs of payment;  for equipment costs o invoices; o delivery slips / certificates of first use; o proofs of payment; o depreciation method of calculation;  for costs of other goods and services o invoices; o proofs of payment; and o other relevant accounting documents. General eligibility rules The auditor must verify that the costs declared comply with the general eligibility rules set out in Article 6.1 of the Grant Agreement. In particular, the costs must:  be actually incurred;  be linked to the subject of the Grant Agreement and indicated in the beneficiary's estimated budget (i.e. the latest version of Annex 2);  be necessary to implement the action which is the subject of the grant;  be reasonable and justified, and comply with the requirements of sound financial management, in particular as regards economy and efficiency;3  have been incurred during the action, as defined in Article 3 of the Grant Agreement (with the exception of the invoice for the audit certificate and costs relating to the submission of the final report);  not be covered by another EU or Euratom grant (see below ineligible costs);  be identifiable, verifiable and, in particular, recorded in the beneficiary's accounting records and determined according to the applicable accounting standards of the country where it is established and its usual cost-accounting practices;  comply with the requirements of applicable national laws on taxes, labour and social security;  be in accordance with the provisions of the Grant Agreement (see, in particular, Articles 6 and 9-11a) and  have been converted to euro at the rate laid down in Article 15.6 of the Grant Agreement: 3 To be assessed in particular on the basis of the procurement and selection procedures for service providers. 4 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 o for beneficiaries with accounts established in a currency other than the euro: Costs incurred in another currency must be converted into euros at the average of the daily exchange rates published in the C series of the EU Official Journal determined over the corresponding reporting period. If no daily euro exchange rate is published in the EU Official Journal for the currency in question, the rate used must be the average of the monthly accounting rate established by the Commission and published on its website; o for beneficiaries with accounts established in euro: Costs incurred in another currency should be converted into euros applying the beneficiary’s usual accounting practice. The auditor must verify whether expenditure includes VAT and, if so, verify that the beneficiary: - cannot recover the VAT (this must be supported by a statement from the competent body) and - is not a public body acting as a public authority. The auditor should base his/her audit approach on the confidence level following a review of the beneficiary's internal control system. When using sampling, the auditor should indicate and justify the sampling size. Specific eligibility rules In addition, the auditor must verify that the costs declared comply with the specific cost eligibility rules set out in Article 6.2 and Articles 9.1.1, 10.1.1, 11.1.1, 11a.1.1 and 11a.2.1 of the Grant Agreement. Personnel costs The auditor must verify that:  personnel costs have been charged and paid in respect of the actual time devoted by the beneficiary’s personnel to implementing the action (justified on the basis of time sheets or other relevant time-recording system);  personnel costs were calculated on the basis of annual gross salary, wages or fees (plus obligatory social charges, but excluding any other costs) specified in an employment or other type of contract, not exceeding the average rates corresponding to the beneficiary’s usual policy on remuneration;  the work was carried out during the period of implementation of the action, as defined in Article 3 the Grant Agreement and  the personnel costs are not covered by another EU or Euratom grant (see below ineligible costs);  for additional remunerations: the 2 conditions set out in Article 6.2.A.1 are met (i.e. that it is part of the beneficiary’s usual remuneration practices and is paid in a consistent manner whenever the same kind of work or expertise is required and that the criteria used to calculate the supplementary payments are objective and generally applied by the beneficiary, regardless of the source of funding used);  for in-house consultants: the 3 conditions set out in Article 6.2.A.2 of the Grant Agreement are met (i.e. that the in-house consultant works under the beneficiary’s 5 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 instructions, that the result of the work carried out belongs to the beneficiary, and that the costs are not significantly different from those for personnel performing similar tasks under an employment contract). The auditor should have assurance that the management and accounting system ensures proper allocation of the personnel costs to various activities carried out by the beneficiary and funded by various donors. Subcontracting costs The auditor must verify that:  the subcontracting complies with best value for money (or lowest price) and that there was no conflict of interests;  the subcontracting was necessary to implement the action for which the grant is requested;  the subcontracting was provided for in Annex 1 and Annex 2 or agreed to by the Agency at a later stage;  the subcontracting is supported by accounting documents in accordance with national accounting law  public bodies have complied with the national rules on public procurement. Travel and subsistence costs The auditor must verify that travel and subsistence costs:  have been charged and paid in accordance with the beneficiary's internal rules or usual practices;  are not covered by another EU or Euratom grant (see below ineligible costs);  were incurred for travels linked to action tasks set out in Annex 1 of the Grant Agreement. Equipment costs The auditor must verify that:  the equipment is purchased, rented or leased at normal market prices;  public bodies have complied with the national rules on public procurement;  the equipment is written off, depreciation has been calculated according to the tax and accounting rules applicable to the beneficiary and only the portion of the depreciation corresponding to the duration of the action has been declared and  the costs are not covered by another EU or Euratom grant (see below ineligible costs). Costs of other goods and services The auditor must verify that:  the purchase complies with best value for money (or lowest price) and that there was no conflict of interests;  public bodies have complied with the national rules on public procurement;  the costs are not covered by another EU or Euratom grant (see below ineligible costs). 6 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Ineligible costs The auditor must verify that the beneficiary has not declared any costs that are ineligible under Article 6.4 of the Grant Agreement:  costs relating to return on capital;  debt and debt service charges;  provisions for future losses or debts;  interest owed;  doubtful debts;  currency exchange losses;  bank costs charged by the beneficiary’s bank for transfers from the Agency;  excessive or reckless expenditure;  deductible VAT;  VAT incurred by a public body acting as a public authority;  costs incurred during suspension of the implementation of the action;  in-kind contributions from third parties;  costs declared under other EU or Euratom grants (including those awarded by a Member State and financed by the EU or Euratom budget or awarded by bodies other than the Agency for the purpose of implementing the EU or Euratom budget); in particular, indirect costs if the beneficiary is already receiving an operating grant financed by the EU or Euratom budget in the same period;  costs incurred for permanent staff of a national administration for activities that are part of its normal activities (i.e. not undertaken only because of the grant);  costs incurred for staff or representatives of EU institutions, bodies or agencies. 3.2 Verification of receipts The auditor must verify that the beneficiary has declared receipts within the meaning of Article 5.3.3 of the Grant Agreement, i.e.:  income generated by the action (e.g. from the sale of products, services and publications, conference fees) and  financial contributions given by third parties, specifically to be used for costs that are eligible under the action. 3.3 Verification of the beneficiary’s accounting system The auditor must verify that:  the accounting system (analytical or other suitable internal system) makes it possible to identify sources of financing for the action and related expenses incurred during the contractual period and  expenses/income under the grant have been recorded systematically using a numbering system that distinguishes them from expenses/income for other projects. 7 Associated with document Ref. Ares(2021)5882948 - 27/09/2021 Certificate on the financial statement (CFS) To [Beneficiary/affiliated entity’s full name address] We, [full name of the audit firm/organisation], established in [full address/city/country], represented for signature of this audit certificate by [name and function of an authorised representative], hereby certify that: 1. We have conducted an audit relating to the costs declared in the financial statement of [name of beneficiary/affiliated entity] (the [‘beneficiary’][‘affiliated entity’]), to which this audit certificate is attached and which is to be presented to the Consumers, Health, Agriculture and Food Executive Agency under Grant Agreement No [insert number] — [insert acronym], covering costs for the following reporting period(s): [insert reporting period(s)]. 2. We confirm that our audit was carried out in accordance with generally accepted auditing standards in compliance with ethical rules and on the basis of the provisions of the Grant Agreement and its Annexes (and in particular the audit methodology described in Annex 5). 3. The financial statement was examined and all necessary tests of [all][[X]%] of the supporting documentation and accounting records were carried out in order to obtain reasonable assurance that, in our opinion and on the basis of our audit  total costs of EUR [insert number] ([insert amount in words]) are eligible, i.e.:  actual;  determined in accordance with the [beneficiary’s][affiliated entity’s] accounting principles;  incurred during the period referred to in Article 3 of the Grant Agreement;  recorded in the [beneficiary’s][affiliated entity’s] accounts (at the date of this audit certificate);  comply with the specific eligibility rules in Article 6.2 of the Grant Agreement;  do not contain costs that are ineligible under Article 6.4 of the Grant Agreement, in particular:  costs relating to return on capital;  debt and debt service charges;  provisions for future losses or debts;  interest owed;  doubtful debts;  currency exchange losses; 8 Associated with document Ref. Ares(2021)5882948 - 27/09/2021  bank costs charged by the [beneficiary’s][affiliated entity’s] bank for transfers from the Agency;  excessive or reckless expenditure;  deductible VAT;  VAT incurred by a public body acting as a public authority;  costs incurred during suspension of the implementation of the action;  in-kind contributions provided by third parties;  costs declared under other EU or Euratom grants (including those awarded by a Member State and financed by the EU or Euratom budget or awarded by bodies other than the Agency for the purpose of implementing the EU or Euratom budget); in particular, indirect costs if the [beneficiary][affiliated entity] is already receiving an operating grant financed by the EU or Euratom budget in the same period;  costs incurred for permanent staff of a national administration, for activities that are part of its normal activities (i.e. not undertaken only because of the grant);  costs incurred for staff or representatives of EU institutions, bodies or agencies;  [are claimed according to the euro conversion rate referred to in Article 15.6 of the Grant Agreement;]  total receipts of EUR [insert number] ([insert amount in words]) have been declared under Article 5.3.3 of the Grant Agreement and  the [beneficiary’s][affiliated entity’s] accounting procedures are in compliance with the accounting rules of the state in which it is established and permit direct reconciliation of the costs incurred for the implementation of the action covered by the EU grant with the overall statement of accounts relating to its overall activity. [However, our audit opinion is qualified for:  costs of EUR [insert number]  receipts of EUR [insert number] which in our opinion do not comply with the applicable rules.] 4. We are qualified/authorised to deliver this audit certificate [(for additional information, see appendix to this certificate)]. 5. The [beneficiary][affiliated entity] paid a price of EUR [insert number]) (including VAT of EUR [insert number]) for this audit certificate. [OPTION 1: These costs are eligible (i.e. incurred within 60 days of the end of the action referred to in Article 3 of the Grant Agreement) and included in the financial statement.][OPTION 2: These costs were not included in the financial statement.] Date, signature and stamp 9 Digitally sealed by the European Commission Date: 2021.09.27 19:10:21 CEST This electronic receipt is a digitally signed version of the document submitted by your organisation. Both the content of the document and a set of metadata have been digitally sealed. This digital signature mechanism, using a public-private key pair mechanism, uniquely binds this eReceipt to the modules of the Funding & Tenders Portal of the European Commission, to the transaction for which it was generated and ensures its full integrity. Therefore a complete digitally signed trail of the transaction is available both for your organisation and for the issuer of the eReceipt. Any attempt to modify the content will lead to a break of the integrity of the electronic signature, which can be verified at any time by clicking on the eReceipt validation symbol. More info about eReceipts can be found in the FAQ page of the Funding & Tenders Portal. (https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq) Commission européenne/Europese Commissie, 1049 Bruxelles/Brussel, BELGIQUE/BELGIË - Tel. +32 22991111

Allikas: Sotsiaalministeerium dokumendiregister →